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Introduction
INTRODUCTION
Magnetic navigation is the use of a magnetic fi eld to re-orientate a magnetically-enabled 
wire or device. The fi eld is directed by external magnets that are moved by a computer-
controlled system. This technology could improve percutaneous coronary interventional 
procedures as it improves 3 specifi c and complementary capabilities, namely precise tip 
adjustability, computer-enhanced, image-guided tip orientation, and computer–enhanced 
image processing. 
Although this technology is relatively new, it already appears that this system can equal, 
and even improve on, current conventional wire technique. The current usability, combined 
with the exciting potential of future developments, could result in a formidable adjunct to PCI.
This thesis deals with the early use of the system, development of diff erent strategies for the 
exploitation of the unique novel features that the system has. Specifi cally it will describe a 
number of areas. 
1. Background, history and system description
The aim of this introduction is to provide a brief description of the background of magnetic 
procedures with respect to Stereotaxis Inc, and a description of the magnetic moment, and a 
short description of the current system together with the specially-produced wires.
2. Feasibility in phantom models, and initial system development
This section deals with aspects related to feasibility of use, validation of the software, and 
initial experience in diff erent clinical situations and fi nally with the potential use in treating 
one of the sequelae of coronary disease i.e. poor left ventricular function by the possible 
delivery of cardiac stem cells.
3. Initial experience in clinical practice and illustrative case reports
This section deals with the clinical use in percutaneous coronary intervention concentrating 
on the initial patient studies.
4. Investigation of benefi ts in subgroups 
This section concentrates on particular subsets of coronary intervention patients and the 
specifi c hypotheses that can be drawn from these.
Mark bw.indd   17 25-05-10   15:15
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BACKGROUND, HISTORY AND SYSTEM DESCRIPTION 
In vivo magnetic navigation for delivering medical therapies is a small but not new fi eld. 
Vascular studies using magnetic navigation fi rst began over 50 years ago when Tillander used 
magnetic fi elds to guide an articulated steel-tip catheter in rabbit aortae (1,2). After these 
initial investigations, small external permanent magnets were used to stereotactically direct 
iron particles for thrombosis of intracranial aneurysms (3-5). Later, rotating electromagnets 
were used, enabling better control (6). The fi rst human use was for neonatal heart catheter-
ization in 1991 for the diagnosis of anomalous congenital cardiac drainage (7). 
Stereotaxis Inc. offi  cially started as a company in 1991 with an initial goal of enhancing 
wire passage in neurosurgical procedures. In the case of Stereotaxis, much of the initial 
academically-driven work was dedicated solely to hyperthermia therapies of deep-seated 
brain tumors. The system has been through a number of iterations of magnet confi gurations. 
Some of the previous system confi gurations are shown below - the Telstar family – Tristar, 
Unistar and Pullstar, together with the current system, Niobe®.
The Stereotaxis Niobe® magnet control system represents the commercial realization of 
magnetically-targeted therapy to the heart. The system received regulatory approval for hu-
man clinical use in cardiac electrophysiology and interventional neuroradiology in 2000, and 
for interventional cardiology in 2003. 
While previous systems were only suitable for relatively large vessels or chambers because 
of the size of the catheter magnets required, the development of magnets of ≤0.014”, see 
fi gure 1.5, the standard diameter of coronary guidewires, has allowed application to Inter-
ventional Cardiology.
Figure 1. The Tristar confi guration had a superconducting magnet with an open fi eld and was electrically 
controlled. See this fi gue in color in the Appendix page 373.
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The Stereotaxis Niobe® magnet control system is an advanced cardiology instrument con-
trol system for use in a hospital’s interventional surgical suite to enhance the treatment of 
coronary artery disease and arrhythmias. The Magnetic Navigation System is designed to en-
able physicians to complete complex interventional procedures by providing image guided 
delivery of catheters and guidewires through the blood vessels and chambers of the heart 
to treatment sites. This is achieved using computer-controlled, externally applied magnetic 
fi elds that govern the attitude of the working tip of the catheter or guidewire, with the aim of 
improving navigation and potentially leading to shorter procedure times and reduced x-ray 
exposure and contrast media use.
Figure 2. The Unistar confi guration had a permanent magnet that had a lower fi eld strength but was less 
expensive and was mechanically controlled. See this fi gue in color in the Appendix page 373.
Figure 3. The Pullstar confi guration was a permanent magnet that gave a gradient fi eld for low cost 
aneurysm treatment. This was manually controlled. See this fi gue in color in the Appendix page 374.
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The current system is a combination of the Niobe® Stereotaxis magnet control system that 
controls the magnet movements and is controlled by the Navigant™ Work Station. The de-
velopment of this system has been enabled by the availability of low-cost modern magnetic 
materials combined with the use of digital imaging plates that are minimally aff ected by 
magnetic fi elds.
Two large neodymium-iron-boron (Nd-B-Fe) magnets are mounted on mechanical po-
sitioners that produce an interacting magnetic fi eld. Magnetic moment is exerted upon a 
magnet when the applied fi eld is off set from a magnet’s principal magnetization axis, and 
this moment causes the magnet to align with the external fi eld. 
The current list price for the Stereotaxis system is $1.9 million. The size of a typical modern 
Stereotaxis interventional suite is 770 square feet (72 square meters). The cost of magnetic 
shielding generally ranges from $50,000–$100,000 and consists of minimal common steel 
shielding in the walls, ceiling and fl oor. 
There is a range of magnetically enabled Stereotaxis 0.014” guidewires, see fi gure 1.5, 
that are priced at a marginal premium over conventional wires. All other PCI equipment is 
standard and compatible with the Stereotaxis guidewires and MNS.
Figure 4. The Niobe® confi guration has 2 permanent magnets on mechanically controlled positioners at 
either side of the patient. See this fi gue in color in the Appendix page 374.
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Figure 5. The structure of the current magnetic wires. See this fi gue in color in the Appendix page 375.
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MAGNETIC NAVIGATION IN PERCUTANEOUS CORONARY INTERVENTION
Magnetic navigation is the use of adjustable magnetic fi elds to precisely direct wires and 
equipment for clinical applications. It is a recently developed option that is now available for 
interventional cardiology. Procedures are based on the production of a three-dimensional 
reconstruction of the vessel lumen from standard angiographic images. Knowledge of the 
positions of the table and image intensifi er during angiography allows calculation of the 
vessel coordinates in real space within the patient’s chest. The applied magnetic fi eld can be 
changed at any time to redirect the wire tip in order to improve navigation through complex 
and tortuous anatomy. The digital information of the coronary reconstruction can be used 
in further novel ways. Firstly, the integration of multislice computerized tomography images 
adds information about the path of the previous lumen of chronic total occlusions. Secondly, 
the computed center-line of the reconstructed vessel can be superimposed onto the live 
fl uoroscopy images as a three-dimensional guide. The combination of improved navigation 
together with the other available system features may improve time, contrast, and material 
usage in a range of coronary lesions. Future potential developments include improvements 
in equipment and software, and potential therapeutic strategies under consideration include 
the use of equipment to perform remote control procedures, and the integration of the sys-
tem to improve bone marrow–derived stem cell delivery. 
INTRODUCTION
The fi eld of interventional cardiology has been characterized by the rapid introduction and 
uptake of new treatments and devices such as stents (1), clopidogrel (2) drug-eluting stents 
(3), bivalirudin (4) and new guidewire technology. These new technologies have driven the 
continuously increasing total number of percutaneous coronary interventions (PCI) (5). A 
recent promising development is the use of a magnetic navigation system (MNS) to steer 
a guidewire through coronary arteries. This technology is already accepted for the perfor-
mance of electrophysiological studies (6–9) and has tested favorably in neurosurgery both in 
animal models (10) and in humans (11). Interventional coronary procedures present more of 
a moving target when compared with neurosurgery and require smaller magnets when com-
pared with electrophysiology. The combination of smaller wire tip magnets together with 
new software and imaging features has made the MNS available as a new platform for PCI. 
Magnetic navigation allows a magnetically enabled wire tip to be pointed in any orientation. 
This allows the adjustment and readjustment of the direction of the wire tip in vivo whenever 
needed. In addition, the system produces three-dimensional images, integrates information 
with multislice computerized tomography (MSCT), and is able to use this three-dimensional 
information superimposed on live fl uoroscopy. The potential areas where such a system 
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provides new options include challenging and tortuous anatomy, chronic total occlusions 
(CTOs), reduction in time, contrast, and materials, and remote control PCI. This article reviews 
a brief history of magnetic procedures, the current status, some future possibilities, and some 
limitations within the area of non-electrophysiological cardiac interventions.
The System
The magnetic navigation system (Niobe®, Stereotaxis, St. Louis, Missouri) has been developed 
for use with digital coronary angiography. The system consists of two permanent magnets, 
mounted on mechanical positioners, on either side of the fl uoroscopy table (see Fig. 1). 
These magnets produce an interacting magnetic fi eld to produce an approximately spherical 
15 cm uniform magnetic fi eld of 0.08 T. The magnets move along three diff erent coordinates 
and rotate about the z axis, move toward or away from the navigation volume along the z 
axis, and tilt about an axis located just behind the magnet. This allows the direction of the 
applied magnetic fi eld vector to be orientated in 360o in all planes. The three-dimensional 
location of the X-ray image is known from the positions of the image intensifi er, angiography 
system, and table. A three-dimensional reconstruction is created from the angiographic im-
ages using dedicated reconstruction software (CardiOp-B, Paieon Medical Inc., Rosh Ha’ayin, 
Israel). This reconstruction is used by the MNS to give three-dimensional coordinates that are 
localized in real space (within the chest of a patient during a procedure). This provides two 
new abilities. Firstly, the three-dimensional model allows the computation of the orienta-
tions of the magnetic fi eld needed for alignment with the center-line at every point of the 
virtual coronary artery. Secondly, the three-dimensional coordinates are known in real space 
and this provides the data for the MNS to change the magnetic fi eld vector, and therefore the 
Figure 1. Magnetic navigation system is shown with the magnets in position on either side of the patient. 
See this fi gue in color in the Appendix page 375.
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resulting magnetic moment on the wire tip, at every location in the vessel. The magnetic mo-
ment is equal to the product of the strength of the applied magnetic fi eld, the cross-sectional 
area of the tip magnet, and the sine of the angle of the magnet direction relative to the 
applied magnetic fi eld. The result is control of the direction of the wire tip, in vivo, without the 
need for a preshaped wire tip angle. There is a recently introduced and broadened range of 
dedicated, magnetically enabled wires (Titan™ series) for PCI available for use with the MNS. 
History
The use of magnets to control an intravascular catheter was fi rst reported in 1951 (12) while 
the fi rst human use was a neonatal heart catheterization in 1991 for the diagnosis of anoma-
lous congenital cardiac drainage (13). The current MNS has been developed over the past 15 
years. Previous systems were only suitable for relatively large vessels because of the size of 
the catheter magnets required. The current system now has tiny magnets (≤0.014’’) and is the 
most widely used. This system received regulatory approval for human clinical use in cardiac 
electrophysiology and interventional neuroradiology in 2000, and for interventional cardiol-
ogy in 2003. It has been shown to be feasible in neurosurgery (10,11) and is a well-accepted 
technique in electrophysiology (6–9).
CURRENT STATUS
Navigation. 
The core feature of the system is the ability to alter the direction of the wire tip within a patient 
during a procedure to give improved wire tip control compared to conventional procedures. 
First, the ability to precisely direct the wire tip means that the wire can be redirected and 
readjusted throughout the procedure to confi gurations that exactly suit the angulations and 
direction of the vessel, or alternatively used in a precisely defi ned probing pattern to inter-
rogate the vessel ahead. This ability is not aff ected by friction on the shaft of the wire that can 
impair manipulation in tortuous vessels. Second, it overcomes the problem of a conventional 
tip that can become damaged and misshapen during a procedure and so impair manipula-
tion. Finally, the passage of the wire is guided by the magnetic vector rather then rotational 
manipulation and this may reduce wire entanglement. This problem sometimes occurs in 
bifurcation procedures where wires can become intertwined with manual manipulation and 
prevent passage of materials. These abilities mean that the lesion can be approached, and 
navigated through, with a straight tip. A straight tip may reduce the chance of the wire tip 
impacting against the vessel wall or unintentionally navigating into side branches. A major 
goal in the development of this system has been to enable the successful passage of the 
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wire through vessels that prove challenging to conventional guidewires. In this context, two 
situations are particularly relevant: fi rstly, tortuous and/or heavily calcifi ed vessels where a 
conventional guidewire loses manipulability as described above; secondly, CTOs where the 
path of the vessel is not visible and the required tip direction is unclear. 
Diffi  cult Anatomy
This technology has been examined in a number of diff erent situations with regards to 
diffi  cult lesions. Passage of a wire to distal segments of in vitro phantoms was not only suc-
cessful but, in addition, fl uoroscopy times were found to be signifi cantly reduced (14). This 
potentially reduces radiation exposure both to patients and personnel. The system has been 
shown to be feasible for PCI in vivo (15,16), and furthermore, both of these studies showed 
that the magnetically enabled wire was capable of crossing lesions where a conventional 
wire had failed. In addition to normal PCI, MNS can support other specialist intracoronary 
procedures such as percutaneous alcohol septal ablation (17).
These navigational advantages are enhanced by a range of imaging possibilities including 
the three-dimensional lumenogram, the bull’s-eye view, and the endoluminal view (see Figs. 
2 and 5). In addition, the MNS has dedicated ranges of magnetically enabled guidewires (the 
Titan™ and Cronus® ranges) that vary in stiff ness, magnet length, and tip angulation to tailor 
the system to each individual coronary artery. These 0.014’’ wires are entirely compatible 
with all current standard PCI equipment and standard access sites, both radial and femoral. 
The combination of precise navigation and additional imaging options available may reduce 
time, contrast, fl uoroscopy, and material use.
Figure 2. This shows the three-dimensional reconstruction in the left panel and the endoluminal view of 
the LAD/diagonal bifurcation in the right panel. Note that these are live, moving, real-time images during a 
procedure. See this fi gue in color in the Appendix page 376.
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CTOs and MSCT Integration
A second lesion type that continues to be vexing is the CTO. Success rates for PCI of CTOs are 
around 65% to 80%, depending on the technique used and presence of other diseases such 
as diabetes (18–21). 
A number of strategies have been suggested to facilitate the treatment of CTOs, e.g., intra-
coronary thrombolytic infusion (22), the use of tapered tip guidewires (20), imaging with 
(16-slice) MSCT (23) and the use of a laser guidewire (24). The ability to precisely steer and 
change the orientation of the wire tip may be crucially important in avoiding wire exit, 
Figure 3. The left panel shows 64-slice cardiac MSCT with vessels; a tissue attenuation line is seen in the RCA 
after the RV branch. The right panel shows a post-processed image of the vessel that more clearly shows the 
30-mm occlusion. See this fi gue in color in the Appendix page 376.
Figure 4. The fl uoroscopy image is marked on the system with dots ready for three-dimensional integration 
in the left panel with the MSCT marked with dots for integration in the right panel. These give the specifi c 
three-dimensional coordinates that allow integration of the two modalities (see Fig. 5). See this fi gue in color 
in the Appendix page 376.
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and may hold a major advantage in comparison with a conventional wire that has a fi xed, 
unchangeable angulation. However, with regard to CTOs, the MNS has a further major advan-
tage as it can also integrate 64-slice MSCT images (see Figs. 3–5). This imaging technique can 
identify both a distal vessel that is fi lled via collaterals and also show a tissue attenuation line 
(the scarred tissue of the original vessel lumen). This imaging allows a path to be visualized 
and then synchronized with the MNS (see Figs. 3–5) to direct the wire tip along the previous 
vessel lumen (or at least the scar tissue) to the distal vessel. These features have helped the 
success of the MNS in the initial experience of CTO procedures (25).
Future Developments
The MNS is a fl exible system and, as well as improvements in the areas described above, it can 
be expected that the current capabilities will be extended and further potential strategies 
will be discovered. This system is a platform that adds new abilities to conventional PCI. Some 
possibilities in both strategy and equipment currently under consideration are described 
below.
Figure 5. The Stereotaxis screen is shown with the integrated MSCT image and reconstruction made. In the 
upper panels the green dots indicate where attenuated tissue of previous vessel was seen on the MSCT, 
while the lower panels show fl uoroscopy images with a superimposed three-dimensional reconstruction 
that follows the path identifi ed by the MSCT. See this fi gue in color in the Appendix page 377.
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Newer and Improved Equipment
The newest system available off ers tilting magnets for better imaging (the older system 
limits RAO and LAO projections to approximately 30o because of the magnets) and software 
upgrades. In addition, the current range of wires is being increased. A new intermediate-
grade wire will increase the range of stiff ness of the wires and a new blended nitinol-stainless 
steel wire may off er improved fl exibility with memory. Further potential wire developments 
include coil magnet and multimagnet confi gurations of the wire tip that may off er increased 
fl exibility within tortuous anatomy and better deformation in extremely tortuous segments. 
Contrast Reduction
A further feature of the MNS is the ability to project a white line overlay onto the fl uoroscopy 
screen. This can be used as a guide for wire passage and enables the operator to pass the wire 
with minimal or no use of contrast (26) (see Fig. 6). Contrast-induced renal dysfunction, and 
the dialysis needed in some cases, remains a cause of morbidity and mortality in procedures 
involving intravascular contrast (27). While some medical manoeuvres, such as fl uid (28) 
N-acetyl-cysteine (29) and theophylline (30) administration, may confer some protection, 
evidence suggests that limiting intravascular contrast load to 100 mL may be a cutoff  dose 
for the development of acute renal failure requiring dialysis (27). The ability to pass the wire 
without contrast may allow such a goal to be reached in patients with pre-existing renal 
problems. 
Figure 6. The left panel shows the endoluminal view that is synchronized with the position of the marker 
on the fl uoroscopy screen. The right panel shows the fl uoroscopy screen with the white line overlay, the 
dashed line is the desired vector, and the solid line is the applied vector (in this example the desired vector 
has just been moved and the applied vector is in the process of moving to that position). Note that these 
are live, moving, real-time images during a procedure. See this fi gue in color in the Appendix page 377.
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Chronic Total Occlusions
In addition to the advantages described above for the treatment of CTOs, the ongoing 
development of a magnetically enabled radio frequency ablating wire may be highly 
advantageous. This will combine the current advantages of highly adjustable steering, the 
identifi cation of the missing section of the vessel (shown by MSCT integration), and the abil-
ity to ablate intervening scar tissue. 
Remote Control
A further new concept in PCI is the ability to remotely control the delivery system. Remote 
control equipment (see Fig. 7) in the form of the Remote Navigation System® (Navicath 
Ltd., Haifa, Israel) has been successfully tested in both in vitro and in vivo models (31). This 
successful testing in models was mirrored by the successful use in the majority of a series 
of clinical PCI cases (32). Remote control procedures have already been shown to be pos-
sible in electrophysiology (6). Such remote control procedures have the advantages of 
more exact movement of wires. Wire advancement by a remote system could potentially be 
integrated with the MNS to advance the wire and change the magnetic vector in tandem 
thereby enabling robotic procedures. Theoretically such movements could even be gated 
Figure 7. The Remote Navigation system® is shown in a catheterization suite. (Courtesy of T. Wenderow, 
CEO, Navicath Ltd.). See this fi gue in color in the Appendix page 378.
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to the ECG to advance the tip and this might overcome some of the limitations of the static 
three-dimensional reconstruction. This combination would add the advantages of improved 
wire control to those of remote control procedures with reduction of irradiation of personnel 
and the reduction of collateral problems such as back pains from wearing lead coats.
Stem Cell Therapy
Stem cell therapy presents another possibility for MNS that may give both precisely directed 
delivery and also utilize integration with other forms of imaging. Intramyocardial injections 
of bone marrow–derived stem cells have been shown to have a potential for improving re-
gional and global left ventricular function (33). However, delivery of stem cells to the correct 
areas has remained inexact with relatively crude methods of identifying where the injections 
are to be placed on delivery and where they have been placed on restudy. The identifi cation 
of infarcted areas on MSCT (34) may add a further tool that can be integrated into the MNS 
for such target localization. The MNS gives highly precise three dimensional control and, with 
the possible development of a magnetically enabled injection catheter, the current MSCT 
integration may help localization of the infarct area to give a more tailored delivery. The 
combination of such localization techniques with the mapping abilities of systems like the 
recently developed NOGA® XP Cardiac Navigation System (Biosense Webster Inc./Biologics 
Delivery System Group, Diamond Bar, CA; Cordis Corporation) may give complementary 
information and result in more exact delivery. Integration of other digitized information from 
sources such as three-dimensional intracardiac echocardiography or magnetic resonance 
imaging could give functional data on improvements in wall segment motion. 
LIMITATIONS
This new system has a number of weaknesses that may be considered in terms of software, 
hardware, strategy, and general limitations. 
Software
The MNS software has many useful features; however, some aspects remain limited. Recon-
structions are static images with no variation with respiration and heart motion, there is a 
restricted range of forward advancement along the virtual vessel to 1–5 mm per touch of the 
screen, and the alignment can be problematic. Vessel reconstructions are restricted to two 
branches and are based on angiography fi lms alone resulting in limited resolution. Recon-
structions of the exact vessel borders and hazy lesions may have poor defi nition leading to 
underestimation of stenoses and diffi  culty with sharp, short lesions. 
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Hardware 
The equipment has some physical limitations such as the length of the wire tip magnet, 
which, with a standard of 3 mm, may hinder advancement in extremely tortuous and nar-
rowed segments. In addition, the integration of other imaging modalities directly into the 
system remains incompletely explored.
Strategy
Strategies for using this system in the performance of PCI are under development and these 
will depend on the indication for the procedure. The system remains relatively new with 
limited operator experience and current strategies utilize ad hoc reconstruction of the vessel, 
which may be time-consuming during a procedure. The timing of the reconstruction may 
have an impact on image quality and readiness for use in procedures. The usefulness of the 
center-line overlay for the minimization of the contrast load is not yet clarifi ed.
General 
As a whole, currently, the system functions well. However, this system is still in further de-
velopment and further refi nements are expected. Furthermore, this system is an aid in the 
performance of PCI, so should problems occur or, in the worst-case scenario, the system fails, 
then standard PCI can be performed.
CONCLUSION
The MNS is a new platform for PCI that gives the operator more precise control of wire tip 
direction as well as broadening imaging and integration abilities. This system facilitates 
navigation for diffi  cult vessels and CTOs, it gives useful control of direction derived from 
MSCT integration, and it may lead to a reduction in irradiation and discomfort to operators, 
personnel, and patients. For the future, the versatility of the system indicates further possible 
avenues for investigation such as reductions in contrast and irradiation, and navigable abla-
tion and injection capabilities. Further investigation and development is under way. 
ACKNOWLEDGMENTS
The authors would like to thank Joep Maeijer, Jan Tuin, and Tal Wenderow for their help with 
the images.
Mark bw.indd   36 25-05-10   15:15
37
Magnetic Navigation in Percutaneous Coronary Intervention
REFERENCES
 1. Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon expandable stent implan-
tation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 
331:489–495.
 2.  Müller C, Büttner HJ, Petersen J, et al. A randomized comparison of clopidogrel and aspirin versus 
ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 2000;101:590–
593.
 3.  Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with 
a standard stent for coronary revascularization. N Engl J Med 2002;346:1773–1780.
 4.  Lincoff  AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade 
compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coro-
nary intervention: REPLACE-2 randomized trial. JAMA 2003;289:853–863.
 5.  American Heart Association. 2000 Heart and Stroke Statistical Update. Available at http://ameri-
canheart.org/statisics/03cardio.html
 6.  Pappone C, Vicedomini G, Manguso F, et al. Robotic magnetic navigation for atrial fi brillation 
ablation. J Am Coll Cardiol 2006;47:1390–1400. Epub 2006 Mar 15. 
 7.  Ernst S, Hachiya H, Chun JK, et al. Remote catheter ablation of parahisian accessory pathways 
using a novel magnetic navigation system—a report of two cases. J Cardiovasc Electrophysiol 
2005;16:659–662.
 8.  Ernst S, Ouyang F, Linder C, et al. Initial experience with remote catheter ablation using a novel 
magnetic navigation system: Magnetic remote catheter ablation. Circulation 2004;109:1472–
1475. Epub 2004 Mar 15.
 9.  Ernst S, Ouyang F, Linder C, et al. Modulation of the slow pathway in the presence of a persistent 
left superior caval vein using the novel magnetic navigation system Niobe. Europace 2004;6:10–
14.
 10.  Grady MS, Howard MA 3rd, Dacey RG Jr, et al. Experimental study of the magnetic stereotaxis 
system for catheter manipulation within the brain. J Neurosurg 2000; 93:282–288.
 11.  Chu JC, Hsi WC, Hubbard L, et al. Performance of magnetic fi eld-guided navigation system for 
interventional neurosurgical and cardiac procedures. J App Clin Med Phys 2005;6:143–149.
 12.  Tilander H. Magnetic guidance of a catheter with articulated steel tip. Acta Radiol 1951;35:62–64.
 13.  Ram W, Meyer H. Heart catheterization in a neonate by interacting magnetic fi elds: A new and 
simple method of catheter guidance. Catheter Cardiovasc Diagn 1991; 22:317–319.
 14.  García-García HM, Tsuchida K, Meulenbrug H, et al. Magnetic navigation in coronary phantom: 
Experimental results. EuroInterv 2005;1:321–328.
 15.  Tsuchida K, García-García HM, Tanimoto S, et al. Feasibility and safety of guidewire navigation 
using a magnetic navigation system in coronary artery stenoses. EuroInterv 2005;1:329– 335.
 16.  Atmakuri SR, Lev EI, Alviar C, et al. Initial experience with a magnetic navigation system for 
percutaneous coronary intervention in complex coronary artery lesions. J Am Coll Cardiol 
2006;47:515–521.
 17.  Bach RG, Leach C, Milov SA, et al. Use of magnetic navigation to facilitate transcatheter alcohol 
septal ablation for hypertrophic obstructive cardiomyopathy. J Invasive Cardiol 2006;18:E176–
E178.
 18.  Safl ey DM, House JA, Rutherford BD, et al. Success rates of percutaneous coronary intervention of 
chronic total occlusions and long-term survival in patients with diabetes mellitus. Diab Vasc Dis 
Res 2006;3:45–51.
Mark bw.indd   37 25-05-10   15:15
Chapter 2
38
 19.  Abbott JD, Kip KE, Vlachos HA, et al. Recent trends in the percutaneous treatment of chronic total 
coronary occlusions. Am J Cardiol 2006;97:1691–1696.
 20.  Olivari Z, Rubartelli P, Piscione F, et al. Angioplasty for chronic total occlusion by using tapered-tip 
guidewires. Catheter Cardiovasc Interven 2003;59:305–311.
 21.  Hoye A, van Domburg RT, Sonnenschein K, et al. Percutaneous coronary intervention for chronic 
total occlusions: The Thoraxcenter experience 1992–2002. Eur Heart J 2005;26:2630–2636.
 22.  Abbas AE, Brewington SD, Dixon SR, et al. Intracoronary fi brin-specifi c thrombolytic infusion facil-
itates percutaneous recanalization of chronic total occlusion. J Am Coll Cardiol 2005;46:793–798.
 23.  Yokoyama N, Yamamoto Y, Suzuki S, et al. Impact of 16- slice computed tomography in percutane-
ous coronary intervention of chronic total occlusions. Catheter Cardiovasc Interven 2006;68:1–7.
 24. Segev A, Strauss BH. Novel approaches for the treatment of chronic total coronary occlusions. J 
Interven Cardiol 2004;17:411–416.
 25.  García-García HM, Tsuchida K, van Mieghem C, et al. Multislice computed tomography and mag-
netic navigation—initial experience of cutting edge new technology in the treatment of chronic 
total occlusions. Eurointervention, in press.
 26.  Patterson M, Tanimoto S, Tsuchida K, et al. Magnetic Navigation with the endo-luminal view and 
the X-ray overlay—Major advances in novel technology. Eurointervention, in press.
 27.  McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: Inci-
dence, risk factors, and relationship to mortality. Am J Med 1997;103:368–375.
 28.  Bader BD, Berger ED, Heede MB, et al. What is the best hydration regimen to prevent contrast-
induced nephrotoxicity? Clin Nephrol 2004;62:1–7.
 29.  Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced 
reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180–184. 
 30.  Katholi RE, Taylor GJ, McCann WP, et al. Nephrotoxicity from contrast media: Attenuation with 
theophylline. Radiology 1995:195:17–22.
 31.  Beyar R, Wenderow T, Lindner D, et al. Concept, design and pre-clinical studies for remote control 
percutaneous coronary interventions. EuroInterv 2005;1:340–345.
 32.  Beyar R, Gruber L, Deleanu D, et al. Remote-control percutaneous coronary intervention. Con-
cept, validation and fi rst-inhumans pilot clinical trial. J Am Coll Cardiol 2006;47:296– 300.
 33.  Perin PC, Dohman HFR, Borojevic R, et al. Transendocardial, autologous bone marrowcell trans-
plantation for severe, chronic ischaemic heart failure. Circ 2003;107:2294–2302.
 34.  Nieman K, Cury RC, Fecencik M, et al. Diff erentiation of recent and chronic myocardial infarction 
by cardiac computed tomography. AJC 2006; doi:10.1016/j.amjcard.2006.01.101.
Mark bw.indd   38 25-05-10   15:15
Mark bw.indd   39 25-05-10   15:15
Ramcharitar S
Patterson MS
van Geuns RJ
van Miegham C
Serruys PW
Nature Clinical Practice Cardiovascular Medicine 2008;5(3):148-56.
Mark bw.indd   40 25-05-10   15:15
CHA PTER 3
Technology Insight: magnetic navigation in 
coronary interventions
Mark bw.indd   41 25-05-10   15:15
Chapter 3
42
SUMMARY
Magnetic navigation is rapidly emerging as a useful technology in the fi eld of interventional 
cardiology. Precise control of the direction of a guide wire or a device in three-dimensional 
space off ers a means to access vessels and areas of the heart that are often challenging to 
access with conventional methods. In this comprehensive Review, we detail the develop-
ment of magnetic navigation technology and how this tool has been adapted for use during 
percutaneous coronary intervention. We aim to provide an up-to-date analysis of what is 
currently possible with this technology and an insight into what the future holds, particularly 
with respect to chronic occluded arteries and cell transplantation.
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INTRODUCTION
The growth of interventional cardiology has led to numerous technological developments (1) 
the development of metallic and biodegradable stents that elute novel bioactive molecules 
(2); specialized guidewires with subtle diff erences for accessing diff erent types of lesion 
(3); and various new pharmacological agents (4). One area that has not seen substantial 
progress thus far is the technology used to precisely guide a wire across a lesion. In most 
instances, crossing a lesion still relies heavily on both the skills of the interventional cardiolo-
gist performing the procedure and the mechanical properties of the guidewire. The Niobe® 
Magnetic Navigation System (MNS; Stereotaxis Inc., St Louis, MO) is a novel technology that 
can precisely control the tip of a magnetically enabled wire or device in vivo (5). Preliminary 
data suggest that the MNS could be useful in tortuous vessels or in complex lesions such 
as bifurcations, in which the initial bend placed on the wire might not be ideal for crossing 
tandem lesions (6). Magnetic navigation also means the wire is less likely to deviate into side 
branches, therefore, reducing radiation exposure and the amount of contrast required (7). 
The combination of dedicated magnetically enabled devices with three-dimensional (3D) 
imaging methodologies such as multislice CT (MSCT) and the NOGA® mapping system 
(Cordis Corporation, Miami Lakes, FL), can increase the accuracy in targeting chronic total 
occlusions (CTOs) and stem-cell implantation. To date, the transition of this technology into 
interventional cardiology has been slow. In many centers the MNS was fi rst used in cardiac 
electrophysiological procedures, for which the benefi ts are well established; only now are 
centers extending the use of this technology to the interventional setting, despite the 
obvious advantages that the MNS off ers. This somewhat cautionary approach stems from 
the fact that no randomized clinical trials have currently compared the MNS with older, 
more-established techniques. This issue clearly needs addressing, with future developments 
in both the software and hardware designs being investigated in timely clinical trials. At pres-
ent, the expenses incurred in setting up an MNS will also infl uence its popularity. This Review 
discusses some of the major technological developments in the context of interventional 
cardiology and provides an insight into what is currently possible and what might be pos-
sible with this novel technology in the future.
Early developments
Vascular studies using magnetic navigation fi rst began over 50 years ago when Llander (8), 
and later Tillander (9), used magnetic fi elds to guide an articulated steel-tip catheter in rab-
bit aorta. After these initial investigations, small external permanent magnets were used to 
stereotactically direct iron particles for thrombosis of intracranial aneurysms (10-12), later, 
rotating electromagnets were used, enabling better control (13). In 1991, Ram and Meyer 
performed the fi rst magnetically guided angiography in a human. They successfully used a 
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magnetized catheter controlled with external permanent magnets in a neonate with ana-
tomically complex congenital heart disease (14).
Despite initial success, further development was hampered by low fi eld strengths, the need 
for large magnets and the lack of precise 3D control (15,16). In order for stereotactic localiza-
tion and computer-controlled vector guidance to be possible, considerable advances in both 
medical physics and magnet design were required (17). Further advancements in these areas 
and the use of MRI coregistered with real-time fl uoroscopy enabled the navigation of both 
a small object in a canine brain (18) and magnetically enabled catheters in pig brains (19). 
These experiments led to the MNS fi rst being used in interventional radiology and cardiac 
electrophysiology, and now in interventional cardiology (20–22). Across these disciplines 
there are now more than 100 systems installed worldwide. It should be noted, however, that 
applying this technology in interventional cardiology presents a greater challenge than in 
more established indications such as neurosurgery. Unlike the brain, the heart is a dynamic 
structure, and the patient’s chest moves with respiration. 
The Niobe® magnetic navigation system
Navigation hardware
The Niobe® MNS (Figure 1A) has four key components: two permanent adjustable magnets 
mounted on mechanical frames situated at either side of the fl uoroscopy table; navigation 
software (Navigant®, Stereotaxis, St Louis, MO) to control the magnets by creating a virtual 
roadmap and magnetic vectors after imaging data are gathered; a real-time fl uoroscopy sys-
tem to display a virtual map of the live image; and fi nally, a sterile touch-screen monitor for 
controlling the system, ideally placed at the operating table. In the second-generation sys-
tem, Niobe® II, the mechanical frames enabling the magnets to be positioned were adapted 
to allow the magnets to translate or tilt about their axes. This tilting action enabled more 
angiographic projections— the previous version of Niobe® had limited right anterior oblique 
and left anterior oblique views because of the bulkiness of the magnets. The majority of 
systems are integrated with a modifi ed C-arm fl at-panel detector fl uoroscopic imaging suite 
(AXIOM Artis dFC; Siemens AG, Malvern, PA), but there are systems that can also incorporate 
biplane fl uoroscopic imaging and rotational angiography.
Biplane fl uoroscopy has the advantage of reducing the amount of contrast used during im-
age acquisition, but once the images are transferred into the Navigant® software the lateral 
C-arm must be stored in order for the magnets to be positioned. Rotational angiography, 
on the other hand, enables a 3D image to be generated directly from a single acquisition. 
When the patient is correctly positioned and isocentered, the magnets interact to produce 
a spherical magnetic fi eld 15 cm in diameter and uniformly of 0.08 Tesla—the ‘magnetic vol-
ume’. Within this volume any applied magnetic vector can precisely direct a 2–3 mm magnet 
mounted on the tip of a wire (Figure 1B) or steerable device so that a full 360° rotation can 
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be achieved. Clinically approved devices include guidewire and electrophysiological ablation 
catheters; other devices currently in development include coronary and peripheral ablative 
radiofrequency wires, multidirectional probing catheters, and catheters fi tted with needles 
that are designed for cell implantation.
Navigation software 
Free-mode navigation Magnetic navigation is performed by presetting a magnetic vector 
using the touch-screen monitor. Following programming, the vector is displayed as a dotted 
line on the live fl uoroscopy image, and the permanent magnets—illustrated by a solid vector 
line—move to align a magnetic fi eld to this vector. Wire advancement is controlled manu-
ally to follow a desired incremental distance and is guided by either two-dimensional (2D) 
or 3D software features in Navigant®. The 2D navigational modes include the use of preset 
navigational vectors that are adapted to a particular coronary anatomy. This software also 
allows the user to create new presets if necessary, for example in patients who have vascular 
anomalies or to target coronary artery bypass grafts. Other approaches include the ‘bulls 
eye view’, which allows navigation around a central axis, and is, hence, a particularly useful 
technique for CTOs. The 3D Navisphere® program (Stereotaxis, Inc., St Louis, MO) is a spheri-
cal navigation object that contains regularly spaced polar lines (e.g. latitude and longitude 
lines). The aim of this program is to improve recognition of the 3D structure of the coronary 
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Figure 1. The Niobe® Magnetic Navigation System. (A) A typical magnetic navigation system set-up 
showing the magnets, C-arm and the control room. (B) The Titan® magnetic navigation wire showing the 2 
or 3 mm magnet located at its tip.
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artery tree. Navigation is also feasible through the ‘clock face’ mode, which mimics the dial 
of a clock (Figure 2). This technique permits fast navigation relative to other techniques, 
but does require some understanding of the spatial coronary anatomy. Direct anatomical 
navigation is possible by directly introducing a fl uoroscopic image in Navigant®; however, 
2D image representation of a 3D structure has obvious limitations. True-vessel navigation 
uses an accurate 3D representation of the coronary artery. Navigant® software can create 
such a virtual map from two X-ray images provided that they are 30° apart. This program 
uses a feature called constellations to map identical points on both images, thus, generating 
a 3D navigational path or ‘centerline’ through the vessel lumen (Figure 3A). Alignment of the 
centerline with the live fl uoroscopy image is required for navigation. A 3D representation 
of the coronary anatomy and centerline can also be created from two fl uoroscopic images 
using the CardiOp-B® software (Paieon Inc., New York, NY; Figures 3 and 4). The advantage of 
using this program is that it can limit vascular foreshortening (23) and improve the accuracy 
of quantitative coronary angiography measurements (24,25). Using this software, naviga-
tional vectors can be directed through a virtual representation of the vessel lumen, so subtle 
changes in the vessel morphology can be accentuated (Figure 3C) (26). A 3D road map can 
also be created from an MSCT dataset. The importance of MSCT in interventional cardiology 
stems from its ability to detect early-stage coronary artery disease (27,28), identify vascular 
anomalies and provide information on coronary plaques composition (29). Using Navigant®, 
the vessels can be isolated from the dataset and a 3D volume-rendered reconstructed MSCT 
image can be incorporated into the virtual roadmap for magnetic navigation (Figure 4B). The 
mapping of points along the vessel is used to create a virtual lumen and a centerline (Figure 
4D), which is coregistered and aligned to the fl uoroscopic image for navigation. The ability of 
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Figure 2. The clockface navigational mode. By touching the perimeter the vector moves in that direction; 
controls for anterior and posterior movements are at the edges.
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MSCT to ‘fi ll in’ the occluded vessel segments that are not seen angiographically means that 
it is a useful tool for navigating through CTOs (Figure 5A), with newer versions of Navigant® 
able to show both the endoluminal view and the multiplaner reconstructed cross-sections 
(Figure 5B).

Lesion
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Nature.indt   1 28/11/07   9:46:50 am
Figure 3. True-vessel navigation using an accurate three-dimensional representation of the coronary artery. 
(A) A constellation road map created from two-dimensional X-ray images; chosen points are depicted by 
squares along the navigational path. (B) Navigation using a three-dimensional reconstruction created with 
the CardiOp®-B software. (C) Navigation by means of the endoluminal view. Abbreviation: OM, obtuse 
marginal branch.
A B
C D
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Figure 4. Three-dimensional representation of the coronary artery. (A) A threedimensional reconstruction 
of the artery using the CardiOp®-B software. (B) The same arteries extracted from a multislice CT data set 
(C and D), displayed as navigational centerlines with a directional vector on the live fl uoroscopic images.
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The MNS and intervention: What is currently possible?
Patent coronary arteries
Tortuous and severely angulated coronary arteries are associated with reduced procedural 
success rates and a raised incidence of CABG surgery (30). A guidewire must be maneuvered 
without causing complications such as dissection or perforation. Several phantom studies 
in hepatic celiac arteries and the cerebral arteries have demonstrated higher procedural 
success using the MNS than with manual manipulation, and shown that the MNS is easier, 
more accurate and faster even when used by inexperienced operators (31–33). Studies in a 
coronary phantom, however, reported longer crossing times with the MNS than with a stan-
dard wire, although fl uoroscopic times were signifi cantly reduced (34). The longer crossing 
times could have been related to the use of fi rst generation Cronus® (Stereotaxis Inc., St Louis, 
MO) magnetic wires—subsequent generations have been easier to track. Indeed, a recent 2D 
phantom study using fi ve increasingly tortuous vessel models found that as vessel complex-
ity increased the newer generation wires—Titan® and Pegasus® (Stereotaxis Inc., St Louis, 
MO)—were signifi cantly better in reducing both the crossing and fl uoroscopy times than 
were conventional wires (35). Moreover, in some of the phantom models, prior experience of 
magnetic navigation was not a prerequisite for successful crossing. Overall wire usage was 
signifi cantly reduced with the MNS. A seminal paper by Atmakuri et al. showed the eff ec-
tiveness of magnetic navigation during percutaneous coronary intervention (PCI) in native 
coronary arteries that would have been diffi  cult to cross with conventional methods because 
of severe tortuousity (36). In this study of 68 lesions in 59 patients, successful MNS crossings 
were achieved in 85% of cases. More importantly perhaps, magnetically guided intervention 
was successful in 9 (63%) of the 13 patients in whom PCI with a conventional wire had previ-
ously failed. The procedural success rates for magnetically guided intervention as the primary 
intervention and following failed conventional PCI (‘secondary’ intervention) were 84% and 
62%, respectively, with longer median fl uoroscopy and crossing times observed in second-
A B
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Figure 5. Using the Navigant® system the multislice CT data set can be used to create: (A) a road map of a 
chronic total occlusion not seen angiographically and (B) cross-sections along the map.
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ary procedures. Similar success was reported in a study of 21 consecutive diseased coronary 
arteries, although guidewire navigation with the MNS was found to be slower than manual 
navigation (37). The patients enrolled in this study did, however, have simple, straightforward 
lesions indicating that the MNS could be more suitable for use in complex coronary lesions 
and as a secondary procedure following failed conventional wire placement. This theory 
is exemplifi ed further by the successful results seen when the MNS was used following an 
unsuccessful alcohol septal ablation that failed because of severe angulation (130°) (38) and 
when used to cross a crushed stent of a bifurcation that was complicated by dissection (39). 
At present it is not clear how wide the applicability of magnetic-assisted navigation is likely to 
be in patent vessels. In order to evaluate this issue, our group has been assessing prolonged 
conventional crossing times to characterize the lesions and vessels that might be appropriate 
for magnetic navigation. 
Occluded coronary arteries
CTOs have been described as one of the last frontiers in interventional cardiology (40). 
Despite advances in technology and the development of specialized devices and dedicated 
wires, the rate of successful crossings is still unsatisfactory (41). An attractive strategy for 
treatment of CTOs was postulated by Serruys in 2006 (1). The fi rst stage of this strategy 
involves magnetic navigation to steer a guidewire through the occlusion. Second, optical 
coherence tomography, intravascular ultrasonography or MSCT cross sections are employed 
to ‘look forward’ within the vessel to ensure that the wire is ideally positioned in the true 
lumen. Finally, ablative power at the tip of the wire is used to recanalize the CTO (42). The fi rst 
successful study to demonstrate the feasibility of MSCT angiography and magnetic-enabled 
PCI used a system that ‘looked forward’ at the occlusion—the bull’s eye view—making the 
search pattern for microchannels through the occlusion more uniform by avoiding repeti-
tions (43). Although mapping the occluded segments was easily accomplished, the bulky 2–3 
mm magnetic tips used were a notable limitation. Furthermore, the fact that navigation was 
performed using a fi xed roadmap (centerline) rather than a dynamic one gated to the elec-
trocardiogram meant that there was discordance between the live fl uoroscopy image and 
the centerline—another limitation. Ordinarily, when navigating through a patent vessel this 
discordance is not a problem as the wire is contained within the vessel’s lumen, so that when 
the heart moves with each beat the wire can still follow the trajectory of the predetermined 
vectors. In CTOs, however, the lack of a patent lumen means that as the heart moves, the tip 
of the wire can be perpendicular to the vascular wall and when pushed can protrude. Hence, 
it is of paramount importance to develop technologies that allow dynamic road mapping 
(centerline) to be superimposed on the live fl uoroscopy image, especially when consider-
ing magnetic enabled radiofrequency ablation. Paieon Inc. is developing a dynamic road-
mapping system based on their software that can recognize systolic and diastolic phases on 
fl uoroscopic images. This system might have a role in patent vessels or those with subtotal 
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occlusion, but not necessarily in CTOs because contrast media is needed to demarcate the 
vessel contours. Much more appealing are methods aimed at electrocardiographic phase 
gating of the MSCT derived centerline to the live fl uoroscopic image following alignment 
to recognizable landmarks such as spinous processes and the catheter tip. This technique 
ensures that at a designated point in the cardiac cycle both the centreline and the live fl uo-
roscopic image of the vessel are superimposed, enabling safe advancement of the ablating 
wire. Development of the magnetic enabled wire with radiofrequency ablation functionality 
is nearing completion (Figure 6). This device is composed of a 0.014 inch wire with a small 
radiofrequency electrode at its tip and three small magnets embedded proximally.
An external generator supplies the radiofrequency energy needed for ablation. A safety 
and feasibility pilot study of this wire in ‘within stent’ CTOs is planned for early 2008 at the 
Thoraxcenter, Rotterdam, The Netherlands. 
Stem-cell injection
Intramyocardial injection of bone-marrow derived stem cells is a novel technology that has 
the potential to induce myocardial regeneration and improvement in left ventricular func-
tion (44). Currently, electromechanically guided injection is the preferred mode of delivery 
in patients with chronic myocardial ischemia (45). Indeed, clinical studies have shown that 
transendocardial injections of stem cells using the NOGA® mapping system are feasible and 
safe (46). In this system, once the mapping electrode makes a good contact with the myo-
cardium and the operator recognizes the appropriate electrical signal strengths, stem cells 
are injected through a needle linked to the device. One major drawback with this system is 
the diffi  culty of reaching remote areas of the left ventricle with manual manipulation of the 
catheter. This drawback can be addressed by using the magnetically enabled MNS-guided 
Magnets
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Figure 6. A diagrammatic representation of the magnetically enabled radiofrequency ablating wire for 
chronic total occlusions.
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NOGA® electromechanical mapping catheter (Stereotaxis Inc.; Figure 7). The guiding can be 
performed remotely to reduce operator radiation exposure. Moreover, the magnetic momen-
tum at the catheter tip precludes the need for shaft support, allowing the use of a softer cath-
eter that is less likely to penetrate the myocardium and cause a perforation. By using MSCT or 
MRI to identify the infarcted area, relevant data can be integrated into Navigant® to further 
augment the accuracy of target localization. A recent animal study showed the preclinical 
feasibility of Stereotaxis-compatible NOGASTAR mapping and MYOSTAR® injection catheters 
(Cordis Corporation, Miami Lakes, FL) both equipped with a small permanent magnet at 
the tip (47). Remote NOGA® mapping was possible with a computer-controlled catheter 
advancement system (Cardiodrive unit; Stereotaxis Inc., St Louis, MO). The introduction of the 
NOGA® map into Navigant® provided 3D vectors for the navigation of a magnetically enabled 
MYOSTAR® catheter. The combination of these technologies resulted in a 95.8% success rate 
of magnetic-guided injection of mesenchymal precursor cells into the myocardium. When 
labelled, cells were detected in all but one segment on histology.
What does the future hold?
Magnetic navigation is still in the developmental phase and as such will not revolutionize the 
way we currently perform PCI. By considering magnetic navigation as an adjunct technique 
to current practices, however, this technique could be used to benefi cial eff ect in clinical 
situations that are technically diffi  cult or associated with low procedural success. The de-
velopment of both software and hardware is, therefore, in the context of adjunct therapy. 
More powerful magnetic fi elds (i.e. 0.1–0.12 Tesla, increased from the current 0.08) and 
software upgrades to further improve the precision of wire control are in development. In 
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Figure 7. A diagrammatic representation of magnetically enabled cell injection catheter following an 
automatic map in the myocardium.
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terms of CTOs, future developments include dynamic road mapping and appropriate gat-
ing of the MSCT images with real-time fl uoroscopic images. In addition, alignment between 
angiographically determined 3D reconstructed non-occluded segments and the occluded 
sections obtained through MSCT will be more accurate. Moreover, as MSCT cross-section 
analysis provides important information on plaque composition and can accurately identify 
the vessel’s border—a ‘true’ centerline can be reconstructed by ‘stacking’ the gated cross sec-
tions if the center of each cross section (Figure 5B) is determined precisely. Incorporation of 
this idea in future versions of the Navigant® software is being contemplated, so that a gated 
wire can be advanced in a frame-like fashion to ensure central wire transit. The unwarranted 
complexity of several MNS workstations, which can slow processing speed, will be reduced 
in the future by a new single-screen user interface (Odyssey™ Network Solutions, Stereotaxis, 
St Louis, MO) that links diagnostic information from several sources. To further improve the 
speed of navigation without compromising safety there will, however, need to be improve-
ments in alignment of the centerline to the real-time fl uoroscopy image, possibly through 
dynamic electrocardiographic gating. This improvement would allow the operator to drag 
the vector with confi dence, instead of using 1–5 mm jumps along the centerline. With this 
development, the MNS could then compete with conventional wires in all lesions, not just 
complex cases. New advances in material science have permitted the development of several 
guidewires with variable degrees of support and fl exibility, tailored to individual coronary 
lesions.
The newest generation in wire design—the Pegasus®—is made from a nitinol–stainless 
steel composite for improved fl exibility with minimal deformity. Future wire-related develop-
ments will include magnets that can change the stiff ness of the wire to improve the delivery 
of a device, multimagnet confi gurations to enable smoother transition across the tip, and 
wires with the ability to feedback their position in space. The ability to accurately identify 
a wire’s position can be useful when combined with a robotic wire advancement system. 
To date, such systems have been successfully employed in electrophysiological procedures 
(48,49) but have not yet been extended to MNS-guided PCI. A stand-alone remote navigation 
system (CorPath®, Corindus Ltd, Haifa, Israel) for wire advancement and stent deployment 
using a joystick to control the wire’s axial (i.e. advance, retract) and rotational movements has 
been shown to be feasible (50), which opens the possibility of linking such a device to the 
MNS to achieve full automation. 
LIMITATIONS
Even though the concept of directional wire guidance has been eff ectively realized, the areas 
in which the system off ers a clear advantage over current approaches still need to be identi-
fi ed, which explains the slow market penetration in interventional cardiology. In addition, 
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apart from a few institutional registries, there are limited data on this new technology. The 
lack of randomized, controlled trials makes comparisons with existing technologies purely 
speculative. Furthermore, new operators experience a learning phase before achieving an 
adequate level of competence, irrespective of whether they are a physician or technical staff . 
Similarly, as the software develops, there is a need for continuing educational updates or 
seminars to ensure that operators are kept abreast of new developments. At present, the 
main limitation with the software remains the alignment of the virtual image to the real-time 
image. There is also a need for dynamic road mapping of the vessel; at present operators 
navigate through a static image. The 3D-reconstruction packages used still have limitations 
with respect to accuracies in tracing the vascular contours from which the central path for 
navigation is ultimately derived. The physical limitations of magnets attached to the wire 
tip could hinder advancement in extremely tortuous vessels, highlighting the importance 
of the multimagnet design that off ers a smoother transition. Ultimately, the success of 3D 
magnetic-enabled procedures still depends heavily on the time it takes to prepare the road 
map. The time taken can vary enormously depending on the vessel characteristics and must, 
therefore, be taken into account during procedural planning. The 2D navigation approach is 
quicker; however, the level of accuracy is compromised.
CONCLUSIONS
Magnetic navigation in coronary intervention is rapidly evolving. State-of-the-art magnetic 
devices are now competing with conventional non-magnetically enabled wires and devices. 
These technological advances are creating new roles for stereotactic magnetic navigation, 
which in the future will include a wider range of invasive cardiac procedures. 
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SECTION 1: MAGNETIC NAVIGATION
Magnetic navigation is the use of a magnetic fi eld to re-orientate a magnetically-enabled 
wire or device. The fi eld is directed by external magnets that are moved by a computer-
controlled system. Each function of the system is designed to improve wire steering. This 
young technology could improve percutaneous coronary interventional procedures as it 
gives an unprecedented improvement in 3 specifi c and complementary capabilities, namely 
precise tip adjustability, computer-enhanced, image-guided tip orientation, and computer–
enhanced image processing. This chapter will explore the benefi ts that revolve around these 
three capabilities.
Although this technology is relatively new, it already appears that this system can equal, 
and even improve on, current conventional wire technique. The effi  cacy of this system is 
becoming evident at a point in time that is relatively soon after its regulatory approval. The 
current usability, combined with the exciting potential of future developments, could result 
in a formidable adjunct to PCI.
The System
The Stereotaxis Niobe® magnet control system is an advanced cardiology instrument con-
trol system for use in a hospital interventional suite. It is designed to enable physicians to 
complete more complex interventional procedures by providing image guided delivery of 
catheters and guidewires through the blood vessels and chambers of the heart to treatment 
sites, see fi gure 1.
The current system combines the Navigant™ Work Station that runs the computer software 
control for the Stereotaxis Niobe® magnet positioning system. This magnet positioning sys-
tems moves two large neodymium-iron-boron (Nd-B-Fe) magnets mounted on mechanical 
positioners, see fi gure 1. These result in an interacting magnetic fi eld that produces a predict-
able vector at their midpoint. Magnetic moment is generated on a magnet when the applied 
fi eld is off set from a magnet’s principal magnetisation axis and this causes the magnet to 
align with the external fi eld. The computer-controlled, externally-applied, magnetic fi eld 
aligns a magnet on the working tip of the catheter or guidewire to govern the tip direction. 
The system obtained regulatory approval for use in humans in 2003. 
The current list price for the Stereotaxis system is $1.9 million. The size of a typical modern 
Stereotaxis interventional suite is 770 square feet (72 square meters). The cost of magnetic 
shielding generally ranges from $50,000–$100,000 and consists of minimal common steel 
shielding in the walls, ceiling and fl oor. There is a range of magnetically enabled Stereotaxis 
0.014” guidewires, see fi gure 2, that are priced at a marginal premium over conventional 
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wires. All other PCI equipment is standard and compatible with the Stereotaxis guidewires 
and MNS.
Figure 1. System in position for PCI. M indicates magnets in tilt position for better lateral movement of the 
image intensifi er. T indicates touch screen interface to give real-time instruction to the MNS. S indicates in-
lab main screen monitor. See this fi gue in color in the Appendix page 378.
Figure 2. Schematic of the structure of the Titan Soft Support and Cronus wires. See this fi gue in color in the 
Appendix.
Mark bw.indd   62 25-05-10   15:15
63
Magnetically supported percutaneous coronary interventions
Limitations of conventional manual wire manipulation
Traditionally 2D fl uoroscopic images are interpreted using the training and anatomical 
knowledge of the physician to estimate and probe for the correct wire orientation to enable 
passage of the wire or device through a vessel. The tip of a conventional wire has a fi xed angu-
lation that is shaped before insertion. This tip is manipulated at a distance of approximately 
1m by rotating the part of the wire that is external to the guiding catheter. Conventional 
manual wire manipulation is therefore a process of trial and error that is inherently limited by 
a number of problems.
First the wire direction is judged from the 2D image seen on a fl uoroscopy screen image that 
is seldom at exactly 90o to the coronary vessel and therefore susceptible to foreshortening. 
Foreshortening can become problematic by hiding angulations and even the entire lesion. 
Second, rotation of the shaft to redirect the fi xed tip, seen in 2D, is imprecise as it is not 
possible to judge whether the tip is pointing into or out of the screen. While steering is gener-
ally easy in straightforward coronary anatomy, diffi  culty may occur in the multiple bends of 
a tortuous, calcifi ed vessel that increases deformation of the wire, aff ecting wire rotation and 
therefore control. 
Third, the conventional tip angle cannot be varied in cases where anatomy varies from 
straight segments to highly angulated segments and back again, thus a compromise tip 
angle has to be made. In simple anatomy this angle is often not crucial, and the wire can 
be passed distally easily. However in tortuous vessels with multiple angles, this compromise 
angle may not be suitable for all angles and this may result in the tip pointing inappropriately 
into the vessel wall.
These factors combine in tortuous and diffi  cult anatomy to restrict wire delivery, increase 
use of irradiation, equipment and contrast and, in the worst case scenario, reduce procedural 
success.
Abilities provided by the MNS
Magnetic navigation in percutaneous coronary intervention provides an unprecedented 
versatility that revolves around a number of capabilities.
Precise tip adjustability 
As the magnetic fi eld steers the front-end of the wire, the angulation of the tip can be exactly 
varied to the required angulation. This means that the tip can be kept co-axial to the vessel 
when crossing a straight segment and then directed at specifi c angles for tortuous bends or 
sharply angulated sidebranches. This control may help to prevent inadvertent sidebranch can-
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nulation, facilitate the passage of extreme angulations or avoid dislodgement of friable mate-
rial loosely attached to the wall e.g. in degenerated vein grafts or thrombus in acute lesions.
In addition, the magnetic fi eld acts to stabilise the tip and tends to keep the tip pointing in 
the specifi ed direction. This may reduce prolapse when resistance at the tip is encountered. 
This stabilisation of the tip at a certain angulation may improve the chance of the tip cleanly 
entering a tight lesion or a sidebranch. 
Computer-enhanced, image-guided tip orientation 
Orientation of the magnetic fi eld in 3 dimensions is automatically achieved with the use of 
computer control. In practice this is done by using the preset vectors (standard 3D vectors 
derived from the average 3D direction of the coronary segment in 50 CT scans) or alterna-
tively a patient-specifi c model from individually created 3 dimensional reconstructions of the 
patient’s coronary arteries. This means that 3D information is integrated by the computer-
adjusted magnetic fi eld direction control to produce precise steering of the tip. Such 3D 
information may facilitate navigation in cases where the complexity may not be obvious on 
a 2D fl uoroscopy screen.
Computer-enhanced image processing 
The use of computers allows the production of digitalised images of the coronary arteries 
in great detail. These reconstructions can be made with the patient on the table or from 
previously acquired images. The fact that these images are digital allows post-processing 
that results in new ways to use the information giving new clinical applications such as the 
white-line overlay or the integration of MSCT.
The production of a patient-specifi c, tailored vessel reconstruction is performed with 
dedicated reconstruction packages such as the Cardi-Op BTM software, (Paieon Medical Inc., 
Rosh Ha’ayin, Israel) integrated in the Navigant™ Work Station, and the 3DCA software on 
Figure 3. A severe lesion involving an anastomosis of a saphenous vein graft on a LAD. The left panel shows 
the angiographic image, the panel in the middle shows the Philips reconstruction and the right panel 
shows the Paeion reconstruction. See this fi gue in color in the Appendix page 379.
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the stand-alone Interventional Tools workstation (Philips Medical Systems, Eindhoven, The 
Netherlands) (see fi gure 3). Both systems perform the reconstruction by triangulating points 
from 2 static images at diff erent angulations at least 30o apart, but diff er in that the Paieon 
system uses frames from 2 separate contrast injections at separate angles while the Philips 
system uses 2 frames from a single rotational acquisition. Frames are normally chosen in 
diastole to minimise movement artefact.
Current applications of post-processing
Computed centre-line 
This is derived from the calculated center-line of the reconstruction and is currently used in 
two ways. 
First, the centre-line provides the patient-specifi c 3D trajectory of the vessel that is the basis 
for the magnetic fi eld direction control used by the Niobe® system. The system sets the magnet 
positions to produce this magnetic fi eld direction and therefore the direction that the tip of the 
magnetic wire will align itself to. The reconstruction therefore gives not only an individual re-
construction but also an individualized 3D direction for every point along that reconstruction. 
Second, the centre-line is the basis of a white-line overlay that is projected onto the fl uoros-
copy screen. As the MNS has the data on the angulation and position of the image intensifi er 
and table, this white-line overlay is orientated at the appropriate angulation for the fl uoro-
scopic view and changes in real-time as the image intensifi er moves. This gives the operator 
a permanently visible roadmap on the fl uoroscopy screen that automatically adjusts to the 
angle of view to which he can compare either the shape of the wire or the contrast image.
Figure 4. The left panel shows the coronary tree as extracted from MSCT by the Philips 3DCA system while 
the right panel shows the vessels extracted directly from CT by the Siemens package. See this fi gue in color 
in the Appendix page 379.
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MSCT integration
The introduction of patient-specifi c information from non-invasive, off -table investigations 
has obvious advantages. The use of MSCT can provide a complete coronary tree model for 
use during the procedure. With cardiac MSCT becoming both more accurate and more avail-
able in the ER for diagnosis, the possibility of reducing the on-table procedural burden of 
time and contrast use becomes more realistic. 
This benefi t not only applies to patent vessels but may be more valuable in the area of 
chronic total occlusion (CTO). First, MSCT can visualise the distal section of an occluded ves-
sel to enable the wire to be steered in that direction. Second, the trajectory of the occluded 
segment may be visible. Third, information regarding the consistency of an occlusion or the 
surrounding tissue may be obtained e.g. for the extent of calcifi cation. This information may 
be valuable in assessing the chance of success, choosing the strategy needed or directing the 
wire. However, the true benefi t in CTO may only be realised when the loop can be fully closed 
with accurate tip localisation and dynamic mapping.
Summary of potential advantages
The system therefore gives a number of theoretical specifi c advantages to the PCI procedure 
that can be coupled with specifi c functionalities.
Navigation
Tip adjustment  -  the ability to bend and direct the tip as requested, even to extreme 
angulations.
Front-end steering  - the avoidance of friction aff ecting manipulation.
Precision direction  - for steering along a path or for probing patterns.
3D orientation  - the ability to reliably use the third dimension during wire passage.
Wire stabilization  -  the exact selection and maintenance of a direction along a vessel or 
into a sidebranch.
Lack of tip rotation -  tip direction becomes independent of friction on the shaft and the tip 
movements become more controlled
MSCT integration - Computer-enhanced patient-specifi c 3D information.
Operator
White-line overlay  - a patient-specifi c visual map projected directly on the fl uoroscopy screen
Endoluminal view  - an ‘internal’ view of the vessel that can be useful for sidebranch orientation.
MSCT integration - missing vessel segments, extra-luminal details.
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Procedure
Reduced irradiation - reduced irradiation may occur from better navigation, 
Reduced contrast -  contrast-sparing strategies using of diagnostic angiography fi lms or 
MSCT for navigation.
Shorter procedures -  quicker and more effi  cient procedures not only benefi t the patient 
but also the operator for example less irradiation or less time wearing 
protective lead coats
CONCLUSION
The system has a number of new capabilities that may bring advantages to a PCI procedure. 
Individually a specifi c advantage may not play a crucial role in each and every procedure 
but together may allow for smoother and less troubled wire passage. Ultimately magnetic 
navigation could potentially increase effi  ciency, reduce procedure time, facilitate the appli-
cation of advanced technologies, decrease irradiation of the operators and thus better use 
hospital resources to lower overall hospital costs. The following section will review the cur-
rent literature to assess whether there is support for these theoretical benefi ts and whether 
this is translated into a clinical benefi t.
SECTION 2: LESSONS FROM THE LITERATURE
Publications to date fall into a number of categories
Reviews
These articles have introduced and given an overview of the technology (1,2). They have 
generally explored the currently evolving technique, describing the potential methods of 
utilisation and the situations where these may become useful. They have also introduced and 
previewed up-coming features and technology and speculated about the new areas where 
this technology may extend to the future such as remotely controlled procedures or stem 
cell injection.
Phantom studies
These studies have looked at the use of the magnetic navigation in artifi cial phantoms to 
assess manoeuvrability and indicate which vessels might benefi t the most. The earliest study 
used a 3 dimensional phantom with channels representing the LAD, Cx and RCA (3). It was 
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performed soon after regulatory approval, and with an early version of the software at a 
time when operators had had minimal experience with the system. It compared the speed 
(procedure time) and the amount of radiation (fl uoroscopy time) needed to pass a wire, ei-
ther conventional or magnetic, to a particular coronary segment. In most segments this early 
iteration of the system did not show improvement in navigating most segments but only 
suggested benefi t in distal lesions such as the RDP with reductions in procedure time and 
fl uoroscopy time. An additional part of the study examined the use of the system in stented 
bifurcations and suggested an advantage. 
A later study used a 2 dimensional Perspex® model with 3 and 2mm channels to compare 
the eff ectiveness of conventional and magnetic wires in increasingly tortuous trajectories 
as well as comparing Interventionalists with diff erent levels of experience (4). This study 
showed that, while there was no signifi cant advantage in more straightforward trajectories, 
magnetic navigation improved wire passage in the more tortuous trajectories. Furthermore 
in inexperienced hands the improved success rate was maintained in more complex lesions. 
This improved success rate was associated with a reduction in the number of wires needed to 
complete complex trajectories properly. 
In conclusion, these phantom studies suggest a number of benefi ts and give some indi-
cation as to the areas where magnetic navigation may be particularly advantageous. First, 
there appeared to be particular benefi t in tortuous trajectories with the suggestion that this 
technology may help in the treatment of bifurcation lesions. Second, there appeared to be 
improvement across all levels of experience. Third, there was a reduction in equipment use. 
However, phantom studies have the limitations of their artifi cial nature exemplifi ed by their 
lack of movement, absence of stenoses, and an unnatural surface for wire passage and con-
clusions need to be drawn with caution and preferably should be mirrored by the fi ndings of 
clinical studies.
Case reports
The use of magnetic navigation has been described in a number of specifi c cases. Such case 
reports not only describe the feasibility of using the system in particular circumstances but 
also showcase the capabilities of the system.
An early case report demonstrated the ability to complete failed conventional procedures. 
In this case, a primary PCI had been performed conventionally but the bifurcation stenting 
procedure could not be completed with a kissing balloon dilatation as conventional wires 
would not cross into the sidebranch despite prolonged attempts (5). Attempts to cannulate 
the sidebranch conventionally had produced an angiographically visible perivascular dissec-
tion parallel to the sidebranch. A further attempt to cannulate the sidebranch was performed 
later in the magnetic catheterisation suite. Here it proved relatively simple to cannulate the 
sidebranch and perform a kissing balloon dilatation. This led to a good angiographic result 
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with obliteration of the perivascular dissection. This case not only demonstrated the ability 
to complete a case that could not be fi nished conventionally but also exemplifi ed a pos-
sible advantage in bifurcation lesions where wire passage through the side of the stent was 
required, echoing the results of phantom studies. 
It is clear that such navigation might be useful in complicated emergency procedures 
and this message was reinforced in a further primary PCI case (6). In this primary PCI case 
procedure, material was more evident on one side of the vessel while crossing the lesion. 
The magnetic fi eld was orientated to direct the wire away from the material. In addition, 
once fl ow was re-established, a bifurcation was seen. A bifurcation procedure was performed 
without incident. In this case the ability to steer the wire away from friable material and to 
steer without wire rotation (that would sweep around the circumference of a vessel and pos-
sibly dislodge material) could be an advantage in procedures where embolisation might be 
a risk such as primary PCI or diseased SVGs. In addition, the bifurcation proved easy to treat, 
again reinforcing a message about crossing a stent in a bifurcation. 
A further demonstration of use in complex anatomy was described in a case that had proved 
resistant to conventional technique (7). In this case 2 previous conventional procedures had 
failed despite the use of 5 catheters and 7 guidewires. A patient-specifi c 3D reconstruction 
was made from on-table angiography to give a tailored path from the LMS via the Cx to a 
remnant section of open vein graft and then on to the posterior descending branch of the 
RCA that fi lled retrogradely. While this did not prove to be a simple procedure, as it required 
an over-the-wire balloon and a support wire, it demonstrates the ability of the system to 
successfully navigate an extremely tortuous trajectory. In addition it also cautions that, while 
the wire may reach distal territories, new strategies to allow delivery of angioplasty materials 
may be needed.
The system has also been described in a diffi  cult case of alcohol septal ablation to cannulate 
the septal when conventional wires had failed (8). As it can occasionally prove problematic 
to enter septal branches, magnetic navigation may help to cross these extreme angulations. 
In this case there was a retrofl exed 130° angulation of the origin of the septal artery that a 
number of conventional wires had failed to properly cannulate due to prolapse when at-
tempting to advance more deeply. This case again demonstrates the ability of the system to 
navigate a single acute angulation that was impossible with conventional wires.
In conclusion these case studies demonstrate a number of points. They parallel the mes-
sage from phantom studies regarding the usefulness of the system in bifurcation procedures, 
extreme angulations, and complex, tortuous anatomy. They show that the system is clinically 
useful in failed conventional cases, in primary PCI, and in cases where extreme care is neces-
sary to avoid embolisation. However case reports are limited in that they are uncontrolled 
anecdotal reports that may have involved other factors than just the complexity of the lesion.
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Technical reports
There are a number of reports investigating the performance of technical aspects of the sys-
tem predominantly focussing on the accuracy of the measuring ability of the system (9,10).
These technical papers have both looked at the accuracy of calculated measurements of 
the dimensions of the reconstructions. In the fi rst study, 22 angiographic images of precision-
drilled plexiglass phantoms in pigs were compared both by the 3D reconstruction software 
(CardiOp-B™) and standard 2D software (CAAS II™). This showed that while there was good 
agreement of the 2 systems, underestimation was greater in the 3D system. A second study 
compared the 3D measurements with a newer 2D measurement system and showed a similar 
superiority of the 2D system. These results are not entirely surprising as the 3D reconstruction 
has been in development for a much shorter time than the 2D and in addition, it is impor-
tant to realise that the 3D reconstruction software has been primarily designed to provide 
reconstructions rather than measurements. However the reports identify the interest in the 
potential of such 3D imaging technology and the emphasis on continued development of 
this software.
Feasibility studies
The feasibility of the system has been described by a number of centres and at various stages 
since the system obtained regulatory approval (11-14). A very early study examined general 
feasibility of passage of a wire in 68 lesions in 59 patients (11). This study describes some of 
the very fi rst experience and, even at this early stage, showed a reasonable success rate of 
88% in crossing the lesion. Many of these procedures were completed with a conventional 
wire but it was noted that in 4 procedures the conventional wire failed and the magnetic 
wire succeeded, and that 3 of these failures were through the side of a stent into a jailed 
sidebranch, again paralleling results from the phantom and case studies. A second study at 
the same institution, also performed soon after system acquisition, compared crossing with a 
magnetic wire and then crossing-over to a conventional wire in 21 lesions (12). This study in-
cluded lesions described as having relatively simple and straightforward characteristics. The 
patients included were among the fi rst 70 patients attempted at that institution. While on 
one hand, this study found signifi cantly longer crossing times, more fl uoroscopy and greater 
contrast use, on the other hand it showed a success rate for the magnetic wire of 90%. These 
latter 2 studies both used the fi rst generation of magnetic wires and an early version of the 
navigation software and did not demonstrate a clear benefi t.
A further study looked at a more diffi  cult group of patients who were judged as diffi  cult or 
impossible for conventional technique (primary attempt group, n = 46) or had failed conven-
tionally (secondary attempt group, n = 13) (13). This study showed a reasonable success rate 
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of 84% in the diffi  cult (primary) group and a rate of 62%, well over half, in the conventional 
failure (secondary) group.
A further feasibility study has shown the initial experience of a center soon after system 
installation on a less-selected group of patients more representative of daily practice (14). 
The success rates were again reasonably high at 86%. However an important note was high-
lighting of a problem with complex subtotal stenoses.
In conclusion, these feasibility studies show that the system is useable and gives reason-
able success rates soon after system installation. However, there was no evidence of a clear 
superiority shown in these studies. However there has been some improvement with the 
newer generation of wires, newer software and more experience.
Comparative studies
The OLVG Registry (15) study provides the fi rst large single centre patient series describing 
the results obtained using magnetic navigation for PCI. This patient series included every 
patient treated by magnetic navigation from day 1. The procedures were examined by subdi-
viding the fi rst 320 patients into groups of 80 to examine issues such as a learning curve, and 
comparing the total group with historical controls. This center was deliberately organised 
with a small group of staff  highly familiar with the system in order to examine issues related 
to optimisation of the start-up of system use. 
In this fairly complex group of patients, success rates were high at 92% and procedural 
parameters were at least within the limits of usual practice. This study clearly showed a learn-
ing curve with improvements of over 50% in fl uoroscopy time between the fi rst group of 80 
patients and the latest of the groups. An estimate of a learning curve of approximately 100 
procedures was felt to be needed under these circumstances (small, dedicated team, routine 
use of the system in terms of regularity and use in all patient groups). This improvement 
appeared to be across the board with reduction in procedure and fl uoroscopy times and less 
contrast use. The system had a high initial success rates and was highly applicable and safe in 
day-to-day practice. The system was used with the both transradial and femoral approaches.
An important point is the identifi cation of inferior results in certain lesion types, such as 
CTO or severely eccentric tortuous lesions, and such lesions frequently needed to cross-over 
to dedicated angioplasty wires. 
The comparison with historical controls showed no signifi cant diff erence in fl uoroscopy 
and procedural times but a reduction in contrast use. Moreover, in the MNS group signifi -
cantly more lesions per patient were treated, while procedural and fl uoroscopy times were 
within the same range as the single lesion stent control group.
In conclusion the system was shown to be feasible, eff ective and there appeared to be 
reduction in contrast, irradiation and consumables that was particularly evident in complex 
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cases. A learning curve was demonstrated that has implications for the use of the system in 
other institutions.
Further analysis of this registry looked at particular sub groups with case matching to 
provide further insights into the eff ects. Cases have been matched for age, gender and vessel 
segment. In these case-matched groups, simple elective single vessel disease cases show a 
benefi t with a reduction in contrast but no signifi cant reduction in procedural or fl uoroscopy 
time. However, complex cases show a signifi cant improvement of all three of these param-
eters. The implications of this, if confi rmed by randomised control trials, could be signifi cant 
with two particular points of interest. First, the ability to reduce contrast even in simple cases 
may have implications for procedures in groups at risk of contrast-induced nephropathy. 
Second, this demonstrated a greater advantage in complex anatomy, not just in terms of 
success or failure but also in reduction in time, irradiation and contrast. This suggests that this 
technology may give particular improvement in the performance of complex, diffi  cult cases.
Stem cell injection
A possible development in stem cell delivery by intramyocardial injection may result from use 
of a magnetically-enabled, dedicated injection catheter, see fi gure 5 (1,15,17). This catheter 
has been shown to be eff ective in cell injection and accurate in targeting predefi ned seg-
ments (16). The use of magnetic navigation may not only improve accuracy of delivery but 
may also enable better identifi cation of suitable target areas as it allows easy, simultaneous 
electromechanical mapping with a combination of information derived on both movement 
(longitudinal linear shortening) and also electrical activity (unipolar voltage). 
Figure 5. Stem cell delivery catheter combined with better electromechanical measurements. See this fi gue 
in color in the Appendix page 379.
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Identifi cation of diffi  cult lesions
An important issue that emerges from review of the literature is the need for identifi cation 
of the most appropriate lesions for magnetic navigation. A system that is based upon the 3D 
morphology of the vessel from 3D reconstruction has been described (18). This examined 
the time needed to cross a lesion using a conventional wire and correlated this to various 
anatomical factors. A registry of procedures (awaiting publication) suggests that there was 
indeed a trend towards less infl uence on crossing times times in vessels/lesions having high 
complexity scores. The ability to predict diffi  culty and a method of classifying and comparing 
complex procedures may help to defi ne the patient population that would help derive the 
greatest benefi t.
Summary of points from the literature
The system is both feasible and useable for clinical use in PCI.
Particular anatomy appears to derive particular benefi t. These are tortuous segments, 
extreme angulation and bifurcations especially when crossing into sidebranches through a 
stent. These attributes clearly relate to complex or failed cases.
The literature indicates that use of magnetic navigation in such lesions may lead to benefi t 
in terms of procedural time, fl uoroscopy time and contrast use.
There appears to be a learning curve that may be optimised by the use of an defi ned, small 
group of users that regularly perform procedures. In addition early experience should not 
concentrate solely on diffi  cult cases.
There may be a wider range of diverse clinical indications that may benefi t from this tech-
nology such as alcohol septal ablaton or the delivery of stem cells.
LIMITATIONS
Procedural
Initial use of the system can be time consuming due to of a lack of familiarity with what is 
a complex system that requires the isocenter position, moving the magnets into the cor-
rect position, and time to reconstruct. However, once there is an established routine, these 
manoeuvres become fl uid and quick.
Care is suggested with intracardiac devices such as pacemakers and AICDs as the magnetic 
fi eld may aff ect function. While no problems have been described thus far, the eff ect of a 
magnetic fi eld on the device should be ascertained beforehand e.g. fi xed rate pacing for 
pacemakers or inhibition of shock delivery for AICDs. Settings should be checked before and 
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monitoring should be in place when the patient is brought into the magnetic fi eld. A further 
device check is advisable after the procedure. 
Software
The angiographic reconstructions still have a number of weaknesses. First, the reconstruc-
tions produced are susceptible to error if the diagnostic images are of poor quality. Angio-
graphic images that are foreshortened in one or both views may severely underestimate the 
true angulation, a problem that is not infrequently seen in reconstructions of the LMS where 
the wire may not get enough angulation to turn into the appropriate major vessel. Second, 
the precision of the reconstructions is marginal. As seen with the technical reports, dedicated 
systems for measurement perform better then the systems used for navigation, this may 
have consequences and infl uence the accuracy of the models and therefore the accuracy 
of navigation. Third, the reconstructions are static and normally taken from diastolic frames. 
This has repercussions on passage of the wire at other phases of the cardiac cycle as the 
diastolic direction may be diff erent to the direction in systole for the same point in the vessel.
On a minor level, the WLO is static and may exhibit a distracting scissoring of the WLO and 
the fl uoroscopic image.
The software is constantly under development to optimize ergonomics.
Hardware
Wires
The wire-tip is a solid magnet that is 3 or 2mm long. Clearly, this does not have the fl exibility 
of conventional wires that have a long history of development. This mainly leads to two 
problems:
Narrow channel angle grip
If calcium or tough scar tissue is present in an angulation it may prevent defl ection of the 
tip and maintain an orientation that directs the tip into the vessel wall and into the intimal 
layer. It can be physically impossible for the solid infl exible wire tip to pass through a narrow, 
highly angulated channel, see fi gure 6. This may explain the results in sub-total and chronic 
total lesions that may involve sharp turns in calcifi ed scarred tissue on a microscopic level.
Wire lock 
The solid wire tip can become trapped behind stent struts or calcium. Traction on the wire 
will lead to a kink at the junction of wire and magnet and the wire becomes ‘locked’, see 
fi gure 7. At this point the risk of wire fracture becomes high. The problem can be avoided by 
Mark bw.indd   74 25-05-10   15:15
75
Magnetically supported percutaneous coronary interventions
ensuring correct tip orientation during the procedure and can be reversed by advancing the 
wire tip, possibly supported with a balloon to free the tip.
A range of new wires such as the Pegasus and multi-magnet wires may alleviate these 
problems.
Figure 6. Schematic showing the wire tip attempting to turn a tight bend and being forced into the vessel 
wall.
Figure 7. The two stage process of wire lock
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Magnets
The magnetic fi eld direction control is achieved by the movement of heavy solid external 
magnets on the positioners. The inertia of these magnets means that the response time is 
slow and, for example, is one factor against the development of dynamic roadmaps.
CONCLUSION
New technology frequently suff ers from slow uptake. This technology is relatively new with 
limited market penetration due to a combination of factors. This has resulted in this tech-
nology for PCI being restricted to a few pioneer institutions and results from factors such 
as the limited amount of evidence that is currently available due to the limited time since 
regulatory approval combined with the system cost and the investment in time and eff ort to 
learn the technique.
SECTION 3: FUTURE DEVELOPMENT
Clinical 
Data is now accumulating from studies as to the possible clinical advantages of using the 
system and strategies to enhance the learning curve are developing (14). More data is 
needed from randomised trials to convincingly show benefi t and to identify which strategies, 
anatomy and patient groups can benefi t the most. Methods for identifying, classifying and 
comparing complex procedures need further development 
Technological
Future directions for research should include improvements in the software design and 
advancements in the hardware such as wire technology, RF ablation wire see fi gure 9 and 
remote control equipment, see fi gure 9.
Software developments include newer versions of the Navigant™ software. In particular, 
ease of use of current functions and improvements in integration are planned.
Hardware projects in development include a magnetically controllable RF wire for hard and 
tough lesions, fi gure 8 remote control system, fi gure 9 and the Odyssey screen, fi gure 10.
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Figure 8. Magnetically controllable RF wire for hard and tough lesions. See this fi gue in color in the Appendix 
page 380.
Figure 9. Remote control system. See this fi gue in color in the Appendix page 380.
Figure 10. Odyssey screen. See this fi gue in color in the Appendix page 380.
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SECTION 4: CONCLUSION
This new technology combines precise tip control, with image guided steering and the fl ex-
ibility of computer enhancement. The 3D reconstruction of a virtual coronary artery can be 
performed in real-time while the patient is on the table during an interventional procedure. 
These images may not only give a better appreciation of the anatomy with regards to tortu-
osity but also give a volume-rendered model with the computer-calculated magnetic fi eld 
direction control that allow magnetic navigation. These individualised, scale models supply 
the directions for defl ecting the wire as it passes through the vessel. 
The current advantages of this system in PCI include precise tip orientation, image-guided 
computer control and computer-enhanced image-processing. The current literature shows 
that there may be advantages of the system compared to conventional technique. Specifi -
cally, vessels with severe angulation(s), tortuousity, and particularly bifurcations that involve 
crossing stent struts may derive the greatest benefi t. However, sub-total calcifi ed lesions may 
prove less attractive with the current wire confi guration. Identifying the appropriate classes 
of lesion may reinforce the benefi t with respect to time, irradiation and contrast use that 
could have knock on eff ects on complications (such as contrast-induced renal dysfunction), 
the complexity of procedures (such as particularly complex or failed conventional procedures 
and on new areas of intervention).
This new technology could transform the practice of interventional procedures with the 
introduction of computer enhanced imaging and guidance that revolves particularly around 
the production of 3D models. 
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In vivo validation of a novel three- 
dimensional quantitative coronary 
angiography system (CardiOp-B™): 
comparison with a conventional two-
dimensional system (CAAS II™) and with 
special reference to optical coherence 
tomography
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ABSTRACT
Aims: To validate a novel 3-D QCA system (CardiOp-B™) and compare the 2-D (CAAS II™) 
and 3-D systems in in vivo experimental settings. The phantom lumen diameters were also 
assessed ex vivo by optical coherence tomography (OCT). The accuracy of the 3-D system has 
not been appreciated.
Methods and results: Precision-drilled plexiglass phantoms with 5 diff erent luminal diam-
eters that ranged from 0.5 to 1.9 mm were percutaneously inserted into the coronary arteries 
in four Yorkshire pigs. Twentytwo angiographic images of the artifi cial phantom coronary 
artery stenoses in the pigs were acquired as an in vivo validation test. Quantitative assess-
ments of the minimum and mean lumen diameters were performed using both QCA systems. 
Ex vivo images of the same phantom lumens were also taken and measured using OCT. Both 
of the 2-D and 3-D QCA systems signifi cantly underestimated the actual phantom lumen 
diameters with the exception of measurements taken in the lateral projection at isocenter 
using the 2-D QCA systems. This underestimation was more signifi cant in the 3-D system (ac-
curacy of 0.19 at isocenter; 0.23 by catheter calibration). There was good agreement between 
the two QCA systems. OCT measured the ex vivo lumen diameter of plexiglass phantoms 
precisely.
Conclusions: The accuracy of the luminal diameter measurements with the current 2-D sys-
tem was still superior to the 3-D system. Further development and validation studies under 
various conditions are warranted. The excellent results achieved by OCT with the ex vivo 
images indicate its potential as an intravascular quantitative imaging tool for future clinical 
practice. 
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INTRODUCTION
The fi eld of quantitative coronary angiography (QCA) has undergone substantial improve-
ment since the fi rst automated QCA developments took place 1980’s (1). Two major clinical 
applications have stimulated this improvement: 1) the on-line use during coronary interven-
tion procedures in catheterisation laboratories; 2) the use as an angiographic endpoint for 
the assessment of stent or pharmacological treatments in experimental and clinical trials. On 
the other hand, the use of two-dimensional (2-D) interpretation of lesion or vessel anatomy 
and the lack of information about the vessel wall (other than for calcifi cation) are well known 
limitations of current angiography and are situations where intravascular ultrasound (IVUS) 
can provide supplemental information. Development of online three-dimensional (3-D) ves-
sel reconstruction systems based on angiography may be a solution to the former limitation. 
The concept of 3-D reconstruction of coronary tree was postulated as early as the 1980’s (2). 
The routine use of a 3-D quantitative angiography system in the catheterisation laboratory 
could be a major improvement in interventional cardiology. Recently, a novel 3-D visualisation 
and quantitative analysis software system (CardiOp-B™, Paieon Medical Inc., Rosh Ha’ayin, 
Israel) has been introduced. This newly developed software system uses the detected vessel 
contours in two projections during coronary angiography to visualise a 3-D reconstruction of 
an arterial segment. Quantitative results are presented based on the reconstruction. Its utility 
and potential advantage over 2-D QCA systems has been reported (3,4). However, to date 
there have been no studies determining the accuracy of the 3-D quantitative angiographic 
technique by the in vivo measurement of precisely known vessel lumens. Our group has 
implemented in vivo validation techniques using radiolucent cylindrical plexiglass or poly-
amide stenosis phantoms with precision-drilled eccentric lumens in the fi eld of quantitative 
angiographic analysis (5-7). The aim of this study was to validate a novel 3-D QCA system 
(CardiOp-B™) and compare the 2-D and 3-D systems in in vivo experimental settings that 
simulated a diagnostic coronary angiogram. Aside from the primary objective, we also tested 
the accuracy of optical coherence tomography (OCT), a light-based imaging modality with 
a high resolution (10 μm), in the ex vivo measurement of lumen diameter using the same 
plexiglass phantoms. This additional examination was performed in order to investigate its 
potential as a quantitative intravascular imaging modality in the future. 
METHODS
This study was conducted according to the guidelines of the American Heart Association on 
animal use in research and was approved by the ethics committee on animal experimenta-
tion of the Erasmus Medical Center. 
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Plexiglas stenosis phantoms
The stenosis phantoms were manufactured at the workshop of the Erasmus Medical Center. 
The phantom stenoses that were used consist of radiolucent plexiglass (acrylate) and poly-
amide cylinders that have had precision-drilled circular lumens of 499 (aimed to be 0.5mm), 
707 (0.7 mm), 982 (1.0 mm), 1,367 (1.4 mm) and 1,921 μm (1.9 mm) in diameter (Figure 1). The 
outer diameters of the cylinders are 3.0 or 3.5 mm; the mean lengths of phantoms are 8.28, 
7.96, 7.85, 8.01, and 7.38 mm in 0.5, 0.7, 1.0, 1.4, 1.9 mm diameter phantoms, respectively. 
Optical calibration of the stenosis channels using 40 fold magnifi cation gives a tolerance of 
0.003 mm. A second 1.3 mm diameter lumen, parallel to the stenosis lumen, has been drilled 
in the cylinders to enable their attachment to the tip of 4 Fr Fogarty catheters (Vermed, 
Neuilly en Thelle, France). The lumens of the Fogarty catheters contained a removable metal-
lic stylet that aided the intracoronary insertion of the phantoms as well as their positioning 
in the radiographic isocenter. Details of our experimental approach to QCA validation have 
been previously described (5-7).
Animal preparation
Four Yorkshire pigs (average weight, 40 to 45 kg) were pretreated with intramuscular ket-
amine (20 mg/kg) and intravenous etomidate (5 mg/kg). The animals were then intubated 
and ventilated with a mixture of oxygen and isofl urane. Anaesthesia was maintained with 
a continuous intravenous infusion of pentobarbital (5-20 mg/kg/hour). 12 Fr introducer 
sheaths were inserted into both carotid arteries to allow the sequential insertion of the guid-
Figure 1. A: The magnifi ed tip of one of the Fogarty catheters used for mounting the phantom. Note the 
transparent radiolucent cylinder connected to the tip of the catheter with a channel of 1.9 mm diameter 
(white arrow) and the catheter lumen used for insertion of removable metallic stylet (black arrow). B: The 
catheter tip photographed perpendicularly to the long axis of the phantom lumen. Note the almost perfect 
circular aspect of the precision-drilled lumen (diameter 1.9 mm, white arrow). The catheter lumen used for 
insertion of metallic stylet is indicated with a black arrow. See this fi gue in color in the Appendix page 381.
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ing catheter and phantoms. Jugular access was used for the administration of medication 
and fl uid. An intravenous bolus (10,000 IU/l) followed by a continuous infusion of heparin 
was given. 
In vivo image acquisition of stenosis phantoms by fl uoroscopy
The digital angiograms were obtained with a biplane cine angiographic system (Axiom 
Artis™, Siemens, Forchheim, Germany) that employs a matrix size of 1,024 x 1,024 pixels. 
The radiographic system settings used were the same (kVp, mA, ms) in all projections. All 
phantoms were imaged in two projections simultaneously. After engaging the 6 Fr guiding 
catheter (Mach 1™, Boston Scientifi c Corp., Natick, MA, USA) in either the left or right coro-
nary artery, intracoronary isosorbide-dinitrate (1 mg) was administered. The fi rst angiogram 
was then performed for orientation purposes. The phantoms were wedged in the coronary 
arteries and positioned in the Xray isocenter using the tip of the metal wire as a marker. The 
wire was removed prior to angiography. Coronary angiography was performed by manual 
injection of contrast medium (Visipaque™ 320 mg I/ml, Amersham Health B.V., Eindhoven, 
The Netherlands). The ventilator was disconnected transiently during contrast injection to 
minimise the eff ect of diaphragmatic movement on angiographic images. 
Calibration
Two diff erent calibration methods were used during off -line analysis. 
1) Calibration at the isocenter: this method was performed using an automatic isocentric 
calibration - this is one of the calibration options of the biplane angiographic system. The 
calculated calibration factor is used for 2-D and 3-D QCA analyses by entering the number in 
millimetres in the manual calibration mode; 
2) Conventional catheter calibration: the non-tapering part of the tip of each 6 Fr guiding 
catheter fi lled with contrast was used as a reference. 
Quantitative angiographic analysis of ex vivo and in vivo phantom images
The off -line measurement of the minimum lumen diameter (MLD) and the mean lumen di-
ameter (mean LD) were performed by 2-D QCA (CAAS IITM version V2.0.1, Pie Medical Imaging, 
Maastricht, The Netherlands) as well as by 3-D QCA system (CardiOp-BTM version 1671017, 
Paieon Medical Inc.). For in vivo analysis, an end diastolic cine frame was selected. Manual 
edge correction is an option available in both systems, but this was intentionally never al-
lowed in the present analyses. In the 2-D system, a restriction option was applied in order to 
correct for an unsatisfactorily detected contour in one image. This option is not technically 
a manual correction, but off ers users the possibility of excluding parts of the image of the 
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detection by restricting the area of interest. For the one measurement with the 3-D system, 
the automatically determined stenotic segment was manually corrected to avoid the mea-
surement of the MLD at the site of a discrete intraluminal fi lling defect. Minimum values as 
well as mean values were determined as the diameters of the stenosis phantom lumens. Each 
angiographic image that was analysed or calibrated (for catheter calibration) was designated 
specifi cally by the number of the frame count so that all of the analyses using both QCA 
systems were performed upon identical images. 
2-D QCA system
The diameter of the stenosis phantoms was calculated with an automatic contour detection 
technique. The user is able to defi ne a number of centreline points within the vessel segment. 
The frontal and the lateral images are analysed separately. The mean LD of the phantom lu-
men is obtained with the CAAS II™ system from a user defi ned region of interest (ROI) where 
the two vessel contours are considered to be parallel (Figure 2). 
C
mm
C A
Diameter
3,40
0,90
A B C
Figure 2. Angiographic visualisation of the artifi cial coronary obstruction produced by a 1.0 mm stenosis 
phantom in the left anterior descending artery (A) with subsequent quantitative measurement of luminal 
diameter by 2-D QCA system (CAAS II™) (B, C). The bidirectional arrow indicates the region of interest for 
mean luminal diameter (C). See this fi gue in color in the Appendix.
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3-D QCA system
This system uses the contours detected in the frontal and lateral images in combination with 
the projection data in the DICOM format into a 3-D reconstruction of an arterial segment. The 
two acquired images that are used for reconstruction must diff er by an angle of at least 30 
degrees. In this study, two orthogonal views, simultaneously acquired by the biplane system, 
were used for reconstructing a 3-D vessel image. If calibration was performed in one view, 
further calibration was not requested in the second corresponding view. To perform quan-
titative analysis, the user is requested to mark three points: proximal and distal reference 
points and point within the stenosis. The severity of the stenosis is indicated by the colour 
given by the computer to the reconstructed segment that varies from white (healthy vessel) 
to dark red (99% cross-sectional area stenosis) (Figure 3). The minimum luminal diameter 
values are automatically given as one of the default quantitative data. As mean LD within the 
user-defi ned ROI is not automatically supplied in this system, we obtained the values using a 
text import wizard of MS Excel 2003. The current version of 3-D QCA system does not provide 
quantitative degree of vessel curvature and bifurcation angle between main and side branch.
Figure 3. Illustration of the 3-D reconstruction process by CardiOp-BTM. Color-coded 3-D reconstruction 
of coronary artery with artifi cial stenotic segment (3-D Reconstruction view) is derived from 2 orthogonal 
views (Frontal and Lateral). The 3-D colour varies according to the severity of stenosis ranging from white 
(healthy vessel) to dark red (99% cross-sectional area stenosis). The squares in pale blue, yellow and green 
denote proximal reference point (P), most stenotic point (S) and distal reference point (D) of the target 
lesion, respectively. The region of interest (ROI) for calculation of mean luminal diameter can be manually 
defi ned by moving the proximal (P) and distal (D) points (Defi nition of ROI for mean LD; Graph view). 
See this fi gue in color in the Appendix page 381.
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Ex vivo image acquisition of stenosis phantoms by OCT
We prepared a fl uid mixture containing 90% degassed water and 10% ethanol as an ex vivo 
replacement for blood. The room temperature was kept at 22 °C. These conditions are similar 
to those required for the preparation for an ex vivo validation of intravascular ultrasound 
(8,9). The OCT wire was inserted into the fi ve diff erently sized phantom lumens. Images were 
obtained with the M2 OCT imaging system (Lightlab Imaging, inc.). The M2 OCT system uses 
a 1,310-nm broadband light source to produce images with an axial resolution of 15 μm and 
a lateral resolution of 25 μm by the principle of interferometry. The M2 uses the ImageWire™ 
imaging probe to deliver light to the tissue and collect the returning signals. The ImageWire™ 
consists of 0.006-inch (0.15 mm) fi beroptic core, inside a sheath with a maximum o.d. of 0.019 
inch (0.48 mm). 
OCT image analysis
The images were stored for off -line analysis in the OCT system computer. The analysis was 
performed using proprietary software from Lightlab Imaging, Inc. with a mouse based 
interface. The system was calibrated to the refl ection of the OCT imaging wire that is the 
standard calibration technique for this system. Lumen diameter and lumen area in each of 
the 5 phantoms were measured.
Intra- and inter-observer variability assessment
Two independent observers, who were blinded to the real phantom diameters, assessed 
reproducibility by measuring the minimum and mean luminal diameter using each of the 
two QCA systems. In the ex vivo cases imaged by OCT, only the cross sectional diameter was 
analysed and used for evaluation of reproducibility. These examinations by two observers 
were performed on diff erent days. One of the two observers performed second measure-
ments on diff erent days for assessment of individual reproducibility. 
Statistical analysis
The individual values for minimum and mean luminal diameter obtained by both QCA 
systems were compared with the corresponding values of the phantom by paired t test (two-
tailed). Additionally, the data were plotted against the actual phantom diameter values and 
a linear regression analysis was applied. The mean diff erences between measured luminal 
diameters and the corresponding phantom dimensions were computed and considered to 
be an index of the accuracy of the measurements, while the standard deviation of the diff er-
ences was defi ned as an index of precision. The relative standard deviation was calculated 
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(precision / mean of measured diameter value x 100) to assess the degree to which the sets 
of diameter data points varied. In order to determine the agreement between 2-D and 3-D 
QCA systems, Bland-Altman analysis was performed (10). Statistical analyses were performed 
with SPSS 12.0.1 for Windows (SPSS Inc., Chicago, IL, USA). A p value < 0.05 was considered 
statistically signifi cant. 
RESULTS
Thirty coronary angiographic images were acquired after intracoronary insertion of the 
stenosis phantoms. Three images were excluded from the QCA analysis because of extreme 
foreshortening of the stenosis segment in frontal views. Five images that had insuffi  cient 
arterial fi lling using the 0.5 or 0.7 mm phantoms were also excluded. The remaining 22 im-
ages were used for the diameter measurements using both QCA systems. In vivo intra- and 
inter-observer variability of the 2 QCA systems and ex vivo OCT was calculated in all the 22 
analysable images ( 1). Satisfactory reproducibility was noted in all of the two QCA systems 
and OCT. 
Table 1. Intra- and inter-observer variability of lumen diameter.
Intra-observer Inter-observer
Diff . r Intercept Slope Diff . r Intercept Slope
Ex vivo analysis
 OCT lumen diameter 0.03±0.02 1.000 –0.01 0.99 0.00±0.05 0.996 0.04 0.97
In vivo analysis
 2-D QCA system
  Isocentric
   Frontal MLD –0.01±0.03 0.997 –0.01 1.01 0.02±0.11 0.969 -0.02 1.00
   Lateral MLD 0.00±0.03 0.998 0.00 1.00 0.06±0.09 0.985 0.03 0.92
   Frontal mean LD –0.01±0.03 0.998 –0.02 1.01 0.02±0.08 0.982 -0.02 1.00
   Lateral mean LD 0.01±0.05 0.993 0.02 1.00 0.06±0.08 0.986 0.03 0.93
  Catheter
   Frontal MLD –0.01±0.06 0.991 0.05 0.94 0.00±0.10 0.972 0.01 0.99
   Lateral MLD 0.02±0.05 0.993 0.00 1.02 –0.03±0.09 0.983 0.01 1.02
   Frontal mean LD –0.01±0.08 0.981 0.06 0.93 0.00±0.07 0.984 0.00 1.00
   Lateral mean LD 0.00±0.05 0.991 0.04 0.97 –0.02±0.07 0.989 0.00 1.02
 3-D QCA system
  Isocentric
   MLD 0.01±0.03 0.997 0.01 1.00 0.01±0.09 0.973 0.06 0.95
   Mean LD 0.00±0.03 0.997 –0.04 0.97 0.03±0.06 0.988 0.11 0.93
  Catheter
   MLD 0.00±0.06 0.986 –0.02 1.03 0.01±0.08 0.973 0.09 0.92
   Mean LD –0.01±0.05 0.994 –0.05 1.04 0.03±0.09 0.972 0.11 0.92
LD = luminal diameter; MLD = minimum luminal diameter; OCT = optical coherence tomography; QCA = 
quantitative coronary angiography
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In vivo assessment of luminal diameter by 2-D and 3-D QCA
The comparative results of the actual phantom lumen diameter and the dimensional values 
derived from both QCA systems are shown in Table 2 along with Figures 4 and 5. 
In both systems, accuracy was better with isocentric calibration compared to catheter calibra-
tion. Mean luminal diameter measurements yielded better accuracy than minimum values in 
any of the dimensional measurements. Among the 8 methods of diameter measurements in 
the 2-D QCA, mean luminal diameter by isocentric calibration in lateral view proved to have 
the best accuracy (0.01 mm). Both systems signifi cantly underestimated the actual phantom 
diameter values, except for minimum and mean diameters in the lateral view with isocentric 
calibration. There was again good correlation between luminal diameter measurements and 
phantom actual diameter values with both QCA systems (r=0.961 ~ 0.987). However, the 
2-D QCA system demonstrated better values of accuracy than the 3-D system in diameter 
measurements regardless of the calibration option.
Table 2. Summary of in vivo validation results of 2-D and 3-D QCA systems (CardiOp-B™) (22 observations)
Measured 
diameter (mm)
Accuracy Precision Relative 
SD* (%) 
Correlation SEE Intercept Slope p-value of 
paired t test
2-D QCA
 Isocentric
  Frontal MLD 1.07 0.10 0.12 11.1 0.968 0.11 0.04 0.88 0.001
  Lateral MLD 1.06 0.10 0.08 7.9 0.985 0.07 0.00 0.91 < 0.0001
  Frontal mean LD 1.19 –0.03 0.09 7.9 0.983 0.08 0.17 0.88 0.17
  Lateral mean LD 1.15 0.01 0.09 7.6 0.987 0.07 0.13 0.88 0.43
 Catheter
  Frontal MLD 0.98 0.18 0.12 12.4 0.971 0.10 0.01 0.83 < 0.0001
  Lateral MLD 1.01 0.16 0.11 11.2 0.977 0.09 0.03 0.84 < 0.0001
  Frontal mean LD 1.09 0.07 0.11 9.9 0.980 0.08 0.11 0.84 0.005
  Lateral mean LD 1.10 0.06 0.10 9.2 0.984 0.07 0.12 0.84 0.009
3-D QCA
 Isocentric
  MLD 0.98 0.19 0.13 13.7 0.966 0.10 0.04 0.80 < 0.0001
  Mean LD 1.04 0.13 0.10 9.4 0.985 0.07 0.05 0.85 < 0.0001
 Catheter
  MLD 0.93 0.23 0.14 15. 2 0.970 0.09 0.05 0.76 < 0.0001
  Mean LD 0.99 0.18 0.13 11.4 0.984 0.07 0.05 0.80 < 0.0001
* (precision/mean of measured diameter value) x 100
LD = luminal diameter; MLD = minimum luminal diameter; OCT, QCA = quantitative coronary angiography; 
SD = standard deviation
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Agreement between 2-D and 3-D QCA systems
A direct comparison between the 2-D (frontal views) and the 3-D QCA systems is shown in 
Figure 6. The two systems demonstrate good correlations in diameter measurements (r=0.947 
isocenter, minimum; r=0.982, isocenter, mean; r=0.940, catheter, minimum; r=0.976, catheter, 
mean). The plot of diff erences between both systems demonstrates satisfactory agreement 
over the entire range of phantom sizes. This proved to be true for calibration at the isocenter 
as well as for catheter calibration (Figure 6). 
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Figure 4. Two-dimensional QCA assessment of minimum (continuous black lines) and mean luminal 
diameter (continuous grey lines) with calibration at the isocenter in frontal (A) and lateral views (B) and 
with catheter calibration in frontal (C) and lateral views (D). The dashed lines indicate the line of identity.
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Figure 5. Three-dimensional QCA assessment of minimum (continuous black lines) and mean luminal 
diameter (continuous grey lines) with calibration at the isocenter (A) and with catheter calibration (B). The 
dashed lines indicate the line of identity. See this fi gue in color in the Appendix page 382.
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Ex vivo assessment of luminal diameter by OCT
Figure 7A depicts the linear regression analysis of comparison between actual phantom 
luminal diameter versus ex vivo diameter values derived from OCT. OCT-based dimensional 
values proved to correlate extremely well with the real luminal diameter (accuracy= – 0.03, 
precision=0.02, relative standard deviation=1.8%, r=1.000, intercept=0.01, slope=1.02). OCT 
clearly visualised the circular lumen of plexiglass phantom (Figure 7B). 
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Figure 6. Bland-Altman plots of the diff erences between the minimum and mean luminal diameter 
measurements acquired by the 2 systems versus means of the measurements. A: minimum diameter with 
calibration at the isocenter. B: mean diameter with calibration at the isocenter. C: minimum diameter with 
catheter calibration. D: mean diameter with catheter calibration. The data from the frontal view are used as 
2-D QCA measurements. See this fi gue in color in the Appendix page 383.
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Figure 7. A: Linear regression analysis of the phantom lumen diameter versus the cross-sectional luminal 
diameter measured with OCT. B: Representative OCT images of the stenosis phantom with 1.4-mm lumen. 
Arrow: 1.4-mm lumen for measurement; arrow head: lumen for guidewire. See this fi gue in color in the 
Appendix page 383.
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DISCUSSION 
The results of the present study indicate the following three fi ndings: 1) the 3-D QCA system 
signifi cantly underestimated actual phantom diameter values compared to the 2-D system; 
2) the 3-D QCA system showed a good agreement with the 2-D QCA system; 3) the values 
of the ex vivo diameter measurements by OCT were almost identical to the actual phantom 
diameter values. As the number of coronary interventions has increased over the years, the 
complexity of target lesions has increased concomitantly. Development of a 3-D visualisa-
tion and quantitative analysis system has been encouraged by the increasing need to better 
understand the true vessel structure and the spatial orientation of complex features and to 
quantify vessel morphology more precisely. There is a growing interest in applying this new 
technology as an additional imaging tool in interventional cardiology. Recently, the feasibil-
ity and potential superiority of 3-D QCA system in the measurement of 38 coronary lesions 
was reported by comparing it with a 2-D QCA system (Medview™, Medcon Telemedicine 
Technology, Tel Aviv, Israel) (3). However, this 3-D QCA system should be evaluated in com-
parison with the largely validated conventional 2-D QCA systems (5,7,11,12). Moreover, the 
accuracy or limitations of this system can only be appreciated by measuring in vivo vessels of 
known lumen dimensions. This is especially important since the accuracy of the reconstruc-
tion is not only the basis for quantitative results but also for producing a correctly visualised 
image. In theory the 3-D quantitative analysis should fully correct for foreshortening and 
out-of-plane magnifi cation diff erences. Systematic underestimation of luminal diameter 
measurements was noted for both QCA systems and this was more signifi cant in the 3-D 
system. The image acquisition was performed by hand injection of contrast and this may 
result in less radiographic opacity of stenotic segment compared to mechanical injection. 
Consequently automated detection of vessel boundaries might have been aff ected leading 
to smaller diameter values than expected having been derived. However, even with mechani-
cal contrast injection, the angiographic examination of these high-grade stenosis phantoms 
cannot always be satisfactory because of possible intraluminal thrombus that results from 
the reduced blood fl ow or from the presence of intraluminal cellular debris collected during 
the insertion of the phantoms. The values of the both QCA systems with catheter calibration 
were smaller than those obtained with calibration at isocenter. This might be explained by an 
out-of-plane magnifi cation phenomenon: a greater distance between the image intensifi er 
and the catheter tip than between the image intensifi er and the isocenter that would result in 
a smaller calibration factor (13,14). In the 2-D QCA system, lateral views showed better accu-
racy and precision than frontal views. Foreshortened images were more frequently observed 
in frontal views than in lateral views. Accordingly, suboptimal contour detection of frontal 
images might have occurred. Although theoretically the 3-D reconstruction should enable 
the correction of foreshortening and out-of-plane magnifi cation errors, these improvements 
could not be identifi ed in the present analysis. OCT is a novel imaging modality that provides 
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intravascular images that have a resolution of approximately 10 - 20 μm. This 10-fold greater 
resolution in comparison with IVUS enables visualisation of microscopic structures within the 
coronary arteries (15,16). In vivo dimensional and volumetric measurements of implanted 
coronary stents have shown that OCT can produce accurate results that are comparable to 
IVUS (17). Post-mortem analysis suggested that OCT can measure the intima-media thickness 
more accurately than IVUS (18). Currently OCT is regarded as a modality that may surpass 
the performance of angiography or IVUS after stent implantation (19,20). The present study 
provided ex vivo validation of OCT with respect to diameter measurements. Unfortunately, 
we could not compare OCT to IVUS because the IVUS catheter could not cross phantom 
lumens smaller than 1.0 mm. Furthermore in vivo examination would most likely prove dif-
fi cult in these high-grade stenoses as the presence of a wire itself might result in the rapid 
development of intolerable ischaemic changes for the animals even before the induction of 
further ischaemia by the OCT occlusion balloon.
LIMITATIONS
This validation test using concentric cylindrical phantoms was originally designed to test 2-D 
QCA systems (5,7,11,12). The use of phantoms with a regular circular lumen does not allow 
the assessment of asymmetry. Here the use of reconstruction from two projections included 
in one 3-D result supplies information of lesion asymmetry more precisely than that available 
from 2-D analysis. Since the precise and validated eccentric phantoms were not readily avail-
able, we decided to conduct the present study with previously established approach using 
concentric phantoms (5,7,11,12). The 3-D reconstruction is based on two imaged diameters 
that results in an oval cross section where the 2-D analysis is based on one image results in a 
single diameter to be used for a circular cross section. However, densitometric analysis avail-
able in the 2-D QCA system can provide estimates for cross sectional areas in complex lesions 
(21,22). Our results were based on a series of small-size (< 2 mm) lumen phantoms. From a 
clinical point of view, validation tests using larger-size (> 2.25 ~ 2.5 mm) phantoms might 
be more relevant to investigate whether this 3D system is useful as a tool to determine the 
optimal device size, or to confi rm the acute post-procedural results during the interventional 
procedures.
CONCLUSIONS
The minimum and mean luminal diameter measured with the 3-D QCA system underes-
timated the true phantom lumen diameter more than 2-D QCA. However, since there was 
a strong correlation with the 2-D QCA system, this system could be a useful alternative in 
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clinical practice. OCT precisely measured the lumen diameter of plexiglass phantoms in this 
ex vivo experimental setting. In addition to its usefulness in the quantitative assessment 
of coronary plaque, this imaging tool could be developed further as a reliable device for 
intravascular quantitative assessment with the advancement of less invasive preparation for 
the image acquisition.
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ABSTRACT
Objectives: To directly compare the magnetic navigation system (MNS) guidewires with 
conventional guidewires in branching tortuous phantoms with operators of varying MNS 
and percutaneous coronary intervention experience. 
Background: Vessel tortuosity, angulation, and side branches remain limiting factors in 
coronary interventions. The MNS addresses these limitations by precisely directing the tip of 
a magnetised guidewire in vivo aided by two permanent adjustable external magnets. 
Methods: Crossing and fl uoroscopy times of six operators were evaluated in fi ve tortuous 
PerspexTM phantom vessels in three consecutive attempts. Standard guidewire (SG) usage 
was unrestricted. Two second generation magnetic guidewires (MG) were used. Failure was 
noted if the cross was unsuccessful within 5 min. 
Results: The magnetic navigation was vastly superior to SG techniques with increasingly 
tortuous phantoms. It dramatically decreased both the crossing and fl uoroscopy times with 
maximal reduction from 201.7 ± 111 to 36.4 ± 13 sec, P < 0.001 and 204.7 ± 24 to 47.2 ± 19 
sec, P < 0.001, respectively. The MNS had a 98.8% procedural success rate compared to 68% 
with SG techniques. Moreover it considerably limited the amount of wire usage from 5.5 to 
1.3. Operators with prior MG experience performed signifi cantly better than those without, 
except in the simplest phantom where the diff erence was non signifi cant (33.8 ± 13 sec vs. 
41.7 ± 17 sec, P = 0.2). 
Conclusion: MNS signifi cantly reduces both the crossing and fl uoroscopy times in tortuous 
coronary phantom models achieving excellent success rates with dramatic reductions in 
guidewire usage. Operators with prior MNS experience had an advantage over the inexpe-
rienced.
A Randomised Study Comparing 
Conventional and Magnetic Guidewires in a 
2D Branching Tortuous Phantom
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INTRODUCTION
The tortuosity and side branches in a coronary tree can determine the procedural outcome 
of a percutaneous coronary intervention (PCI) (1). An appropriate guidewire that manoeuvres 
easily through a tortuous segment or side branch can avoid complications such as a dissec-
tion or a perforation. The success in crossing a lesion depends both on the appropriate shape 
at the tip of the guidewire and the manual dexterity of the operator. As such the tip of a 
guidewire may require reshaping several times during an interventional procedure in a pro-
cess of trial and error. Additionally, the frictional contact of a preshaped wire on the vascular 
wall can limit the amount of torque transmitted by the operator leading to wire prolapse. As 
complexity increases these standard coronary guidewire limitations can often lead to longer 
procedural and fl uoroscopy times together with the use of higher contrast loads (2). The 
magnetic navigation system (MNS) with its steerable wire can potentially address some of the 
above limitations (3). In a random set of patients who underwent PCI, both the procedural 
and fl uoroscopy times were signifi cantly reduced (4) and confi rmed results obtained in a non 
tortuous coronary vessel phantom (5). To address tortuosity, more complex and tortuous 
anatomy phantom models of the hepatic, celiac arteries (6), and the cerebral arteries (7) have 
been previously used to compare MNS with standard techniques but thus far no comparison 
has been made with tortuous coronary phantoms by practicing interventional cardiologist.
In this randomised study we assessed the effi  cacy of the MNS guidewires with conventional 
guidewires in phantom vessels with varying degrees of angulation and reduction in vessel’s 
calibre so as to mimic a coronary trunk and its’ side branch. Our aims were to determine: (a) 
the crossing time to reach to a fi xed point on the phantom using magnetic navigation in 
comparison to manual manipulation of the wire in the hands of interventional cardiologists 
with varying MNS experience, (b) to determine if there is a reduction in fl uoroscopy time, (c) 
and to assess the procedural success and wire usage between the two diff erent approaches 
for each of the phantom vessels evaluated.
Materials and Methods
The Magnetic Navigation System The Stereotaxis Niobe® II MNS (Stereotaxis, St. Louis, MO) 
has two permanent adjustable magnets that can be rotated, translated, or tilted to produce 
a uniform magnetic fi eld of 0.08 T. This fi eld precisely directs a tiny magnet mounted on the 
tip of a guidewire by changing its’ magnetic moment and allows fi ne control of the orienta-
tion of the tip of the guidewire in space. The system is integrated with a modifi ed C-arm 
fl at-panel detector fl uoroscopic imaging suite (AXIOM Artis dFC, Siemens Medical Solutions, 
Forchheim, Germany) for angiographic imaging. A three-dimensional (3D) virtual vessel 
roadmap can be created from two angiographic images provided that they are 30o apart 
by using reconstruction software (CardiOp-B, Paieon Medical, Rosh Ha’ayin, Israel). As our 
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phantom models were two-dimensional (2D) we chose the alternative 2D mode displayed 
as a ‘‘clock-face’’ on a touch screen monitor (Fig. 1). In this 2D navigation mode touching the 
screen at a particular point results in the Navigant software calculating a vector that directs a 
magnetic fi eld to align the wire tip in the desired direction. The advantage of this technology 
is that it allows a full 360o omni directional rotation of the tip of the wire at anytime during 
the procedure, in vivo, without the need for a preshaping wire’s tip.
The Guidewires 
The Titan™ Soft Support coronary guidewire (Stereotaxis, St. Louis, MO) is a 180 cm moderate 
support, hydrophilic coated wire with a diameter of 0.014 in./0.36 mm having a fl exible 2-cm 
distal coiled tip that has a 2 or 3 mm gold cup neodymium-iron-boron magnet attached. The 
Pegasus™ guidewire is similar to the Titan Soft Support coronary guidewire apart from its 
more hydrophilic nitinol coating. The conventional wires used in the study were PT Graphix™ 
Intermediate, Choice™ PT Floppy (Boston Scientifi c, Miami, FL), Miracle bros™3G (Abbott 
Vascular Devices, Redwood, CA) and high torque BMW (Guidant, Santa Clara CA). 
The Phantom 
The phantom is a PerspexTM model with 3 and 2 mm channels simulating fi ve diff erent tortu-
ous vessels with varying degrees of diffi  culty graded 1–5 due to increasing angulations and 
Figure 1. The ‘‘clockface’’ navigation system. See this fi gue in color in the Appendix page 384.
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side branches (Fig. 2). In the least tortuous phantom A both the magnetic (MG) and standard 
(SG) guidewires were required to traverse a 120o turn followed by a right angle bend in a 
simulated vessel of 3 mm calibre. This was in contrast to the most challenging and tortuous 
simulated vessel (phantom E) where a 3 mm vessel gave rise to a 2 mm side branch at a 
right angle and then made a sharp 120o turn. To simulate tissue lubricity the phantoms were 
wetted with a mixture of soap and diluted contrast.
The Procedure
The phantom model was fi tted with a 6 French diagnostic catheter, fi lled with 20% contrast 
solution and placed in the magnetic fi eld of the MNS. Six interventional cardiologists from 
our institution were divided into three groups depending on their level of experience with 
magnetic navigation and SG techniques. In the group 1, operators 1 and 2 had the most 
MNS experienced with each having performed more than 35 magnetic aided cases. Group 2 
(operators 3 and 4) had moderate MNS experience with less than 35 cases and group 3 had 
MNS inexperienced operators (operators 5 and 6) and they were also the most junior of all the 
conventional interventionalists. The operators were randomly assigned to start with either a 
Figure 2. The phantom A–E with diagramatic representation of the level of diffi  culty. The angles and ‘‘vessel’’ 
caliber are as follows: (A) 3 mm, 120o turn into a 3 mm, 90o turn; (B) 3 mm, 120o turn into a 3 mm, 90o turn; (C) 
3 mm, 60o turn into a 3 mm, 120 turn and then into a 60o turn to a 2 mm vessel; (D) 3 mm, 90o into a 2 mm 
followed by a 90o turn; (E) 3 mm, 90o into a 2 mm followed by a 120o turn. The ‘‘arrow’’ indicates the starting 
point and the asterisk (*) show the end of each phantom run. See this fi gue in color in the Appendix page 384.
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SG of their choice or one of the two 2nd-generation magnetically enabled wires. Operators 
had to manipulate their guidewire past a fi xed point along the simulated phantom vessel 
(A–E). The crossing and fl uoroscopy times were measured when the wire positioned at the 
tip of the catheter passed a predetermined fi xed point on the phantom (Fig. 2). Recordings 
for both the MG and SG were triplicated for each simulated phantom vessel and an average 
crossing and fl uoroscopy time was determined for each group of operators. To compensate 
for any deterioration in the guidewire’s tip or wire performance during the procedure the op-
erators were allowed to exchange a damaged wire for a new or diff erent guidewire as many 
times as deemed necessary so as to achieve a successful cross within 5 min. If the vessel was 
not crossed during this 5-min period then the attempt was classed as unsuccessful due to a 
time failure. Each time failure was recorded as 300 sec for both the crossing and fl uoroscopy 
times. However, it must be stressed, that this value was in fact an underestimation of the time 
it would have taken if the operator had eventually crossed the simulated vessel. 
Statistics 
As the crossing times and fl uoroscopic exposure times were continuous variables they are 
presented as means and standard deviation. T-test and one-way ANOVA (Bonferoni) were 
used to determine if there were signifi cant diff erences in the procedural time and fl uoro-
scopic times. Analyses were performed using SPSS 11.5 for Windows (SPSS, Chicago, IL). P 
value <0.05 was considered statistically signifi cant.
RESULTS
Crossing and Fluoroscopy Times in Phantoms A–E
Overall, the MG was vastly superior to the SG in both the crossing and fl uoroscopy times (Fig. 
3). The SG was faster than the MG in phantom A (41.8 ± 26 sec vs. 47.9 ± 20 sec, P = 0.3) how-
ever the diff erence was not signifi cant (Fig. 3A). In phantom B, the average MG crossing time 
was shorter than the SG (49.3 ± 23 sec vs. 76.5 ± 65 sec, P = 0.1) but was signifi cantly less in 
the more tortuous phantoms C and D with dramatic reductions in crossing times from 201.7 
± 111 to 36.4 ± 13 sec, P < 0.001 and 204.7 ± 24 to 47.2 ± 19 sec, P < 0.001, respectively. Similar 
results were observed with the most angulated phantom E where it was greatly superior in 
manipulating through a 2 mm side branch (89.1 ± 65 sec vs. 247.3 ± 82 sec, P < 0.001). In the 
majority of cases the trend of fl uoroscopy times (Fig. 3B) closely mimicked that observed in 
the crossing times. As such, phantom A had longer fl uoroscopy times with the MG (47.7 ± 23 
sec vs. 72.0 ± 58 sec, P = 0.1) and phantom B had longer fl uoroscopy times with the SG (47.7 
± 23 sec vs. 72 ± 58 sec, P = 0.1). With increasing complexity (phantoms C–E) there were both 
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signifi cant and dramatic reductions in fl uoroscopy times similar to that reported with the 
crossing times.
Sub-Group Analysis of Crossing Times in Phantoms A–E
On the subgroup analysis of the operator performances (Fig. 4), in the simplest phantom 
A the most MNS experienced operators (group 1) were signifi cantly faster (28.5 ± 9 sec vs. 
60.7 ± 18 sec, P < 0.007) than those inexperienced (group 3). This was not surprising as the 
inexperienced group needed to get acquainted with the equipment. The overall decrease 
performance of the MG to the SG (41.8 ± 26 sec vs. 47.9 ± 20 sec, P = 0.3) was thus due to 
the longer times attained by groups 2 and 3 since group 1 was faster with the MG (28.5 sec 
vs. 32.8 sec). In phantom B, group 1 performances with the MG were also signifi cantly faster 
than group 3 (26.2 ± 4 sec vs. 53.7 ± 13 sec, P = 0.025) but there was no signifi cant diff erence 
observed between groups 2 and 3 (68.0 ± 24 sec vs. 53.7 ± 13 sec, P = 0.4). Of note in this 
phantom, both groups 1 and 3 times with the SG were more than twice that of MG (64.7 and 
112.8 sec vs. 26.2 and 53.7 sec, respectively) with the intermediate experienced group 2 hav-
ing no signifi cant diff erence with either wire (MG, 68.0 sec and SG, 52.0 sec). As the tortuosity 
and branching increased (phantoms C–E) there was a dramatic diff erence between the MG 
and SG performances amongst all the groups (Fig. 4).
In phantom C there was no signifi cant diff erence between all the MG users regardless of pre-
vious MNS experience and in phantom D only group 1 remained signifi cantly faster than group 
3 (39.5 ± 12 sec vs. 62.7 ± 21 sec, P = 0.008). With the conventional wire technique a similar 
Figure 3. (A) The average crossing times/sec obtained using SG and MG for all operators with phantoms 
A–E. (SG, standard guidewire; MG, magnetic guidewire). (B) The average fl uoroscopy times/sec obtained 
using SG and MG for all operators with phantoms A–E. (SG, standard guidewire; MG, magnetic guidewire). 
See this fi gue in color in the Appendix page 385.
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trend was observed with no signifi cant diff erences between the senior (groups 1 and 2) and 
the junior (group 3) operators in both phantoms C (190.8 ± 113 sec vs. 223.7 ± 112 sec, P = 0.6) 
and phantom D (205.9 ± 106 sec vs. 202.3 ± 109 sec, P = 0.9). This trend continued in phantom E 
where groups 1 and 3 had non signifi cant time diff erences (244.2 ± 99 sec vs. 271.5 ± 70 sec, P = 
0.9) with the SG and group 1 still being signifi cantly faster with the MG than group 3 (48.8 ± 12 
sec vs. 141.5 ± 85 sec, P = 0.03). Overall, the operators with previous MNS experience (groups 1 
and 2) performed better (62.8 ± 31 sec vs. 141.5 ± 85 sec, P = 0.01) in this phantom. 
Procedural Success and Wire Usage in Phantom A–E
There were 100% successful crossings in phantoms A and B with both the MG and SG (Fig. 
5A). In phantom C and D, the procedural success with the SG was (10/18) 56% and (9/18) 50%, 
respectively as compared to a 100% success with the MG. The success of the SG in the most 
tortuous phantom E was only (8/18) 33% and the MG (17/18) 94%. The one failure with the 
MG was observed in an operator with no prior MNS experience. Up to eight SG were used by 
operator 1 with a 60% overall success rate (9/15 successful crossings), to manipulate through 
all the phantoms (Fig. 5B). In contrast, a maximum of two MG (operator 5) were used for the 
same task with a 93% success rate (14/15 successful crossings). The overall ratio of SG to MG 
usage was found to be 5.5 SG to 1.3 MG. 
DISCUSSION
MNS is an established technique in cardiac electrophysiological procedures (8,9) and is 
emerging as a powerful tool in interventional cardiology (10). The results in crossing simple 
and straight forward lesions has been equivocal (4) but importantly it has been successfully 
Figure 4. The average crossing times/sec obtained using SG and MG for groups 1–3, operators with 
phantoms A–E. (SG, standard guidewire; MG, magnetic guidewire). See this fi gue in color in the Appendix 
page 385.
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used to cross coronary lesions that failed with SG techniques (2,11). In the modifi ed ACC/AHA 
lesion classifi cation lesions with severe angulation (>90o) and extreme proximal tortuosity are 
known to have lower procedural success rates (12). In addition, PCI on tortuous vessels with 
side branches also have a higher incidence of emergency coronary artery surgery (13) and 
greater radiation exposure to both the operator and the patient (14). By precisely guiding a 
wire in a full 360o rotation MNS may off er a potential solution to address the tortuosity report-
edly encountered in 24% of all PCI cases (15). Moreover, because the tip of the magnetic wire 
is oriented only when needed there is potentially less trauma to the vessel wall and less wire 
prolapse (16). Our study aimed to assess the MNS guidewires and conventional wires in phan-
tom models mimicking angulations and tortuosity with side branches seen in a PCI setting. 
We realized that phantom models are not wholly equivalent to what is encountered in the 
reality of the catheterization laboratory. However, they do play a vital role in the comparative 
assessment of diff erent techniques and training. This is primarily because any confounding 
factors such as variation in coronary anatomy or external infl uences such as voluntary and 
involuntary movement of a patient can be eff ectively excluded. As such it therefore justifi es 
previous phantoms experiments used to comparatively assess MNS with conventional tech-
niques (5–7,17). Our results unequivocally demonstrate that magnetic navigation is vastly 
superior to SG techniques in phantom models with increasing tortuosity and side branches. 
The MNS dramatically reduced both crossing and fl uoroscopy times with a 98.8% procedural 
success rate compared to a 68% with SG techniques. Moreover it considerably limited the 
amount of wire usage from 5.5 to 1.3. The only phantom where it was not superior was in 
the least tortuous phantom A. This was not surprising as the angulations in this phantom 
were non-acute and the side branch was of similar caliber to the main vessel, confi rming 
Figure 5. (A) The overall procedural success using SG and MG for phantoms A–E. (SG, standard guidewire; 
MG, magnetic guidewire). (B) The SG and MG usage in operators 1–6 for phantoms A–E. (SG, standard 
guidewire; MG, magnetic guidewire). See this fi gue in color in the Appendix page 385.
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previous results in simple phantom models (4). Even though the MG was slower than the 
SG in phantom A, it must be stressed that the diff erences between the two wires were not 
statistically signifi cant. With more demanding angulations and smaller side branches the 
dominance of MG prevailed with a highly signifi cant reduction in crossing and fl uoroscopy 
times over the SG. The importance of this fi nding is that it unambiguously demonstrates 
that a novel technology can be tailored to address a defi nitive problem encountered by the 
interventional cardiologist. It clearly shows that for simple angulations there is no net gain 
with MNS but as the angulation and complexity increases then the MG is far more attractive 
due to its ability to redirect the tip of the wire in situ (6). Remarkably, the most dramatic diff er-
ence of the MG over the SG was noted in phantoms of intermediate tortuosity (phantoms C 
and D). These two phantoms were created to mimic a 3 mm giving rise to a 2 mm side branch 
with increasing angulations. The calibre of the side branches at the angulations of 60o, 90o, 
and 120o turns is not too dissimilar to those usually encountered in the normal coronary tree. 
Importantly, in these phantoms there were no signifi cant diff erences between the operators 
regardless of previous MNS experience apart from those most and inexperienced in phantom 
D. This is in contrast to previously published data on a neurosurgical phantom where the 
MNS was more accurate and faster in the hands of the least experienced investigators (7). 
Although this is indeed the case for the total number of operators with experience compared 
with no MNS experience, if the data was further analyzed to look at the diff erence between 
the most experienced and those with no experience then the results would not be too dis-
similar to our fi ndings, suggesting that the most experienced have a slight advantage over 
the inexperienced. This was further illustrated in the most tortuous phantom E where the 
signifi cant diff erence between the two groups persisted and is exemplifi ed by the only MNS 
failure occurring with an operator having no prior MNS experience. This suggests that with 
a very tortuous vessel prior knowledge on the MG behaviour might be advantageous and 
substantiates the results of the SG, where all the operators had prior experience with these 
wires and hence there was no signifi cant diff erence between the most and least experienced 
operators. 
LIMITATION
Our study was limited by the fact that 2D phantoms were not representative of the 3D char-
acteristics of ordinary coronary arteries. In addition, these 2D models were limited to ‘‘clock-
face’’ navigation rather than the more precise 3D reconstruction software. The phantoms also 
employed static road mapping for wire progression rather than the transient dynamic road 
mapping used in patients.
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CONCLUSION
MNS is an emerging tool in interventional cardiology and has been successfully employed 
to cross lesions that failed with conventional techniques. In our phantom study we have 
unequivocally shown that a MG is vastly superior to a SG with dramatic reductions in cross-
ing and fl uoroscopy times in phantom models that mimic coronary arteries with increasing 
tortuosity and side branches. As the complexity of the phantoms increased operators with 
prior MNS experience performed better than those with no previous MNS exposure. There 
was an outstanding procedural success with the MNS (98.8% vs. 68%) together with a clear 
reduction in guidewire usage (5.5 vs. 1.3).
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ABSTRACT
Aim: The in vivo comparison of the accuracy of two 3-dimensional quantitative coronary 
angiography (QCA) systems. 
Methods: Precision-drilled plexiglass phantoms with fi ve diff erent luminal diameters (0.5–1.9 
mm) were percutaneously inserted into the coronary arteries of four Yorkshire pigs. Twenty-
one angiographic images of these stenotic phantoms were acquired for in vivo validation 
testing. Quantitative assessments of the minimum, maximum, and mean luminal diameters 
together with the minimum luminal area were determined using two 3D QCA systems, the 
CardiOp-B® and CAAS 5. 
Results: The CardiOp-B system signifi cantly underestimated the minimum luminal diameter 
MLD whilst both systems signifi cantly overestimated the maximum luminal diameter at the 
minimal luminal area (MLA) over the phantom’s true value. The CAAS 5 system had a greater 
degree of accuracy/mm (mean diff erence = 0.01 vs. 0.03) and precision/mm (SD = 0.09 vs. 
0.23) than the CardiOp-B in assessing the minimal LD. An increased precision/mm (SD 5 0.01 
vs. 0.29) and accuracy/mm (mean diff erence = 0.03 vs. 0.11) in the mean LD was observed 
with the CAAS 5. In comparing the MLA/mm the CAAS 5 was more precise/mm2 (SD = 0.14 
vs. 0.55) and accurate/mm2 (mean diff erence = 0.12 vs. 0.02) to the true phantom MLA com-
pared to the CardiOp-B system. 
Conclusions: In a 21 phantom study, the CAAS 5 3D QCA system had a greater degree of 
accuracy and precision in both the luminal and area measurements than the CardiOp-B 3D 
QCA system.
First Direct In Vivo Comparison of Two 
Commercially Available 3D QCA Systems
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INTRODUCTION
In the percutaneous treatment of coronary artery disease the on-line two-dimensional quan-
titative angiography (QCA) is often the chosen method to determine both the vessel length 
and size to guide stent implantation (1). There are, however, several limitations with this 
technique as depending on the angiographic views the vessels can appear foreshortened or 
overlapped resulting in inaccurate measurements (2). Moreover, in tortuous vessels this can 
lead to an underestimation of the appropriate length of stent required to cover the lesion (3). 
Recently, a novel method, the three-dimensional (3D) reconstruction of standard coronary 
angiography using an algorithm integrating single-plane images has been validated (4). 
This technology is aimed at providing a solution to many of the limitations inherent with 2D 
QCA. In addition, the enhanced accuracy in determining the lesion length and luminal diam-
eter the 3D reconstructed image can be incorporated in a designated navigation software 
(Navigant® Stereotaxis, St Louis, MO) to enable magnetically aided guidewires to precisely 
transit through the vessel lumen (5). The accuracy of the luminal diameter can be crucial for 
a successful wire transit to avoid vascular wall trauma or plaque disruption (6). The potential 
benefi ts of this 3D QCA technology has led two companies Paieon Medical, Rosh Ha’ayin, 
Israel and Pie Medical Imaging, Maastricht, the Netherlands to develop the CardiOp-B and 
CAAS 5 systems, respectively. Both systems are similar in using two angiographic images to 
reconstruct a 3D image but in the current version of the CardiOp-B the calibration standard 
is performed manually whilst in the CAAS 5 system it is automated. The aim of this study was 
to compare the accuracy of the detection of a luminal stenosis using two 3D QCA systems in 
vivo using radiolucent cylindrical plexiglass or polyamide stenotic phantoms with precision-
drilled eccentric lumens implanted in porcine coronary arteries (7).
METHODS 
The ethics committee on animal experimentation at the Erasmus Medical Center, Rotterdam, 
NL approved the study that was conducted in accordance to the guidelines of the American 
Heart Association on animal use in research.
Preparation and Insertion of the Stenotic Phantoms 
The stenotic phantoms (Fig. 1) were precisely engineered by the Department of Bioengineering 
at the Erasmus Medical Center. Radiolucent plexiglass (acrylate) and polyacrylamide cylinders 
of diameters 3.0 or 3.5 mm and length of 8.28, 7.96, 7.85, 8.01, and 7.38 mm were precision-
drilled to have circular lumens of 499 (aimed to be 0.5 mm), 707 (0.7 mm), 982 (1.0 mm), 1,367 
(1.4 mm), and 1,921 (1.9 mm) lm in diameter, respectively. This accuracy calibrated optically at 
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40-fold magnifi cation achieved a maximum tolerance of 0.003 mm. A second 1.3 mm diameter 
lumen was drilled parallel to the stenosis lumen to attach to the tip of 4-Fr Fogarty catheters 
(Vermed, Neuilly en Thelle, France) to facilitate the intracoronary insertion and positioning of 
the phantoms. Four Yorkshire pigs (average weight, 40–45 kg) were pretreated with intramus-
cular ketamine (20 mg/kg) and intravenous etomidate (5 mg/kg). The animals were then intu-
bated and ventilated with a mixture of oxygen and isofl urane. Anesthesia was maintained with 
a continuous intravenous infusion of pentobarbital (5–20 mg/kg/ hr). About 12-Fr introducer 
sheaths were inserted into both carotid arteries to allow the sequential insertion of the guid-
ing catheter and the phantoms. Jugular access was used for the administration of medication 
and fl uids. An intravenous bolus (10,000 IU/l) followed by a continuous infusion of heparin was 
given. Following the experiments, the animals were humanely euthanized. 
In Vivo Image Acquisition of Stenosis Phantoms by Fluoroscopy 
Biplane cine angiographic system (Axiom ArtisTM, Siemens, Forchheim, Germany) was used to 
create digital angiograms of matrix size of 1024 X 1024 pixels. Identical radiographic imaging 
settings were employed (kVp, mA, ms) in the two projections used to image each phantom 
to maintain consistency. Following intubation of the left or right coronary artery with a 6-Fr 
guiding catheter (Mach 1TM, Boston Scientifi c, Natick, MA) intracoronary isosorbide-dinitrate 
(1 mg) was administered and an angiogram was made to aid orientation of the phantom in the 
Figure 1. The magnifi ed tip of one of the Fogarty catheters view along its long (A) and short axis (B) with 
a transparent radiolucent cylinder (phantom) having a channel of 1.9 mm diameter (white arrow) and the 
catheter lumen used for insertion of removable metallic stylet (black arrow) to aid positioning. See this fi gue 
in color in the Appendix page 381.
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vessel. The phantoms were wedged in the coronary arteries and positioned in the X-ray isocen-
ter using the tip of a metal wire marker placed on the Fogarty catheter. Coronary angiography 
was performed by manual injection of contrast medium (VisipaqueTM 320 mg I/ml, Amersham 
Health B.V., Eindhoven, The Netherlands). The ventilator was disconnected transiently during 
contrast injection to minimize the eff ect of diaphragmatic movement on angiographic images. 
Three Dimensional QCA Analyses of In Vivo Phantom Images 
In total, 21 readings were made in 21 diff erent arteries; four arteries had phantoms of diameters 
1.9 mm, six arteries had phantoms of 1.4 mm, six arteries had 1 mm diameter phantoms, four 
arteries had 0.7 mm phantoms, and one artery had a 0.5 mm phantom. The in vivo analysis of 
each phantom was performed in end-diastole on the same number of the frame count and 
was ECG gated so that all of the analyses using both QCA systems were performed on identi-
cal images. Calibration of the CardiOp-B system was done manually using the conventional 
catheter calibration of the nontapering part of the tip of each 6-Fr guiding catheter fi lled with 
contrast. The CAAS 5 system performs an automatic calibration based on the DICOM informa-
tion in the image. Once calibrated, the two orthogonal views (at least 30o apart) that were 
simultaneously acquired in the biplane system were then used to reconstruct the 3D vessel 
image (Fig. 2). This was achieved by marking three points in the CardiOp-B system: proximally, 
distally, and at the stenosis on the two angiographic images. In the CAAS 5, this was done 
by defi ning a common image point (a landmark common to both images), and two points 
distal and proximal to the stenotic region (8). The software then created automatic contour 
detection and if this was inaccurate then fi ner adjustments were made to the edge detection 
manually in the CardiOp-B system and the restriction option, an algorithm that excludes gross 
image artifacts such as the diagnostic catheter was applied in the CAAS 5 system. The restric-
tion option is therefore not a manual edge correction but instead it off ers users the possibility 
of excluding parts of the image of the detection by restricting the area of interest.
Following contour detection and corrections/restrictions if required, the 3D reconstruction 
of the artery was automatically created. The software determined the minimum luminal area 
(MLA) and the pixel size at each position in the 3D space. Based on the position of the MLA 
and the known pixel size, the minimum luminal diameter (MLD) for each of the angiographic 
images was automatically calculated. Assuming a noncircular shape at the MLA then there 
will be two MLD values (maximum and minimum LD) obtained, the smallest representing the 
absolute MLD. The mean luminal diameter was based on the values in between the borders of 
a predetermined segment in the phantom (Fig. 2). Along the centerline in between this seg-
ment, the diameter at each scanline was taken and divided by the total number of scanlines 
to automatically aff ord the mean LD. The following data was therefore compared, the mini-
mum LD (MLD) and the maximum LD at the MLA, together with the minimum luminal area 
MLA and the mean LD over the region of interest (ROI) in each 3D QCA system to that of the 
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phantom models. We purposely chose to perform only one measurement per phantom given 
the primary interest in the relative accuracy and precision of both techniques, instead of an 
assessment of the intra- and inter-observer variability of the QCA techniques. Expert users 
from both the Pie Medical and Paieon companies were used to perform the measurements. 
Statistical Analysis
Continuous variables are presented as mean ± standard deviation and compared using the 
Wilcoxon signed-rank test. Categorical variables are expressed as counts and percentages. The 
Figure 2. The 3D reconstruction of a phantom derived from two orthogonal views (frontal and lateral) using 
the CASS 5 system. The 3D color varies according to the severity of stenosis ranging from white (healthy 
vessel) to dark red (99% crosssectional area stenosis). The yellow squares denote proximal reference point 
(P*), most stenotic point (S), and distal reference point (D) of the target lesion, respectively. The region of 
interest (ROI) for calculation of mean luminal diameter can be manually defi ned by moving the proximal (P*) 
and distal (D) points (Defi nition of ROI for mean LD; Graph view). See this fi gue in color in the Appendix page 386.
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mean of the diff erences between measurements and phantom dimensions of both systems 
was computed and considered to be an index of the accuracy of the measurements, while 
the standard deviation of the diff erences was defi ned as an index of precision. Bland–Altman 
plots (9) were used to assess the agreement between both 3D QCA systems and the phantom 
models. Pearson’s correlation was used to determine the degree of correlation between the 
measurements. Statistical analyses were performed with SPSS 12.0.1 for Windows (SPSS, 
Chicago, IL). A P value < 0.05 was considered statistically signifi cant.
RESULTS
Comparison of Minimum LD with Phantom ‘‘True’’ Values
In this study the CardiOp-B system had only one manual adjustment to correct the detected 
contour whilst six adjustments were used in the CAAS 5 system to restrict the contours to the 
region of interest. Overall, the comparison of both 3 D QCA systems with the true LD noted 
in the 21 phantom models revealed a closer association with the CAAS 5 system than in the 
CardiOp-B (Table I). 
Table 1. Comparison of the Two 3D QCA Systems (CardiOp-B® and CAAS 5) Accuracy, Precision, and the 
Correlation to the True Luminal Diameter of the 21 Stenotic Phantoms
Accuracy Precision Correlation Slope Intercept P value
CardiOp-B® vs. phantoms
 Min LD
  (MLD) 0.03 0.23 0.87 0.87 0.15 0.03
 Max LD 0.24 0.40 0.78 0.86 0.23 0.001
 Mean LD 0.11 0.29 0.84 1.02 0.08 0.31
 MLA 0.12 0.55 0.87 1.09 0.01 0.74
CAAS 5 vs. phantoms
 Min LD
  (MLD) 0.01 0.09 0.99 0.92 0.06 0.26
 Max LD 0.06 0.11 0.97 1.12 0.10 0.015
 Mean LD 0.03 0.10 0.98 0.87 0.19 0.39
 MLA 0.02 0.14 0.99 0.91 0.13 0.95
Accuracy = mean diff erences between recorded measurements and the phantom; Precision = standard 
deviation and P value is derived from the recorded measurements and the phantom. 
The CardiOp-B system signifi cantly underestimated the minimum LD (MLD) whilst both systems 
signifi cantly overestimated the maximum LD at the MLA over the true value. In assessing the 
MLD, the CAAS 5 system had a greater degree of accuracy/mm (mean diff erence = 0.01 vs. 0.03) 
and precision/mm (SD = 0.09 vs. 0.23) compared with that observed with the CardiOp-B system. 
The Bland–Altman plots of the MLD (Fig. 3a and b) showed that both systems had one outlier 
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reading beyond 2 SD. This value was, however, smaller in the CAAS 5 system resulting in a better 
overall correlation to that of the phantom’s actual diameter (r = 0.99 vs. 0.87) and infl uencing 
the degree of precision. Notably, in the CardiOp-B system 11/21 (52%) of the measurements laid 
outside ± 10% of the true phantom LD compared with 3/21 (14%) of the measurements derived 
using the CAAS 5 system. Table I and Fig. 3a and b compares min LD (MLD) in both systems. 
Comparison of Mean LD with Phantom ‘‘True’’ Values
There was no signifi cant diff erence observed when the mean LD in either system was com-
pared with the luminal diameter of the phantoms (Table I). The Bland–Altman plots revealed 
two observations outside ± 2 SD range in the CardiOp-B analysis compared with only one 
Figure 3. Bland–Altman plots of the minimal LD (a) CardiOp-B® with the phantoms (b) CAAS 5 with the 
phantoms.
Figure 4. Bland–Altman plots of the MLD (a) CardiOp-B® with the phantoms (b) CAAS 5 with the phantoms.
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observation noted in the CAAS 5 system (Fig. 4a and b). As observed with the minimum LD 
values there was an increased precision/mm (SD = 0.10 vs. 0.29) and accuracy/mm (mean 
diff erence = 0.03 vs. 0.11) with the CAAS 5 mean LD values with the latter having a closer 
correlation with the true value (r = 0.98 vs. 0.84). Figure 4a and b compares mean LD in both 
systems.
Comparison of Minimal Luminal Area with Phantom ‘‘True’’ Values
The Bland–Altman plots of the MLA further demonstrated higher precision/mm2 (SD = 0.14 
vs. 0.55) and accuracy/mm2 (mean diff erence = 0.02 vs. 0.12) with the CAAS 5 (Fig. 5a and b). 
Moreover, in the CardiOp-B system 14/21 (67%) of the measurements laid outside ± 10% of 
the true phantom MLA compared with 7/21 (33%) of the measurements derived using the 
CAAS 5 system. Consequently, the Pearson coeffi  cient demonstrated a closer correlation with 
the CAAS 5 than the CardiOp-B system (r = 0.99 vs. 0.87). Figure 5a and b compares mean LD 
in both systems. 
DISCUSSION
3D QCA has been shown in phantom models (10) as well as in stented vessel segments (11), 
and complex lesions like bifurcations (12) to have a closer correlation to the true vessel’s 
dimensions than 2D QCA. Moreover in conventional angiography, overlapping vessel can 
impair the optimal visualization of a lesion and if the lesion is eccentric then it may be missed 
altogether (13). In the formulation of a 3D QCA, the system uses a 3D computer-based model-
ling algorithm to integrate the 2D projections, identify key vessel features like bifurcations 
and the centreline, calculate and display the vessel’s cross-sectional contours that are subse-
Figure 5. Bland–Altman plots of the MLA (a) CardiOp-B® with the phantoms (b) CAAS 5 with the phantoms.
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quently ‘‘fi lled in’’ to create the virtual vessel. Both the CardiOp-B system and CAAS 5 system 
adopt this system when generating the reconstructed vessel but there are subtle diff erences 
between the 2 programs that may infl uence the degree of accuracy. The CardiOp-B system 
utilizes a manual guide catheter mode calibration method in contrast to the CAAS 5 system 
that uses an automatic calibration at the region of interest (ROI). With the manual method, the 
catheter size in French or mm has to be inputted for system recognition and calibration. This 
is an established method that has been shown to have greater precision than the equivalent 
2D measurements with respect to the minimal lesion diameter (P < 0.005), minimal lesion 
area (P < 0.05), and lesion length (P < 0.01) (4). However, it has been reported that because 
the catheter may not be in the same plane as the ROI that this method of calibration can give 
rise to diff erences in magnifi cation and measurements and infl uence the accuracy (13). In ad-
dition, the way in which the contour is drawn on the 2D angiographic image also highlights 
an important diff erence that may also infl uence the accuracy and precision between the 
two systems. Both the CardiOp-B and CAAS 5 systems have the ability to manually correct 
the generated contours if they are adjudged to be inaccurate. Although this is subjective, 
in this paired comparative study contour adjustment had to be performed on one of the 21 
phantom models in the CardiOpB as the detected contour deviated signifi cantly from the 
vessel’s edge. In the rest of the models, edge detection was adjudged satisfactory. No edge 
corrections were needed in the CAAS 5 but the catheter had to be excluded from the ROI 
on six occasions. Because the edge detection is used to deduce the measurement, the less 
manual correction needed then greater is the accuracy of the automated system.
The aim of this study was to evaluate the accuracy and precision of both the CAAS 5 and 
CardiOp-B 3D QCA system with respect to precisely engineered stenotic phantoms in vivo. 
The rational was that in addition to evaluating precision in measurements, the importance 
of the study stems from the demand to accurately determine the luminal diameter so that a 
precise endoluminal road map of a vessel can be achieved for magnetic navigation when the 
3D reconstructed image is incorporated in the Navigant software (14). The lack of accuracy 
may result in the guidewire exiting from the vessel lumen to cause a perforation. The results 
demonstrated good overall correlation of the minimal LD and maximum LD at the MLA 
together with the mean LD and MLA in each system to the true values of the phantoms. How-
ever in the CardiOp-B system, the range of these correlations were slightly less (0.78–0.87) 
compared with the CAAS 5 system (0.97– 0.99). In addition, systematic underestimation of 
luminal diameter measurements has been previously reported for the CardiOp-B system QCA 
system (11).
In assessing the minimum LD (MLD), greater precision and accuracy was observed with 
the CAAS 5 arguably because of two observations in the CardiOp- B system varying markedly 
from the true value (Δ min LD 47% and 25%) in comparison to one observation (Δ min LD 
34%) in the CAAS 5 system. However, what is important to note is that in terms of the ac-
curacy is that 11/21 (52%) of the measurements laid outside ± 10% of the true phantom LD 
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using the CardiOp- B system compared with 3/21 (14%) of the measurements derived using 
the CAAS 5 system. This was also mirrored with the MLA measurements where two thirds 
of the values in the CardiOp-B system 14/ 21 laid outside ± 10% of the true phantom MLA 
compared with one third (7/21) with the CAAS 5 system. The result highlights the perceived 
superiority of automatic isocenter calibration together with improved edge detection (15). 
Despite the variability in 3D QCA measurements in both systems, we should remain apprecia-
tive of the fact that this novel technology creates a 3-dimensional coronary map and as such 
has widespread application to both scientifi c research and clinical practice. By doing so, it 
solves many of the limitations currently observed with 2D QCA and unlike other imaging 
modalities like multislice computed tomography and magnetic resonance imaging it can 
provide absolute measurements of coronary luminal diameter and lengths in real time. It is 
therefore hopeful that the fi ndings of our study will stimulate further research in this exciting 
new imaging fi eld. 
LIMITATIONS
This study is the fi rst direct comparison of two commercially available 3D QCA systems. The 
study was, however, limited by the relatively small sample size of 21 phantom models. This 
was due to diffi  culties in obtaining more animal models. The concentric phantoms used in 
this study do not represent natural coronary lesions, as they do not allow the assessment 
of asymmetry. It is better to use eccentric phantoms but precise and validated eccentric 
phantoms were not available. The validation tests with these cylindrical concentric phantoms 
were, however, used by our group recently to test 2D and 3D QCA systems (10).
CONCLUSION
In a 21 phantom study, the CAAS 5 3D QCA system had a greater degree of accuracy and 
precision in both the luminal and area measurements than the CardiOp- B 3D QCA system. 
Further development and validation studies are warranted in order for this novel technology 
to be increasingly adopted in routine clinical practice.
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ABSTRACT
This report demonstrates the production and use of a 3D reconstruction of a coronary sinus 
from a single injection rotational angiogram. The detailed virtual model enabled easy mag-
netic navigation of a wire for device placement in cardiac resynchronization therapy. 
Rotational coronary sinus venography and 
magnetic navigation to facilitate LV lead 
placement in CRT
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INTRODUCTION
The use of the magnetic navigation system (MNS: Stereotaxis, St Louis, Missouri, USA) in 
electrophysiology is now well established. This system has been described in detail previ-
ously (1,2). Using computer-controlled movements of the magnets, a 15-20 cm uniform 
magnetic fi eld volume can be directed in 360o in all planes to defl ect a magnetic wire tip 
precisely. This control is coupled with an ability to reconstruct a patient-specifi c vessel and 
provide image-guided navigation for each and every section of the vessel. A 3D model can be 
produced that enables magnetic fi eld direction control from the computer generated image. 
Published reports have shown the clinical utility of the MNS in routine electrophysiology 
catheter ablation procedures, including specifi c reports describing its use in atrial fi brillation 
(3,4), atrioventricular nodal reentrant tachycardia (5), atrioventricular reentrant tachycardia 
(6), right ventricular outfl ow tract tachycardia (7), parahisian accessory pathways (8), and 
more complex arrhythmia ablation procedures such as ventricular tachycardia (9). 
Recent studies indicate its usefulness in CRT to facilitate the placement of left ventricular 
leads in cardiac resynchronization therapy device implantation procedures (10,11). This 
report demonstrates the feasibility of producing an on-table, real-time coronary sinus re-
construction to facilitate lead placement in a cardiac vein. This virtual coronary sinus was 
produced with a single contrast injection and the use of rotational angiography.
CASE REPORT
A 76 year old lady with poor left ventricular function due to ischaemic heart disease was 
admitted for cardiac resynchronization therapy and ICD implantation. She had previously 
undergone CABG and had had a DDD pacemaker implanted for Mobitz II heart block.
An old atrial active fi xation lead was successfully extracted while the old ventricular tined 
lead was left in situ. An Endotak Reliance SG active fi xation shock lead (Guidant) was placed 
in the RV apex and a Capsure Fix active fi xation lead (Medtronic) in the RA. The coronary 
sinus (CS) was cannulated using a CS guiding catheter. The table was put in the isocenter 
position, the CS was occluded using a balloon catheter, and 20 ml of diluted contrast used 
to perform rotational venography. A 3D virtual coronary sinus was reconstructed using 3DCA 
software (Philips Medical Systems, Eindhoven, The Netherlands), see fi gure 1. This model was 
imported into the MNS, see fi gure 3. A Titan™ 3mm angled Soft Support wire passed on the 
fi rst attempt using navigation based on the model into a side branch of the great cardiac 
vein. An Easytrack 3 lead (Guidant) passed easily over this. A Contak Renewel 4 RF (VVED-CRT; 
Guidant) was implanted. All checks were satisfactory at implantation and at follow-up. 
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Discussion
CRT is an important technique in reducing morbidity and improving patient well-being. Car-
diac resynchronization therapy (CRT) improves quality of life and prolongs survival in appro-
priate patients with QRS prolongation or left ventricular (LV) dysynchrony (12-15). However 
a number of diffi  culties may hamper lead placement in CRT procedures such as diffi  culty in 
obtaining coronary sinus (CS) access, effi  ciently selecting CS branch vessels, maintaining lead 
stability, and avoiding both phrenic nerve stimulation and lead dislodgement (16-20). 
Figure 1. The reconstruction of the coronary sinus in 2 views, the left panel shows AP and the right panel 
shows LAO 30o.
Figure 2. The Stereotaxis screen; The upper panels show the model (upper right) and the endoluminal view 
(left upper) while the lower panels show the model superimposed on stills of the fl uoroscopy.
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Feasibility studies suggest that the MNS without full 3D reconstruction appears to be at 
least as good as manual technique (10,11). The rotational venogram provides a number of 
possible benefi ts that may facilitate lead placement in CRT. The production of a patient-
specifi c 3D model supplies the vectors required for image-guided steering of the wire along 
the length of the vessel, see fi gure 3. In addition, this 3D model supplies a white line overlay 
(of the centre-line of the model) that automatically adjusts to the view on the fl uoroscopy 
screen. This acts as a guide to wire positioning. This technique has two clear advantages 
for contrast use and procedure time for 2 reasons. First, a patient-specifi c 3D model of the 
coronary sinus and its branches is produced from a single injection of contrast, thus reducing 
contrast and time. Second, the use of the patient-specifi c vectors should facilitate wire place-
ment and re-positioning potentially leading to reduced contrast use and procedure times.
CONCLUSION
The combination of improved navigation and a reduced burden to the patient and operator 
may be facilitated by such easy on-table 3D reconstruction as it allows computer generated 
image guidance of magnetic fi eld direction control and better wire steering. This may lead to 
faster wire placement by facilitating wire delivery to a target sidebranch and also easier repo-
sitioning should unsatisfactory lead stability or phrenic pacing occur. This will lead ultimately 
to limitation of contrast load, radiation time, and procedure times. 
Figure 3. The left panel shows the wire passed distally, while the right panel shows the fi nal result with 
implanted pacing lead and device.
Mark bw.indd   133 25-05-10   15:15
Chapter 8
134
ACKNOWLEDGEMENT
The authors are grateful to Joep Maeijer for help with preparation of the images.
Mark bw.indd   134 25-05-10   15:15
135
Rotational coronary sinus venography and magnetic navigation to facilitate LV lead placement in CRT
REFERENCES
 1. Patterson M, Schotten J, van Mieghem C, Kiemeneiji F, Serruys PW. Magnetic Navigation in Percuta-
neous Coronary Intervention. J Interv Cardiol. 2006 Dec;19(6):558-65. 
 2. Tsuchida K, García-García HM, Tanimoto S, et al. Feasibility and safety of guidewire navigation using 
a magnetic navigation system in coronary artery stenoses. EuroInterv 2005;1:329–335.
 3. Pappone C, Vicedomini G, Manguso F, et al. Robotic magnetic navigation for atrial fi brillation abla-
tion. J Am Coll Cardiol 2006;47:1390–400.
 4. Di Biase L, Fahmy TS, Patel D, Bai R, Civello K, Wazni OM, Kanj M, Elayi CS, Ching CK, Khan M, Popova L, 
Schweikert RA, Cummings JE, Burkhardt JD, Martin DO, Bhargava M, Dresing T, Saliba W, Arruda M, 
Natale A. Remote magnetic navigation: human experience in pulmonary vein ablation. J Am Coll 
Cardiol. 2007 ;50(9):875-6. 
 5. Ernst S, Ouyang F, Linder C, Hertting K, Stahl F, Chun J, Hachiya H, Bansch D, Antz M, Kuck KH. Initial 
experience with remote catheter ablation using a novel magnetic navigation system: magnetic 
remote catheter ablation. Circulation. 2004;109(12):1472-1475.
 6. Thornton AS, Rivero-Ayerza M, Knops P, Jordaens LJ. Magnetic navigation in left-sided AV reen-
trant tachycardias: preliminary results of a retrograde approach. J Cardiovasc Electrophysiol. 
2007;18(2):467-472.
 7. Thornton AS, Jordaens LJ. Remote magnetic navigation for mapping and ablating right ventricular 
outfl ow tract tachycardia. Heart Rhythm 2006 ;3(6):691-6.
 8. Ernst S, Hachiya H, Chun JK, Ouyang F. Remote catheter ablation of parahisian accessory pathways 
using a novel magnetic navigation system - - a report of two cases. J Cardiovasc Electrophysiol. 
2005;16(6):659-62.
 9. Aryana A, d’Avila A, Heist EK, et al. Remote magnetic navigation to guide endocardial and epicardial 
mapping of scar-related ventricular tachycardia. Circulation. 2007;115:1191-1200.
 10. Gallagher P, Martin L, Angel L, Tomassoni G. Initial clinical experience with cardiac resynchroniza-
tion therapy utilizing a magnetic navigation system. J Cardiovasc Electrophysiol. 2007;18(1):1-7.
 11. Rivero-Ayerza, M, Thornton AS, Theun DAMJ, Scholton MF , Mekel JM, Res J, Jordaens LJ. Left Ven-
tricular Lead Placement Within a Coronary Sinus Side Branch Using Remote Magnetic Navigation of 
a Guidewire – A Feasibility Study. J Cardiovasc Electrophysiol 2006; 17:1-6.
 12. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; I. The Cardiac 
Resynchronization—Heart Failure Study: The eff ect of cardiac resynchronization on morbidity and 
mortality in heart failure. N Engl J Med 2005;352:1539-1549.
 13. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, Di Carlo L, DeMets 
D, White BG, DeVries DW, Feldman AM, P.a.D.i.H.F.I. the Comparison of Medical Therapy. Cardiac 
resynchronization therapy with or without an implantable defi brillator in advanced chronic heart 
failure. N Engl J Med 2004;350:2140-2150.
 14. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, 
Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J. MIRACLE 
Study Group. Multicenter InSync Randomized Clinical Evaluation: Cardiac resynchronization in 
chronic heart failure. N Engl J Med 2002;346:1845-1853.
 15. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, Garrigue S, Kappenberger L, Haywood 
GA, Santini M, Bailleul C, Daubert J-C. I. The Multisite Stimulation in Cardiomyopathies Study: Eff ects 
of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. 
N Engl J Med 2001;344:873-880.
Mark bw.indd   135 25-05-10   15:15
Chapter 8
136
 16. Saxon LA, Ellenbogen KA. Resynchronization therapy for the treatment of heart failure. Circulation 
2003;108:1044-1048.
 17. Butter C, Gras D, Ritter P, Stellbrink C, Fleck E, Tockman B, Schubert B, Pochet T, deVoogt W: Com-
parative prospective randomized effi  cacy testing of diff erent guiding catheters for coronary sinus 
cannulation in heart failure patients. J Interv Card Electrophysiol 2003; 9:343-351.
 18. Stellbrink C, Breithardt OA, Hanrath P: Technical considerations in implanting left ventricular pacing 
leads for cardiac resynchronization therapy. Eur Heart J 2004;(Suppl D):D43-D46.
 19. Leon AR, Delurgio DB, Mera F: Practical approach to implanting left ventricular pacing leads for 
cardiac resynchronization. J Cardiovasc Electrophysiol 2005;16:100-105.
 20. Leon AR, Abraham WT, Young JB. Implantation results over two thousand implant attempts from 
the MIRACLE program. Heart Rhythm 2004;1(1s):S39.
Mark bw.indd   136 25-05-10   15:15
Mark bw.indd   137 25-05-10   15:15
Patterson MS
Duckers E
Ramcharitar S
Meliga E
van Weenen S
Maugenest A-M
Perin E
Serruys PW
Eurointervention Supplement 2007;2(supp B), B42-B46.
Mark bw.indd   138 25-05-10   15:15
CHAP TER 9
Magnetically Supported Procedures and 
Cardiac Regeneration
Mark bw.indd   139 25-05-10   15:15
Mark bw.indd   140 25-05-10   15:15
141
Magnetically Supported Procedures and Cardiac Regeneration
INTRODUCTION
Cardiac failure secondary to ischaemic heart disease is a leading cause of morbidity and mor-
tality. Infarction leads to cell loss by oxidative stress and reperfusion injury. Chronic ischaemia 
and myocyte loss produces progressive expansion of the infarct area, fi brous replacement of 
the myocardium and predisposes to dilation of the left ventricle, a major factor in survival. 
Progenitor/stem cell therapy has potential for promoting structural and functional repair of 
the myocardium. Progenitor/stem cells may stimulate either angiogenesis by the release of 
growth factors and anti-apoptotic factors (including Akt, VEGF and FGF), and/or vasodilation 
(by VEGF) with an increase in iNOS bioavailability that may help maintain cell viability and 
encourage blood fl ow. More controversially, progenitor/stem cells from the bone marrow, 
circulating blood or embryonically-derived, may lead to myocardial cell regeneration. How-
ever to date, improvements in cardiac function and structure have been modest. Current 
delivery techniques include 2-D angiographically guided endocardial injection and catheter 
based intracoronary release. However, these techniques have general limitations that include 
imprecise on-table identifi cation of the best areas to target, poor ability in targeting a specifi c 
area, and mediocre identifi cation of the treated area at follow-up. In addition, intracoronary 
release has specifi c drawbacks such as induction of ischaemia, or the ‘shedding’ of cells into 
the general circulation. Two particular clinical settings that appear particularly appropriate 
for progenitor/stem cell therapy are those of recent anterior myocardial infarction that results 
in reduced LV function and of chronic, ischaemic, dilated cardiomyopathy. The development 
and integration of electromechanical mapping technology, NOGA® XP (Biologics Delivery 
Systems™, Cordis Corporation, Diamond Bar, CA, USA) with the development of a magnetically 
navigable injection catheter, the MyoStar™ injection catheter (Biologics Delivery Systems™), 
could transform cell delivery. This article will review the principles of magnetic navigation 
with the forthcoming technology; consider how localisation, delivery and follow-up might 
potentially be improved compared with current techniques; discuss the relevance to two 
of the clinical settings that might derive the most benefi t; and mention the possibilities of 
improved percutaneous revascularisation that might be used to optimise the local milieu for 
progenitor/stem cell survival. The purpose of this article is to suggest and speculate upon 
how this technology might allow integration of the real-time visualisation of target tissue 
with site directed deliverability in order to reduce procedure times and irradiation, and to 
simultaneously improve effi  cacy and follow-up.
MAGNETIC NAVIGATION SYSTEM
The magnetic navigation system (Niobe®, Stereotaxis, St. Louis, MO, USA) consists of two 
adjustable permanent magnets on either side of the fl uoroscopy table (see Figure 1).
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In essence the system does three things. Firstly, the system operates using a 3-D recon-
struction that is either produced from angiographic images (as in the case of coronary arter-
ies) or, alternatively, an imported 3-D reconstruction from an external system e.g. NOGA® XP. 
Secondly, the spatial orientation and location of this reconstruction is matched to the real-life 
patient’s internal cardiac anatomy; i.e. coronary artery or cardiac chamber. Thirdly, the model 
gives the real-time, on-line vectors to direct an external magnetic fi eld to orientate a magnet 
on an intravascular device to match the direction required for navigation through the 3-D 
reconstruction. The result is the ability to use 3-D information in real-time in patient therapy.
The magnetic navigation system has been described in detail previously. Briefl y, the inter-
acting magnetic fi eld produces a 15 cm uniform magnetic fi eld of 0.08 Tesla that can be 
increased to 0.1 Tesla. Computer controlled movements of the magnets allow redirection 
of this externally applied magnetic fi eld vector in 360° in all planes. For cardiac chambers a 
3-D volume rendered reconstruction is imported and aligned for navigation. For coronary 
artery use, the 2-D locations of points on X-ray images are known in relation to the image 
intensifi er, angiography system and table and this allows production of a 3-D reconstruction 
from 2 views separated by at least 30°. The result is real-time, on-table localisation of the 
reconstruction within the chest of a patient during a procedure to allow direction of therapy. 
Adjustment of the magnetic vectors from the model synchronised to the X-ray system adjusts 
tip-magnet direction in the patient to produce defl ection of the wire. This gives reproducibly 
precise steering of the tip of the intravascular device and this steering is independent of the 
factors that can restrict conventional procedures such as poor transmission of manipulation.
Figure 1. Magnetic navigation system is shown with the magnets in position on either side of the patient. 
See this fi gue in color in the Appendix page 375.
Mark bw.indd   142 25-05-10   15:15
143
Magnetically Supported Procedures and Cardiac Regeneration
NEW TECHNOLOGY FOR PROGENITOR/STEM CELL DELIVERY
Previous methods for endocardial stem cell delivery had several drawbacks in identifi cation, 
cell delivery and therapy. Identifi cation of the sites for injections was poor and depended on 
strategies such as marking acetate sheets overlaid on the X-ray screen, delivery was time-
consuming with poor targeting, and follow-up was hampered by imprecise knowledge of 
where the injections had been and therefore depended on generalised LV measurements 
rather then the region of interest. The magnetic navigation system can integrate other 3-D 
volume rendered information such as MSCT, MRI or the NOGA® XP mapping system, see 
Figure 2, to give precise steering/direction of injections. Infarct localisation is possible by 
current techniques such as MSCT, which is capable of identifying infarcted areas of myocar-
dium, and integration can provide a 3-D volume rendered map of the damaged myocardium. 
However this information is not real-time and was of limited use in treating the patient on the 
table. New technology is under current development. The NOGA® XP mapping system gives 
information on the functional and electrical properties of the myocardium simultaneously 
with real-time, precise localisation by producing a map of the left ventricle (see Figure 2).
This may allow diff erentiation between the extent of the infarct and peri-infarct regions as 
well as giving valuable information for followup. This, together with the MyoStar™ injection 
catheter to allow magnetically enabled cell delivery (see Figure 3) may not only allow areas to 
be identifi ed by electrical and mechanical mapping measurements but also deliver injections 
of cell therapy. Potentially, this could give several major advantages. Firstly, integration of 
real-time electromechanical mapping would give a real-time, on-table 3-D LV map for exact 
localisation. Secondly, electromechanical mapping may discriminate between viable and 
non-viable infarcted areas e.g. identifying electrically active but non-contractile areas such 
as stunned myocardium. Therefore this combination of detection methods could enable 
Figure 2. Graphic showing reconstruction of LV mapping. See this fi gue in color in the Appendix page 386.
Mark bw.indd   143 25-05-10   15:15
Chapter 9
144
new strategies that tailor delivery of cell therapy to particular areas. Thirdly, a magnetically 
navigable injection catheter could precisely direct cell injection and simultaneously integrate 
spatial and electrical information. Fourthly, an electromechanical map could aid follow-up 
both to identify the region on the map that was previously treated, and also to give quantifi -
able information for specifi c locations on the map. Defi nable delivery of stem cells would 
allow investigation of specifi c locations or patterns of cell delivery. As diff erent parts of an 
infarcted area may have discordant electrical and mechanical properties, with intact electrical 
but poor mechanical activity, this may allow identifi cation of stunned myocardium in penum-
bral regions that might derive particular benefi t from stem cell injection. Additionally, current 
estimates of the resolution of the new system suggest that this could localise positions to 
within 1 mm that would represent a major improvement. An idea of the type of the informa-
tion that may be available with this system for diagnosis and follow-up is seen in Figure 4.
Figure 3. MYOSTAR™ injection catheter to have electromechanical guidance provided by the NOGA® XP. See 
this fi gue in color in the Appendix page 379.
Figure 4. NOGA™ electrical (UNIV, at top) and mechanical (LLS, at bottom) maps from a human patient in 
the stem cell treatment group. The maps on the left are those performed at the time of injection and maps 
at right are those at four month follow-up. An area of viability, showing normal electrical activity, can be 
noted on the upper right map. The maps on the right show improvement in both electrical and mechanical 
function. LLS = linear local shortening; UNIV = unipolar voltage. See this fi gue in color in the Appendix page 387.
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LIMITATIONS OF CURRENT CELL DELIVERY TECHNIQUES
The strategy of endocardial injection has suff ered from a number of limitations. The current 
technique of LV angiography gives mediocre localisation as the entire LV volume is seen only 
in 2-D pictures from diff erent views. This technique gives little idea of the location of the 
watershed or penumbral area that might contain stunned rather then necrotic cells. Injection 
sites, and particularly areas that might be particularly susceptible to improvement with cell 
therapy, are poorly identifi able in real-time, and are diffi  cult to access with current equip-
ment. Intracoronary injection has been the other widely used technique and has its own 
limitations. Release of cells depends on haematogenous spread, and this may be poor in 
areas that are poorly revascularised or are still occluded, therefore reducing the eff ective-
ness in these areas. This inhomogeneous delivery may prevent delivery to salvageable areas 
that have competitive fl ow from a neighbouring territory that is, however, insuffi  cient for 
long-term survival. As intracoronary injection often uses occlusion of the proximal vessel this 
results in further ischaemic insult with further, possibly irreversible, damage and cell loss 
and reduced perfusion pressure leading to collapse of pinched microvasculature. Addition-
ally, loss of cells that do pass through the microvasculature into the general circulation, also 
known as ‘shedding’, may lead to the drawback of these progenitor cells reaching areas where 
conditions favourable for angiogenesis are present but clinically unwanted, e.g. neoplastic 
neovascularisation or ischaemic areas such as retinopathy.
IMPLICATIONS FOR THE CLINICAL SITUATION OF CELL DELIVERY
Two particular situations may be particularly appropriate for treatment of cell therapy; these 
are recent anterior infarction with signifi cant LV impairment and non-revascularisable chronic 
ischaemic cardiomyopathy. While these situations have some similarity such as extensive cell 
loss and unattractiveness for cardiothoracic surgery, there are specifi c reasons why precisely 
directed endocardial injection may hold particular advantages. These have advantages over 
and above the general advantages of improved diagnosis with two modalities, precise site-
directed delivery and follow-up discussed above.
The purpose of using cell therapy in the treatment of recent acute MI is to prevent malad-
aptation or remodelling and so preserve LV contractile function and thus exercise tolerance. 
This group may be the most eff ective group to treat with cell therapy in order to maximise 
myocardial cell salvage. As discussed above, endocardial injection may be advantageous 
over intracoronary delivery as it delivers cells to areas that have a restricted or absent blood 
supply. This direct delivery via the endocardium overcomes the problem of tissue swelling 
related to ischaemic damage that may cause pinching of the microvasculature to reduce hae-
matogenous delivery to peripheral sections of the infarct territory, i.e. to the penumbral areas 
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that may be particularly suitable for salvage. In addition, endocardial injection decreases 
shedding of cells into the circulation since cells are injected within the tissue thus placing 
decreased numbers of cells into the bloodstream. In the treatment of chronic heart failure 
there has already been tissue loss and often this is combined with severe ischaemic coronary 
disease. Cell therapy aims to reverse the chronic changes by improving the vascular bed and 
salvaging as much myocardium as possible. This situation would particularly benefi t from 
addition of new myocardial cells, although the ability to produce new myocytes remains con-
troversial. Precise delivery to electrically and mechanical defi nable areas could allow uniform 
coverage or other distributions to target specifi c areas. In addition the risk of perforation 
of a thin myocardium may be minimised by use of electrical signals via the adjustable and 
retractable needle providing exact depth control together with monitoring of the ECG for 
reverse potentials.
REVASCULARISATION
A further option enabled by the magnetic navigation system is the ability to treat complex 
coronary disease. As the predominant cause of LV dysfunction is ischaemic heart disease, the 
partial or complete recovery of the native coronary circulation may encourage both recovery 
of native myocytes and provide a milieu for better uptake and diff erentiation of stem cells.
The ability of the system to support PCI has been demonstrated in a number of scenarios 
from simple to complex lesions and evidence suggests that this system may be particularly 
advantageous in more diffi  cult anatomy and is capable of successfully treating CTO’s. The 
integration of MSCT data (see Figure 5) allows the missing segment of the vessel to be judged 
(see Figure 6) and the superimposition of this data by co-registration gives an indication of 
the pathway.
Figure 5. The panel on the left shows the raw data from angiography and the panel on the right shows the 
reconstructed MSCT. See this fi gue in color in the Appendix page 387.
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CONCLUSION
Magnetic navigation may aid the performance of cardiac stem cell transplantation by allow-
ing integration of spatially localised, 3-D volume rendered information with real-time tissue 
visualisation in multiple modalities to give site directed deliverability to reduce procedure 
times and irradiation, and improve effi  cacy simultaneously.
The development of the NOGA® XP system and the magnetically navigable MyoStar™ 
injection catheter may lead to improved detection of non-functional myocardium, better 
delivery and more precise follow-up.
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Figure 6. The panel on the left shows the co-registered points applied to the MSCT image that was imported 
into Navigant and the panel on the right shows the computer reconstructed pathway that is derived from 
CT and projected onto the reconstruction in Navigant. See this fi gue in color in the Appendix page 387.
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First experience with remote left ventricular 
mapping and transendocardial cell injection 
with a novel integrated magnetic navigation-
guided electromechanical mapping system
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ABSTRACT
Aims: The purpose of this preclinical feasibility study was to evaluate a novel integrated plat-
form in which magnetic navigation is used to remotely guide electromechanical mapping of 
the left ventricle (LV) and transendocardial cell injections. Using an integrated remote system 
would greatly facilitate intramyocardial delivery of stem cells for treating ischaemic heart 
disease.
Methods and results: We used the computer-controlled Stereotaxis magnetic navigation 
system to guide the NOGA electromechanical mapping system in mapping viable myocar-
dium in the LV of seven pigs. We then tested the feasibility of this system to perform transen-
docardial injections in three of the pigs and to deliver mesenchymal precursor cells (MPCs) to 
targeted myocardial segments in four of the pigs. The success or failure of each injection was 
determined by myocardial contrast staining in the fi rst group and by histopathologic analysis 
in the last group. The mean time (±SD) spent mapping the LV for each pig was 49.3±10.6 
min. The success rate for transendocardial injections was 94.4%, as indicated by myocardial 
contrast staining. There was a 95.8% success rate for targeted injections of MPCs, and 4’,6-di-
amidino-2-phenylindole-labeled MPCs were detected in all but one segment of one pig. No 
epicardial haemorrhage or injury was observed, although there was some venous drainage.
Conclusions: The integrated Stereotaxis/NOGA system has excellent remote navigability in-
side the LV cavity while sparing the operator from radiation exposure. This system also allows 
transendocardial cell injections to be performed with a high success rate. Further studies are 
needed to defi ne the safety profi le of this system for clinical use.
Remote LV mapping and transendocardial 
cell injection with magnetic navigation-
guided mapping system
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INTRODUCTION
Recent studies have suggested that the heart has an intrinsic ability to regenerate after 
injury (1-3). This new fi nding has stimulated research on stem cell therapy for ischaemic 
heart disease (4-7). Preliminary preclinical data have shown that intramyocardial delivery 
of stem cells results in better cell retention than do intracoronary or retrograde injections 
through the coronary venous sinus (8). Electromechanically guided injection is the currently 
preferred mode of delivery in patients with chronic myocardial ischaemia. Using the NOGA 
electromechanical mapping (EMM) system to deliver transendocardial injections has been 
shown in clinical studies to be feasible and safe (4,5,9,10). The capability to perform online 
assessment of myocardial ischaemia and viability using unipolar voltage mapping has also 
been previously described (11-13). Segments of myocardium with unipolar voltage less than 
6.9 mV are associated with transmural scarring on MRI, with a sensitivity of 93% and specifi c-
ity of 88% (12). The ability of the NOGA system to obtain a detailed map of the LV cavity with 
1-mm precision, combined with its ability to diff erentiate viable from non-viable myocar-
dium, permits the accurate targeting of cell delivery to ischaemic or viable myocardium. The 
Stereotaxis magnetic navigation system (MNS) comprises two magnets that can be oriented 
to generate a 0.08-T directional magnetic fi eld. This new system has had good preliminary 
safety results in patients with complex anatomy undergoing percutaneous coronary inter-
ventions (14). The safety and feasibility of this system for guiding electrophysiology catheters 
for diagnostic and interventional procedures has also been shown (15,16). Integrating the 
NOGA EMM system with the Stereotaxis MNS would allow remote navigation inside the left 
ventricular (LV) cavity. In theory, the electromagnetic force exerted at the catheter tip would 
preclude the need for support from its shaft, thus allowing for the use of a softer catheter 
that is less likely to penetrate the myocardium and cause perforation. The new catheter also 
allows for transendocardial injections in remote areas of the LV not easily reached with the 
current manually directed catheters. This remote navigation capability of this system would 
also avoid excessive mapping times and undue exposure of the operator to radiation. The 
purpose of this preclinical feasibility study was to evaluate a novel integrated Stereotaxis 
MNS-guided NOGA EMM system for remote mapping and stem cell injections. We used a 
porcine model to test the ability of this system to construct a LV electromechanical map and 
to deliver transendocardial injections to various myocardial segments.
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METHODS
Stereotaxis MNS-guided NOGA EMM system
The MNS (Niobe®, Stereotaxis, St. Louis, MO, USA) consists of two computer-controlled per-
manent magnets, located in a fi xed housing apparatus, that can be manoeuvred relative to 
each other to create a directional magnetic fi eld (16). The apparatus is located on either side 
of the fl uoroscopy table (AXIOM Artis, Siemens, Malvern, PA, USA) and can be adjusted to 
the patient’s body position. While in the “navigate” position, the magnets create a relatively 
uniform magnetic fi eld (0.08 T) of approximately 15 cm in diameter inside the patient’s chest. 
The Stereotaxis-compatible NogaStar® mapping and MyoStar® injection catheters (Biolog-
ics Delivery Systems, Cordis Corporation, Diamond Bar, CA, USA) are equipped with a small 
permanent magnet positioned at the tip that aligns itself with the direction of the externally 
controlled magnetic fi eld, thereby enabling the catheter to be steered eff ectively. Chang-
ing the orientation of the outer magnets relative to each other changes the orientation of 
the magnetic fi eld, leading to defl ection of the catheter (17) (Figure 1). All magnetic fi eld 
vectors can be stored and, if necessary, reapplied while the magnetic catheter is navigated 
automatically. In addition, a computer controlled catheter advancer system (Cardiodrive 
unit, Stereotaxis, St. Louis, MO) is used to allow truly remote catheter navigation without 
the need for manual manipulation after the catheter has been inserted into the ascending 
aorta. The video workstation (Navigant II, Stereotaxis, St. Louis, MO, USA), in conjunction 
with the Cardiodrive unit, allows precise orientation of the catheter by 1° increments and by 
1-mm steps in advancement and retraction. The system is controlled by joystick or mouse 
and allows remote control of the injection catheter from inside the control room, away from 
radiation sources. The NOGA system enables users to identify viable myocardium by assess-
Figure 1. Mapping the LV cavity with the NogaStar® catheter. Left: unipolar voltage map of the LV cavity, 
showing the Stereotaxis-compatible NogaStar® catheter, the vector of the catheter position (green), and 
the directional vector (yellow) created by the magnetic fi eld. Right: Navigant II screen showing integration 
of the fl uoroscopy image and the endocardial map. See this fi gue in color in the Appendix page 388.
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ing unipolar voltage (12). Thus, integrating the NOGA XP (Microsoft Windows platform) with 
the Stereotaxis MNS would allow for remote LV navigation and targeted stem cell delivery 
into viable ischaemic myocardium. The integration of the two systems at the level of the user 
interface is achieved by simply placing a three dimensional vector into the NOGA map that 
can be moved by clicking and dragging a computer mouse. Catheter movement tracks the 
orientation of the vector. No catheter manipulation is required.
Animals
This study was reviewed and approved by the Institutional Animal Care and Use Committee 
of Washington University (St. Louis, MO, USA) and met the criteria of the National Institutes 
of Health and American Heart Association for animal research. Seven healthy adult domestic 
pigs of either sex, weighing between 30 and 55 kg, were subjected to cutdown exposure of 
the femoral artery for catheter insertion, performance of the EMM procedure, and transen-
docardial injections.
Remote electromechanical mapping procedure
In brief, general anaesthesia was induced with intravenous pentothal (17 mg/kg) and main-
tained with isofl urane (1.5% to 2.25%) in each pig. The pig’s right femoral artery was then ex-
posed, an 8F introducer was positioned, and the NogaStar® catheter was manually advanced 
into the ascending aorta. The Cardiodrive unit was used to advance the catheter though the 
aortic valve into the LV cavity while orienting the magnetic fi eld vector posterosuperiorly 
to bend the catheter tip against the valve leafl ets. After the catheter entered the LV cavity, 
the vector was redirected to the apex, and the catheter was advanced until it contacted the 
endocardial surface. Electromechanical mapping was performed by orienting the vector and 
advancing or retracting the catheter with the Cardiodrive unit until a complete map of the 
LV cavity was acquired.
Transendocardial injections
The prototype magnetic injection catheter (Stereotaxis-compatible MyoStar®) was evaluated 
for its navigational characteristics, magnetic defl ection capabilities, and the amount of push 
force exerted by the catheter tip. In a previous study, a prototype injection catheter showed 
good success in navigating a Stereotaxis small heart phantom; the catheter was able to reach 
all targets of interest in the LV via the retrograde approach. The injection catheter prototype 
catheter tip could also be defl ected by 150° when the unsupported (or freely defl ectable) 
length was 5 cm. This is comparable to the tip defl ection of 132° obtained with the MyoStar® 
catheter with a similar free length. The push force exerted by the injection prototype catheter 
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just before the catheter tip buckles, unaided by any magnetic fi eld, was 70 g when the unsup-
ported length was 4.5 cm. Under similar conditions, the tip force exerted by the MyoStar® 
catheter overloaded the test gauge (> 100 g) without any buckling of the catheter tip. The 
maximum tip force exerted by the prototype catheter decreases progressively as the tip is 
bent in response to the applied magnetic fi eld. This will likely contribute to added safety 
during transendocardial injections in regard to avoiding myocardial perforation (Figure 2). 
Before performing the transendocardial injections, we manually divided the EMM into a 
polar map with 13 segments, excluding the most basal segment of the heart (Figure 3). The 
NogaStar® catheter was replaced with the MyoStar® catheter, and the needle length was set 
at 5 mm. Phase I of the study tested the feasibility of using the integrated Stereotaxis/NOGA 
system to perform transendocardial injections.
Figure 2. Magnetic defl ection of the prototype catheter. Images show magnetic defl ection of a prototype 
catheter in various directions in a 0.08-T fi eld when the catheter is extended 4.5 cm from rigid support. 
See this fi gue in color in the Appendix page 388.
Figure 3. Manually reconstructed polar map from one representative animal of phase I of the study. The 
basal segments were excluded. See this fi gue in color in the Appendix page 388.
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In three pigs, each of the 13 predefi ned segments was targeted and injected with 0.2 ml 
of isosmolar contrast medium (iodixanol [Visipaque], Amersham Health, Princeton, NJ, USA). 
Each segment received three injections of contrast medium. In the second animal the apical 
segments received an additional nine injections. The presence of contrast stained myocardium 
by fl uoroscopy confi rmed the success or failure of each transendocardial injection. For each in-
jection, the catheter angle relative to the endocardial surface was recorded as well as the force 
exerted by the catheter tip against the endocardium (measured as quartiles from 0 (minimum 
force) to 4 (maximum force), and the presence of premature ventricular contraction (PVC) 
upon needle exposure. Phase II of the study tested the ability of the integrated Stereotaxis/
NOGA system to deliver bone marrow derived allogeneic mesenchymal precursor cells (MPCs; 
Angioblast Systems) to targeted segments. The fi rst stem cell-injected animal received unla-
belled MPCs and the three animals that followed were injected with 150 million 4’,6-diamidino-
2-phenylindole (DAPI)-labeled MPCs diluted in 4.8 cc of phosphate buff ered saline. In all four 
animals the injections were targeted to the mid-ventricular segments (anterior, anteroseptal, 
inferoseptal, inferior, inferolateral, and anterolateral). Four stem cell injections of 0.2 cc were 
delivered to each predefi ned segment. As in phase I, we recorded for each injection the 
catheter angle relative to the endocardial surface, the force exerted against the endocardium 
(measured as quartiles from 0 to 4), and the presence of PVC upon needle exposure. The pigs 
were euthanised after the procedure, and their hearts were sent for histopathologic analysis.
Histopathologic analysis
After each animal was euthanised, the aortas and hearts were rapidly excised. Shortly after 
excision, the pericardial sac of each phase I and II study animal was examined for signs of 
eff usion, and each heart was evaluated for epicardial haemorrhage or injury. Additionally, in 
the phase II animals, each heart was also evaluated for the presence of DAPI-labelled cells as 
follows. The heart was perfusion-fi xed and then sliced into 1-cm-thick sections (bread-loaf 
technique). Each slice was photographed on both sides. A portion of the slices was then 
placed in 10% buff ered formalin for immediate histological evaluation, and the other portion 
was frozen in Tissue Tek optimal cutting temperature compound (Sakura Finetek USA, Tor-
rance, CA, USA) and stored at – 80°C for subsequent histologic analysis. The histopathology 
slides were correlated with the correspondent injected segment to detect DAPI-labeled MPCs 
by fl uorescence microscopy. Needle tracks were identifi ed, and the depth of each injection 
(vertical distance from the endocardial surface) was calculated.
Statistical analysis
Descriptive statistics were performed using SPSS software (standard version 11.0, SPSS). 
Numerical variables are reported as mean±SD. Categorical data are reported as proportions.
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RESULTS
The integrated Stereotaxis/NOGA system was used to perform remote EMM and transendocar-
dial injections in seven pigs. The weight of the animals, the number of map points per animal, 
and the time spent for the mapping and injection procedures are summarised in Table 1. 
Table 1. Animal weights and procedure times.
Pig # Weight (kg) Number of mapping points Total mapping time (min) Total injection time (min)
1 55.0 65 60 143
2 40.0 56 45 80
3 52.0 67 60 60
4 45.0 59 55 60
5 55.0 79 50 45
6 54.5 57 45 35
7 29.5 38 30 36
Mean 47.3 60.1 49.3 65.6
SD 9.7 12.5 10.6 37.6
The mean mapping time (±SD) was 49.3±10.6 min per animal, or 49.4±6.3 s per mapping point. 
Phase I: injection feasibility
A total of 126 0.2-ml injections of iodinated contrast dye were performed. One hundred and 
nineteen injections (94.4%) were successful; that is, they resulted in myocardial contrast 
staining. The presence of PVC upon needle exposure predicted successful transendocardial 
injection with a sensitivity of 98% and a specifi city of 71%. The catheter angle relative to the 
endocardial surface varied from < 30° to 90°, and the force exerted against the endocardium 
varied on a scale of 0 to 4. Transendocardial injections had a high rate of success regardless of 
the catheter angle and force (Table 2). 
Table 2. Success rates of intramyocardial injections by catheter angle and force exerted against endocardium.
Myocardial staining Success
Present Absent rate (%)
Catheter angle (degrees)
 <30 21 1 95.5
 30-59 54 2 96.4
 60-89 39 3 92.9
 90 5 1 83.3
 Total 119 7 94.4
Venous drainage, defi ned as contrast staining of the vein, was observed in 50 (39.7%) of the 
126 injections. Histopathologic analysis revealed no evidence of pericardial eff usion, epicar-
dial haemorrhage, or injury. 
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Phase II: Stem cell injection feasibility
A total of 96 injections of MPCs were performed. In the fi rst animal injected with unlabelled 
MPCs, the presence of MPC clusters and corresponding needle tracks in the myocardium 
was confi rmed by gross microscopy (Figure 4). In the remaining three animals that received 
transendocardial injections of DAPI-labelled MPCs, the presence of MPCs was assessed under 
fl uorescence microscopy. The depth of the injections was also assessed at higher magnifi ca-
tion. MPCs were detected in 23 of the 24 injected segments for each animal, comprising a 
success rate of 95.8% (Figure 5). Histopathologic analysis revealed no evidence of pericardial 
eff usion. In each animal, needle tracks could be identifi ed in 18 of the 24 injected segments. 
In 16.7% of injected segments, the needle track length reached the entire thickness of the 
correspondent myocardial segment. The remaining needle tracks identifi ed injections with 
a mean depth of 53.5±17.3% of the LV wall thickness. The only injected segment (out of 24 
injected segments) that did not contain injected cells was the mid-inferior segment of pig #7. 
In this pig, DAPI-labelled cells were found at the epicardial surface, and small petechiae were 
found in the mid-anterior segment (Figure 6). This pig had a substantially lower body weight, 
a lower heart weight (235 g), and thinner LV walls than did the other animals.
Figure 4. Transendocardial injections of unlabelled MPCs. (A) Several needle tracks (arrows) and an area 
of micro-haemorrhage (box) in the subepicardial space. (B) Distribution of MPCs along a needle track, with 
concomitant haemorrhage (red areas). (C) Cluster of MPCs at higher magnifi cation. See this fi gue in color in the 
Appendix page 389.
Figure 5. Frozen sections of an injected myocardial segment imaged under fl uorescence microscopy (blue, 
DAPI-labelled nuclei; green, α- sarcomeric actinin). A. Small cell cluster corresponding to an injection site. B. 
DAPI-labelled MSCs dispersed throughout the apex. Magnifi cation: x20. See this fi gue in color in the Appendix 
page 389.
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DISCUSSION
This initial preclinical experience provides preliminary evidence of the feasibility of remote 
EMM, transendocardial injections, and LV cavity navigation with the integrated Stereotaxis 
MNS guided NOGA system. The new Stereotaxis-compatible mapping (NogaStar®) and injec-
tion (MyoStar®) catheters have demonstrated excellent capacity for intraventricular naviga-
tion, being able to reach every endocardial segment needed to construct an electromechani-
cal map and successfully perform endocardial injections. Furthermore, this system preserved 
navigation precision and map quality while sparing the operator from exposure to radiation 
during the procedure. Magnetically driven navigation has important advantages over con-
ventional catheter manipulation inside the LV. Because the force driving the catheter and 
holding it stable against the endocardium is exerted on the tip of the magnetically guided 
catheter, its shaft does not need to provide backup support and is fl exible enough to allow the 
movement guided by the magnetic fi eld. This feature permits the catheter to bend at acute 
angles to reach remote segments while keeping a stable position after needle exposure. This 
allows for easy mapping and injection of LV segments, such as the high anterior wall, that are 
extremely diffi  cult to reach with conventional catheter techniques. The excellent navigabil-
ity of the catheter and the magnetic force holding it against the myocardium could explain 
the high success rate of our transendocardial injections (Figure 7) regardless of the catheter 
angle or its force against the endocardium. In addition, the softer shaft of the magnetically 
guided catheter may help prevent cardiac perforation. The present study off ers new insights 
into transendocardial injections. First, we found that the presence of a PVC upon needle ex-
tension can be used to guide transendocardial injections. In the fi rst set of transendocardial 
injections, the presence of PVC predicted the success of the injections with high sensitivity. 
Second, a substantial number of contrast injections (nearly 40%) resulted in some degree of 
Figure 6. Small petechiae (arrow and circled area) in the anterior wall of pig #7. See this fi gue in color in the 
Appendix page 389.
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drainage by the coronary venous system. This phenomenon could infl uence retention rates 
after delivery of cells though this route, so transendocardial delivery strategies may need to 
be optimised to limit venous delivery of cells.
Study limitations
Because of the small number of animals and the constant needle length used in this study, the 
full safety profi le of this new catheter navigation system could not be established. Although 
there was no histopathologic evidence of pericardial eff usion, injected cells were found in the 
epicardium of one pig, which also had petechiae in the epicardial surface. Further preclinical 
studies specifi cally designed to assess safety should be performed before this system is used 
for transendocardial injections in patients. The success rates with this new catheter may have 
been overestimated because of the small number of animals used, although we did perform 
a large number of injections that were well distributed throughout the LV. In addition, the 
success rates achieved with this new catheter have not been compared head-to-head with 
those achieved with conventional manual navigation.
Figure 7. Image from fl uoroscopy of a transendocardial injection, showing the acute angle made by the 
catheter. Myocardial staining confi rms the intramyocardial position of the needle. Vein drainage is evident 
(arrow).
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CONCLUSIONS
The integrated Stereotaxis MNS-guided NOGA EMM system can be used for remote navigation 
inside the LV cavity and allows the performance of transendocardial injections with a high 
success rate. The feasibility of this system for transendocardial cell delivery was confi rmed by 
histopathologic analysis. More studies are needed to defi ne the safety profi le of this system. 
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ABSTRACT
Objective: The Stereotaxis Niobe® magnetic navigation system (MNS; Stereotaxis, St. Louis, 
MO) facilitates precise vector based navigation of magnetically-enabled guidewires for per-
cutaneous coronary intervention (PCI) by using two permanent magnets located on opposite 
sides of the patient table to produce a controllable magnetic fi eld. The objective of this study 
is to describe the results of a large patient series using this system, to compare the results 
with a historical control group, and to detail the MNS learning curve. 
Methods: We prospectively collected data on 439 lesions in 350 consecutive PCI patients 
using the MNS predominantly using the radial approach. All data were entered into a custom-
ized database to capture the key parameters and then compared with a previously collected 
stent registry from the same center. 
Results: In 410/439 lesions (93%) the wire crossed the lesion successfully using the MNS. 
Twenty-fi ve of the 35 failures were chronic total occlusions. No wire perforations or dissec-
tions occurred in this population. Lesion crossing time was 81 ± 168 sec (mean ± SD), and 
fl uoroscopy time was 64 ± 123 sec. A clear learning curve was evident after the fi rst 80 pa-
tients. Contrast use was reduced when compared with a historical control group. Procedural 
and fl uoroscopy times were similar. 
Conclusions: Use of the MNS may enable the successful performance of more complex 
procedures in the cardiac catheterization laboratory with an improvement in time effi  ciency. 
Use of the Stereotaxis Niobe® Magnetic 
Navigation System for PCI: Results From 350 
Consecutive Patients
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INTRODUCTION
Percutaneous coronary intervention (PCI) has become the standard of care for the treatment 
of ischemic lesions of the coronary arteries. While the success rates of PCI are generally excel-
lent, there exists a subset of procedures that are either diffi  cult or impossible to complete 
due to a myriad of factors, such as complex angulations or recalcitrant disease processes. 
Recently, a magnetic navigation system (MNS) has been developed for the precise steering 
of endovascular devices. Use of the MNS in cardiology procedures is becoming increasingly 
established. Several published reports have shown the clinical utility of the MNS in routine 
electrophysiology catheter ablation procedures, including specifi c reports describing its use 
in atrioventricular nodal reentrant tachycardia (1), atrioventricular re-entrant tachycardia (2), 
right ventricular outfl ow tract tachycardia (3), and parahisian accessory pathways (4). Ad-
ditional studies have demonstrated the ability of the system to add benefi t to more complex 
arrhythmia ablation procedures such as ventricular tachycardia (5) and atrial fi brillation (6,7), 
and to facilitate the placement of left ventricular leads in cardiac resynchronization therapy 
device implantation procedures (8). 
With the advent of the magnetically enabled wires and the advanced software tools for 
interventional cardiology, investigators have reported their initial experiences on the use of 
MNS in routine (9,10) and complex (11) PCI procedures. Case studies have been published 
on the use of MNS in complex interventions such as alcohol septal ablation (12) and crushed 
stent crossing (13), and an animal study has been published detailing its potential utility in 
left ventricular transendocardial cellular injection (14). Recently an exhaustive review of the 
use of this technology in PCI has been published, including a description of several future 
concepts and developments (15). To date, however, no extensive clinical series on the use or 
learning curve of MNS in a large series of PCI patients has been published in the literature.
The objective of the present study is to detail the results of PCI with the MNS in a large 
consecutive patient series, to compare these results with a similar historical cohort, and to 
describe the learning curve associated with this system.
METHODS
Patient Population
Three-hundred and fi fty consecutive patients with 439 lesions underwent PCI at our hospital 
using the MNS. All patients undergoing PCI were treated via the right radial approach un-
less contraindicated. Patient data was prospectively collected and entered into a custom-
designed PCI database.
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Medication and PCI
Patients were pretreated with aspirin (600 mg Aspegic i.v.), clopidogrel (600 mg plavix p.o.) 
and heparin (100 IU per kg). Patients were orally sedated with oxazepam 5 mg. Choice of type 
of guide catheter, balloon catheter and stents was left to the discretion of the operator.
Magnetic Navigation System
The Niobe MNS (Stereotaxis, Saint Louis, MO), is a fully integrated system (workstation and 
magnet control equipment) for navigating proprietary catheters and guidewires that have 
very small magnets placed at their distal tips. The orientation of these devices is controlled by 
precise manipulation of the fi eld generated by two large neodymium–iron–boron magnets 
that are mounted on mechanical positioners on either side of the patient. Rotation and 
translation of these magnets maintain a net magnetic fi eld of 0.08-T within a 20-cm diameter 
sphere in the patient’s upper thorax. These magnets are permanent and can be stowed and 
retracted away from the patient when not in use. 
The MNS is fully integrated at our center with the Integris Allura FD10 cardiovascular 
imaging system (Philips Medical Systems, Eindhoven, The Netherlands) as shown in Fig. 1. 
The operator interfaces with the system via the Navigant™ navigation work station (NWS) 
software interface (‘‘NWS,’’ Stereotaxis, St. Louis, MO). The NWS has several features that are 
specifi cally engineered for interventional cardiology procedures. These features include 
3D preoperative navigation that allows the user to import and coregister standard digital 
imaging and communication in medicine images and perform ‘‘point and click’’ navigation 
on the imported image. In addition, the NaviView software (CardiOp-B, Paieon Medical, Rosh 
Ha’ayin, Israel) allows use of angiographic images from the procedure to generate a 3D vessel 
reconstruction that can also be used for ‘‘point and click’’ navigation (Fig. 2).
Fig. 1. The Stereotaxis Niobe MNS. The magnet positioners are on either side of the patient table, with the 
Philips Integris Allura FD10 Single plane C-arm fl uoroscopy machine in the center. See this fi gue in color in 
the Appendix page 390.
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In our centre, there was no standard protocol for choice of wire and navigation technique 
(2D mode, 3D mode, or a combination of these), although 3D mode navigation was predomi-
nantly used in patients with more complex pathology.
Magnetically Enabled Wires
A series of magnetically enabled disposable guide wires that are custom designed to inte-
grate with and be precisely navigated by the MNS are available in a variety of sizes and a 
range of stiff ness. For this study, we utilized the Titan™ Guidewires, a family of endovascular 
guidewires specifi cally designed to be more fl exible and steerable for navigation in small, 
angulated vessels and the Assert™ Endovascular Guidewire, a magnetically controlled wire 
with a stiff er (2.29 g), more pushable tip engineered for crossing diffi  cult coronary lesions. A 
schematic of a Titan Guidewire is shown in Fig. 3.
Fig. 2. NaviView Feature. This three-dimensional reconstruction was created from the fl uoroscopic 
angiogram as shown using the NaviView software feature (powered by the Paieon software). See this fi gue 
in color in the Appendix page 390.
Fig. 3. Titan™ Guidwires. This schematic shows the basic design features of the magnetically enabled Titan 
Endovascular Guidewires. See this fi gue in color in the Appendix page 390.
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Historical Control Group
Thousand four hundred and seventy seven patients underwent single vessel single lesion 
coronary stent implantation in our center between March 2001 and December 2002. Data 
were prospectively stored in a dedicated database. 
After matching for senior operators, for 6F guide use and for an equal distribution of elec-
tive PCI and primary PCI, 385 patients remained for comparison with the MNS group. No 
major changes in PCI protocols were introduced (except for use of the MNS) that could infl u-
ence procedural time, fl uoroscopy time and contrast use between 2001 and 2007. The basic 
technique involved transradial direct stenting via 6F guides, just as in the present protocol. 
The same operators and nursing staff  were involved in these interventions. 
Learning Curve Evaluation
An early analysis of the results in the fi rst 80 patients (99 lesions) was compared with the total 
outcome and with three consecutive groups of 80 patients. The parameters used to describe 
a learning curve were time and fl uoroscopy time required to cross a lesion, total procedural 
time, total fl uoroscopy time and success rates. 
Statistical Analysis
Continuous variables are expressed by mean ± SD and were compared by the unpaired 
two-tailed student’s t-test. Proportions were compared with the Chi-square test. A P-value 
< 0.05 was considered to be statistically signifi cant. All data was analyzed using Primer of 
Biostatistics software (Stanton A. Glantz, Mc.Graw-Hill, San Francisco).
Defi nitions
To facilitate the interpretation of the data collected in this study, the following standard 
defi nitions were used:
-  Time to cross lesion: Time (sec) required to advance the wire from the tip of the guide 
catheter to a point well distal to the target lesion.
-  Fluoroscopy time to cross lesion: Fluoroscopy time (sec) required to advance the wire from 
the tip of the guide catheter to a point well distal to the target lesion.
-  Contrast used to cross a lesion: Amount of contrast (in ml) required to advance the wire to a 
point well distal to the lesion.
-  Procedural time: Time from the start of the puncture to complete removal of the fi nal guide 
catheter. 
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-  Fluoroscopy time: Fluoroscopy time from start of puncture to complete removal of the fi nal 
guide catheter.
-  Contrast use: Total amount of contrast used during the procedure.
Vessel and lesion tortuosity, calcifi cation, and lesion eccentricity were graded on a semi 
quantitative scale, varying from none, moderate to severe.
RESULTS
From 20 September 2006 to 1 May 2007, 350 consecutive patients assigned to two operators 
(FK and MP) underwent PCI with the MNS. In 335 patients (95.7%) the radial approach was 
used. Patient characteristics and angiographic data of the MNS group and the control group 
are summarized in Tables 1–4, respectively. 
Table I. Patient characteristics1
MNS group (n = 350) Control group (n = 385)
N SD/Percentage N SD/Percentage P-value
Age (years) 62.9 11.6 62.5 11.9 NS
Male 26.5 75.7 29.1 75.6 NS
Diabetes mellitus 62 17.7 44 11.4 0.02
Family history 111 31.7 98 25.5 NS
Current smoker 87 24.8 102 26.5 NS
Hypertension 138 39.4 146 37.9 NS
Cholesterol 95 27.1 145 37.6 0.003
AP CCS 0–1 11 3.2 11 2.9 NS
AP CCS 2 63 18 27 7.0 <0.001
AP CCS 3 159 45.4 133 34.5 0.003
AP CCS 4 117 33.4 214 55.6 <0.001
Previous PCI 115 32.8 66 17.1 <0.001
Previous MI 74 21.2 107 27.8 0.05
Previous CABG 43 12.3 31 8.1 NS
Stable AP 214 61.1 161 41.8 <0.001
Unstable AP 77 22 145 37.7 <0.001
Primary PCI 46 13.1 50 13.0 NS
Other 13 3.8 29 7.5 NS
AP, angina pectoris; CABG, coronary artery bypass grafting; CCS, Canadian Cardiovascular Society; 
MI, myocardial infarction
Although 52.6% of patients had multivessel disease, a single vessel was treated in 82.6% of 
patients. A total of 439 lesions were treated in the 350 patients (mean of 1.25 lesions per 
patient). 
Vessel and lesion specifi cations, including QCA data (n = 439) are displayed in Table 3. 
Mean lesion length was 18.3 ± 13.3 mm (mean ± SD). TIMI 3 fl ow was present in 301 ves-
sels (68.6%). More complex lesions (type B2 and C) were found in 68.8%. Severe tortuosity 
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Table 2. Patient Characteristics
MNS group (n 5 350) Control group (n 5 385)
N Percentage N Percentage P-value
1 Vessel disease 166 47.4 205 53.2 NS
2 Vessel disease 125 35.7 105 27.3 0.02
3 Vessel disease 59 16.9 75 19.5 NS
1 Lesion treated 290 82.6 385 100 <0.001
2 Lesions treated 57 16.3 0 0 <0.001
3 Lesions treated 3 0. 8 0 0 <0.001
Radial 335 95.7 359 93.2 NS
Table 3. Lesion Characteristics
MNS group (n 5 439) Control group (n 5 385)
Vessels N Percentage N Percentage P-value
RCA 111 25.4 93 24.2 NS
LM 4 0.9 10 2.6 NS
LAD/D/AL 211 48.1 206 53.5 NS
CX 58 13.2 52 13.5 NS
OM 40 9.1 10 2.6 <0.001
VBG 15 3.4 14 3.6 NS
QCA Mean SD Mean SD P-value
RD (mm) 2.61 0.59 2.84 0.57 <0.001
MLD (mm) 0.54 0.48 0.61 0.47 0.04
DS (%) 79.2 17.6 77.7 16.0 NS
Length (mm) 18.3 13.3 – – –
Flow N Percentage N Percentage P-value
TIMI 0 68 15.5 76 19.7 NS
TIMI 1 26 5.9 26 6.8 NS
TIMI 2 44 10 34 8.8 NS
TIMI 3 301 68.6 249 64.7 NS
AL, anterolateral branch; CX, circumfl ex coronary artery; D, diagonal; LAD, left anterior descending; LM, 
left main stem; OM, obtuse marginal; RCA, right coronary artery; VBG, venous bypass graft; DS, diameter 
stenosis; MLD, minimal luminal diameter; RD, reference diameter.
Table 4. Lesion Characteristics
MNS group (n 5 439) Control group (n 5 385)
Type N Percentage N Percentage P-value
Type A/B1 137 31.2 138 35.8 NS
Type B2 99 22.6 88 22.9 NS
Type C 203 46.2 159 41.3 NS
Pathology N Percentage Not assessed
Tortuosity+++ 49 11.2 - - -
Calcifi ed+++ 74 16.8 - - -
Eccentric+++ 169 38.5 - - -
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(11.2%), calcifi cations (16.8%) and eccentricity (38.5%) were seen in 11.2, 16.8, and 38.5% of 
lesions, respectively. 
Out of 439 lesions, 404 could be crossed with MNS (92%). Of the 35 failed attempts to 
cross, 25 were chronic total occlusion (CTO) (71.4%). Following a failed attempt, 30 attempts 
were made with conventional wires without MNS (85.7%). Of these, 14 (46.6%) were suc-
cessful. Totally 49 CTO’s have been attempted with varying techniques (2D 49%; 3D 51%). 
In all instances the lesion could be reached. However, only 24 (49%) CTO’s were successfully 
crossed with a magnetic wire. In 20 out of the 25 failed attempts (80%), the procedure was 
continued with conventional wires, of which 9 (45%) could fi nally cross the lesion. The mean 
total number of coronary wires used was 1.5 ± 0.8.
Final procedural success was obtained in 410 of the 439 lesions giving a success rate of 
93.4%. No wire perforations and dissections occurred. Time to cross the lesion (n = 410) was 
81 ± 168 sec (range 1–2,160 sec) and fl uoroscopy time was 64 ± 123 sec (range 1–1,581 sec). 
Time to cross A and B1 type lesions (n = 136) was 51 ± 94 sec, whereas in type B2 and C lesions 
(n = 5 268) this took 96 ± 194 sec [P = 0.01]. Fluoroscopy times to cross lesions were 41 ± 73 
and 76 ± 141 sec, respectively [P = 0.008]. All type A and B1 lesions could be crossed and all 
failed attempts to cross (n = 35) were found in type B2 and C lesions [P < 0.001].
In the fi rst 3 months of MNS use (80 patients and 99 lesions crossed) these times were 142 
± 272 (range 4–2,160 sec) and 109 ± 202 sec (range 4–1,581 sec), respectively [P = 0.005]. 
When divided into groups of 80 patients, a trend to a reduction in times was obvious (Fig. 4).
Total procedural and fl uoroscopy times were 33.9 ± 19.3 (range 7.5–138 min) and 9.2 ± 7.6 
min (range 1.2–56 min), respectively. In the fi rst 80 patients these values were 37.4 ± 17.1 
(range 12–94) [P = 0.05] and 11.0 ± 9.5 min (range 2.3–56) [P = 0.01] (Fig. 5).
The mean amount of contrast agent required to cross the lesion was 5.4 ± 12.0 ml. No 
contrast was used in 51% of patients and 0–10 cc of contrast was used in 36.1% of lesions. 
Total amount of contrast used was 138 ± 91 ml (range 20–600 ml). In the fi rst 80 procedures 
total contrast consumption was 153 ± 98 (range 30–600 ml) [P = 0.19]. 
Fig. 4. Decreasing times in seconds (mean ± SD) to cross lesion and fl uoroscopy times in four consecutive 
groups of 80 patients. See this fi gue in color in the Appendix page 391.
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Signifi cantly more lesions were treated in the MNS group (1.25 ± vs. 1.0 ± 0; P < 0.001). 
Despite this diff erence in favor of the control group, procedural and fl uoroscopy times were 
similar: 34.3 ± 20.4 [NS] and 10.2 ± 8.3 min [NS], respectively. More contrast was used in the 
control group when compared with the MNS group, with a mean of 212 ± 112 ml [P < 0.001].
DISCUSSION
This study provides the fi rst large single center patient series describing the results obtained 
using MNS for PCI. In this fairly complex group of patients, success rates were high and pro-
cedural parameters were at least within the limits usual in our practice. Moreover, in the MNS 
group signifi cantly more lesions per patient were treated, while procedural and fl uoroscopy 
times were within the same range as the single lesion stent control group. Inevitably there 
were diff erences between the study population and the historical control group (Tables 1– 3). 
However, factors infl uencing outcome have been matched to the greatest extent possible. 
Operator experience, use of transradial approach, use of 6F guides, coronary stenting and 
patient acuity were considered to be the most infl uencing parameters. Actually, the MNS 
group was less favorable (1.25 lesion per patient), since the control group only contained 
single vessel stenting (1 lesion per patient). In addition, in the control group all lesions could 
be crossed by the wire, while in the MNS group this was just the target issue. 
Recently data were published on an evaluation of fl uoroscopy times and correlation of 
outcomes after single vessel PCI (16) In 9,650 patients treated at a single center from 2000 to 
2004, procedural and fl uoroscopy times were 81.6 ± 60.6 and 18.3 ± 12.2 min, respectively. 
The procedural data from our current series compare quite favorably with these data, as well. 
The fact that currently most failures in our practice occurred in patients with CTO and that 
only 49% of CTO’s could be crossed by use of magnetic wires alone, are not due to navigation 
problems but rather are due to shortcomings in wire technology. Since MNS for PCI is a young 
Fig. 5. Decreasing procedural and fl uoroscopy times in minutes (mean ± SD) in four consecutive groups of 
80 patients. See this fi gue in color in the Appendix page 391.
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technique, these magnetically enabled wires do not yet have all specifi cations required to 
deal with very tortuous, calcifi ed, and totally occluded lesions. However, improvement in wire 
technology is imminent and should help to increase the success rates for CTO. In addition, the 
3D reconstruction software tools are currently being improved. The ability to reconstruct the 
complete vessel with the lesion in a more detailed fashion may allow further refi nement of 
navigation. We decided to obtain MNS in our PCI practice because the technique off ers a wide 
scale of both current and future advantages. The combination of several visualization tech-
niques with fl uoroscopy, means that success rates might be improved in complex situations 
with shorter procedural times and with the use of fewer disposable materials. In addition, the 
technique off ers the possibility of reducing contrast agent usage, which obviously is of great 
value, especially in the diabetic population. Faced with a growing population of patients with 
complex coronary pathology, these issues are becoming of practical and economic impor-
tance. Once the system was installed in our center, a core group of two cardiologists, three 
nurses and one technician were designated to use the system to concentrate knowledge 
and experience and to become independent from the support team of Stereotaxis. In a later 
phase, this group will train the other members of the interventional group to expand PCI 
practice by MNS. One may argue that MNS is not required for simple pathology and this is 
recognized by our group. However, by treating a large consecutive group of patients with the 
MNS, operators, nurses, and technical staff  became thoroughly familiar with the system and 
its technical options in a relatively short period of time and this resulted in a steep decrease 
in learning time. In comparison with the fi rst 80 patients, all of our procedural parameters 
signifi cantly improved. Once the operator and staff  become experienced with the system, 
the MNS can be used in very complex situations as well, which will lead to optimal success 
rates. With continuously improving hardware and software and wire technology, it is our 
conviction that the MNS will become a standard tool in future catheterization laboratories.
Study Limitations
The main caveat of this study is the lack of a contemporary control group or of a randomized 
assignment of patients. We sought to mitigate this shortcoming by limiting our comparison 
group with a consecutive series of single vessel single lesion PCI patients done at the same 
center by a senior interventional team using the same basic techniques (transradial stenting 
via 6F guides). Although not as rigorous as a prospective, randomized, controlled trial, we 
believe that the similarities between the two groups off er a valid comparison that will be of 
value to the interventional community. 
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CONCLUSION
Magnetic navigation is highly applicable, safe, and successful in day-to-day practice. When 
adequate profi ciency is achieved, no additional time is added to the procedure when com-
pared with conventional methods.
Use of the MNS was associated with a reduction in contrast use, when compared with a 
matched historical control group at our center. Future directions for research should include 
advancements in wire technology and improvements in the software design.
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ABSTRACT
Objective: A randomized comparison of the magnetic navigation system (MNS) to conven-
tional guidewire techniques in percutaneous coronary interventions. 
Background: The MNS precisely directs a magnetized guidewire in vivo using two perma-
nent external magnets. 
Methods: A total of 111 consecutive patients were enrolled. Crossing success, crossing-/fl uo-
roscopy times, and contrast usage were directly compared. Lesions were classifi ed according 
to the AHA/ACC criteria. Three tertiles of vessel/ lesion complexity (low (<5), medium (6–10) 
and high (>10)) were defi ned using 3D reconstructions and angiographic information. 
Results: The crossing success for magnetic and the conventional wires were 93.3 and 95.6%, 
respectively. Crossing and fl uoroscopy times were longer with the magnetic wires (72.9 ± 50.3 
sec vs. 58.1 ± 47.2 sec, P < 0.001 and 66.2 ± 44.1 sec vs. 55.2 ± 44.4 sec, P = 0.03, respectively). 
In vessels with low and medium complexity the magnetic wires had signifi cantly longer times 
(P < 0.001) but for those with high scores (>10) a trend towards shorter times was observed. 
The MNS resulted in a small but signifi cant reduction in contrast usage (2.3 ± 3.5 ml vs. 4.5 
± 4.4 ml, P < 0.001). Moreover by superimposing a virtual roadmap of the vessel on the live 
fl uoroscopy image 48% of the lesions were crossed without requiring contrast agents with 
the MNS. 
Conclusion: The MNS has comparable crossing success to conventional PCI. It is relatively 
slower but there is a trend to support a potential advantage in more complex vessels. By 
simultaneously employing a virtual roadmap there is a small but signifi cant reduction in 
contrast usage. 
A Randomized Comparison of the Magnetic 
Navigation System Versus Conventional PCI
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INTRODUCTION
Magnetic navigation is an innovative technology that can accurately control the position-
ing of a guidewire or a catheter in vivo (1). To accomplish this, a small (2–3 mm) magnet 
embedded at the tip of the wire or catheter is reoriented by a predetermined and rapidly 
updated external magnetic fi eld. The fi eld is generated by two permanent external (0.08 
Tesla) magnets that can rotate, tilt, or translate on movable positioners (2). Within this fi eld 
a magnetic vector is created through computer driven software to direct the tip of the de-
vice (the magnetically enabled wire or catheter). The advantage of in vivo control has been 
previously demonstrated in cardiac electrophysiological procedures whereby inaccessible 
pathways can be eff ectively targeted, even remotely (3). In percutaneous coronary inter-
vention (PCI) the initial bend placed on the wire to engage the target vessel might not be 
ideally suited to cross the target lesion. As such, preliminary studies in patients with complex 
lesions and tortuous vessels have shown an advantage with magnetic assisted intervention 
(MAI) in cases that failed with conventional PCI (4). However, to date the only randomized 
direct comparison of the magnetic navigation system (MNS) to conventional approaches 
was performed in increasingly tortuous phantom models where it was suggested that the 
MNS might be advantageous (5). To further assess the implication of this novel technology to 
PCI, it is necessary to include randomized comparisons in native coronary lesions. Areas that 
warrant investigation include evaluating procedural success, crossing/fl uoroscopy times to-
gether with contrast media usage. It is perceived that for some of these parameters the MNS 
may be advantageous as reorienting the wire in situ and the navigational road map created 
from a 3D reconstructed image—superimposed on real-time fl uoroscopy— may indirectly 
infl uence the procedure (6). To assess the performance of the MNS we performed the fi rst 
direct randomized comparison with conventional wire technique in patients presenting with 
stable and unstable angina.
MATERIALS AND METHODS
Patient Selection and Defi nitions
In a 12-month-period commencing September 2006, 111 consecutive patients admitted with 
stable and unstable angina were single-blinded randomized to cross the culprit lesion twice, 
either using a conventional or a magnetically-enabled guidewire. All patients were appropri-
ately informed about the procedure and gave their consent. Angina was defi ned according 
to the Canadian Cardiovascular Society and Braunwald classifi cation, respectively (7,8). 
Patients were excluded if they were haemodynamically unstable or had contraindications 
for magnetic-assisted intervention (MAI) such as a pacemaker. The objectives of the study 
were the direct evaluation of the crossing success, crossing/ fl uoroscopy times, and contrast 
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usage. This was assessed by measuring the time (sec) and contrast media (ml) required to 
cross the lesion having fi rst placed the guidewire at the tip of a guiding catheter engaged at 
the ostium and following the wire passage distal to the lesion. The wire was then withdrawn 
and the comparative wire was then used to coincide with the start and end position of the 
fi rst wire. Lesions not crossed within 6 min with either wire were labeled as wire failures as 
previously defi ned by our published phantom studies (5). Included within the 6 min was the 
time taken for wires to be removed from the catheter and reshaped to achieve a successful 
crossing. Wires that were damaged in crossing could be exchanged for a similar or diff erent 
conventional or magnetically enabled wire if necessary. The operators (four in total) had 
unrestricted access to the choice of either magnetic or conventional guidewires and were 
interventional cardiologists who were also trained in MAI procedures. The crossing success 
of each wire was defi ned as the amount/percentage of successful crossings within 6 min. The 
procedural success was defi ned as successful crossings without time restrictions using the 
complementary technique having failed with the fi rst wire technique to cross within 6 min. 
The MNS
The Niobe® II MNS (Stereotaxis, St. Louis, M. USA) integrated with a modifi ed C-arm fl at-
panel detector-fl uoroscopic imaging suite (AXIOM Artis dFC, Siemens Medical Solutions, 
Forchheim, Germany) for angiographic imaging was used throughout this study. The system 
allows two diff erent modes for navigation by using either 2-dimensional (2D) such as in the 
‘‘clockface’’ method (Fig. 1A) or 3-dimensional (3D) maps of the coronary artery (1). In this 
study navigation was performed using a 3-dimensional reconstructed (3DRC) virtual vessel 
roadmap generated from two angiographic images 30° apart (CardiOp-B, Paieon Medical, 
Rosh Ha’ayin, Israel) (Fig. 1B). The 3DRC was fi rst coregistered with the fl uoroscopic image 
(Fig. 1C) and a navigational pathway created through the lumen of the 3DRC (Fig. 1D). This 
pathway was then displayed as a fi xed centreline on the real-time fl uoroscopic image. The 
operator was then able to manually advance the navigational vectors associated with this 
centreline at a predetermined distance (1–9 mm) by pressing the advance/go button on 
the touch screen monitor. In cases of complex 3DRC the navigation was performed using 
the 2D ‘‘clock face’’ model. In this model navigational vectors are displayed in a circle that 
looks like the face of a 12-hr clock on the touch screen monitor. By pressing points around 
the perimeter of the circle/clock, the software (Navigant®) calculates vectors to redirect the 
magnetic fi eld and realign the wire tip to the chosen direction (Fig. 1A). In both the 2D and 3D 
navigational modes the operator manually advances the guidewire once the vector reaches 
the desired position. As training with the magnetic system requires both an understanding of 
the software and the hardware on average a novice needs at least 12 hr of practical training 
to be fully acquainted with all the techniques and tools. In our department, which is a leading 
center that evaluates the MNS to PCI we feel that after 35 magnetic cases the operator can 
Mark bw.indd   184 25-05-10   15:15
185
A Randomized Comparison of the Magnetic Navigation System Versus Conventional PCI
be called an experienced user. In addition, one trained technician is required to operate the 
system from a control viewing room in the catheterization laboratory.
The Guidewires
The conventional wires used in the study were PT Graphix™ Intermediate, Choice™ PT Floppy 
(Boston Scientifi c Corp. Miami, FL), Whisper (Abbott Vascular Devices, Redwood, CA) and high 
torque BMW (Guidant Corp, Santa Clara, CA). The magnetic guidewires used were all 180-cm-
long Titan™ Soft Support wires with a 2-mm angled or 3-mm long straight magnetic tips 
attached to a 0.014 in./0.36-mm stainless steel core (Stereotaxis, St. Louis, MO. USA).
Lesions and Vessel Characterizations
Lesions were defi ned as type A, B1, B2, and C in accordance with the American College of 
Cardiology/American Heart Association ACC/AHA classifi cations (9). Type A lesions were 
generally discrete (<10-mm length), concentric, readily accessible nonangulated lesions 
with little or no calcifi cation and did not involve the ostium or major side branches. Type 
B1-lesions were longer (10–20 mm), or eccentric, or with moderate tortuosity and angulation 
(45o–90o). These lesions might have moderate to heavy calcifi cation and could involve the 
ostium or a bifurcation. Lesions classed as type B2 had more than one B1 criteria.
Figure 1. (A) The clockface navigational mode showing a vector depicted by an arrow that can be 
repositioned by selecting points around the perimeter of the clock; (B) a 3-dimensional reconstruction 
of a coronary bypass graft to the native left anterior decending artery and (C) the registration with 
the fl uoroscopic image; (D) navigating at the bifurcation of the virtual reconstructed graft showing a 
navigational pathway through the lumen.
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Type C lesions were diff usely diseased (>2 cm in length) with extreme tortuosity and angu-
lations (>90o). When involving a complex bifurcation there is a potential risk of losing the 
side branch. Given the limitations of the AHA/ACC classifi cation, namely in not considering 
the vessel characteristics which may infl uence the ability to get a wire across our group has 
developed a simple score system for predicting prolonged crossing times to select patients 
who would benefi t from MAI (10). The score takes into consideration the angulation of the 
proximal segment, the number of bends to reach the lesion, total vessel angulation, length, 
calcifi cation, number of sidebranches, and if there is a stent proximal to the lesion. It also 
incorporates the following lesion characteristics: side-branch in the lesion or within 10 mm of 
the lesion, lesion angulation and calcifi cation, the lesion length and the length of lesion more 
than 80% diameter stenosis, and also if the lesion is due to instent restenosis (Table 1) (11). 
Table I. A Scoring System Based on Vessel and Lesion Characteristics
Vessel characteristics Score ()
1st turn (Aorta-Prox vessel angulation) (0): <90 o, (1): 90 o –135 o, (2): >135o
Turns (number) before lesion 1 turn = 1, 2 turns = 2 etc, max (5)
5 worst angulations (0): <45 o, (1): 45 o –90 o, (2): 90 o –135 o, (3): 135 o –180 o, (4): >180 o
End to end length ostium-lesion/mm (0): <50 mm (1): 50–100 mm, (2): >100 mm
Visible calcifi cation (0): none, (1): mild, (2): severe
Visible side branch before lesion max (2)
Stent before lesion (0): no, (1): yes
Lesion characteristics  
Side branch within 10mm (0): no, (1): yes
Side branch in lesion (0): no, (1): yes
Lesion angulation (0): <45o, (1): 45–90 o, (2): 90–135 o, (3): 135–180 o, (4): >180 o
Lesion calcifi ed (0): no, (1): yes
Lesion length/mm (0): <10 mm, (1): 10–20 mm, (2): >20 mm
Length/mm of >80% stenosis (0): <1 mm, (1): 1–3 mm, (2): 3–10 mm, (3): >10 mm
Through a stent (0): no, (1): yes (1stent), (2): yes (through struts)
Specifi c morphological abnormality, e.g. aneurysms, fi stula etc. (0): no, (1): yes for each max 6
The vessel angulations and turns defi ned as a change in angulation of >45° were determined 
using the virtual 3DRC images created in the CardiOp-B® and integrated in the Navigant. 
This scoring system was used to defi ne three tertiles of vessels taking into account the lesion 
characteristics: low (<5), medium (6–10), and high (>10) so that the performances of the 
wires in relation to the vascular anatomy could be evaluated.
Statistical Analysis
Continuous variables are presented as mean ± standard deviation. Parametric student t test 
was used to determine if there were signifi cant diff erences between the parameters assessed 
using the two techniques. Spearman nonparametric correlation was used to defi ne a trend 
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between the crossing/fl uoroscopy times, contrast media usage, and lesion/vessel type. 
Analyses were performed using SPSS 11.5 for Windows (SPSS, Chicago, IL). P value < 0.05 
was considered statistically signifi cant. Scatter plot distribution was examined correlating 
complexity score with crossing/fl uoroscopy times and contrast media usage for both the 
magnetic and the conventional wires.
RESULTS
In 93% of the cases magnetic navigation was performed with a 3-dimensional reconstructed 
(3DRC) virtual vessel roadmap superimposed on the real time fl uoroscopy image. The ‘‘clock 
face’’ technique was used for the remaining cases. In the 111 patients having 165 lesions 
there were 7 magnetic wire and 3 conventional wire failures corresponding to a crossing 
success within 6 min of 93.3 and 95.6%, respectively. In addition, in another four cases (four 
lesions) both wires failed in the same patient within 6 min. In three of these, the lesions 
were eventually crossed successfully (one magnetically and two conventionally). In one case 
where both wires failed, the patient proceeded to coronary arterial bypass surgery. The over-
all procedural success in this study was 99.3% with 91.5% of the lesions crossed within 6 min. 
Table 2. Patient characteristics
(N): Patients %
Patient characteristics
Age/years 64.4 (45–90)a
Sex (male) 74.2%
Non/Unknown Smoker (N = 68) 66.0%
Ex-smoker (N = 28) 27.2%
Current Smoker (N = 7 6.8%
Diabetes (N = 23) 22.3%
Insulin (N = 4) 3.9%
Hyperlipidaemia (N = 65) 63.1%
Hypertension (N = 49) 47.6%
Family History (N = 47) 45.6%
Indication
Stable Angina (N = 78) 75.7%
Unstable Angina (N = 25) 24.3%
Previous PCI (N = 30) 29.1%
CABG (N = 7) 6.8%
Diseased vessel
1 Vessel Disease (N = 49) 47.6%
2 Vessel Disease (N = 43) 41.7%
3 Vessel Disease (N = 11) 10.7%
Renal dysfunction (Creatinine > 100lmol/l) (N = 10) 9.7%
aRange
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The direct comparison of successful crossing in the same vessel was performed in 151 lesions 
(151 vessels) corresponding to 103 patients. The patient characteristics are shown in Table 2.
The average age of the patients was 64.4 years with three quarters being male. Over one 
fi fth were diabetic, with 3.9% on insulin and almost two-thirds were hyperlipidaemic. Three 
quarters of the patients presented with stable angina. Nearly, one third of the patients had 
previous PCI with 6.8% having prior surgery. There was a similar distribution of single and 
multi-vessel disease within the total population. In 9.7% of the patients a creatinine >100 
lmol/l was observed. Lesions classifi ed according to the AHA/ACC criteria were 15 Type A 
(10%), 30 Type B1 (20%), 95 Type B2 (63%), and 11 Type C (7%). The LAD was targeted in 60 
patients (40%), followed by the RCA (N = 29, 19%), then the diagonal (N = 26, 17%), the LCx (N 
= 25, 16%), marginalis (N = 9, 6%), and the ramus intermediate (N ± 2, 1%). 
Crossing and Fluoroscopy Times
Overall the crossing times (sec) with the magnetically enabled wires were longer than the 
conventional standard wire approach (72.9 ± 50.3 sec vs. 58.1 ± 47.2 sec, P < 0.001) especially 
in AHA/ACC B2 lesions (P < 0.01) (Table 3). 
Table 3. Crossing Times in Lesions Classifi ed According to the AHA/ACC Criteria
A B1 B2 C A + B1 B2 + C All
n = 15 (10%) n = 30 (20%) n = 95 (63%) n = 11 (7%) n = 45 (30%) n = 106 (70%) N = 151
Crossing time/sec
 Magnet 61.8 ± 42.4 62.5 ± 41.5 74.3 ± 53.4 105 ± 38.3 62.3 ± 42.8 77.4 ± 52.9 72.9 ± 50.3
 Standard 46.5 ± 33.7 51.7 ± 30.8 59.7 ± 54.2 76.5 ± 19.8 50.0 ± 31.9 61.5 ± 52.0 58.1 ± 47.2
 P value 0.15 0.72 0.01 0.06 0.02 0.002 <0.001
Fluoroscopy time/sec
 Magnet 54.0 ± 22.7 55.3 ± 33.5 69.9 ± 48.9 79.8 ± 23.6 54.9 ± 30.3 71.0 ± 47.9 66.2 ± 44.1
 Standard 44.3 ± 37.4 50.0 ± 28.6 56.9 ± 50.9 71.7 ± 18.2 48.1 ± 30.4 58.2 ± 48.8 55.2 ± 44.4
 P value 0.27 0.34 0.13 0.40 0.14 0.009 0.03
The crossing times proportionally increased with the lesion complexity (Fig. 2A). Simpler type 
A and B1 lesions were quicker to cross with either wire than the more complex B2 and C 
lesions, but subanalyses of the crossing times revealed that the magnetic wires were signifi -
cantly slower than the conventional wire in both groups. In the group consisting of type A 
and B1 lesions the times for magnetic wires compared to the conventional wires were (62.3 
± 42.8 sec vs. 50.0 ± 31.9 sec, P = 0.02) and in the group containing the lesions B2 and C the 
times were (77.4 ± 52.9 sec vs. 61.5 ± 52.0 sec, P < 0.002, respectively). In a comparative as-
sessment of the fl uoroscopy times, the conventional approach with the standard wires were 
overall superior to the magnetic wires although the diff erence was less (66.2 ± 44.1 vs. 55.2 ± 
44.4 sec, P < 0.03) compared with the crossing times (Table 3 and Fig 2B). 
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The Relationship of the Crossing and Fluoroscopy Times to the complexity score. 
Scatter plots were performed and correlation of the complexity scores were performed for 
both the crossing and fl uoroscopy times with the standard conventional and magnetic wires. 
Although there was no obvious correlation seen, a lower slope and R2 was observed with the 
magnetic group. This may suggest that the magnetic wire had less of an infl uence on both the 
crossing and fl uoroscopy times in vessels/lesions having high complexity scores—(standard 
conventional wire’s slope and correlation coeffi  cient of the crossing times/sec with complexity 
score was 7.5 and 0.2, respectively; magnetic wire’s slope and correlation coeffi  cient of the 
crossing times/sec with complexity score was 4.3 and 0.06, respectively; similarly, standard 
conventional wire’s slope and correlation coeffi  cient of the fl uoroscopy times/sec with com-
plexity score was 7.2 and 0.21, respectively; magnetic wire’s slope and correlation coeffi  cient 
of the fl uoroscopy times/sec with complexity score was 4.0 and 0.07, respectively). When the 
complexity scores were subgrouped into tertiles of less than 5 and from 6 to 10 the crossing and 
fl uoroscopy times were signifi cantly prolonged (P < 0.001) with the magnetic wires compared 
to the conventional standard wires (Fig. 3). Interestingly, for the tertile greater than 10 both the 
crossing and fl uoroscopy times with the magnetic wire were shorter than that observed with 
conventional wires although they were not signifi cant (P values of 0.24 and 0.21, respectively). 
Figure 2. Relationship of (A) Crossing and (B) Fluoroscopy times of both the conventional and magnetic 
wires to the lesion subtypes.
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Crossing Times and the Minimum Luminal Diameters
Regardless of the studied vessel’s minimum luminal diameters (MLD) the magnetic wire was 
slower. In vessels with a MLD > 2 mm the magnetic wire crossing times/sec compared to the 
standard conventional wires were 52.8 ± 42.9 sec vs. 34.2 ± 20.2 sec, P < 0.03. Similarly, in 
vessels having MLDs of 1–2 mm and < 1 mm the crossing times/sec were 74.1 ± 52.7 sec vs. 
56.9 ± 46.1 sec, P < 0.004 and 75.8 ± 49.6 sec vs. 63.7 ± 51.1 sec, P < 0.05 respective to that of 
the standard conventional wires.
Contrast Media Usage
The Spearman nonparametric correlation test demonstrated a positive trend between con-
trast media usage and lesion complexity with the conventional wire technique (P = 0.025). 
This increase in contrast media usage was eliminated when the MNS was employed (P = 0.63) 
with the Spearman nonparametric correlation for trend. Type A lesions showed no signifi cant 
diff erence in contrast usage (ml) in crossing with either the magnetic or conventional wire 
(1.5 ± 1.8 vs. 1.9 ± 2.3 P = 0.59, respectively) (Fig. 4). As lesion complexity increased signifi -
cantly less contrast (ml) was needed with the MNS:- Type B1 (2.5 ± 3.2 vs. 4.0 ± 2.6, P = 0.01); 
Type B2 (2.3 ± 3.8 vs. 4.9 ± 4.9, P < 0.001); Type C (2.9 ± 3.4 vs. 5.9 ± 4.9, P = 0.03). 
Overall, the MNS gave a small but signifi cant reduction in contrast usage (2.3 ± 3.5 vs. 4.5 ± 
4.4, P < 0.001) relative to the conventional technique. Interestingly, no contrast was required 
when crossing in 72 lesions (48%) with the MNS and in 31 lesions (21%) with the conventional 
approach (Table 4). 
Figure 3. Relationship of the crossing and fl uoroscopy times to the complexity score per tertile (FT = 
fl uoroscopy time; CT = crossing time).
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Moreover, regardless of the vessel crossed, the MNS required less contrast than the conven-
tional wire and this was also observed with increasing complexity scores (Fig. 5). Vessels with 
scores >10 complex vessels had the largest reduction, 7.0 vs. 2.6 ml. Vessels with scores 6–10 
had almost a two-fold reduction (2.7 vs. 4.9 ml) and those with scores of less than 5 had a 
limited reduction of 1.0 ml. As observed with the crossing and fl uoroscopy times a lower 
slope was recorded with the magnetic wire when the complexity scores were correlated with 
contrast usage, Fig. 6.
Table 4. The Lesions Crossed Using Zero Contrast
Number of lesions crossed without contrast
Lesion type
Magnetic wire
72
Conventional wire
31
Type A 8 7
Type B1 14 3
Type B2 47 19
Type C 3 2
Figure 4. Comparative contrast usage based on lesion type. 
Figure 5. Comparative contrast usage based on vessel type and complexity score.
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DISCUSSION
The application of the MNS to PCI is a promising technology (12). There are now over 100 
systems installed in catheterization laboratories worldwide. The system has advantages over 
traditional PCI techniques with its ability to redirect a magnetized guidewire in situ. This has 
been shown to be useful in situations where the ability to cross a lesion with a standard wire 
failed and in coronary phantom models with increasing tortuosity (5). Even though there is 
clearly an advantage in precisely controlling the tip of a guidewire, the interventional com-
munity has been slow to adopt MNS. There are several reasons why there maybe reservations: 
(a) the presence of a rigid 2- to 3-mm-long magnet at the tip of the wire can compromise the 
performance achievable with conventional wires, 
(b) many conventional wires have achieved a level of sophistication having evolved over 
several generations to enhance both their trackability and device deliverability,
(c) the ‘‘ocular-hand coordination’’ seems currently unbeatable because of the delay in 
responsiveness in the MNS hardware—the speed in moving the large external magnets to 
align to the desired vectors,
(d) there is a steep learning curve that must be reached by both the interventionalist and 
skilled technical staff  (6,13), 
(e) together with the additional fi nancial costings for both the MNS and staff  training, 
(f ) moreover, any gain in crossing time might be compromised by the preparation of the MNS 
case although in some clinical scenarios this may prove to be benefi cial long term e.g. MSCT 
cointegration for CTO, 
(g) but more importantly, there is little randomized data to support the use of the MNS to 
PCI. Some of these limitations are currently being addressed with newer generations of wire 
design together with software updates that can off er automated navigational vector ad-
vancement—but many of them are yet to be resolved (14). In this fi rst randomized study di-
Figure 6. The scatter plot relationship between contrast and all the complexity scores.
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rectly comparing the performance of the MNS to conventional PCI techniques we exclusively 
assessed one system (technique) versus the other. In some studies a ‘‘hybrid’’ approach can be 
contemplated whereby the magnetic wire is used initially as a conventional wire technique 
until a problem of crossing is encountered at which point the external magnets are engaged 
and then the MNS utilized to facilitate the crossing of the wire through the lesion/vessel (13). 
This approach was discussed but not acted upon to keep the data independent and ‘‘clean’’ 
for both techniques. Overall the crossing success of the magnetic wires was comparable to 
that of the standard guidewires (93.3% vs. 95.6%). Analysis of the four cases that failed to 
cross with both wires within 6 min was in two of the cases subtotal occlusions that failed with 
the magnetic wires and was eventually crossed with conventional wires. The case that failed 
with the conventional wire and was crossed with the magnetic wire was in a vessel with an 
acute angulation. The only case where both wires failed after numerous attempts the patient 
had an aneurysmal swelling that led into a pinpoint occlusion.
It was not surprising that overall the crossing and fl uoroscopy times were longer with the 
magnetic wire. This is partly because of limitations with the software available at the time of 
the study that required manual updates of the navigational vectors. This had to be performed 
by pressing an advancing icon on the touch screen monitor. It meant that the operator had a 
time delay prior to advancing the magnetic guidewire as the system updated. Newer versions 
of the software are being developed to address this limitation. But despite this limitation the 
only signifi cant diff erence was seen in AHA/ACC B2 lesions as in these cases the operators 
generally chose smaller incremental distances for the vector to follow. Larger incremental 
distances were often used in type A and B1 lesions so the diff erences between the two tech-
niques were less apparent. In type C lesions, the magnetic wire was not signifi cantly slower 
due to observed limitations with conventional wire techniques in these lesion subtypes (15). 
In general, the fl uoroscopy times were less than the crossing times because manipulations 
such as reshaping the conventional wire did not require fl uoroscopy but was still being timed. 
Consequently, no signifi cant diff erences in fl uoroscopy times observed between the two 
systems. The ACC/AHA criteria was however developed almost 20 years ago using 11 simple 
angiographic factors to defi ne a lesion complexity in the comparison with the outcomes of 
PCI (16). It is based solely on the lesion and does not take into account the complexity of the 
vessel as a whole, which can sometimes infl uence the procedural outcome. In an attempt to 
circumvent this several other grading systems exist but they are generally based on simple 
angiographic features and hence fail to take into account the 3-dimensional (3-D) nature of 
the coronary tree (17,18). Moreover, visual estimates from angiographic images are known 
to have poor inter-observer reproducibility (19). By employing dedicated 3D software more 
detailed information can be used to defi ne a complexity scoring systems based on both the 
vessel and lesion characteristics (11). Using this approach and dividing the scores in tertiles 
of low (5 or less), medium (between 6 and 10), and high complexity (greater than 10) a 
positive trend for the magnetic wire was observed for crossing and fl uoroscopy times in the 
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high complexity group. Both the magnetic wire crossing and fl uoroscopy times signifi cantly 
increased over the conventional methods used in vessels with low and medium complexity 
scores. But with high complex scores lower times were recorded with the magnetic wire (78.0 
vs. 93.7 sec and 74.2 vs. 90.5 sec, respectively). This trend does however support anecdotal 
clinical reports that in selected cases with increased complexity the MNS can be advanta-
geous (20,21). Attempts however to further subcategorize the population with the high 
complexity scores were unsuccessful because of the size of the study.
To assess measurable diff erences between the two techniques we quantitatively recorded 
the amount of contrast media used to cross the lesion. We appreciated the fact that this 
volume is relatively small in comparison to the total amounts traditionally used in an entire 
procedure. Nevertheless when assessed as a measurable diff erence between the two tech-
niques the MNS did reduce the amount of contrast used to cross a lesion primarily because 
it integrates a 3-dimensional roadmap to provide a visual clue to the position of the wire on 
the fl uoroscopic image. As a result the signifi cant diff erence between contrast and lesion 
complexity observed with the conventional wire was eff ectively eliminated with the MNS. 
In vessels with complexity scores > 10, there was almost a three fold reduction in amount of 
contrast used. Moreover 48% of the lesions were crossed without the need of contrast as a 
direct eff ect of following a superimposed road map on the live fl uoroscopy image. This is an 
important fi nding in support of developing technologies aimed at reducing contrast usage 
that can ultimately aff ect clinical consequence such as contrast-induced nephropathy (CIN). 
Already the use of an overlay created from an MSCT cointegration with the MNS can aid the 
visualization of CTOs, which may limit the need for retrograde contrast media injection (14). 
Contrast usage has also been reduced by using 3D reconstruction (3DRC) software to correctly 
defi ne the optimum angiographic projections needed for stent deployment (22,23). In addi-
tion some technologies can accurately localize a wire/device—global positioning—within 
the coronary artery (24). If these technologies were amalgamated with more sophisticated 
magnetic wires such as Stereotaxis’s multi-magnet design having three smaller 1-mm inter-
spaced magnets at the tip and furthermore is integrated with a system for automatic wire 
advancement then an entirely new approach to conventional PCI and contrast usage would 
be eff ectively realized (1,25). But for every emerging technology there is a limited period for 
it to be adopted so it is important that the current limitations and reservations be addressed 
if the MNS is to succeed in the competitive area of PCI. 
LIMITATIONS
The 3DRC used in this study was time-consuming and took up to 30 min to complete. The pro-
duction of the reconstruction required angiography of a suitable standard and this was not 
always possible from standard views due to foreshortening or overlapping. A static road map 
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created from the 3DRC image was superimposed on a dynamic real-time image for magnetic 
navigation. Only patent vessels were included, as the re-crossing of totally occluded vessels 
by the comparative wire was avoided because of inherent clinical risk. There were a number 
of operators and types of wires and this, together with no selection of the target vessel seg-
ment, may have led to heterogeneity. The lesion score was also not externally validated. In 
addition, this study examines only one specifi c aspect of the PCI related to crossing of lesions 
and does not address other necessary elements such as the passage and deployment of the 
balloon and stent. Lastly, this study was performed at a University specialist tertiary referral 
unit and the case mix might be diff erent to that seen elsewhere.
CONCLUSION
The MNS has a comparable crossing success to conventional PCI techniques in crossing le-
sions as defi ned by the ACC/AHA criteria. The longer crossing and fl uoroscopy times refl ect 
limitations in manually updating the navigational vectors on the roadmap displayed on 
the live fl uoroscopic image. In defi ning the vessel complexity taking into account the full 
3-dimensional characteristics a positive trend was found in support of using MNS in more 
complex vascular lesions/anatomies. Moreover the incorporation of the 3DRC navigational 
pathway with the MNS off ered a small but signifi cant reduction in the amount of contrast 
needed to cross a target lesion when compared to a conventional wire approach. Nearly half 
of the cases required no contrast agent to guide the magnetic wire transit within the vessel.
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ABSTRACT
This report illustrates an undescribed mechanism of causing magnetic angioplasty wire 
fracture and goes on to describe how to avoid it occurring and how to correct it should it 
occur. The cause is the transition point in the wire between a fl exible wire shaft and the infl ex-
ible magnetic tip of a magnetically enabled wire. In the fi rst stage of the problem, the wire 
becomes trapped in a doubled-back position. Subsequently traction causes the second stage 
that kinks the wire and hooks behind a structure, in this case a stent, causing magnetic wire 
lock. Further traction has a high chance of wire fracture. Correction, although challenging, 
remains possible before wire fracture occurs. While there is no intrinsic problem with the 
technology, attention to this problem by the operator will reduce its occurrence and there-
fore its sequelae.
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INTRODUCTION
The fracture of a coronary angioplasty wire can potentially lead to serious consequences such 
as thrombosis, perforation or death (1). Fortunately wire fracture occurs infrequently with a 
published rate of 0.02% of procedures (2). A variety of mechanisms have been described pre-
viously (2-10). The newly evolving technique of magnetic navigation provides new abilities 
that may be advantageous in percutaneous coronary intervention (11-13) but these wires 
have a certain structure that may require special attention in order to avoid problems. 
The Niobe® II magnetic navigation system (Stereotaxis, St Louis, Missouri, USA) has been 
described in detail previously (11-13). It produces a 15-20 cm spherical volume with a uniform 
magnetic fi eld that is centered on the heart of the patient and can be reliably and reproduc-
ibly directed in 360o in all planes. Selecting the 3D direction on the computer screen, leads 
to movement of the 2 external magnets to give a precisely directed magnetic fi eld vector 
that will actively defl ect the magnetic wire tip resulting in reproducibly precise steering. This 
active steering may give easier and ‘cleaner’ wire passage through complex anatomy (13), 
give 3D guidance of the wire from computer generated models, and allow integration of 
other information from investigations such as MSCT (11).
Magnetically enabled wires have a tiny solid magnet at the tip made of neodymium-
iron-boron, see fi gure 1, to allow them to be actively steered by an external magnetic fi eld. 
Currently all magnetic wires are manufactured under instruction from, and marketed by, 
Stereotaxis. The transition between the fl exible wire and the infl exible tip predisposes to 
the occurrence of a two-stage process of wire entrapment leading to magnetic wire lock 
(MWL). The fi rst stage is the entrapment of the wire in a doubled-back position, see fi gure 2. 
At this point the wire is only loosely fi xed behind the structure. The second stage results from 
Figure 1. The structure of currently available magnetic wires with their solid magnetic tip.
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proximal traction with the wire-tip fi xed that leads to kinking of the wire, leaving it hooked 
behind the stent struts, see fi gure 2. Further traction has a high chance of wire fracture.
This report aims to illustrate this problem, emphasize its avoidance and suggest a correc-
tive strategy. 
Figure 2. Diagrammatic representation of MWL, 1 denotes the double-backed wire with the tip caught 
between two stent struts (stent strut denoted by ‘‘s’’). 2 shows the acute angle caused by traction at the 
transition point between shaft and magnet—the wire is now locked.
Figure 3. The left panel shows the bifurcation lesion aff ecting the LAD and diagonal, the right panel shows 
the wires in place, the magnetic wire can be seen at this point to be doubled back (arrowed).
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CASE REPORT
Case 1 – Magnetic wire lock leading to wire fracture
A 57 year old male presented with stable Canadian Cardiovascular Society grade II angina 
pectoris despite treatment with triple medication. Angiography showed a signifi cant bifur-
cation lesion involving the Left Anterior Descending artery (LAD) and a large diagonal, see 
fi gure 3. A Titan™ 3 mm angled Soft Support wire (Stereotaxis, St Louis, Missouri, USA) was 
placed into the diagonal and a second into the LAD, see fi gure 3. Two overlapping drug elut-
ing stents were deployed in the diagonal with the proximal end in the LAD. The wire from the 
diagonal was placed easily into the LAD. However, on withdrawal of the wire from the LAD, 
the solid tip of the wire became trapped behind the stent at the bifurcation, see fi gure 4. The 
Figure 4. These panels show the wire tip caught in the stent, the left panel shows the appearance with 
contrast, and the right without.
Figure 5. The left panel shows both wires before withdrawal, and the right panel shows only the fractured 
wire tip (arrowed) in LAD.
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wire could not be advanced and, with further traction, the wire unravelled and broke, see 
fi gure 5. The patient remained asymptomatic and was treated conservatively.
Case 2 – Correction of magnetic wire lock
A 66 year old man presented with Canadian Cardiovascular Society grade III angina pectoris. A 
MIBI scan showed ischaemia both anteriorly and laterally. Angiography showed an occluded 
circumfl ex artery (Cx) and a bifurcation lesion of the LAD/diagonal. The patient was scheduled 
for a staged attempt to reopen the Cx and, if successful, to then undergo treatment of the 
bifurcation lesion. The occluded Cx was successfully recanalized using magnetic navigation. 
1 week later he was scheduled for a procedure to the bifurcation lesion of the LAD and the 
diagonal, see fi gure 6. Two Titan™ 3 mm angled Soft Support wires were placed in the LAD 
and diagonal. On infl ation of the LAD stent the wires were correctly orientated, see fi gure 6. 
However, when exchanging the wires, the wire in the diagonal became trapped, see fi gure 7, 
with a curve of the wire visible (arrowed in fi gure). The wire could not be advanced. A 1.5mm 
Maverick was advanced to support the wire just proximal to stent. At this point the wire was 
successfully advanced. By the use of careful manipulation and reorientation of the magnetic 
fi eld, the wire was straightened and withdrawn. The procedure was completed with a further 
stent into the diagonal and the fi nal result after kissing balloons was completely satisfactory, 
see fi gure 8.
Figure 6. The left panel shows the bifurcation before intervention, the right panel shows the stent 
placement in the LAD when the wires were correctly orientated.
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DISCUSSION 
The occurrence of wire fracture is infrequent (1). A range of causal mechanisms have been 
postulated including entrapment in the vessel wall (2-4), transection by a device (5-8), or 
metal fatigue due to repetitive strain (9). This range of causal mechanisms is mirrored by 
a range of management strategies that include, fi rst, conservative (2), second, retrieval by 
wires (10,14), by grabbing devices (2,15), or by snares (16-18), or third, surgery (19,20). The 
management strategy chosen depends on factors such as the location of the wire, the clinical 
Figure 7. The left panel shows the doubled back wire tip at the stent (arrowed), the left panel shows the 
wire tip pushed forward clear of the stent (arrowed) before being straightened.
Figure 8. Final result.
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scenario and the knowledge of possible management strategies, and requires a balanced 
view of the pros and cons of each strategy.
With a magnetic wire, the transition between the fl exible shaft of the wire and the solid 
infl exible tip magnet can act as a hinge point. MWL appears to occur as a 2-stage process. 
The fi rst stage of MWL is entrapment of the tip behind the stent in a doubled-back position, 
see fi gure 2. This may only loosely fi x the tip of the wire and at this point it may be relatively 
simple to advance the wire. The second stage depends on traction on the wire producing a 
sharp kink in the wire, leaving it eff ectively hooked behind the stent struts, locking it in place, 
see fi gure 2. 
Avoidance of MWL should be the initial strategy by ensuring that the magnet does not fold 
back on the shaft of the wire. If the wire tip does become doubled before reaching a distal 
enough position for stent placement, further advancement should be stopped, and either by 
retraction of the shaft or by manipulation of the magnetic fi eld, the tip should be returned to 
the proper orientation for further advancement. 
Correction of the problem in the fi rst stage. 
If the wire is in the process of being pulled back and the wire becomes doubled back on itself, 
retraction should be stopped before the kink in the wire occurs and a strategy to straighten 
the tip pursued.
Correction of the problem in the second stage. 
If the wire has been pulled back and the wire has become kinked, there are a number of 
further strategies that are possible. Attempts should be made to re-advance the wire. If this is 
unsuccessful by simply pushing the wire, then support on the wire shaft can be increased by 
advancing an over-the-wire balloon up to the stent. The wire is supported within the lumen 
of the balloon catheter and behind the stent. This may allow the tip to be pushed forward. 
This solution, that proved eff ective in this case, is only one of several possible strategies for 
treating this problem and other strategies should be considered and applied as appropriate. 
Ongoing advances in the wire design, such as the use of nitinol in the new Pegasus™ wires, 
or a fl exible, multi-magnet tip, should be pursued in order to reduce this problem.
CONCLUSIONS
This case demonstrates a previously undescribed two stage mechanism of MWL that led to 
wire fracture and demonstrates one possible strategy for treating it. While no intrinsic defect 
exists, a quirk in the current design leaves it vulnerable to this problem. The use of magnetic 
Mark bw.indd   206 25-05-10   15:16
207
Magnetic Wire Lock: prevention and correction to avoid Wire Fracture
wires requires a diff erent approach and diff erent awareness from the operator. Identifi cation 
of this problem, together with strategies to prevent or manage it, will reduce its occurrence 
and sequelae.
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ABSTRACT
Aims: To develop a clinical prediction rule based on 3D reconstruction of coronary arteries 
that would prospectively identify lesions that are diffi  cult to cross and could benefi t from 
magnetic navigation.
Methods and results: The coronary anatomy of a cohort of 120 lesions that had undergone 
percutaneous coronary intervention (derivation set) was analysed using 3D reconstruction 
for vessel and lesion characteristics. The crossing time was the total clock time to reach a 
satisfactory distal position after leaving the guiding catheter. Multivariable logistic regres-
sion and linear shrinkage with bootstrapping were used to develop a clinical prediction rule 
that dichotomised cases into easy or diffi  cult (prolonged crossing time). A value of 6 was the 
best cut-off  value. This clinical prediction rule was applied to a second independent cohort 
of patients (validation set) where crossing time was measured. The bootstrapped c-statistic 
of the model was 0.82 indicating excellent discrimination.
Conclusions: 3D reconstruction helped to develop a simple, accurate clinical prediction rule 
to identify diffi  cult cases for conventional wires and in whom magnetic navigation may be 
preferable.
Integration of 3D reconstruction in the 
SELection criteria for Excessive Crossing 
Times for Magnetic PCI
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INTRODUCTION
Currently the majority of percutaneous coronary intervention (PCI) procedures are performed 
satisfactorily with conventional wires. However, there is a proportion of PCI procedures 
where diffi  culty, or sometimes failure, occurs. As equipment improves and PCI extends into 
more diffi  cult territories, e.g. smaller, more tortuous, heavily calcifi ed and more distal lesions, 
there will be an increasing challenge to manual dexterity. The recently introduced magnetic 
navigation system (MNS) from Stereotaxis uses a magnetic fi eld to precisely steer the wire 
that can take direction from a 3D model of the vessel created from angiographic images, and 
may be of benefi t in such problematic procedures (1). Improved wire delivery may lead to 
reduced procedural time and complications (2-4). 
However, there is no specifi c method of identifying those cases where passing the lesion 
with a wire, or ‘crossing’, is diffi  cult. The currently available range of lesion classifi cation sys-
tems (5-9) is aimed at predicting complications and these have relatively modest accuracies. 
We have investigated a simple, specifi c, measurable and crucial part of the PCI procedure, the 
time to pass the wire from the guiding catheter to a position distal to the culprit lesion. Such 
prediction may have a number of major benefi ts. 
First, better guidance for operators in the assessment of the diffi  culty of a particular case 
may help better risk-benefi t decision-making.
Second, it may allow selection of patients who have diffi  cult morphology for an alternate 
technique such as magnetic navigation. A clinical prediction rule (CPR) may be a useful 
method of ultimately comparing magnetic navigation or other navigation technologies to 
conventional wire manipulation.
The aims of this study were two-fold. First, the development of a simple CPR to predict 
diffi  cult lesions to cross with a conventional wire. Second, the validation of this CPR in lesions 
that had undergone angioplasty.
METHODS
Patient selection
Derivation set
The crossing times of a cohort of 425 consecutive lesions that had elective and semi-urgent 
PCI performed with a conventional wire at a single centre were noted. Lesions that were 
excluded from analysis consisted of occluded vessels where a reconstruction could not be 
produced due to inadequate vessel fl ow (TIMI fl ow of 2 or less) such as primary PCI, acute 
coronary syndrome (ACS), and chronic total occlusion (CTO). ACS patients were generally 
not excluded. In addition, lesions where special techniques had been used, such as biplane 
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angiography or magnetic navigation, were excluded. Several strategies were undertaken in 
order to reduce possible bias.
The crossing times of the patients were consecutively measured and the times were ana-
lysed to show the boundaries of the tertiles (Figure 1). The patient data were left unsorted 
when separated into the three groups of 40 lesions. The fi lms of each of these groups were 
examined consecutively and the inclusion for analysis was determined by a coin toss. The 
person analysing the fi lms and performing reconstructions was completely blinded to the 
crossing time. The derivation set comprised of these three groups and the CPR was devel-
oped from this.
Validation set
The CPR was validated in a second cohort of 415 lesions, the validation set. The same exclu-
sion criteria and strategies were used as in the derivation set. Sixteen lesions were randomly 
selected from each tertile of the crossing times for further analysis. In order to blind the 
analysis, the analyst had no knowledge of the results of the crossing time.
Magnetic navigation system
The MNS (Navigant, Stereotaxis, St Louis, MO, USA) has dedicated 3D reconstruction software 
(CardiOp-B, Paieon Medical Inc., Rosh Ha’ayin, Israel) that produces a virtual model of the 
entire vessel. With the reconstruction package it is possible to take 2 angiographic views and 
identify the vessel edges. The reconstructions were performed from suitable fi lms where 2 
separate fi lms at suitable angulations (of >40°). As the angles of the image intensifi er and 
the position of the table are known, it is possible to triangulate the position of each point 
of the vessel and make a 3D reconstruction of the vessel that is volume-rendered (Figure 
2). All measurements can be made from diagnostic angiography fi lms of suitable quality. 
There were 3, 2 and 6 fi lms that were not suitable for analysis in the shortest, middle and 
longest tertiles respectively –the average inability to produce a reconstruction was therefore 
Percentage patients
Crossing time (secs)
Cut-off point 120secs
12%
10%
8%
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Figure 1. Graph showing distribution of the total population. See this fi gue in color in the Appendix page 391.
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approximately 10% of the total, but with a trend increasing in more complex morphology. To 
produce as accurate and reproducible reconstructions as possible, the images were routinely 
taken in diastole (on or just before the QRS complex). The software has functions that allow 
measurement of length, diameter and area stenosis with respect to the calculated reference 
diameter at that point. The model can then be imported into the Navigant program where 
the angulation of each bend can be measured. The bends were assessed visually and then 
measured to see whether they fi tted the following defi nition. A bend was considered to be 
an angulation of 45° within 10 vessel diameters (for the purpose of this analysis a standard 
vessel diameter was considered to be 3 mm therefore a bend had to occur within 30 mm).
Defi nition of crossing time
A prolonged crossing time was defi ned as the absolute time (in seconds) from the initial entry 
of the wire into the coronary system, out of the guiding catheter, until crossing and reaching 
a suitable position distal to the target culprit lesion in the coronary artery. The crossing time 
includes the time required for any and all procedural manoeuvres once the wire has initially 
left the tip of the guiding catheter, such as the time required to remove and re-shape the 
conventional wire, re-engagement of the catheter should prolapse occur, or to pass a balloon 
for support, and implies the placement of the wire in a satisfactory fi nal position for device 
Figure 2. The upper panels: The left 2 panels show separate angiographic angulations with edges detected 
and the right panel shows a 2D image of the 3D reconstruction. The lower panels: The left panel shows the 
angiographic view of the LAD, the middle and right panels show the reconstruction in diff erent views with 
the angles shown by the 3D reconstruction arrowed. See this fi gue in color in the Appendix page 392.
Mark bw.indd   217 25-05-10   15:16
Chapter 14
218
delivery. This was a registry where no special techniques of passing a wire were used, and 
therefore the operators should have been performing normally. A total of 9 interventional 
cardiologists were involved in these procedures. While a competitive element may have oc-
curred within an operator’s mind, the data once collected was only available to one person. 
This data was not, and has never been, shown in a fashion that would compare one operator 
with another and while operators may well have tried to perform their best, this is felt to be 
an advantage with the ‘best’ crossing times recorded.
The relevant hypothesized anatomical factors encountered with conventional angioplasty 
guidewires can be divided into vessel and lesion characteristics, see appendix 1. We imposed 
an arbitrary maximum to each factor in order to prevent any specifi c factor from dominating 
the grading system.
Vessel characteristics
Number of bends before the lesion (Vb) (Figure 3)
Each bend causes deformation of the wire resulting in friction. A greater number of bends 
leads to increased friction resulting in more diffi  cultly in manipulating the wire. The maxi-
mum score is 5.
Figure 3. Identifi cation of the bends in a vessel and measurement of each angle (possible in the Navigant 
program). See this fi gue in color in the Appendix page 392.
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The total angulation of the 5 worst bends (Vta) (Figure 3)
The greater the cumulative angle, the more the wire is deformed along its course. This results 
in more friction and produces increased diffi  culty during manipulation. This has been dichot-
omised to above 45° (= 1) and below 45° (= 0). The maximum score per bend is 1, maximum 
number of bends is 5.
End-to-end length from the ostium to the lesion (Vl) (Figure 4)
The more distal the lesion is from the ostium, then the greater the chance of encountering 
problematic bends that impair manipulation, and also the longer the time required to physi-
cally pass the wire. This is divided into shorter than 50 mm (=0), between 50 and 100 mm (=1) 
and greater then 100 mm (=2). The maximum is 2.
Vessel calcifi cation (Vc)
Calcium may increase friction as the vessel becomes more rigid and less deformable and 
does not conform to the wire. The frictive eff ect of a specifi c angle will be accentuated if 
deformation cannot occur. The complete angiographic absence of calcium scores 0, mild 
calcifi cation is 1 and severe calcifi cation is 2. The maximum is 2.
Figure 4. The measurement of the length from the vessel ostium to the lesion in CardiOp-B (green square 
indicates proximal marking point and blue square indicates distal marking point). See this fi gue in color in 
the Appendix page 393.
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Visible side-branches before lesion (Vsb) (Figure 5)
Visible side-branches result in a greater chance of taking a wrong bend. This is dichotomised 
to 0 or 1.
Lesion factors
Luminal lesion characteristics such as complex and intricate 3D form or tight lesions with 
little space for manoeuvre aff ect how quickly and easily a wire can pass. Navigation through 
complex, intricate, and/or tight lesions may involve a variety of angles that cannot be easily 
be traversed by a conventional guide-wire with a fi xed bend as it has a specifi c angle of ap-
proach.
Lesion characteristics
Side-branches within 10 mm (Lbb) (Figure 5)
Side-branches within 10 mm of the lesion increase diffi  cultly because, on the approach to 
a lesion fi ner control is necessary, the fi xed wire-tip angle needed for bends now may have 
more of a predisposition for side-branches. This is dichotomised to 0 or 1.
Side-branches in lesion (Lsb)
When the angulated wire tip has to pass through a stenosis, there is a greater chance that the 
tip will be pushed against the wall and this increases the chance of selecting side-branches. 
The lesion angulation will aff ect the friction of the wire passing through the lesion. This is 
dichotomised to 0 for <45° or 1 for > 45°.
Figure 5. The left panel shows visible side-branches (arrowed) greater then 1 mm before the lesion with 
the right panel showing a branch just before the lesion (within 10 mm). See this fi gue in color in the Appendix 
page 393.
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Lesion calcifi cation (Lc)
Calcium makes the lesion rigid and reduces deformability, therefore producing more friction. 
This is dichotomised to 0 or 1.
Lesion length (Ll) (Figure 6)
Longer lesions produce more friction on the wire. This factor has been divided into <10 mm 
(=0), between 10 and 20 mm (=1) and greater then 20 mm (=2). The maximum is 2.
Length of severe (greater than 80% area) stenosis (Lss) (Figure 6)
Tighter lesions have greater contact with the wire and this magnifi es the eff ect of bends 
leading to a greater chance of the wire being forced against the wall. This is dichotomised to 
into 0 for <3 mm and 1 for >3 mm.
Figure 6. The top panels show the measurement of the lesion length (green square indicates proximal 
marking point and blue square indicates distal marking point). The lower panel shows the segment greater 
than 80% measured in CardiOp-B (green square indicates proximal marking point and blue square indicates 
distal marking point) See this fi gue in color in the Appendix page 394.
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Statistical analysis
A prolonged crossing time, Pct, was dichotomised with an arbitrary cut-off  value of 120 sec-
onds based on the observed crossing times (Figure 1). By the design of the study, one-third 
of the lesions had the presence of a long crossing time and two-thirds had a normal crossing 
time.
Statistical modelling
The association between each prognostic factor and the presence or absence of a long 
crossing time was studied by univariate logistic regression analysis. We applied a stepwise 
backward selection process (p=0.100) to select the predictors for the fi nal model. A key 
problem of regression modelling in small data sets is that the regression coeffi  cients are over-
estimated for predictive purposes. We calculated a linear shrinkage factor for the regression 
coeffi  cients with bootstrapping (11). The diff erence between performance in the bootstrap 
samples and the original sample is an estimate of the optimism in the apparent performance 
(miscalibration). This diff erence is averaged to obtain a stable estimate of the optimism. 
‘Shrunk’ coeffi  cients were calculated by multiplication of the standard coeffi  cients with the 
shrinkage factor, which might take values between 0 and 1. The fi nal model was transformed 
into a CPR. Regression coeffi  cients were rounded to the nearest integer. A score was obtained 
for each individual lesion by assigning points for each variable and adding the results.
Predictive performance
The prognostic ability of the model, i.e. the power to discriminate between subjects with and 
without a long crossing time, was estimated with c-statistic. The c-statistic, provides a quan-
titative summary of the discriminative ability of a predictive model. A value of 0.5 indicates 
that the model does not have any discriminatory ability, and a value of 1.0 represents perfect 
discrimination.
Calibration refers to whether prediction models agree with the observed probabilities and 
was assessed with the Hosmer- Lemeshow statistic. Statistical analyses were performed with 
SPSS and S-plus software (MathSoft, Inc., Seattle WA, USA: version 2000).
RESULTS
The mean age was 65 years and 74% of patients were male. All baseline characteristics in 
the derivation set and the validation set were generally similar although there were more 
unstable patients in the validation subset (Table 1). 
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Table 1. Patient characteristics for test and validation groups.
Baseline patient characteristics (N=120) (N=48) P value
Age-yr 65.9±10.6 65.5±10.4 0.8
Male sex-no.(%) 74.3 73.3 0.9
Diabetes mellitus-no.(%) 25.7 35.6 0.2
Hypertension-no.(%) 55.7 60.5 0.6
Hypercholesterolemia-no.(%) 94.8 94.8 0.9
History of smoking cigarettes-no.(%) 18.6 11.6 0.3
Previous PCI-no.(%) 32.4 42.2 0.3
Previous CABG-no.(%) 7.6 6.7 0.8
Previous myocardial infarction-no.(%) 38.8 46.7 0.4
Clinical presentation 0.05
 Stable angina pectoris 62.1 46.7
 Unstable angina pectoris 37.9 53.3
CCS class
 I 5.0 5.3 1.0
 II 38.3 36.8
 III 53.3 52.6
 IV 3.3 5.3
LVEF 0.6
 Good 76.3 66.7
 Moderate 15.8 27.8
 Poor 7.9 5.6
Vessel disease 0.5
 1VD 43.0 31.3
 2VD 30.8 35.5
 3VD 23.4 33.3
The vessel location of the culprit lesion is shown in Table 2.
Table 2. Distribution of vessel location of culprit lesion.
Vessel analysed Number Percentage
Vessel – fi rst tertile
 LAD 15 37.5
 Cx 13 32.5
 RCA 12 30
Vessel – second tertile
 LAD 18 45
 Cx 14 35
 RCA 8 20
Vessel – third tertile
 LAD 10 25.0
 Cx 15 37.5
 RCA 14 35
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There was a spread of values for the crossing times showing that 15% of lesions could still not 
be crossed at 5 minutes (310 s) and 10% by 8 min (480 s) (Figure 1). The CPR was derived after 
applying logistic regression to the sample from the derivation group (results of univariate 
and multivariate analysis shown in Tables 3 and 4) to provide a relative estimate of crossing
complexity: 
Pct=1*Vb+1*(Vl=1)+2*(Vl=2)+2*Vc+1*Lbb)+1*(Ll=1)+2*(Ll=2)
(N.B. abbreviations refer to morphological factors, see appendix 1)
This dichotomises cases into easy and diffi  cult (prolonged crossing time). Pct is an integer 
and a value of 6 was found to be the best cut-off  value. 
Table 3. Results of univariate analysis.
Coeffi  cient P value
Vessel characteristics
Number of bends before lesion (Vb) 0.73 <0.001
The total angulation of the 5 worst bends (Vta) 0.58 0.177
End to end length from the ostium to the lesion (Vl)
50-100 1.18 0.009
>100 1.55 0.045
Vessel calcifi cation (Vc) 2.03 <0.001
Visible side-branches before lesion (Vsb) 1.08 0.017
Lesion characteristics
Side-branches within 10mm (Lbb) 0.01 0.985
Side-branches in lesion (Lsb) 0.58 0.163
Lesion angulation (La) 1.00 0.013
Lesion calcifi cation (Lc) 0.98 0.013
Lesion length (Ll) 0.75 0.055
Length of severe (> 80% diameter) stenosis (Lss) 1.01 0.013
Table 4. Multivariate predictors of the crossing times in the derivation set.
ß coeffi  cient Odds ratio P-value
Bends to lesion, (Vb) 1.0278 5.06 (1.54-16.66) <0.001
(end to length from the ostium to lesion (VI) 50-100mm 1.0495 0.44 (0.12-1.63) 0.119
 >100mm 2.7242 3.75 (0.38-37.13) 0.018
Vessel calcifi cation (Vc) 2.9004 9.85 (2.52-38.42) <0.001
Side-branches in lesion (Lbb) 1.0622 2.31 (0.78-6.89) 0.057
Lesion length (Ll) 10-20 0.8377 0.52 (0.15-1.76) 0.018
 >20 2.0567 2.62 (0.68-10.01) 0.004
The c-index of the standard model was 0.88 and 0.83 for the shrunk model used for the CPR. 
Calibration with the Hosmer-Lemeshow test gave a non-signifi cant p-value. This CPR was 
then applied to the results from the validation cohort. The c-statistic derived from this group 
was 0.82 showing good discrimination.
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DISCUSSION
We have developed a clinical prediction rule (CPR) that examines the whole vessel that is 
undergoing PCI and is able to predict which vessels will require more time to cross. The CPR 
integrates the use of a 3D reconstruction developed from a combination of lesion and vessel 
characteristics to give a relative estimate of crossing complexity. It will allow an assessment 
of the importance of physical factors on wire passage and whether diffi  cult wire passage is 
related to increased complication rates. This is directly applicable to the decision process 
of selecting a patient for a magnetically navigated procedure. This system is fundamentally 
diff erent from previous classifi cation systems that were developed for the prediction of pro-
cedural success and complications. The ACC/AHA guidelines for lesion grading were devel-
oped in 1988 (5), modifi ed in 1990 (6) and use 11 simple angiographic factors to help take 
into account lesion complexity in the comparison of the outcomes of PCI. Further systems, 
such as the SCAI (7), the Mayo Risk Score (8) or the SYNTAX score (9), were subsequently 
developed in order to improve this predictive ability further. However, the discriminatory 
power was lower than expected (6,12) A number of possible reasons may help to explain this 
shortcoming. First, previous grading systems use a number of coronary factors that have gen-
erally been simple, angiographically-defi ned lesion characteristics. Use of such simple lesion 
characteristics may underestimate both the lesion complexity itself and also the importance 
of the rest of the vessel in successfully crossing with a wire. Second, while these factors have 
a great deal of merit in their simplicity, they are visual estimates from angiographic images 
and these are known to have poor interobserver reproducibility (13-15). Third, some systems 
include clinical factors, either as an endpoint or in their grading, that are frequently complex 
and multi-factorial. Diffi  culty in crossing an individual coronary lesion, especially if wire pas-
sage itself results in a clinical complication such as dissection, may only be indirectly related 
to the poor clinical state of an acutely sick patient or to the pre-existing clinical diseases. 
Conversely, a poor clinical state or pre-existing disease may be more closely associated with a 
complication than the adverse coronary anatomy. Therefore the use of clinical factors, either 
the pre-existing clinical diseases or the resultant clinical complication, may obscure a clear 
answer. 
A number of factors have been investigated in previous studies. These indicate that in-
creasing complexity of a lesion is associated with an increasing incidence of complications 
(7,16) and that some anatomical factors of the vessel, such as tortuosity, lesion length or 
angulation, are associated with decreased success of stent passage (17-19). The introduc-
tion and use of new 3D imaging technology enables a more complete anatomical analysis 
of the vessel and lesion in a new way. In order to give the clearest idea of factors that might 
infl uence passage of the wire we analysed the entire vessel as well as the target lesion. This 
approach has not been used before. All the measurements required for the CPR can be 
obtained from adequate diagnostic angiography fi lms. The CPR can be applied in a matter 
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of minutes and is therefore applicable in general practice. This system is completely indepen-
dent of the clinical factors that, while important in the broad clinical outcome, are either only 
loosely related, or even irrelevant, to the passage of a wire through a coronary artery. The 
analysis aimed to refl ect these factors by defi ning the anatomy of both the coronary vessel 
and lesion. There are a number of advantages of this system. First, it uses a 3D reconstruc-
tion to identify and measure specifi c vessel factors and to give hard numbers to predict a 
single, clearly defi nable endpoint. Second, it examines the anatomy of the entire vessel, a 
factor that is clearly crucial to the delivery of a wire. Third, it is independent of the clinical 
factors that obscure the importance of physical factors. Fourth, it has clear applicability in 
choosing patients who might benefi t from a magnetically navigated procedure. There are 
a number of limitations. Currently the reconstruction is time-consuming and can take up 
to 30 minutes to complete. The production of the reconstruction requires angiography of a 
suitable standard and is not always possible from standard views due to foreshortening or 
overlapping. The reconstruction that is produced is static and the impact of movement on 
the measured factors, such as angulation, is unknown. The use of the software does require 
some practice and some manual correction is often needed. This was deliberately kept to 
a minimum. After analysis some factors were not incorporated into the CPR. There may be 
a variety of reasons for this. Some factors occurred infrequently, such as the presence of a 
stent. The infrequent occurrence therefore may not refl ect the unimportance of the factor 
but the eff ect of a small sample size e.g. few patients with stents. Another possible reason for 
a particular factor not showing signifi cance is the variability of the factor itself. Side-branches 
may be cannulated without intention during procedures but this may only occur with side-
branches that come off  at a certain angle and not all as measured in this analysis. Therefore, in 
general, these factors may play some role, but this may only occur in specifi c circumstances, 
or occasionally, and will need further investigation to identify any additional benefi t. More 
generally, there was unselected use of wires and no selection of operators. The limitations 
of this model therefore also relate to individual operators, techniques and equipment. There 
were a number of operators and types of wires and this, together with no selection of the tar-
get vessel segment, may have led to heterogeneity. In addition, this study examines only one 
specifi c aspect of the PCI and deliberately does not address other necessary elements such 
as the passage and deployment of the balloon and stent. Lastly, this study was performed at 
a university specialist tertiary referral unit and the case mix might be diff erent to that seen 
elsewhere.
Despite such limitations, the system could prove useful in application. The ability to predict 
diffi  cult cases may allow consideration for alternative strategies. In this context, the ability of 
the MNS to precisely direct the tip of a wire has a clear potential for improving the treatment 
of patients identifi ed in this way as suggested in the study in this issue of EuroIntervention 
(20). However the system could potentially be used in other ways. As the number of MNS 
in an institution is normally limited to one, reconstruction could be performed on selected 
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subsets of patients. Identifi cation of the patients who would most benefi t would be not only 
benefi cial for patients but would maximise effi  ciency. Alternatively, an automated system 
would also allow all patients to be screened in addition to possibly improving reproducibility.
This CPR will be valuable in several ways. First, to identify which anatomical factors are 
predominant by prospectively identifying diffi  cult cases. Second, this may be a crucial tool in 
deciding whether a patient should undergo a conventional procedure or rather will benefi t 
from magnetic navigation.
CONCLUSION
Previous classifi cation systems have been of signifi cant clinical use but relatively modest 
predictive ability due to a reliance on few lesion features and no vessel features, inclusion 
of clinical features with indirect relevance to the procedure, and the use of broad clinical 
endpoints. This study shows an accurate clinical prediction rule can be developed that uses 
the 3D reconstruction software of the magnetic navigation system to aid identifi cation of dif-
fi cult lesions for guide-wire placement on the basis of specifi c coronary analysis. It provides 
only fi ve measurable, anatomical variables and has a simple but crucial endpoint. This clinical 
prediction rule is a good predictor of prolonged crossing time (c-statistic of 0.82) and may 
provide a more accurate and prospective method of predicting diffi  cult procedures in which 
magnetic navigation might be a better option than the conventional techniques.
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Appendix
Grading factors range of values
Number of bends before lesion (Vb) max 5 (0-5)
The total angulation of the 5 worst bends (Vta)
  0:<45,1>45 
(0-1)
End-to-end length from the ostium to the lesion (Vl) 
 0:<50mm, 1:50-100, 2:>10
(0-2)
Vessel calcifi cation (Vc) 
 0:none, 1:yes
(0-1)
Visible side-branches before lesion (Vsb)  0 or 1 (0-1)
Lesion characteristics
 Side-branches within 10 mm (Lbb)
  0:no, 1:yes
(0-1)
 Side-branches in lesion (Lsb)
  0:no, 1:yes
(0-1)
 Lesion angulation (La)
  0:<45,1:>45
(0-1)
 Lesion calcifi cation (Lc)
  0:no, 1:yes
(0-1)
 Lesion length (Ll)
  0:<10, 1:10-20, 2:>20
(0-2)
 Length of severe (> 80% diameter)    stenosis (Lss) 0:<3mm, 1:>3mm (0-1)
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ABSTRACT
Objective: The objective of this study is to compare magnetic guidewire navigation in percu-
taneous coronary intervention (MPCI) to conventional percutaneous coronary intervention 
(CPCI) for the elective treatment of a single discrete stenosis. 
Background: Magnetic navigation actively steers an angioplasty wire-tip and may improve 
PCI procedures, but it is not known whether the intricacy and increased preparation neces-
sary for using the system negatively infl uences the performance of simple procedures in 
terms of time and contrast use. 
Methods: The procedures of 44 patients (mean age 65 ± 10 year) undergoing elective single 
vessel MPCI of a single discrete stenosis were matched for age, gender, and lesion location 
with 44 concurrent patients (mean age 65 ± 10 year) undergoing CPCI. The major endpoint 
was procedural time. 
Results: Technical success was defi ned as an intraluminal wire position distal to the stenosis. 
Procedural outcome, contrast use, and costs were evaluated. Clinical demographics and 
angiographic characteristics of the two groups were similar, except for a higher incidence 
of previous MI and class III angina pectoris in the conventional group. The technical success 
rate was high and identical in both groups (97.7%). Procedural and fl uoroscopy times were 
not signifi cantly diff erent for MPCI compared to CPCI (21.0 ± 14.5 min vs. 24.7 ± 14.0 min; 4.9 
± 4.8 min vs. 7.3 ± 10.3 min, P = NS). There was a signifi cant reduction in median contrast use 
(60 ml/patient (41–100) vs. 100 ml/patient (64–130); P = 0.006]. 
Conclusion: Magnetic navigation does not increase procedural time, irradiation, equipment 
use, or cost compared to conventional PCI of a single discrete stenosis. It proved feasible, 
yielding high rates of procedural success with less contrast use.
Comparison of Magnetically Navigated and 
Conventional Wire PCI of a Single Discrete 
Stenosis
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INTRODUCTION
Magnetic navigation uses two computer-controlled magnets to produce an adjustable 
magnetic fi eld to precisely defl ect a tip-mounted magnet on an angioplasty wire. This 
gives the fundamentally new ability of actively controlling the ‘‘front-end’’ of the wire. The 
precise steering of a wire-tip has a number of potential advantages including maintenance 
of a coaxial vessel orientation, more accurate sidebranch cannulation, and a reduction in 
problems inherent with conventional wires such as entanglement in two wire procedures. 
Percutaneous coronary intervention (PCI) using magnetic navigation appears to be feasible 
for all lesion types (1–5). However, while reports in both phantom (3) and humans (6,7) have 
reported benefi t, the advantages for diff erent and specifi c patient subgroups remain unde-
fi ned. Importantly, magnetic guidewire navigation PCI (MPCI) requires both time for system 
preparation and also familiarity for effi  cient use. Therefore, it remains unclear as to whether 
the burden of the more extensive preparation and performance of this wire technique pro-
longs procedure time or rather is compensated for by smoother, less troubled and ‘‘cleaner’’ 
wire passage and thus a more effi  cient procedure. This clearly has implications on the use 
of this technique, for example, whether it should be restricted to the most diffi  cult cases. 
Patients who are treated by elective PCI of a single discrete stenosis form a relatively simple 
and homogeneous group in whom the anatomy is known from preceding diagnostic angi-
ography and there is generally a low occurrence of complicating factors such as the presence 
of thrombus or suboptimal hemodynamic condition. On the other hand, time-consuming 
techniques or technology would be most likely to have an impact on these procedures. 
Therefore, we examined the procedural outcomes of patients having MPCI for elective treat-
ment of a single discrete stenosis and compared them with those of concurrent matched 
control patients undergoing conventional guidewire navigation PCI (CPCI) to assess whether 
the procedures are comparable in terms of time, irradiation, or contrast use.
MATERIALS AND METHODS
Selection of Patients and Age-Matched Controls
Between January 2007 and May 2007, 375 patients underwent elective single lesion PCI in 
our center. From this patient group, 68 patients had undergone elective single vessel MPCI 
for elective treatment of a single discrete stenosis that would require a maximum of two 
stents. An attempt was made to match all of these patients for gender, age (± 5 years), and 
intracoronary location of the lesion with concurrent patients undergoing elective CPCI. The 
conventional cases were taken from the general catheterization database that has single 
vessel disease as an input parameter. The fi lms were individually reviewed to ensure that 
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only single, discrete lesions were chosen and that no other investigation such as contrast 
angiography, IVUS, or FFR had been performed on the target or other vessel. Gender and 
coronary segment were matched and then patients were matched by the closest age.
Exclusion criteria for both groups were diagnostic revisualization of another vessel/lesion 
during the procedure, performance of another diagnostic procedure such as fractional fl ow 
reserve measurement, the use of intravascular ultrasound, multiple lesions in the target 
vessel, multi-vessel PCI, bifurcation lesions, acute and chronic total occlusions, or a previous 
failed conventional attempt for the same target lesion. It was possible to match 44 suitable 
MPCI patients for age, gender, and coronary segment with 44 control patients who had 
undergone CPCI. 
The Magnetic Navigation System
The Niobe® II magnetic navigation system (MNS; Stereotaxis, St Louis, MO) has been de-
scribed in detail previously (1–3). The MNS is fully integrated at our center with the Integris 
Allura FD10 cardiovascular imaging system (Philips Medical Systems, Eindhoven, The Nether-
lands) as shown in Fig. 1. The operator interfaces with the system using a touch screen to the 
Navigant™ Work Station software (Stereotaxis, St Louis, MO). A 15–20 cm uniform spherical 
Figure 1. The Niobe® Magnetic Navigation System position for PCI. M indicates magnets in tilt position for 
better lateral movement of the image intensifi er. T indicates touch screen interface to give real-time instruction 
to the MNS. S indicates in-lab main screen monitor. C indicates the controls for magnet deployment. See this 
fi gue in color in the Appendix page 394.
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magnetic fi eld volume is produced that is centered on the heart of the patient and can be 
reliably and reproducibly directed at 3600 in all planes. Selecting a 3D direction on the com-
puter screen (see Fig. 2) leads to movement of the two external magnets to give a precisely 
directed magnetic fi eld vector that will actively defl ect the magnetic wire tip resulting in 
reproducibly precise steering.
The current list price for the Stereotaxis MNS is $1.9 million. The size of a typical modern 
magnetically enabled catheterization suite is 770 ft2 (72 m2). The cost of magnetic shielding 
generally ranges from $50,000 to $100,000 and consists of minimal common steel shielding 
in the walls, ceiling, and fl oor.
Magnetically Enabled Wires
A series of magnetically enabled disposable guide wires that are custom-designed for use 
with the MNS are available in a variety of sizes and in a range of stiff ness. For this comparison, 
the Titan™ guidewires were used (see Fig. 3). These are specifi cally designed to be more fl ex-
ible and steerable for magnetic navigation. These are 180 cm moderate support, hydrophilic 
coated wires with a diameter of 0.014 in./0.36 mm having a fl exible 2-cm distal coiled tip at 
the end of which is a gold cup attached to a 2 or 3 mm neodymium-iron-boron magnet.
Figure 2. The screen of the Navigant™ workstation (2.11 version); the panel (P) shows virtual coronary tree 
of the preset navigation with the list of preset vectors (V) seen above. The panel (C) shows the 2D clock face. 
See this fi gue in color in the Appendix page 395.
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PCI Procedure
All patients gave informed consent to the proposed procedure. The inner diameter of all 
6-Fr guides was 0.70’’. The choice of guiding catheter and equipment was left entirely to the 
discretion of the operator and followed routine practice as did the use of drug-eluting stents, 
bare metal stents, and the use of glycoprotein IIb/IIIa receptor antagonists. There were no 
restrictions on the operators’ choice of conventional wire. The angioplasty wires for magnetic 
procedures were the standard magnetically enabled wires supplied by the company (see 
previous paragraph). The interventional staff  consisted of fi ve senior operators. Three have 
greater than 10 years experience and two less than that; CPCI procedures were performed 
by all fi ve operators, while MPCI procedures were performed by two of the fi ve operators, 
one with greater than 10 years experience and one with less than 10 years. There were nine 
conventional patients (~20%) treated by the two operators who performed the magnetic 
procedures. The data have been taken from either the general catheterization database or 
from a registry of all the magnetic procedures. An arbitrary time period was selected for this 
comparison after a 3-month lead-in period for familiarization with the MNS to refl ect normal 
working practice. Aspirin, 500 mg i.v., and clopidogrel, 600 mg, were given to all patients. 
Weight-adjusted unfractionated heparin, 100 IU/kg, was given as an intravenous bolus at the 
beginning of the procedure. The approach for access was via the radial artery or, in case of 
contraindication, the femoral artery.
Angiographic Variables
All angiograms were stored in a computer database and analyzed off -line by an independent 
observer, using CAAS 2003 Camtronics (Phillips Medical Systems). Lesion types were graded 
according to the ACC/AHA lesion classifi cation (8).
Titan Soft Support
2 mm Magnetic Tip
30° Angled Tip 
2 cm Platinum 
Radiopaque Coil
34 cm Hydrophilic Coating
27 cm       
Stainless Steel Coil
3.5 cm8.8 cm3.2 cm∅ 0.014 "
151 cm Proximal PTFE Coated 
Stainless Steel Core
Figure 3. The structure of TitanTM Soft Support magnet wire. See this fi gue in color in the Appendix page 395.
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Defi nition of End Points
The major endpoint was the amount of time required to complete the procedure. Procedural 
duration was measured from the time of sheath insertion until the removal of the guiding 
catheter at the end of the procedure. Secondary endpoints were fl uoroscopy time, total pro-
cedural time, total contrast use, number of wires, number of balloons and stents, technical 
success, major adverse cardiac events, and procedural costs. Technical success was defi ned 
as an intraluminal wire position distal to the stenoses. Procedural success was defi ned as (1) 
TIMI grade III fl ow (9), (2) <30% residual stenosis, and (3) absence of clinical events during 
the procedure (death, acute stent thrombosis, myocardial infarction, emergency coronary 
artery bypass grafting, and stroke). Fluoroscopy times were automatically recorded by the 
Poly Diagnost (C2) Digital Cardiac Imaging System (Phillips Medical Systems). Procedural 
costs included the materials and laboratory and staff  time. Laboratory and staff  time were 
calculated by multiplying the procedural time + 30 min by 17 euro/ min; the latter fi gure was 
based on time-tested cost estimates, obtained from a large data set collected by a company 
linked to the Erasmus University Hospital of Rotterdam, the Netherlands. Materials included 
in the cost analysis were coronary guidewires, angioplasty balloons, premounted bare-metal 
or drug-eluting stents, and angiographic contrast agent.
Statistical Analysis
For comparison of continuous variables between the two groups, the unpaired two-tailed 
Student’s t-test was used or, for the median of the contrast use (as for skewed data), the 
Mann–Whitney U-test. Comparison of categorical variables between the two groups was 
performed using the Chi-square test or, in case of a minimum expected count less than fi ve, 
the Fisher exact test. Continuous variables were expressed as mean ± SD for nonskewed 
data; medians were expressed as 95% CI for skewed data. Categorical data were expressed 
as numbers of patients and percentage of patients. A P value less than 0.05 was considered 
statistically signifi cant. Statistical tests were carried out with the SPSS 14.0 statistical software 
package.
RESULTS
Baseline Demographics
Forty-four consecutive patients having MPCI for elective treatment of a discrete single lesion 
were compared to 44 matched control patients having CPCI. Baseline clinical characteristics 
(Table I) were similar in both groups, although a previous history of MI and also angina CCS-
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class III occurred more frequently in the CPCI group. Baseline angiographic variables were 
equally distributed in both groups (Table 1). 
Table 1. Baseline Characteristics
Characteristics Magnetic PCI (N = 44) Conventional  PCI(N = 44) P value
Age (year) 65±10 65±10 0.99
Male sex 70.5 70.5 1.00
Diabetes mellitus 22.7 12.5 0.22
Hypertension 43.2 51.3 0.53
Hypercholesterolemia 29.5 37.5 0.44
Family history of CAD 25 25 1.00
History of smoking cigarettes 27.3 30 0.78
Previous PCI 34.1 43.2 0.38
Previous CABG 22.7 9.1 0.08
Previous myocardial infarction 6.8 34.1 0.002
CCS anginal class 
 I 5.3 0 0.50
 II 36.8 12.5 0.03
 III 52.6 87.5 0.002
 IV 2.6 0 1.00
Vessel disease
 1VD 61.4 54.5 0.52
 2VD 29.5 29.5 1.00
 3VD 9.1 16.3 0.31
Target lesion location
 Left anterior descending artery (LAD)
  Prox LAD 31.8 31.8 1.00
  Mid LAD 20.5 20.5 1.00
  First diagonal 2.3 2.3 1.00
 Left circumfl ex artery (CX)
  Obtuse marginal 9.1 9.1 1.00
  Prox CX 6.8 6.8 1.00
 Right coronary artery (RCA)
  Prox RCA 9.1 9.1 1.00
  Mid RCA 15.9 15.9 1.00
  Dist RCA 4.5 4.5 1.00
ACC/AHA lesion class
 A 22.7 18.2 0.60
 B1 36.4 31.8 0.65
 B2 13.6 18.2 0.56
 C 27.3 31.8 0.64
For age mean ± SD is given and for all other cases percentage of patients are given. CAD = coronary artery 
disease; CCS = Canadian Cardiovascular Society.
The intracoronary segment locations were, by design, equally distributed in both groups.
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Procedural Outcome
Vascular access was successful via the radial approach in 100% of the magnetic procedures 
and in 97.7% of the conventional procedures. Procedural and fl uoroscopy times were not 
signifi cantly diff erent (MPCI:CPCI, 21.0 ± 14.5 vs. 24.7 ± 14.0, P = 0.23, 4.9 ± 4.8 vs. 7.3 ± 10.3, 
P = 0.16, respectively), and overall technical and procedural success was high (97.7%) in both 
groups (Table 2). 
Table 2. Procedural Outcome
Variable Magnetic PCI (N ¼ 44) Conventional PCI (N ¼ 44) P value
Technical success 97.7 97.7 1.00
Procedural success 97.7 97.7 1.00
Successful radial approach 100 97.7 1.00
Successful second access femoral approach 0 2.3 1.00
Dissection 4.5 6.8 1.00
Stent length per patient, mm 20.1 ± 8.0 19.4 ± 7.8 0.69
Stent diameter per patient, mm 3.0 ± 0.4 3.0 ± 0.5 0.57
No. of stents implanted per patient 1.3 ± 0.8 1.5 ± 0.8 0.42
No. of drug-eluting stents implanted per patient 0.7 ± 0.9 0.8 ± 0.9 0.36
No. of bare-metal stents implanted per patient 0.7 ± 0.6 0.6 ± 0.9 0.78
No. of balloons used per patient 0.6 ± 1.0 0.6 ± 0.8 1.00
No. of wires implanted per patient 1.1 ± 0.3 1.3 ± 0.6 0.20
Procedural duration, min 21.0 ± 14.5 24.7 ± 14.0 0.23
Fluoroscopy time, min 4.9 ± 4.8 7.3 ± 10.3 0.16
Contrast consumption (median), ml 60 (41–100) 100 (64-130) 0.006
Procedural costs, euro 2,786 ± 1,859 3,148 ± 1,636 0.36
The results are presented either as the percentage value of the group or as the mean value ± one standard 
deviation.
The median contrast use was marginally but signifi cantly reduced when comparing MPCI and 
CPCI [60 ml/patient (41–100) vs. 100 ml/patient (64–130); P = 0.006].
Material Consumption and Costs
The data for the MPCI patients who could not be matched was compared to the data of those 
successfully matched, and no signifi cant diff erence was found between these groups. MPCI 
did not signifi cantly increase procedural duration, and there was no increased use of wires, 
balloons, and stents (DES or BMS) in either group but rather there was a trend to reduc-
tion in all these parameters. MPCI did not result in signifi cantly increased procedural costs 
compared to CPCI.
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DISCUSSION
Magnetic navigation has been shown to be applicable and feasible in interventional cardiol-
ogy (1–7). However, it has been unclear as to whether the more intricate nature of the proce-
dure, in particular with respect to the time needed for preparation, might limit the technique 
to more diffi  cult cases. The system adds a further level of complexity to PCI procedures. 
Specifi cally, the system must be isocentered on the heart of each patient before the magnets 
can be brought in; there is time required to get the magnets to their working position; some-
times the position of the patient must be altered to allow the magnets to come close enough 
to the working position; and the system may limit the position of the image intensifi er, so 
alternative angulations must be sought. Additionally, it can be time consuming creating and 
preparing 3D reconstructions if these are used, especially with inexperienced users. All these 
maneuvers take time that may delay the procedure and thus reduce overall effi  ciency.
In contrast, once in position and with an experienced operator, this new technique gives 
the operator several new and defi nable capabilities that may aid smoother, less troubled, 
and ‘‘cleaner’’ wire passage. As conventional wires are steered by turning the distal angled tip, 
there is a tendency to deviate from a central, co-axial path in the vessel, and there may be 
poor maneuverability if severe proximal tortuosity is present and impairs wire rotation. The 
active front-end steering of the MNS suff ers from no such problems. First, active tip adjust-
ment of the wire gives the ability to bend and direct the tip as required, whether this is to 
maintain the tip coaxially in the vessel or to steer around bends or into sidebranches. Second, 
the automatic inclusion of 3D information, whether by using the clock-face, the presets, or 
3D reconstruction from patient images, routinely adds the use of the third dimension dur-
ing wire passage. Third, this ‘‘front-end’’ method of steering could facilitate some aspects 
of wire passage. Additionally, the system avoids some problems inherent in conventional 
technique. The minimization of tip rotation leads to a reduced chance of wire entanglement 
in procedures where multiple wires are used, and also the magnetic fi eld tends to maintain 
the tip direction and help stabilize the wire. Individually, a specifi c advantage may not play a 
crucial role in each and every procedure but together they may facilitate better procedures. 
The patient group selected for this comparison was restricted to simple procedures, where 
forethought could be given to factors such as strategy, catheter choice, and the working 
position of the image intensifi er. The lesions themselves were not complicated by severe 
calcifi cation, poor- or no-fl ow or thrombus and were suitable for stent placement. While 
complications and problems can arise in any PCI procedure, it was hoped that this group 
would have minimal untoward events and this is indeed refl ected in the short procedure 
times and low contrast use. On the other hand, use of time-consuming technology would be 
most marked in these patients. This comparison was performed relatively soon after acquisi-
tion of the system (after a 3-month lead-in period) when the system had been used relatively 
intensively to establish a set routine. This comparison indicates that there is no disadvantage 
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in using the MNS, as MPCI procedures can be performed safely and effi  ciently, as defi ned 
by procedural time, fl uoroscopy time, and contrast use, which is at least equivalent to CPCI. 
Indeed, these nonrandomized results show a trend to reduced procedural parameters with a 
signifi cant reduction in the median contrast use.
Study Limitations
This comparison has the limitations associated with retrospective cohort studies in that 
procedures were not randomized. Factors infl uencing outcome have been matched to the 
greatest extent possible, but the use of concurrent patients left a third of the possible MPCI 
patients unmatched. Concurrent patients have been used rather than historical controls to 
minimize diff erences in routine catheterization procedure to the greatest possible extent. 
However, the increased incidence of previous myocardial infarction and CCS III angina in 
conventional patient baseline characteristics may suggest that there was more extensive 
disease, although this possibility is contradicted by the statistical equivalence of the AHA/
ACC grading for both groups. The limitations of the magnet navigation system technology 
are discussed above. In addition, only two out of fi ve CPCI operators performed MPCIs and, 
although all fi ve operators are experienced operators and there was proportionately more 
experience in the CPCI group, operator bias cannot be excluded.
CONCLUSION
In conclusion, magnetic navigation PCI appears to give no disadvantage in terms of proce-
dural time or success, irradiation, contrast use or cost in routine elective PCI of a single dis-
crete stenosis. The use of this technology, which may initially appear complex and intricate, 
is associated with equivalent or possibly even a marginal improvement in the simplest of PCI 
procedures when compared with CPCI. Randomized controlled trials are warranted to further 
investigate the use in this population.
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ABSTRACT
Aims: Comparison of magnetic guidewire navigation in percutaneous coronary intervention 
(magnetic PCI) across distal and /or complex lesions versus conventional navigation (conven-
tional PCI).
Methods and results: Forty-seven consecutive patients (age 61 ± 10yr) undergoing elective 
single vessel magnetic PCI for distal and/or complex lesions were matched by age and lesion 
location with 45 patients undergoing conventional PCI (age 63 ± 10yr). Technical success rate 
was defi ned as an intraluminal wire position distal to the stenosis. Procedural outcome and 
costs were evaluated. Baseline demographics and angiographic characteristics of the two 
groups were similar. The technical success rate did not diff er between magnetic and conven-
tional PCI (95.7 vs 97.8%; p=1.00). Signifi cantly shorter procedural and fl uoroscopy time were 
observed for magnetic compared to conventional PCI (29.9 ± 17.6 vs 41.1±21 min, p=0.007; 
7.5 ± 7.3 vs 16.1 ± 22.4 min, p=0.02 respectively). Less contrast was used in the magnetic PCI 
group (58 ml/patient; P=0.02). These advantages resulted in a mean estimated saving of 1400 
euro per patient (P<0.001). Advantages of procedural outcome were even more pronounced 
in the ACC/AHA lesion class C subgroup.
Conclusions: Magnetic compared to conventional PCI is an attractive novel technique that 
proved to be feasible and safe and might be faster in distal and especially complex lesions. 
Magnetically navigated PCI in distal and/
or complex lesions may improve procedural 
outcome and material consumption
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INTRODUCTION
Magnetic guidewire navigation in percutaneous coronary intervention (magnetic PCI) is a 
new technique for steering the front end of an angioplasty wire using a tip-mounted mag-
net. This technique has been shown to be both feasible and practical (1-5). Magnetic PCI 
has proved suitable for all lesion types (2-4). Studies in both phantoms and humans have 
suggested potential benefi ts for magnetic PCI (3,4,6). However, the advantages for diff erent 
patient subgroups remains undefi ned.
Magnetic PCI is based on the production of a 2 or 3-dimensional reconstruction of the 
vessel lumen from standard angiographic images. Knowledge of the positions of the table 
and image intensifi er during angiography allows calculation of the vessel coordinates in real 
space within the patient’s chest. The applied magnetic fi eld can be changed at any time to 
redirect the wire tip that may improve navigation through complex and tortuous anatomy. 
Magnetic PCI could also result in less wire deviation into side-branches (7). Benefi ts of 
magnetic PCI are complete omnidirectional guidewire navigation, precise direction of wires 
using navigational vectors within an adjustable magnetic fi eld and increased accuracy by 
integrating 3-dimensional imaging modalities and 3-dimensional virtual reconstruction soft-
ware (7). These characteristics of magnetic PCI could potentially result in reduced procedural 
and fl uoroscopy duration and lower material and contrast consumption especially when it is 
used in patients with distal and complex lesions (5,8). In addition, lower contrast consump-
tion could possibly result in less contrast induced nephropathy (9). For these reasons, the 
procedural outcomes of patients having magnetic PCI for distal lesions, with special atten-
tion to complex lesions, was compared to concurrent matched control patients undergoing 
conventional guidewire navigation PCI (conventional PCI).
METHODS
Selection of patients
Between January 2007 and May 2007, 375 patients underwent single lesion PCI in the Am-
sterdam Department for Interventional Cardiology, a large regional tertiary centre. From this 
patient group, 47 consecutive eligible participants having elective single vessel magnetic PCI 
for distal and/or complex lesions were included. Distal lesions were defi ned as all coronary 
segments except for segment 1, 2, 5, 6 and 11 according to the modifi ed ACC/AHA coronary 
segment classifi cation. Selected magnetic PCI patients were matched by age, gender and 
coronary segment with 45 control patients having conventional PCI in the same time period. 
Exclusion criteria were simple proximal lesions, multivessel PCI, previous failed conven-
tional PCI for the same target lesion, diagnostic review of another vessel in a staged procedure 
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or inclusion of another diagnostic procedure such as fractional fl ow reserve measurement or 
the use of intravascular ultrasound. An ACC/AHA lesion class type C subgroup was defi ned in 
both groups. All patients gave informed consent to the proposed procedure. 
Magnetic navigation system
The Niobe® Magnetic Navigation System (MNS, Stereotaxis Inc., St Louis, MO, USA), is a fully 
integrated system (workstation and magnet control equipment) for navigating proprietary 
catheters and guidewires that have very small magnets at their distal tips. The orientation of 
these devices is controlled precisely by manipulation of the fi eld generated by two adjust-
able large neodymium-iron-boron magnets that are mounted on mechanical positioners on 
either side of the patient. Rotation and translation of these magnets maintain a net magnetic 
fi eld of 0.08-Tesla within a 20 cm diameter spherical fi eld in the patient’s upper thorax. These 
permanent magnets are stowed and retracted away from the patient when not in use.
The MNS is fully integrated at our centre with the Integris Allura FD10 cardiovascular 
imaging system (Philips Medical Systems, Eindhoven, The Netherlands) as shown in Figure 1. 
The Constellation software included in the Stereotaxis MNS was seldom used for navigation. 
Most of the cases were performed with either free-style (2D clockwise navigation) or full 3D 
reconstruction. The operator interfaces with the system via the Navigant™ Navigation Work 
Station software interface (NWS, Stereotaxis Inc., St. Louis, MO, USA). The NWS has several 
features that are specifi cally engineered for interventional cardiology procedures; these fea-
tures include: 3-dimensional (3D) preoperative navigation that allows the user to import 
and co-register standard angiographic images and perform “point and click” navigation on 
the imported image. In addition, the NaviView software (CardiOp-B, Paieon Medical, Rosh 
Ha’ayin, Israel) allows use of angiographic images from the procedure to generate a 3D vessel 
reconstruction that can also be used for “point and click” navigation (Figure 2). In our centre, 
choice of wire and navigation technique (2D mode, 3D mode, or a combination of these) was 
left to the discretion of the operator. 
Figure 1. The Niobe® Magnetic Navigation System. A typical magnetic navigation system set-up showing 
the magnets and C-arm. See this fi gue in color in the Appendix page 375.
Mark bw.indd   250 25-05-10   15:16
251
Magnetically navigated PCI in distal and/or complex lesions may improve procedural outcome and material consumption
Magnetically enabled wires
A series of magnetically enabled disposable guide wires that are custom designed to inte-
grate with, and be precisely navigated by, the MNS are available in a variety of sizes and 
a range of stiff ness. For this study, we utilised the Titan™ guidewires that are specifi cally 
designed to be more fl exible and steerable for magnetic navigation. A schematic of a Titan 
guidewire is shown in Figure 3. 
PCI procedure
The interventional staff  of the Onze Lieve Vrouwe Gasthuis includes fi ve experienced op-
erators. Conventional PCI procedures were assigned to all 5 operators whereas magnetic PCI 
Figure 2. This 3-D reconstruction was created from the fl uoroscopic angiogram as shown using the 
NaviView software feature. See this fi gue in color in the Appendix page 396.
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procedures were assigned to 2 of the 5 experienced operators. Aspergic, 500 mg i.v., was 
administered before, and clopidogrel, 600mg, was administered after the procedure to all 
patients. Weight adjusted unfractionated heparin, 100 IU/kg, was given as an intravenous 
bolus at the beginning of the procedure. The use of glycoprotein IIb/IIIa receptor antagonists 
was left at the operators` discretion. The approach for access was predominantly the transra-
dial technique or, in case of contraindication, the transfemoral approach. The choice of the 
guiding catheter and equipment was left at the operators’ discretion and followed routine 
practice. The angioplasty wires for magnetic PCI were the standard magnetically enabled 
wires supplied by the company described above. There was no restriction on the operators’ 
choice of conventional wires. Drug-eluting and bare metal stents were chosen at the opera-
tors’ discretion. 
Angiographic variables
All angiograms were stored in a computer database and analysed off -line, using CAAS 2003 
Camtronics (Philips Medical System, Eindhoven, The Netherlands), and analysed by an inde-
pendent observer. Vessel and lesion characteristics have an impact on the performance of 
the PCI procedure as shown by a study in this issue (9). The angulation of the fi rst turn of the 
vessel is defi ned as the fi rst angle within the fi rst 30 mm of the vessel in which the catheter 
is engaged. It is the angle from the ostium at the aorta into the beginning of proximal left 
anterior descending artery, beginning of proximal circumfl ex artery, or the fi rst angle into 
the right coronary artery. The possible grading is <45° (i.e. mild bend), 45°-90° (i.e. moderate 
bend), 90°-135° (i.e. severe bend) and 135°-180° (i.e. extremely severe bend). The number 
of turns before the target lesion was noted. The total cumulative angulation of the 5 worst 
turns was also noted, using the same grading as above. End-to-end length from the ostium 
to the lesion was measured using quantitative coronary angiography. The number of visible 
sidebranches before the lesion, presence of a stent before a lesion, presence of sidebranches 
within 10 mm of the lesion, sidebranches in the lesion, presence of vessel and lesion calcifi ca-
tion were noted. Lesion types were graded according to the ACC/AHA lesion classifi cation 
Titan Soft Support
2 mm Magnetic Tip
30° Angled Tip 
2 cm Platinum 
Radiopaque Coil
34 cm Hydrophilic Coating
27 cm       
Stainless Steel Coil
3.5 cm8.8 cm3.2 cm∅ 0.014"
151 cm Proximal PTFE Coated 
Stainless Steel Core
Figure 3. The Titan® magnetic navigation wire with the 2mm magnet located at its tip. See this fi gue in color 
in the Appendix page 395.
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(10). Specifi c morphological abnormalities were also noted (e.g. aneurysm, dissection fl ap, 
AV malformation). 
Endpoint defi nitions
Endpoints of this study were to compare procedural outcome in both groups (e.g. technical 
success, procedural and fl uoroscopy duration, contrast and material consumption). Technical 
success was defi ned as an intraluminal wire position distal to the stenoses. Procedural suc-
cess was defi ned as 1) TIMI grade III fl ow (11), 2) <30% residual stenosis, and 3) absence of 
clinical events during the procedure (death, acute stent thrombosis, myocardial infarction, 
emergency coronary artery bypass grafting and stroke). Procedural duration was measured 
from the time of sheath insertion until the removal of the guiding catheter at the end of 
the procedure. In case 3D reconstruction was used, procedural duration for magnetic PCI 
included 3D reconstruction time (±5 min). Fluoroscopy times were automatically recorded 
by the Poly Diagnost (C2) Digital Cardiac Imaging System (Philips). Additional endpoints 
were the occurrence of dissection, stent length and diameter per patient, contrast usage and 
material consumption. Estimated procedural costs included the materials and laboratory and 
staff  time. Laboratory and staff  time were calculated by multiplying the procedural time + 30 
minutes by 17 €/minute; the latter fi gure was based on time-tested cost estimates, obtained 
from a large data set collected by Cardialysis, a company linked to the university hospital of 
Rotterdam, the Netherlands. Materials included in the cost analysis were coronary guide-
wires, angioplasty balloons, premounted bare metal or drug-eluting stents and angiographic 
contrast agent. 
Statistical analysis
For comparison of continuous variables between the treatment groups, the unpaired two-
tailed student’s t test was used or, in the case of skewed data, the Mann-Whitney U-test. Com-
parison of categorical variables between the 2 groups was performed using the Chi-square 
test, or in case of a minimum expected count less than 5, the Fisher exact test. Continuous 
variables were expressed as mean ± SD. Categorical data were expressed as numbers of 
patients and percentage of patients. Spearman rank correlation testing (coeffi  cient Rs) was 
performed to identify variables related to procedural duration, fl uoroscopy time and contrast 
usage. Among the variables identifi ed, step-down linear regression was performed until all 
remaining variables were signifi cant, to reveal predictors of procedural duration, fl uoroscopy 
time and contrast usage (12). A P value less than 0.05 was considered statistically signifi cant. 
Statistical tests were carried out with the SPSS 14.0 statistical software package (Chicago, IL, 
USA). 
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RESULTS
Baseline demographics
Forty-seven consecutive patients having magnetic PCI for distal and/or complex lesions were 
compared to 45 matched control patients having conventional PCI. Baseline clinical charac-
Table 1. Baseline clinical characteristics.
Characteristics Magnetic PCI (N=47) Conventional PCI (N=45) P Value
Age-yr 61±10 63±10 0.35
Male sex 31 (66) 31 (68.9) 0.76
Diabetes mellitus 7 (14.9) 9 (20.0) 0.52
Hypertension 24 (51.1) 20 (44.4) 0.53
Hypercholesterolaemia 18 (38.3) 18 (40) 0.87
Family history of CAD 18 (38.3) 12 (26.7) 0.23
History of smoking cigarettes 13 (27.1) 8 (17.8) 0.26
Previous PCI 23 (48.9) 26 (57.8) 0.40
Previous CABG 3 (6.4) 3 (6.7) 1.00
Previous myocardial infarction 14 (29.8) 16 (35.6) 0.56
Clinical presentation
 Stable angina pectoris 30 (63.8) 28 (62.2) 0.87
 Unstable angina pectoris 17 (36.2) 18 (40) 0.71
CCS* anginal class
 I 0 0 –
 II 7 (14.9) 13 (28.9) 0.10
 III 25 (53.2) 25 (55.6) 0.82
 IV 15 (31.9) 7 (15.6) 0.07
Vessel disease
 1VD 18 (38.3) 18 (40) 0.87
 2VD 20 (42.6) 16 (35.6) 0.49
 3VD 9 (19.1) 11 (24.4) 0.54
Target lesion location
Left anterior descending artery (LAD) 24 (51.1) 22 (48.9) 0.84
 Mid LAD 20 (42.6) 13 (28.9) 0.17
 Distal LAD 2 (4.3) 3 (6.7) 0.67
 1st diagonal 2 (4.3) 4 (8.9) 0.43
 2nd diagonal 0 2 (4.4) 0.24
Left circumfl ex artery (CX) 14 (29.8) 13 (28.9) 0.93
 Obtuse marginal 8 (17) 11 (24.4) 0.38
 Distal CX 5 (10.6) 2 (4.4) 0.44
 Left posterior lateral 1(2.1) 0 1.00
Right coronary artery (RCA) 9 (19.1) 10 (22.2) 0.72
 Distal RCA 5 (10.6) 8 (17.8) 0.33
 Right descending posterior 2 (4.3) 1 (2.2) 1.00
 Right posterior lateral 2 (4.3) 1 (2.2) 1.00
For age means ±SD are given, and in all other cases number of patients with percentages (within 
parenthesis). CAD: coronary artery disease. CCS: Canadian Cardiovascular Society.
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teristics (Table 1) did not diff er signifi cantly between groups, although angina CCS-class IV 
tended to occur more frequently in the magnetic PCI group.
Table 2. Baseline angiographic variables. Presented are the number of patients with percentages (within 
parentheses), and in some cases means ±SD.
Variable Magnetic PCI (N=47) Conventional PCI (N=45) P value
Target vessel characteristics
Angulation 1st turn (aorta to proximal vessel)
< 45° 10 (21.3) 4 (8.9) 0.10
45°–90° 32 (68.1) 35 (77.8) 0.30
90°–135° 5 (10.6) 5 (11.1) 1.00
135°–180° 0 1 (2.2) 0.49
No. of turns before lesion 2.3±1.5 2.4±1.4 0.79
Angulation of the 5 worst turns
< 45° 9 (19.1) 3 (6.7) 0.08
45°–90° 27 (57.4) 27 (60) 0.80
90°–135° 10 (21.3) 12 (26.7) 0.55
135°–180° 1 (2.1) 3 (6.7) 0.36
End to end length from ostium to lesion (mm) 50.7±31.2 50.2±32.2 0.94
No. of visible side-branches
before lesion
3.9±2.2 3.6±1.5 0.46
Stent before lesion 5 (10.6) 6 (13.3) 0.76
Target lesion characteristics
No. of side-branches within 10 mm of lesion
0 0 1 (2.2) 0.49
1 41 (87.2) 42 (93.3) 0.49
2 6 (12.8) 2 (4.4) 0.27
No. of side-branches in lesion
0 0 1 (2.2) 0.49
1 36 (76.6) 32 (71.1) 0.55
2 11 (23.4) 12 (26.7) 0.72
Lesion angulation
< 45° 40 (85.1) 30 (66.7) 0.04
45°–90° 6 (12.8) 13 (28.9) 0.06
90°–135° 1 (2.1) 2 (4.4) 0.61
135°–180° 0 0 –
Lesion calcifi cation 20 (42.6) 18 (40) 0.80
Through stent 4 (8.5) 4 (8.9) 1.00
Specifi c morphologic abnormality (e.g. aneurysmal, 
shelf, dissection fl ap, AV malformation)
2 (4.3) 0 0.50
ACC/AHA lesion class
A 3 (6.4 ) 8 (17.8) 0.09
B1 10 (21.3) 12 (26.7) 0.55
B2 12 (25.5) 12 (26.7) 0.90
C 22 (46.8) 13 (28.9) 0.08
No.=number
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Most of the baseline angiographic variables (Table 2) were equally distributed between both 
treatment groups, although the percentage of type C ACC/AHA lesions tended to be higher 
in the magnetic PCI group (46.6% vs 28.9%; P=0.08). 
The number of included chronic total occlusions in the magnetic PCI (6.4%) and conventional 
PCI group (2.2%) were low and did not diff er signifi cantly between groups. The occurrence of 
severe vessel or lesion angulation (90°-180°) was similar between groups. 
Procedural outcome
Successful vascular access was obtained via the radial approach in 97% and in the remainder 
via the femoral artery. Overall technical and procedural success was high (up to 98%) and 
similar in both groups (Table 3). 
Table 3. Procedural outcome of all distal and/ or complex lesions. Presented are the number of patients 
with percentages (within parentheses) or in other cases means ±SD.
Variable Magnetic PCI (N=47) Conventional PCI (N=45) P value
Technical success 45 (95.7) 44 (97.8) 1.00
Procedural success 44 (93.6) 44 (97.8) 0.62
Successful radial approach 46 (97.9) 43 (95.6) 0.61
Successful 2nd access
femoral approach
1 (2.1) 2 (4.4) 1.00
Dissection 4 (8.5) 3 (6.7) 1.00
Stent length per patient (mm) 21.1±6.8 19.2±7.6 0.22
Stent diameter per patient (mm) 2.9±0.4 2.7±0.4 0.08
No. of stents implanted per patient 1.3±0.9 1 .9±1.1 0.005
No. of drug-eluting stents
implanted per patient
0.6±0.9 1. 4±1.1 <0.001
No. of bare-metal stents
implanted per patient
0.7±0.8 0.5±0.7 0.14
No. of balloons used per patient 0.9±1.1 1.4±1.3 0.05
No. of wires implanted per patient 1.5±0.8 1.3±0.7 0.38
Procedural duration-min 29.9±17.6 41.1±21 0.007
Fluoroscopy time-min 7.5±7.3 16.1±22.4 0.02
Contrast consumption-ml 122±82 180±147 0.02
Material costs in Euros 2030±1547 3514±2106 <0.001
Procedural costs in Euros 3323±1806 4723±2288 0.002
No.= number.
One serious clinical event occurred in the magnetic PCI group (acute bare-metal stent throm-
bosis) and one in the conventional PCI group (side branch occlusion). All technical failure 
cases were type C ACC /AHA lesions. Technical and procedural success was high (up to 92%) 
in the type C ACC/AHA lesion subgroup (Table 4). 
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Table 4. Procedural outcome of type C ACC/AHA lesion class subgroup. Presented are the number of 
patients with percentages (within parentheses) or in other cases means ±SD.
Variable Magnetic PCI (N=22) Conventional PCI (N=13) P value
Technical success 20 (90.9) 12 (92.3) 1.00
Procedural success 20 (90.9) 12 (92.3) 1.00
Procedural duration-min 31.3±15.7 55.5±23.1 0.001
Fluoroscopy time-min 9.0±6.9 28.6±34.4 0.01
Contrast consumption-ml 147±91 214±85 0.04
Procedural costs in Euros 3994±2070 6781±2693 0.002
Signifi cantly shorter procedural and fl uoroscopy times and lower contrast consumption were 
observed in favour of magnetic PCI (Table 3). In multivariate analysis, among 12 demographic, 
clinical and angiographic variables tested, magnetic PCI (P<0.001) and absence of ACC/AHA 
lesion type C (P=0.01) were independent predictors for shorter procedural duration. Among 
14 demographic, clinical and angiographic variables tested, magnetic PCI (P=0.01), absence 
of target lesion location in the distal left anterior descending artery (P<0.0001) and absence 
of 3-vessel disease (P=0.04) were independent predictors of shorter fl uoroscopy duration. 
Among 14 demographic, clinical and angiographic variables tested, magnetic PCI (P=0.008), 
absence of a previous myocardial infarction (P=0.006), absence of severe vessel or lesion 
angulation (<135°; P<0.001) and absence of type C ACC/AHA lesion (P=0.02) were indepen-
dent predictors for lower contrast consumption. Advantages in procedural outcome for the 
magnetic PCI group were even more pronounced in the type C ACC/AHA lesion subgroup 
(Table 4).
Material consumption and cost estimation
Magnetic PCI was associated on average with an 11 minute reduction in procedural duration 
(P=0.007) and reduced usage of angiographic contrast agent (58 ml/patient; P=0.02). Signifi -
cantly more stents and balloons, as well as drug-eluting stents per patient, were implanted in 
the conventional PCI group (Table 3). Therefore magnetic PCI resulted in signifi cantly lower 
material and procedural costs compared to conventional PCI, representing a mean proce-
dural saving of 1400 € per patient (P<0.002). Costs remained signifi cantly lower for magnetic 
PCI when corrected for the diff erence in number of drug-eluting stents used (€2727± €1190 
vs €3301± €1395, P=0.04).
The type C ACC/AHA lesion subgroup was larger in the magnetic PCI group (Table 2). In this 
subgroup magnetic PCI had even more pronounced savings (Table 4) in procedural duration 
(diff erence, i.e. delta, with conventional PCI: 24 min), fl uoroscopy time (Δ: 20 min), contrast 
consumption (Δ: 67 ml) and procedural costs (Δ: €2787).
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DISCUSSION
Magnetic PCI is a promising technique in cardiac electrophysiological procedures (13,14) 
and is emerging as a powerful tool in interventional cardiology (1-6). Phantom studies have 
suggested that magnetic PCI provides more benefi t in distal and tortuous lesions and may be 
expected to provide greater advantage in complex procedures (3,4). Therefore, we compared 
in the clinical setting the effi  cacy of elective single vessel magnetic PCI in distal and more 
specifi cally complex lesions to matched controls using conventional PCI. Our study indicates 
that magnetic PCI might be superior to conventional PCI for procedural duration, fl uoros-
copy time, contrast usage and costs. The high technical and procedural success rates were 
similar between groups. It is noteworthy that this group of procedures was challenging as is 
indicated by the time-consuming procedures and high incidence of type C ACC/AHA lesions. 
The incidence of type C ACC/AHA lesion, an independent predictor for worse procedural out-
come, was signifi cantly higher in the magnetic PCI compared to the conventional PCI group. 
Therefore the procedural advantage of magnetic PCI could have been more pronounced if 
ACC/AHA lesions had been equally distributed among groups. It is noteworthy that magnetic 
PCI was an independent predictor for shorter procedural and fl uoroscopy times and lower 
contrast consumption. The signifi cantly lower procedural duration, fl uoroscopy time, con-
trast usage, number of stents and balloons used resulted in signifi cantly lower procedural 
costs with a mean saving of 1400 euro per patient. However, one should bear in mind that the 
acquisition of the Stereotaxis Magnetic Navigation System is highly expensive (±€1.4 million). 
At least one thousand patients should be treated with magnetic PCI to compensate for these 
expenses. The benefi t in procedural outcome for magnetic PCI is even more pronounced in 
patients having magnetic PCI for type C ACC/AHA lesions (Table 4). In complex lesions mag-
netic PCI resulted in a 44% reduction of procedural duration, 69% reduction in fl uoroscopy 
duration, 31% reduction in contrast consumption and a 41% reduction in costs. Treatment 
of these complex lesions is generally more problematic due to the diffi  culty in steering and 
pushing a guidewire through them. As the Magnetic Navigation System provides precise, 
computerised control of the working tip of a guidewire, it can enable physicians to more 
easily locate small openings in, and to advance a guidewire across, these lesions. The pos-
sible benefi t in procedural outcome for magnetic PCI revolves around key abilities of the 
system. First, magnetic PCI procedures incorporate 3D information (presets, constellation 
and reconstruction). The automatic 3D alignment of the magnetic tip with the chosen vec-
tor, rather than manual steering by estimation from the 2D fl uoroscopy screen, improves 
coaxialisation of the guidewire tip in the vessel. This can help to orientate the guidewire tip 
in order to pass a vessel angulation, or into a desired branch, and this may reduce incorrect 
selection of a side-branch, a problem that is inherent with the bent and non-coaxial tip of a 
conventional wire. This reorientation can be performed within the patient at any time during 
the procedure meaning that the wire tip is actively steered. This steering is independent of 
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factors in the proximal section of the vessel such as tortuosity or calcium that may impair the 
rotation and manipulation of a conventional wire that is needed to steer the tip. The result is 
that the operator is not forced to use a single fi xed bend that may not be appropriate to each 
and every bend of a coronary vessel, lesion and side-branch.
Second, the use of a computer enables the introduction of features that give added value 
and were previously unavailable during PCI. An example is the white line overlay map on the 
fl uoroscopy screen, which is a further progression as compared to the use of a separate still 
image on a 2nd screen or ‘roadmap’. The white line overlays the trajectory of the vessel on the 
fl uoroscopy screen, as calculated from the virtual vessel, and is automatically reorientated 
on the screen as the viewing angle of the x-ray image intensifi er is changed. This white line 
overlay acts as a guide and assists wire placement. This may explain the reduced procedural 
duration, fl uoroscopy time and contrast usage observed in the current study.
In addition to effi  cient and successful procedures, economic and practical advantages, 
magnetic PCI results in a substantial reduction in x-ray exposure to physicians, staff  and 
patients as well as potential reduction in contrast induced nephropathy especially in diabetic 
and hypertensive patients (15,16). This study has limitations associated with cohort studies 
in that procedures were not randomised. Selection bias could have occurred. As shown in 
Table 3, stent diameter tended to be larger and the number of stents and balloons implanted 
per patient were lower for the magnetic PCI group. These fi ndings suggest that relatively 
larger vessels and shorter lesions were treated in the magnetic PCI group that could in part 
explain the shorter procedural and fl uoroscopy duration and cost advantage in the magnetic 
PCI group. Only two out of fi ve operators performed the magnetic PCIs in the current study 
after a short learning curve, which has been described earlier (6). Operator bias could also 
have aff ected outcome. One operator, who performed a large part (±43%) of the conven-
tional PCIs in this study, used signifi cantly more drug eluting stents per patient compared 
to the other operators. This could in part explain the higher usage of drug-eluting stents 
and higher costs in the conventional PCI group. Nevertheless all operators were experienced 
and multivariate analysis showed that the operator was not a predictor for outcome. In this 
respect a randomised trial should be performed. However, a randomised trial may also raise 
objections. It is not possible to blind the performing physician to the type of procedure. All 
operators should use both techniques in order to eliminate diff erences in operator skills and 
speed and the risk of competition between operators with consequences for the quality of 
the procedure. On the other hand bias could occur in favour of magnetic PCI when all opera-
tors perform magnetic as well as conventional PCIs.
Another limitation related to magnetic PCI is that certain aspects of the procedure can 
be time consuming such as obtaining the isocenter position and moving the magnets into 
the correct position or time to reconstruct. However, with familiarity, these manoeuvres 
become quick. In addition the choice of magnetic compared to conventional PCI wires is 
limited especially for fl exible wires. This might complicate diffi  cult procedures such as heavily 
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calcifi ed chronic total occlusions. In addition, manipulation of the Titan guidewire in severely 
angulated lesions could be diffi  cult due to the rigidity of the 2 to 3 mm magnet located at 
the tip of the guidewire.
In conclusion, magnetic PCI is an attractive novel technique, which proved to be safe and 
may result in improved procedural outcome in distal and/or complex lesions. A randomised 
trial is needed for proper comparisons.
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ABSTRACT
Bifurcation lesions can be technically demanding to manage, and even in the era of drug 
eluting stents, their procedural success is variable. The use of the crush technique followed 
by ‘‘kissing’’ balloon postdilatation has been shown to improve the overall outcome. However, 
crossing the crushed stent is essential to allow performance of a fi nal dilatation with ‘‘kiss-
ing’’ balloons and is regarded as the main Achilles’ heel of this technique. In this report, we 
describe the fi rst reported, planned procedure to use a magnetic navigation system to steer 
a wire through the crushed stent to use ‘‘kissing’’ balloons that had previously failed with 
conventional wires.
Magnetic Navigation Successful treatment 
of a Crushed Stent in a bifurcation that failed 
conventionally
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INTRODUCTION
Coronary bifurcation lesions are a challenging and frequent problem encountered in patients 
undergoing percutaneous coronary interventions (1). Their overall longterm success rate is 
variable but has improved since the introduction of drug eluting stents (DES). A number of 
stenting techniques are employed in the management of these lesions and they include T-, 
V-, Y-stenting, the ‘‘culotte’’ and the ‘‘crush’’ technique (2). The latter is a technique that ensures 
complete coverage of the side branch ostium so as to ensure drug delivery to minimize reste-
nosis at this site (3). This involves wiring both the main vessel and side branch. The proximal 
part of the stent that is deployed in the side branch protrudes into the main vessel and is 
crushed with another stent that is deployed in the main vessel (4). Crucial to the success of 
this technique is the use of ‘‘kissing’’ balloons to ensure complete apposition of both DES to 
the vessel wall (5). To do this a wire must cross the crushed stent overlying the ostium of the 
side branch (6). In certain cases this can be diffi  cult and may result in a prolonged procedure 
with possible complications such as contrast nephropathy and increased radiation exposure. 
The magnetic navigation system (MNS) can be utilized to steer a wire through the stents’ 
struts to address this limitation of the ‘‘crush’’ technique (7). The MNS has previously been 
successfully used in chronic total occlusions and in vessels with tortuous anatomy but has 
not so far been reported as an aid to bifurcation stenting (8–10).
We report a planned procedure to use magnetic navigation with an appropriate wire to 
cross a crushed stent where previous attempts with conventional wires had failed in the 
emergency setting. This was followed by ‘‘kissing’’ balloon dilatation and led to procedural 
success in a patient with a bifurcation lesion.
THE MAGNETIC NAVIGATION SYSTEM
The MNS has been shown to be eff ective in neurosurgical and cardiac electrophysiologi-
cal procedures (11,12). In percutaneous coronary intervention it is a platform that off ers a 
powerful tool to aid navigation of a guidewire through complex coronary anatomy (13). The 
Stereotaxis Niobe® MNS has two permanent magnets that can be moved (rotated, translated, 
or tilted) to produce a uniform magnetic fi eld of 0.08 Tesla within the patient’s chest. This fi eld 
is used to precisely direct a tiny magnet mounted on the tip of a guidewire by changing its 
magnetic moment. This allows fi ne control of the orientation of the tip of the guidewire in 
space. The Titan™ Soft Support coronary guidewire used in this case is a 180-cm moderate 
support, hydrophilic coated wire with a diameter of 0.014 in./0.36 mm and has a fl exible 2 cm 
distal coiled tip at the endof which is a gold cup attached to a neodymium-iron-boron 2- or 
3-mm magnet.
A three-dimensional virtual vessel roadmap is created from the angiographic images 
using reconstruction software (CardiOp-B, Paieon Medical, Rosh Ha’ayin, Israel). The system 
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computes a navigation plan from the reconstructed virtual path that supplies all the vectors 
required to navigate through the coronary artery. By touching a point of interest on this 
virtual map that is displayed on a touch screen monitor, the Navigant software calculates the 
best vector and directs the magnetic fi eld to align the wire tip with that direction. This can be 
performed at anytime during the procedure, in vivo, and without the need for a preshaped 
wire tip angle.
CASE REPORT
The patient was a 58-year-old man who presented with an anterior ST elevation MI. His risk 
factors included being a non-insulin-dependent diabetic and being on treatment for hyper-
tension. 
The Primary PCI 
Angiography revealed an occluded LAD that, once open, showed a bifurcation lesion at LAD/
D1. This was managed by placing PT Graphix wires into each vessel. A Taxus Liberte 3.0 x 16 
mm stent in the LAD was used to crush the proximal end of a Taxus Liberte 2.5 x 12 mm stent 
in the diagonal. Both stents were deployed without predilatation of the lesion at 16 atmo-
spheres. To perform the ‘‘kissing’’ balloon technique it was necessary to cross the crushed 
stents’ struts to gain entry into the diagonal. This was unsuccessful despite the various tech-
niques employed, such as an over the wire balloon (OTW), to support the wire or by changing 
the angle of the wire tip manually. When a stiff er wire (PT Graphix Super Support) was used, 
it did not enter the true lumen but went subintimally. This was apparent after dilatation with 
a Maverick 1.5 x 15 mm OTW balloon as it resulted in a dissection at the proximal end of the 
deployed stent in the diagonal (Fig. 1A and B). Consequently, it was even more imperative 
to use ‘‘kissing’’ balloons in this case to fully appose the diagonal stent against the dissected 
vessel so as to improve the overall outcome.
Attempts were made to fi nish the procedure and, having tried to cross the stent struts for 
almost an hour, and in the presence of TIMI 3 fl ow down both the LAD and D1, the operator 
elected to leave the sheath in situ and use magnetic navigation in the morning.
The Magnetic Navigation Assisted PCI
The left coronary artery was cannulated with a Mach 1 CLS 3.5 6F guide catheter. The fi rst 
attempt was with another PT Graphix intermediate wire but this again preferentially chose to 
follow the tract of dissection, outside the stent before re-entering the true lumen. Therefore, 
a three-dimensional virtual vessel roadmap was created from the angiographic images by 
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using reconstruction software (Fig. 2A). A vector was then created that navigated a Titan™ 
Soft Support angled magnetic tip wire between the crushed stents’ struts and avoid the false 
lumen (Fig. 2C). Subsequent use of ‘‘kissing’’ balloons, Maverick 2.5x15 mm in the diagonal 
and Maverick 3.0x15 mm in the LAD at 16 atmospheres (Fig. 3A), resulted in full apposition of 
the diagonal stent (Fig. 3B). The patient tolerated the procedure well and his cardiovascular 
status was stable as monitored via an arterial line. 
Figure 1. (A) The results of crushing the proximal end of the stent in D1 with a stent in the LAD and a 
dissection of D1 (arrowed) created iatrogenically by infl ating a balloon between the D1 stent and the vessel 
wall. (B) An IVUS image of the deployed crushed stent showing the dissection (arrowed).
Figure 2. The 3D reconstruction (A) and the endoluminal view of the LAD/diagonal bifurcation (B). The 
magnetically guided TitanTM Soft Support wire (arrowed) successfully crosses the stent strut into the true 
lumen and the Graphix Intermediate wire preferentially chose the false lumen of the dissection (C). See this 
fi gue in color in the Appendix page 396.
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DISCUSSION
Magnetic navigation is a novel technique that was successfully used to cross a crushed stent 
where traditional methods had failed. The tip of the steerable wire employed can rotate in 
three-dimensions depending on the programmable vector created by the magnetic fi eld. 
This has the advantage that it can be performed within the coronary artery itself and is aided 
by a digitally reconstructed image of the coronary vessel. This technique was crucial to the 
success of this case as it was necessary to fully appose the crushed stent against the dissec-
tion using the ‘‘kissing’’ balloons technique.
CONCLUSION
This is the fi rst report of the use of the MNS to successfully cross a crushed stent in the 
management of a bifurcation lesion. The advantage of this technology is that it produces 
a three-dimensional digitally constructed visual map and can precisely direct a guide wire 
along a chosen path. This can potentially reduce the time of the procedure, the amount of 
contrast needed, and radiation exposure.
ACKNOWLEDGMENTS
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Figure 3. (A) The postdilatation with ‘‘kissing’’ balloons using a Maverick 2.5 x 15 mm in the diagonal and a 
Maverick 3.0 x 15 mm in the LAD at 16 atmospheres. (B) The fi nal angiographic result of the crush.
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INTRODUCTION
Magnetically supported PCI is starting to deliver on its potential to improve and extend on 
several aspects of percutaneous cardiac treatment. In particular, the ability to control tip 
direction more accurately and independently of bends or friction has allowed for increased 
utilization. We present a patient in whom both surgery and previous conventional PCI failed 
to produce a satisfactory long term result. The use of magnetic navigation allowed for suc-
cessful revascularization of an extremely tortuous conduit, restoring blood supply to a large 
territory of myocardium.
The System
The Niobe® II magnetic navigation system (MNS: Stereotaxis, St Louis, Missouri) has two ex-
ternal magnets that produce a 15-cm uniform magnetic fi eld. Through computer-controlled 
magnet movements, the magnetic fi eld can be directed 360o in all planes. When the fi eld is 
changed, the defl ection of the magnet at the wire tip also changes, resulting in reproduc-
ibly precise steering. The system has an adjustable touch screen at the lab table that is the 
interface between the operator and the MNS (Figure 1). The current system has three main 
advantages with regards to tortuosity. First, it produces a 3-D, volume-rendered reconstruc-
Figure 1. System in position for PCI. M indicates magnets in tilt position for better lateral movement of the 
image intensifi er. T indicates touch screen interface to give real-time instruction to the MNS. S indicates in-
lab main screen monitor. See this fi gue in color in the Appendix page 378.
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tion from angiographic images, providing better morphological information about the ar-
tery. Second, the spatial coordinates, or location, of the reconstruction within the patient are 
known. Third, the model gives real-time, online vectors, which direct the external magnetic 
fi eld to navigate the wire through the 3-D reconstruction. As a result, operators have the 
ability to utilize real-time 3-D information in patient therapy.
System costs
The current list price for the Stereotaxis Magnetic Navigation System is $1.9 million. The size 
of a typical modern Stereotaxis cath lab room is 770 square feet (72 square meters). The cost 
of magnetic shielding generally ranges from $50,000–$100,000 and consists of minimal com-
mon steel shielding in the walls, ceiling and fl oor. There is a range of magnetically enabled 
Stereotaxis 0.014” guidewires that are priced at a marginal premium over conventional wires. 
All other PCI equipment is standard and compatible with the Stereotaxis guidewires and 
MNS. No additional consumable items are required. All third-party billing occurs as part of a 
standard PCI intervention; therefore, all current reimbursement applies and there is no eff ect 
on current billing practices.
Case Report
This report describes a 60-year-old man with multiple medical pathologies and a burdened 
cardiac history. Past medical history included severe airways disease (FEV1 of 1 litre), ulcer-
ative colitis with chronic iron defi ciency anemia despite iron therapy, previous GI bleeding, 
gout, hypertension and hypecholesterolaemia, and a family history of ischemic heart disease 
and peripheral vessel disease.
The patient had undergone an aortic valve replacement 8 months prior for signifi cant 
calcifi c aortic stenosis. At that time, he received a jump saphenous vein graft (SVG) that 
anastomosed to the obtuse marginal branch (OM) and then the right posterior descending 
coronary artery (RDP). At the time of the operation, the cardiothoracic surgeon had noted 
that although the RCA had been grafted, it was heavily calcifi ed, of poor quality and not 
suitable for further surgical treatment. The patient had a diffi  cult recovery after the coronary 
artery bypass graft (CABG) operation with persistent hypotension, in part due to episodes 
of arrhythmia such as sinus bradycardia that was externally paced, and also atrial fi brilla-
tion (AF), for which he was later cardioverted. He had some generalized oedema and, once 
extubated, dyspnoea that resolved slowly. 
Unfortunately, 2 months after surgery, the patient again began to suff er with chest pains 
(despite a satisfactory Hb) that could not be fully controlled with medication. Angiography 
showed the proximal end of the graft was occluded but with a patent section of graft be-
tween the OM and the RDP.
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However, this remaining section of the SVG was compromised by severe lesions at both 
anastomoses with an adversely acute angle in the stenosis just before the OM anastomosis 
(Figure 2).
Further surgery was refused and conventional PCI using biplane angiography was at-
tempted, with a view to reopening the RCA or if unsuccessful, intervening on the tortuous 
Cx-OM-SVG-RDP (Cx: circumfl ex artery). The RCA was heavily calcifi ed. Despite the use of stiff  
occlusion wires and a variety of balloons for support, a wire could not be passed and the 
attempt was stopped due to the presence of dissection. An attempt to pass the wire into 
the SVG via the left coronary artery (LCA) was unsuccessful due to tortuosity and despite the 
use of multiple catheters and wires. For the attempts on both vessels, a total of 5 guiding 
catheters and 7 angioplasty guide wires, including Asahi Miracle 3, Asahi Miracle 6 (Abbott 
Vascular Devices, Redwood City, CA) and Crosswire NT (Terumo Medical Corporation, Somer-
set, NJ), were used.
The Magnetic Procedure
Reconstruction. 
A decision was made to attempt a further procedure with the MNS. A 3-D reconstruction 
(Figures 3–4) showed that the sum of all the angles from the LMS to the RCA was over 1180° 
(equivalent to over 3 complete turns of a corkscrew). Currently, an analysis of the reasons 
Figure 2. The top left panel shows the occluded RCA that could not be opened anterogradely. The 
other three panels are diff erent views showing Cx tortuousity and severe lesions at proximal and distal 
anastomoses of the SVG. C indicates the Cx. P indicates the proximal anastomosis. D indicates the distal 
anastomosis.
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for prolonged procedures (with respect to wire passage across a lesion) is ongoing. Both the 
number of bends and the degree of angulation seem to be strongly related to a prolonged 
crossing time. Each bend adds friction to conventional wire rotation and therefore steering, 
and this friction becomes greater as the angulation increases (as the wire is more deformed 
and may also be pushed more forcefully against the vessel wall). Thus the cumulative angula-
tion may be extremely relevant to procedural duration and success. 
Navigation. 
One of the prime benefi ts of the MNS 3-D reconstruction is that it provides an endoluminal 
view with a computed 3-D center line (Figure 5). This view off ers a tailored direction for the 
magnetic fi eld vector at every point in the vessel. There is also a white-line overlay that is a 
Figure 3. Panels showing diff erent fl uoroscopy views with vessel edges marked by edge detection software 
(CardiOp-B, Paieon Medical Inc., Rosh Ha’ayin, Israel) before reconstruction. P indicates proximal point. D 
indicates distal point. See this fi gue in color in the Appendix page 397.
Figure 4. Three-dimensional reconstruction of target pathway. C indicates the tortuous Cx. P indicates the 
proximal anastomosis. D indicates the distal anastomosis. See this fi gue in color in the Appendix page 397.
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roadmap on the fl uoroscopy screen. Tip advancement is shown on the white-line overlay 
in tandem with operator advancement of the wire. The 3-D vector changes simultaneously 
to keep the wire pointing down the chosen path. The Titan™ Soft Support 2 mm angled tip 
wire (Cordis Corp., Miami, FL) was navigated through the tortuous LMS, Cx and OM using the 
vectors as far as the stenosis before the fi rst anastomosis (with the adverse angle). At this 
stage, fi ner navigation was required to reach the SVG. Careful interrogation, by changing the 
angulation using the endoluminal view (the vector can be changed in the endoluminal view 
by double-tapping the screen at any point), and increasing the magnetic fi eld strength to 0.1 
Tesla, managed to get the wire tip to angulate enough to pass into the body of the graft. At 
this point, a 1.5 mm Maverick over-the-wire balloon (Boston Scientifi c Corp., Natick, MA) was 
passed to the graft body and used for support. The wire was then advanced through the graft 
using vector control and then into the RDP. In order to maximize support, the balloon was 
advanced to the RDP and an Iron Man support wire (Abbott Vascular) exchanged. 
Intervention. 
Both anastomoses were predilated. However, on the fi rst attempt to pass a stent, there was 
excess resistance in the Cx that nearly caused wire retraction. The Cx was predilated, and 
both the anastomoses and the Cx were then stented (Figure 6). There was a good result, with 
TIMI 3 fl ow at the conclusion of the procedure (Figure 7).
Figure 5. Screen of Stereotaxis Navigant program during procedure, showing top left panel with endoluminal 
view. The top right panel shows the reconstruction. The bottom 2 panels are static captured fl uoroscopy 
images with the reconstruction for that angle superimposed. See this fi gue in color in the Appendix page 398.
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DISCUSSION
The potential advantages of magnetic navigation are especially relevant to excessively tortu-
ous vessels. It is in these cases where the advantages of magnetic steering are most obvious 
over conventional procedures:
Figure 6. Interventions. The top left panel shows predilation of Cx. The top right panel shows stent placement 
in distal anastomosis. The bottom left panel shows stent deployment at the proximal anastomosis. The 
bottom right panel shows one of the stents being deployed in the Cx. C indicates the Cx. P indicates the 
proximal anastomosis. D indicates the distal anastomosis.
Figure 7. Results of stenting from diff erent views. C indicates the Cx. P indicates the proximal anastomosis. 
D indicates the distal anastomosis.
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1) A conventional procedure has to use the same tip shape throughout. While appropriate for 
some angles, it is not ideal for multiple bends of varying angulation. 
2) Once inside the patient, the tip shape of a conventional wire cannot be changed without 
retrieving the wire and losing position or exchanging through a support catheter.
3) After a conventional wire has been passed distally, there may be resistance when trying to 
rotate the wire tip for manipulation. 
In contrast, the tip of a magnetically-enabled wire can be directed at will in any direction. 
Therefore, the tip shape is variable at will, is adjustable in situ for a particular bend and is 
independent of rotation of the wire (and thus friction from the bends in the vessel). Such 
abilities may be of signifi cant benefi t in challenging cases.
While the system is relatively intuitive and usable after minimal experience, we are fi nding 
that further improvement continues steadily as the range of additional features is explored. 
The experience at our institutions is a little over 350 cases and rising. A variety of randomiza-
tion studies and registries are currently ongoing or under analysis. 
Future Directions
The MNS has other potentially valuable capabilities. For PCI, the integration of other 3-D, 
volume-rendered imaging such as multislice computed tomography (MSCT) (Figure 8), as 
well as the possibility of other useful functions such as magnetically navigable ablation or 
remote control navigation, may be advantageous. In addition, the integration of data such 
as the electromechanical maps from the Carto RMT™ system (Cordis, Figure 9) may enhance 
procedures such as stem cell therapy.
Limitations
Software. While 3-D imaging represents improved appreciation of coronary anatomy 
compared to the 2-D black-and-white x-ray images that have been the standard manner of 
visualizing coronary arteries, the current reconstructions are static. Dynamic road-mapping 
is an area under development.
Figure 8. The left panel shows raw MSCT with the path of occluded RCA marked (purple diamonds). The 
right panel shows the reconstructed vessel from the scan. See this fi gue in color in the Appendix page 398.
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Hardware. The internal guide wire magnets are currently rigid 3 mm wire tips, with a 2 mm 
option. While the rigidity can potentially restrict the movement of the magnet tip in a lesion 
of less than 3 mm diameter, to date, there has been only a mild clinical impact, mainly when 
attempting to enter side branches that may come off  at right angles within a tight lesion. A 
fl exible tip (with several magnets) is under development for enhanced navigation.
Strategies. The range of options within the system translates into a number of possible 
strategies that may develop in an evolutionary fashion. One example of a hybrid strategy 
is the manipulation of an angled wire without a magnetic fi eld, bringing in the magnets as 
necessary. The use of presets and the 2-D clockface allow for relatively speedy use of the 
system, and may better suit procedures in simple lesions or where time plays a role, such 
as primary PCI. Performing a 3-D reconstruction may give a better idea of the anatomy and 
provide more individually tailored pre-calculated vectors for navigation.
Bringing together reconstructions from diagnostic images and using navigation with the 
white-line overlay and minimal contrast may be helpful when it is necessary to reduce con-
trast volume. Additionally, 3-D reconstruction may be especially useful in extremely long and 
tortuous segments.
CONCLUSIONS
MNS has been shown to aid PCI of complex and tortuous vessels. System capabilities, together 
with other current and forthcoming options, indicate that MNS could have a major impact 
on the performance of PCI. In our opinion, the fi ner wire tip control, the extended anatomical 
information, the potential for integration in using other 3-D sources such as MSCT in real 
time, together with forthcoming developments such as fl exible wire-tips, ablative wire-tips 
and navigable injection catheters, may produce a formidable system.
Figure 9. An electromechanical map which can be integrated into the Magnetic Navigation System. See this 
fi gue in color in the Appendix page 398.
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ABSTRACT
The magnetic navigation system allows precision wire-tip control that is guided by computer 
generated 3D models based on fl uoroscopic images. These images can be post-processed 
and the information used to facilitate steering of wires in diffi  cult anatomy. This report il-
lustrates two of these reconstruction software packages in a challenging saphenous vein 
graft case.
3D reconstruction from contrast coronary 
angiography in Magnetic PCI
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INTRODUCTION
Magnetic navigation in Interventional Cardiology makes use of on-table 3D reconstruc-
tion imaging to both enhance the visualization of coronary arteries as well as to supply 
individualized directional information to navigate tortuous vessels. These images can be 
post-processed and integrated to facilitate steering of wires and provide information on the 
course and anatomy of the vessel. The Niobe® II Magnetic Navigation System (MNS; Stereo-
taxis, St Louis, Missouri, USA) and it’s use have been described in detail previously (1-5). Using 
computer-controlled movements of the magnets, a 15-20 cm uniform magnetic fi eld volume 
centred on the heart of the patient can be reliably and reproducibly directed in 360o in all 
planes. This reproducibly defl ects a magnetic wire tip to give precise steering.
The MNS is fully integrated at our center with the Integris Allura FD10 cardiovascular imag-
ing system (Philips Medical Systems, Eindhoven, The Netherlands). Two of the reconstruction 
software packages currently available are the 3DCA software on the stand-alone Interven-
tional Tools workstation (Philips Medical Systems, Eindhoven, The Netherlands), and the 
Cardi-Op BTM software, (Paieon Medical Inc., Rosh Ha’ayin, Israel) that is integrated in the MNS 
Navigant software. Both systems reconstruct from 2 frames at diff erent angles, the Paieon 
system uses 2 separate contrast injections at separate angles (see fi gures 1 and 2) while the 
Philips system uses 2 frames from a rotational acquisition using a single contrast injection 
(see fi gures 1 and 2). The new 3DCA reconstruction software from Philips had recently been 
installed and it was decided to use this as well as make a second, ‘back-up’ 3D reconstruction 
from the diagnostic CD (therefore no extra contrast was used).
This report illustrates these 3D reconstruction techniques in a challenging case.
Figure 1. This shows the RAO view; the left panel shows the angiographic view of SVG-LAD showing the 
tandem lesion at and beyond the anastomosis, the middle panel shows 2 views of the 3DCA reconstruction 
and the right panel shows 2 views of the Cardi-Op BTM reconstruction. See this fi gue in color in the Appendix 
page 379.
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CASE REPORT
A 65 yr old man who had had CABG in 1999, with 4 single venous grafts to the LAD, OM1, 
OM3 and the RCA, presented with a recurrence of his stable angina (Canadian Cardiovascular 
Society grade II) on exertion. He had undergone angiography that showed that in the trajec-
tory of the LIMA-LAD graft, there was a complex lesion with 2 subtotal stenoses, the fi rst 
situated just proximal to the anastomosis and the second just distal to the anastomosis in 
the distal LAD, see fi gures 1-3. The territory of the retrogradely perfused proximal LAD was 
not insignifi cant as it supplied a number of septals and a large diagonal branch. However 
the proximal section of LAD was not severely stenosed, see fi gures 1 and 2. The majority of 
magnetic procedures at our institution are unselected and this was one such procedure. 
Percutaneous Interventional strategy.
The radial approach is standard in our institution with a view to reduction of complications 
and convenience for patient and operator so the right radial technique was used with a Kimny 
catheter and weight-adjusted unfractionated heparin. It was decided to predilate the entire 
lesion, with a wire passed retrogradely into the proximal section of LAD for protection in case 
of mechanical pinching by plaque shift. This strategy was chosen for 2 reasons. First the lesion 
was located at the graft anastomosis that included surgically sutured tissue with a possible 
chance of incomplete balloon expansion. Second, if fl ow was well maintained after predilata-
tion, the wire in the proximal section of the LAD would be removed to avoid trapping the 
magnetically tipped wire at an acute angle and risking the problem of magnetic wire lock (6).
Figure 2. This shows the LAO view; the left panel show the angiographic view, the middle panel shows the 
reconstruction produced by the Philips software, the right panel shows the reconstruction produced by the 
Paieon software. See this fi gue in color in the Appendix page 399.
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Percutaneous Intervention.
3D reconstructions were made, see videos 1 and 2. Using these it proved easy to pass Titan™ 
3mm angled Soft Support wires anterogradely into the distal LAD and a second wire ret-
rogradely into the proximal LAD. Predilation produced a good result with no deterioration 
of the proximal section of the LAD, see fi gure 3, so the second wire was retracted into the 
graft. A 3.0 x 12mm Taxus (Boston Scientifi c) was deployed across the anastomosis, see fi gure 
3. At this point the patient experienced chest discomfort with associated anterolateral ST 
depression. In addition to the injection of nitrates, the wire in the graft was advanced with 
the vector adjusted for the proximal section of the LAD in case a dilation to fenestrate the 
stent was needed. This passed easily, however by this time the symptoms had resolved and 
the ST changes returned to baseline. Contrast injection showed a good result with TIMI 3 fl ow 
throughout the territory, see fi gure 3. There was a total of 200ml of contrast media used, the 
fl uoroscopy time was 17.4 minutes and the total procedure time was 64 minutes. The patient 
had had no further symptoms at 6 months follow-up.
DISCUSSION 
This case report demonstrates the 3D reconstruction of diffi  cult coronary anatomy that was 
used to allow easy vessel cannulation of an extreme angulation that could have proved chal-
lenging for a conventional wire. Conventional wire steering in the coronary tree is achieved 
by rotation of the wire that inexactly points the fi xed-angle tip, a process that is aff ected by 
factors such as the angle of the viewed 2D image, the manual dexterity of the operator, and 
the friction or resistance on the wire shaft. 
Magnetic navigation acts directly on the distal, defl ectable wire tip to give precisely guided 
3D wire-tip direction that is independent of wire rotation and resistance on the wire-shaft. 
This report demonstrates the production of a real-time 3D reconstruction with the patient 
on the table. 
Figure 3. The 2 left panels show the predilatation of anastomosis (wire withdrawn) with and without 
contrast with the LAD retrogradely recannulated, the right 2 panels show the stent deployment and fi nal 
angiographic result showing TIMI 3 fl ow in all territories.
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These 3D models of complex lesions give precalculated directions for navigation that may 
be useful in diffi  cult and angulated anatomy. This technology has been shown to be able to 
succeed in angulations that could not be successfully cannulated with a conventional wire 
(7). As the challenge of complex PCI increases (8), magnetic navigation may facilitate such 
procedures. However, the use of such technology will depend on the ease of use together 
with the speed and accuracy of the reconstruction. 
CONCLUSION
This software allows the production of individualized 3D models during the procedure that 
can be used for patient treatment. These images give better representations of the anatomy 
and also supply the computer-calculated vectors that allow magnetic navigation. Poten-
tially this software, and the improvements in image acquisition and image processing, may 
improve wire passage and cannulation of vessels to result in reductions of complications, 
procedural time, irradiation and contrast media use.
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ABSTRACT
Background: Magnetic guidewire navigation assisted percutaneous coronary interventions 
(MPCI) could have certain advantages in the treatment of coronary bifurcation lesions.
Objective: We aimed to report the angiographic characteristics of the bifurcation lesions, 
as well as the procedural- and clinical outcome of the MPCI-patients treated in our center 
during 2005-2009.
Methods: In the study period, a total of 76 patients were assigned to undergo MPCI for 
bifurcation lesions. The lesion characteristics and the eff ect of the treatment were assessed 
by performing pre- and post-procedural diagnostic angiography and quantitative coronary 
angiography.
Results: Stable coronary artery disease was the most common reason for revascularization 
(75%). Two-thirds of the patients (age 65 years, 78% male) had a bifurcation lesion located in 
LAD/D1. Fifty-seven out of 78 lesions (73%) had a diseased side branch and most bifurcation 
angles were ≥45° (65%). Complex stenting techniques were used in the majority of the lesions 
(64%) and only 13 dedicated bifurcation stents were implanted. All 59/78 (76%) fenestration 
attempts were successfully performed. The average acute gain in minimal luminal diameter 
was 1.08±0.81mm, 0.80±0.70mm and 0.59±0.56mm for the proximal-, distal- and the side 
branch, respectively. The procedural success rate was 85% with a procedure time of 107±43 
minutes, fl uoroscopy time of 34±24 minutes and contrast use of 338±136 ml. At a mean of 
1.8-years follow-up, 15 patients (20%) had a major adverse cardiac event, of which 8 were 
post-procedural myocardial infarctions. 
Conclusion: MPCI is associated with good procedural-, fenestration and clinical success rates 
in the treatment of coronary bifurcation lesions.
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INTRODUCTION
Nearly 20% of all percutaneous coronary interventions (PCI) performed worldwide are be-
cause of coronary artery bifurcation lesions (1). Throughout the years, several single stenting- 
and double stenting strategies have been explored to overcome the worse procedural- and 
clinical success rates of the treatment of bifurcation lesions compared to non-bifurcation 
lesions (2,3). Although some bifurcation treatment strategies such as the “crush” technique 
were developed to ensure scaff olding of the side branch ostium, it proved to be technically 
demanding, in certain cases, to enter the side branch for the desired kissing balloon dilatation 
post-stent implantation (4,5). The complexity of these techniques could result in a longer fl uo-
roscopy time and more contrast use, eventually to the detriment of both patient and operator. 
Additionally, some coronary bifurcation lesions are diffi  cult to reach due to the associated 
angulations. Because of these shortcomings, there has been a lot of interest in developing 
dedicated bifurcation stents and implementing novel systems in daily PCI-practice (6-9). 
Magnetic navigation system assisted percutaneous coronary intervention (MPCI) appeared 
to be not only safe and applicable in chronic total occlusions and tortuous vessels, but also sig-
nifi cantly reduced procedural time, contrast use and fl uoroscopy time in distal and/or complex 
coronary lesions compared to conventional PCI (10-12). Even in the treatment of a coronary bi-
furcation lesion that could not be completed conventionally, MPCI showed to be successful (13). 
Until this date there are no studies reporting the treatment of coronary bifurcations lesions 
with MPCI. The aim of the present study was to describe the angiographic characteristics 
of the coronary bifurcation lesions, as well as to assess the acute procedural and clinical 
outcome of MPCI in the treatment of coronary bifurcation lesions. 
METHODS
Patient population 
From August 2005 until April 2009, a total of 76 patients with coronary bifurcation lesions were 
treated in our center due to stable angina, unstable angina or acute myocardial infarction with 
the magnetic navigation system (MNS) (14). Hemodynamic unstability or any contra-indica-
tion for the MNS, such as having a pacemaker, resulted in a conventional PCI. Every patient 
was pre-treated with aspirin and ≥300mg clopidogrel and all procedures were performed 
according to standard clinical guidelines by MNS trained interventional cardiologists, who 
had unrestricted access to both magnetic tipped and conventional guidewires. The utilized 
stenting technique depended on the strategy of the operating interventional cardiologist. 
Between March 2007 and October 2007 patients were treated exclusively with Everolimus-
eluting stents because of the Xience-Stent Evaluated At Rotterdam Cardiology Hospital (X-
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SEARCH). Outside this timeframe, the implantation of type stent, drug-eluting-/non-eluting 
stent and dedicated-/non-dedicated bifurcation stent, was the choice of the operator. 
The post-PCI antiplatelet regimen consisted of ≥80mg aspirin lifelong and ≥75mg clopido-
grel for one month if bare-metal stents were used and ≥3 months if drug-eluting stents were 
used. During this time period, the policy changed into the usage of clopidogrel for at least 12 
months if drug-eluting stents were used. 
The procedural fl ow sheets were used to collect angiographic and procedural data includ-
ing the materials used, contrast media (ml) and procedure time (min.). 
Defi nitions 
Clinical data were collected with the use of our electronic database. All patients using anti-
diabetic medication were categorized as having diabetes. A blood pressure of ≥140/90mHg 
or the usage of antihypertensive medication was defi ned as hypertension, regardless of the 
prevalence of diabetes. Hypercholesterolemia was defi ned as the usage of lipid lowering 
drugs or a fasting total cholesterol ≥6.2mmol/l. 
Procedural success was defi ned as the successful deployment of the stent and a residual 
stenosis <50% by QCA in the presence of Thrombolysis in Myocardial Infarction (TIMI) 3 fl ow 
grade without the occurrence of events (death, acute stent thrombosis, myocardial infarction 
(MI), emergent coronary artery bypass grafting and stroke) during or within 2 days post-
intervention. Procedural time (min.) was measured by calculating the elapsed time between 
the femoral sheath being inserted and the patient leaving the operating room. The contrast 
media (ml) used during the whole procedure was measured. The fl uoroscopy time (min.) 
during the whole MPCI-procedure was automatically recorded by the digital angiography 
system (AXIOM Artis dCF, Siemens, Forchheim, Germany).
Major adverse cardiac event (MACE) was defi ned as a composite of death, myocardial in-
farction (MI) or a target-vessel revascularization (TVR) during follow-up. MI was diagnosed by 
recurrent symptoms, the development of ST-segment elevation or left bundle branch block 
on electrocardiography with a CK-MB rise of three times the upper limit of normal (>22.5ug/l) 
and positive troponin levels (>0.02ug/l) in the laboratory values. TVR was defi ned as a repeat 
PCI procedure in the same index vessel. 
Magnetic Navigation System and guidewires
The MNS (Niobe® II MNS, Stereotaxis, St Louis, Missouri) is a fully independent operating 
system that cooperates with the C-arm single-planar digital angiography system (AXIOM 
Artis dFC, Siemens, Forchheim, Germany). By using two computer-controlled neodymium-
iron-boron magnets located on either side of the fl uoroscopy table, a 15-20 cm spherical 
magnetic fi eld of 0.08 Tesla is created within the patient. The generated magnetic vector can 
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either be controlled by selecting a certain direction on the touch screen of the Navigant™ 
Work Station (NWS, Stereotaxis, Inc., St. Louis, Missouri), which in turn redirects the external 
magnets in all possible positions (rotation, translation, tilt), or by constantly calculating the 
course of the coronary artery in three real space coordinates using dedicated software and 
accordingly adjusting the tip (CardiOp-B, Paieon Medical Inc., Rosh Ha’ayin, Isreal).
The following magnetic tipped guidewires, which were available in variable sizes and stiff -
ness, were used in the coronary interventions: (1) Titan™ (Stereotaxis, St. Louis, M. USA) and 
(2) Cronus™ (Stereotaxis, St Louis, Missouri, USA). Damaged guidewires could be exchanged 
for a similar or a diff erent magnetic tipped wire. 
Coronary bifurcations
The lesion was classifi ed as a bifurcation lesion if the parent vessel (≥2.5mm) had a signifi cant 
diameter stenosis of >50%, with or without involvement of the origin of the side branch 
(≥2mm) by visual estimate. The coronary bifurcation lesions included lesions in the left 
anterior descending coronary artery (LAD) and a diagonal, the left circumfl ex artery (LCx) 
and an obtuse marginal (OM), the left main stem and the LAD or LCx and the right coronary 
artery (RCA) with the posterior descending artery (PDA) or ramus posterolateralis (RPL). The 
coronary bifurcation lesions were classifi ed according to the Medina numeric classifi cation 
and American College of Cardiology/American Heart Association ACC/AHA classifi cations 
(15,16). The bifurcation lesions were treated with one or two stent techniques such as “provi-
sional”, “culotte”, “crush”, “T-stent” and bifurcation lesion dedicated stents (Stentys™, Tryton™ 
and Nile® Croco).
Quantitative coronary angiography
All coronary angiograms were analysed online by two independent researchers. Pre-
procedural and post-procedural quantitative coronary angiography (QCA) was performed 
by using CAAS 5.5 (PIE medical software, Maastricht, the Netherlands). These measurements 
were performed for reference diameter, minimal luminal diameter and percentage diameter 
stenosis in three diff erent segments of the coronary bifurcation. An independent interven-
tional cardiologist was asked for advice in case of a disagreement. 
Statistical analysis
Continuous and categorical data were expressed as mean and percentages (± standard devia-
tion), respectively. The Mann-Whitney U test was used to compare between two diff erent groups 
consisting of continuous variables. All statistical tests were two-tailed (p<0.05 regarded as 
signifi cant) and performed with SPSS for Windows version 15 (SPSS inc., Chicago, Illinois, USA). 
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RESULTS
Sample characteristics
The baseline characteristics of the MPCI-patients are shown in Table 1. 
Table 1: Baseline characteristics of 76 patients with 78 coronary bifurcation lesions undergoing MPCI.
MPCI (n=76)
Coronary bifurcation lesions (n=78)
Demographic characteristics
 Age, years (SD) 65.4 (9)
 Male, % 77.6 (59/76)
Cardiac history (%)
 Prior MI 36.8 (28/76)
 Prior PCI 31.6 (24/76)
 Prior CABG 11.8 (9/76)
Risk factors (%)
 Current smoking 7.9 (6/76)
 Hypertension 51.3 (39/76)
 Hypercholesterolemia 67.1 (51/76)
 Diabetes 21.1 (16/76)
 Familiy history 51.3 (39/76)
Indication (%)
 Stable angina 75.0 (57/76)
 Unstable angina 23.7 (18/76)
 Acute MI 1.3 (1/76)
AHA Lesion class (%)
 Type A 0.0 (0/78)
 Type B1 37.2 (29/78)
 Type B2 50.0 (39/78)
 Type C 12.8 (10/78)
Treated vessel (%)
 RCA 6.4 (5/78)
 LAD 69.2 (54/78)
 LCX 20.5 (16/78)
 LM 3.8 (3/78)
Medication (%)
 Aspirin 100 (76/76)
 Clopidogrel 100 (76/76)
Data are presented as percentages or means (±SD). AHA=American Heart Association; CABG=Coronary artery bypass graft; MI=Myocardial 
Infarction; PCI=Percutaneous coronary intervention; MPCI=Magnetic guidewire navigation percutaneous coronary intervention; RCA=Right 
coronary artery; LAD=Left anterior descending coronary artery; LCx=Left circumfl ex coronary artery; LM=Left main; SD=Standard deviation. 
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Seventy-six patients had MPCI for the treatment of total 78 coronary artery bifurcation le-
sions. The median follow-up period was 1.8 years (interquartile range, 1.2 to 2.5 years). 
The MPCI-patients were on an average 65 (±SD 9.5) years old and 78% of the population 
consisted of men. Fifty-seven patients (75%) were treated due to stable angina, 18 patients 
(24%) due to unstable angina and 1 patient (1%) was treated due to an acute myocardial 
infarction. 
The majority of the lesions involved the LAD/Diagonal bifurcation (n=54 lesions, 69%), fol-
lowed by the LCx/OM bifurcation (n=16 lesions, 21%), RCA/PDA or RPL (n=5 lesions, 6%) and 
left main stem/LAD or LCx (n=3 lesions, 4%).
Procedural and clinical outcome
The procedural characteristics of the coronary bifurcation lesions are showed in Table 2. 
Table 2: Procedural characteristics of the 78 coronary bifurcation lesions treated by MPCI.
Pre-intervention
 Proximal main branch RD, mm (SD) 2.6 (0.7)
 Distal main branch RD, mm (SD) 2.3 (0.7)
 Side branch RD, mm (SD) 1.9 (0.5)
 Proximal main branch MLD, mm (SD) 1.8 (0.8)
 Distal main branch MLD, mm (SD) 1.6 (0.6)
 Side branch MLD, mm (SD) 1.3 (0.5)
 Proximal main branch DS, % (SD) 29.9 (21.2)
 Distal main branch DS, % (SD) 28.4 (20.3)
 Side branch DS, % (SD) 32.3 (21.5)
Post-intervention
 Proximal main branch RD, mm (SD) 3.2 (0.6)
 Distal main branch RD, mm (SD) 2.7 (0.6)
 Side branch RD, mm (SD) 2.2 (0.5)
 Proximal main branch MLD, mm (SD) 2.9 (0.6)
 Distal main branch MLD, mm (SD) 2.4 (0.5)
 Side branch MLD, mm (SD) 1.9 (0.5)
 Proximal main branch DS, % (SD) 8.9 (10.6)
 Distal main branch DS, % (SD) 11.6 (11.9)
 Side branch DS, % (SD) 17.5 (17.2)
Acute luminal gain 
 Proximal main branch, mm (SD) 1.1 (0.8)
 Distal main branch, mm (SD) 0.8 (0.7)
 Side branch, mm (SD) 0.6 (0.6)
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An average of 1.7±0.5 stents were implanted per patient with a total stented length of 31.8±13.4 
mm. A Medina class of (1,1,1) was present in 30 bifurcation lesions (38.5%), (1,0,1) in 15 lesions 
(19.2%), (1,0,0) in 9 lesions (11.5%), (1,1,0) in 10 lesions (13.0%), (0,0,1) in 6 lesions (7.7%), (0,1,0) in 
2 lesions (2.6%) and (0,1,1) in 6 lesions (7.7%) (Figure 1). This resulted in 64 (82%) diseased proxi-
mal main vessels, 48 (62%) diseased distal main vessels and 57 (73%) diseased side branches. 
The XIENCE™ V Everolimus-eluting stent (Abbott Vascular, Santa Clara, California) was the most 
implanted stent (42%), followed by the Paclitaxel-eluting stent (35%) (TAXUS™, Express2™ or 
Liberté™, Boston Scientifi c, Natick, MA, USA). Dedicated stents were used in 13 lesions (16.7%), 
of which 9 Tryton™ side-branch stents (Tryton Medical, Inc., Newton, MA, USA), 3 Stentys™ stents 
(Stentys SAS, France) and 1 Minvasys Nile™ Croco stent (Minvasys, Genevilliers, France)). Pre-dil-
atation and post-dilatation was performed in 45/78 (58%) and 59/78 (76%) lesions, respectively. 
All 59 fenestration attempts were successfully performed. TIMI 3 fl ow was obtained in all patients 
except one, in which the magnetic wire could not successfully cross the lesion. The guidewire 
was entangled in an aneurysm in the LAD, which was located proximal to the bifurcation lesion. 
This patient was referred for an urgent coronary artery bypass because of a dissection.
Stenting technique  
 Provisional, % (SD) 36.4 (0.5)
 Crush, % (SD) 33.8 (0.5)
 Culotte, % (SD) 22.1 (0.4)
 T-stenting, % (SD) 7.8 (0.3)
Stent characteristics 
 Number of implanted stents (SD) 1.7 (0.5)
 Average stent diameter, mm (SD) 3.0 (0.9)
 Total stented length, mm (SD) 31.8 (13.4)
 Dedicated stents used, % (SD) 16.7 (0.4)
  Tryton™, % (SD) 11.5 (0.3)
  Stentys™, % (SD) 3.9 (0.2)
  Nile Croco™, % (SD) 1.3 (0.1)
 Main vessel stented, % (SD) 89.7 (0.3)
 Side branch stented, % (SD) 76.9 (0.4)
 Other vessel stented, % (SD) 25.6 (0.4)
 Fenestration, % (SD) 75.6 (0.4)
 Final kissing balloon, % (SD) 68.0 (0.5)
 Bifurcation angle <45°, % (SD) 32.0 (0.5)
 Bifurcation angle 45°-90°, % (SD) 53.3 (0.5)
 Bifurcation angle 90°-135°, % (SD) 13.3 (0.3)
 Bifurcation angle 135°-180°, % (SD) 1.3 (0.1)
 Procedure time, min (SD) 108.8 (44.1)
 Fluoroscopy time, min (SD)   34.3 (24.1)
 Contrast use, ml (SD) 340.8 (135.7)
MPCI=Magnetic guidewire navigation percutaneous coronary intervention; RD=Reference diameter; 
MLD=Minimal luminal diameter; DS= Diameter stenosis; SD=Standard deviation; DES=Drug-eluting stents 
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Figure 1: The Medina class of the coronary bifurcation lesions. 
Figure 2: Case example. (A) The LAD showed a signifi cant lesion just proximal to the anastomosis of the 
LIMA graft (bifurcation lesion (0,0,1) with the ramus diagonalis). (B1) The QCA pre-stent implantation 
revealed a diameter stenosis of 64% in the side branch (minimal luminal diameter 0.89mm; reference 
diameter 2.48mm). (B2) Magnetic vectors are used to steer guidewire. (C1) Multislice CT can be utilized 
to create a vessel road map. (C2) Three-dimensional reconstruction. (D1) Guidewire through ostial lesion 
(provisional stenting technique). (D2) The QCA post-stent implantation (Xience V 3x8mm), showed a 9% 
diameter stenosis in the side branch (minimal luminal diameter 2.09mm; reference diameter 2.30mm). 
See this fi gue in color in the Appendix page 399.
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The QCA-analysis showed that the acute luminal gain in the proximal main branch, distal 
main branch and side branch were 1.1±0.8mm, 0.8±0.7mm and 0.6±0.6mm, respectively. 
The median contrast use was 341±136 ml and the procedural- and fl uoroscopy times were 
109±44 minutes and 34±24 minutes, respectively. 
At a median of 1.8-years of follow-up, 15 patients (20%) had a MACE, of which 8 post-
procedural myocardial infarctions within the fi rst 48 hours (Figure 3). These patients had a 
mean CK-MB value of 33±11 ugram/liter and a troponin level of 0.92±0.59 ugram/liter. There 
were 4 target-vessel revascularizations and 3 deaths, of which 1 cardiac death, during the 
follow-up period. None of the 76 patients had a stent thrombosis. The procedural time, fl uo-
roscopy time and contrast use of the MPCI-procedures in which fenestration was performed, 
did not signifi cantly diff er from MPCI-procedures without fenestration (113±43 min. versus 
95±46 min., p=0.25; 34±25 min. versus 34±24 min, p=0.95; 341±141 ml versus 341±121 ml, 
p=0.89, respectively). 
DISCUSSION
This study describes the angiographic characteristics of coronary bifurcation lesions and the 
associated procedural- and clinical outcome after MPCI. The main fi nding of this study is that 
MPCI was shown to be feasible in the treatment of coronary bifurcation lesions with good 
clinical- and procedural success rates. All fenestration attempts were successfully performed 
Figure 3: Cumulative major adverse cardiac events curve of the 76 patients treated with MPCI. 
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and only one patient could not be treated due to wire entanglement in a coronary aneurysm. 
Fenestration was not associated with a longer procedural time, fl uoroscopy time or more 
contrast use than procedures without fenestration. 
The optimal treatment of bifurcation lesions remains a delicate issue in the interventional 
cardiology. Stenting of bifurcation lesions are still associated with increased risk of stent 
thrombosis (acute, subacute and late) and higher MACE rates compared to non-bifurcation 
lesions (17,18). Although the implantation of drug-eluting stents in bifurcation lesions have 
been shown to be more eff ective in reducing restenosis, bifurcation stenting still has mod-
erate results (19-21). We previously described that the implantation of drug-eluting stents 
in 241 de novo bifurcation lesions with the crush-technique (n=231 patients) resulted in a 
MACE-free survival of 83.5% at 9-months follow-up (3). In a more recent study, the crush-
technique could not show superiority to provisional stenting in terms of MACE at 6-months 
(15.8% vs. 15%; p=NS) (22). It is noteworthy that these event rates are already comparable 
to our study, however both studies have a follow-up period of less than one year. The main 
factor that ensures a good short- and long term outcome is the performance of a fi nal kissing 
balloon dilatation regardless of the utilized stenting technique (3,5,23,24). The procedural 
duration, fl uoroscopy time and contrast consumption of primary PCI patients, patients with 
a single discrete stenosis and patients with distal and/or complex lesions treated with MPCI 
were all considerably lower than the fi ndings of our study. An explanation for the less proce-
dure time, fl uoroscopy time and the amount of contrast used compared to our study could 
be due to the fact that 25% of our patient population had another coronary vessel treated in 
the same procedure. Moreover, some patients had multiple bifurcation lesions treated during 
the same catheterization.
We believe that the relatively low MACE rate found in our study could be mainly attributed 
to primarily using drug-eluting stents, the good post-procedural QCA results and the high 
degree of kissing balloon dilatation post-stent implantation.     
The MNS is already successfully being used in cardiac electrophysiological procedures and 
has shown to be feasible in a variety of coronary lesions (6,25-29). The ability of precisely 
steering a guidewire through the coronary arteries and (crushed) stents is an innovative 
approach in the treatment of coronary lesions. The actively three dimensional controllable 
magnetic tipped guidewire can especially be useful in diffi  cult vessel angles or in entering the 
side branch. We already described the value of the MNS in gaining entry to the side branch 
through a crushed stent after unsuccessful conventional PCI (13). The conventional PCI could 
not be completed because it was impossible to cross the stent struts of the crushed stent 
in spite of several diff erent wires and techniques. The patient was treated the next morning 
with MPCI. After three-dimensional vessel reconstruction, the magnetic tipped guidewire 
could easily cross the crushed stent. Even in secondary revascularization procedures of 
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bypass grafts which could not be completed with conventional wires due to the associated 
diffi  cult angles, it has proven its value (29). When used for the treatment of distal complex 
lesions, MPCI have been shown to reduce procedural time, fl uoroscopy time and amount of 
contrast use compared to conventional PCI (29.9±17.6 versus 41.1±21 min, p=0.007; 7.5±7.3 
versus 16.1±22.4 min, p=0.02; 122±82 versus 180±147 ml, p=0.02, respectively (27). 
There remain several shortcomings of the MNS, which limits the widespread use. First of all, 
the time it takes to get familiar with the MNS combined with the preparation time of the 
system makes it doubtful whether such a system is profi table for the treatment of bifurcation 
lesions. Secondly, (crucial) time can be lost in redirecting the external magnet in the desired 
positions, in comparison with the fast eye-hand coordination during conventional PCI. Third, 
novel conventional wires have a more even transition of the tip with the shaft in contrast to 
magnetic tipped wires, which therefore are limited in the fl exibility. Finally, the high initial 
costs for the hardware and software of the MNS make it diffi  cult to determine whether such 
systems are profi table to use for just only specifi c subsets of coronary lesions. 
In conclusion, the MNS showed itself to be feasible in coronary bifurcation lesions. The 
main benefi t of this novel system is the easier crossing of stent struts, resulting in a high 
likelihood of crossing success. Due to the fact that wire crossing through the stent struts 
was successful in the fi rst attempt, the fenestration process did not prolong procedure time, 
fl uoroscopy time or contrast use. However, it remains debatable whether the pros of the 
MNS outweigh the cons in the treatment of bifurcation lesions. Nevertheless, a randomized 
controlled trial is necessary to reach conclusive results on this subject. 
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INTRODUCTION
The rapid restoration of full TIMI 3 fl ow is crucial in primary percutaneous coronary interven-
tion (PCI) (1). However, angiographic success is not always obtained (2-6). Magnetic naviga-
tion might facilitate primary PCI by allowing more accurate manipulation. However, there has 
been concern that the use of this procedure could delay reperfusion.
The magnetic navigation system (MNS: Stereotaxis, St Louis, Missouri, USA) can be used 
immediately by using the preset vector control or freestyle navigation with the 2D clockface 
view, see fi gure 1. The system allows for precise navigation without the need for excessive 
wire rotation. In case of more complex anatomy, a 3D reconstruction can be used (Software: 
CardiOp-B: Paieon Medical Inc., Rosh Ha’ayin, Israel) for individualised navigation (7).
This report describes the feasibility of the MNS to quickly and successfully complete a 
complex primary PCI that involved aspiration thrombectomy and a bifurcation procedure. 
Figure 1. The screen of the Navigant workstation, the panel (P) shows virtual coronary tree of the preset 
navigation with the list of preset vectors (V) seen above.  The panel (C) shows the 2D clock face. See this fi gue 
in color in the Appendix page 395.
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Case report
A 48 year old man presented to the emergency department with an evolving STEMI requir-
ing immediate reperfusion. Angiography showed a proximal occlusion of the left circumfl ex 
(LCx) with an obvious fi lling defect and TIMI 0 distal fl ow, see fi gure 2.A Titan™ 3mm angled 
Soft Support wire was chosen. While the wire and an aspiration catheter were brought and 
prepared, the patient was put in the magnetic isocenter position by visualising the catheter 
tip and cardiac silhouette on X-ray in two orthogonal views. Navigation was performed using 
preset vectors through the left main stem (LMS) and proximal LCx to reach the lesion. The 
lesion was eccentric and more irregular on the superior aspect, see fi gure 2. An inferior vector 
was selected on the 2D clock freestyle navigation to cross this section in order to reduce 
contact and possible dislodgement of material. The crossing time from the tip of the catheter 
was 28 seconds and 2 ml of contrast was given. Contrast injection confi rmed TIMI 1 fl ow and 
an aspiration catheter removed a large portion of the thrombus to produce TIMI 3 fl ow in two 
branches, but with obvious residual stenoses, see fi gure 2.
A 3.0 x 25mm Skylor™ produced a good result in the main branch, but there was pinching 
of the ostium of the side branch, see fi gure 3.
It was decided to fenestrate the stent into the side branch. The passage of a second Titan™ 
3mm angled Soft Support wire into the side branch took eight seconds with no contrast 
used. Kissing balloons produced a good result with TIMI 3 fl ow in both vessels, see fi gure 4.
Figure 2. The left panel shows the occluded OM branch with an eccentric lesion, more irregular on the 
superior aspect, before the occlusion, the right panel shows the restoration of fl ow to two distal branches 
after aspiration thrombectomy.
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Further diagnostic angiography showed a moderate lesion in the LAD and a normal, domi-
nant RCA. The total time for the procedure was 23 minutes. The subsequent clinical course 
was uneventful and the patient was discharged three days after admission.
DISCUSSION
There is strong evidence that swift restoration of fl ow in the obstructed infarct artery after 
the onset of symptoms of a STEMI is key determinant of short – and long term outcome 
(3-7) - therefore, current guidelines advocate rapid evaluation for reperfusion therapy and 
the prompt implementation of a reperfusion therapy at presentation (1). PCI is a very eff ec-
tive method for re-establishing coronary perfusion and is suitable for approximately 90% of 
Figure 3. The left panel shows the result of the stent with pinching of the ostium (arrowed) to the inferior 
branch, the right panel shows the deployment of kissing balloons.
Figure 4. The fi nal result showing TIMI 3 fl ow in both distal branches.
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patients (2-6). In cases with more complex anatomy the magnetic navigation system may 
provide extra benefi ts such as 3D reconstruction (7). 
The magnetic navigation system uses two permanent magnets, mounted on mechanical 
positioners, on either side of the fl uoroscopy table (7). These magnets create an interacting 
magnetic fi eld to produce an approximately spherical 15 cm uniform magnetic fi eld of 0.08 
T. The movement of the magnets allows the direction of the applied magnetic fi eld vector to 
be orientated in 360° on all planes. The result is control of direction of the wire tip, in vivo, 
without the need for a pre-shaped wire tip angle.
The current case demonstrates that the procedure can be performed rapidly during primary 
PCI with the use of 2D controls such as the use of preset vectors or the 2D clock face. However, 
should more complex anatomy be uncovered, then an interactive 3D coronary model can be 
created from two views allowing accurate individualised navigation, see fi gure 5.
Theoretically, the MNS may have two particular benefi ts in primary PCI. First, precise con-
trol of the magnetic tip needs less movement when compared with conventional wires that 
must be rotated to steer. This improves not only the navigation to, but also past an eccentric 
thrombus-laden lesion. Possibly this may help to reduce thrombus dislodgement and subse-
quent distal embolisation (8). Second, the lack of rotation of a second wire reduces the risk of 
wire entwinement that could both impair both steering as well as smooth balloon delivery.
Figure 5. The left panel shows the edges detected on the fl uoroscopy image (two views required), the right 
panel shows the 3-dimensional reconstruction of the infarct related coronary artery. See this fi gue in color 
in the Appendix page 399.
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CONCLUSION
Primary PCI is not only feasible with the MNS but may give procedural advantages. Further-
more, the option of 3D reconstruction is available when complex anatomy is uncovered. This 
case demonstrates the feasibility of the MNS to rapidly perform primary PCI and support 
complex procedures that sometimes occur in this emergent situation.
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ABSTRACT
Aims: Comparison of magnetic guidewire navigation in percutaneous coronary intervention 
(MPCI) vs. conventional percutaneous coronary intervention (CPCI) for the treatment of acute 
myocardial infarction.
Methods and results: We compared 65 sequential patients (mean age 61+15 years) under-
going primary MPCI with those of 405 patients undergoing CPCI (mean age 61+13 years). The 
major endpoint was contrast media use. Technical success and procedural outcomes were 
evaluated. Clinical demographics and angiographic characteristics of the two groups were 
similar, except for fewer patients with previous coronary artery bypass grafting (CABG) and 
hypertension in the CPCI group and fewer patients with diabetes in the MPCI group. The 
technical success rate was high in both the MPCI and CPCI groups (95.4 vs. 98%). There was 
signifi cantly less contrast media usage in the MPCI compared with the CPCI group, median 
reduction of contrast media of 30 ml with an OR = 0.41 (0.21–0.81). Fluoroscopy times were 
signifi cantly reduced for MPCI compared with CPCI, median reduction of 7.2 min with an OR 
= 0.42 (0.20–0.79).
Conclusion: This comparison indicates the feasibility and non-inferiority of magnetic naviga-
tion in performing primary PCI and suggests the possibility of reductions in contrast media 
use and fl uoroscopy time compared with CPCI.
Primary PCI by magnetic navigation 
compared with conventional wire technique
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INTRODUCTION
Magnetic navigation uses two computer-controlled magnets to produce an adjustable mag-
netic fi eld to precisely and actively defl ect a tip-mounted magnet on an angioplasty wire. 
This gives the fundamentally new ability of active control of the angle of approach of the 
‘front-end’ of the wire. The precise steering of a wire has a number of potential advantages 
in percutaneous coronary intervention (PCI). It could enhance wire passage by maintaining a 
coaxial vessel orientation, by steering away from eccentric lesions or thrombus, by enabling 
more accurate sidebranch cannulation, or by reducing problems inherent with conventional 
wires such as wire entanglement in two wire procedures. Percutaneous coronary interven-
tion using magnetic navigation is feasible in a variety of lesion types (1-8) and shows an 
advantage in distal lesions (7). However, although use in primary PCI has been described, 
(8) the potential benefi t remains unknown. It is conceivable that magnetic navigation may 
give an advantage in both the straightforward cases (6) and particularly in complex cases (7). 
Timely reperfusion of patients undergoing primary PCI is a priority (9-13). However, magnetic 
guidewire navigation PCI (MPCI) requires both preparation and familiarity for effi  cient use 
and therefore it remains unclear as to whether the burden of the additional preparation and 
performance of this wire technique is detrimental.
We examined the feasibility of MPCI vs. conventional guidewire navigation PCI (CPCI) 
by comparing patients having MPCI for acute myocardial infarction with historical control 
patients who had undergone CPCI as part of a previous trial in primary PCI, the PASSION trial 
(14,15).
METHODS
Selection of patients and age-matched controls
Between November 2006 and July 2007, 240 consecutive patients underwent primary PCI 
in our centre. From this patient group, 65 sequential patients presenting to MPCI operators 
underwent primary MPCI. The patients who underwent MPCI were all within the age of 18–80 
and had not had thrombolysis. There were no patients with a contraindication to aspirin or 
clopidogrel, cardiogenic shock requiring support, known intracranial disease or life expec-
tancy less than 6 months. Patients who were intubated and ventilated did not have their 
procedure in the magnetic navigation room due to restricted space. There were no specifi c 
contraindications to MPCI in this series, but care was taken to check that there were no previ-
ously implanted ferrous devices. None of the patients in the MPCI group had pacemakers or 
implantable cardiac defi brillators. Other non-primary PCI patients with implanted electronic 
devices have undergone MPCI procedures and should be monitored during the procedure 
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and the devices checked afterwards. The baseline characteristics, angiographic character-
istics, and procedural outcomes of these patients were compared with a historical control 
group, which consisted of the cohort of patients that had been treated by primary CPCI for 
acute myocardial infarction as part of the PASSION trial (14,15). Exclusion criteria for the PAS-
SION group have been previously described (14). Patients were excluded if they had received 
thrombolytic therapy, the infarction was caused by in-stent thrombosis or restenosis, there 
was a contraindication to aspirin, clopidogrel, or both, patients were participating in another 
clinical trial, cardiogenic shock was evident before randomization, the neurological outcome 
after resuscitation was uncertain, they had undergone intubation, ventilation, or both, there 
was known intracranial disease, or the estimated life expectancy was less than 6 months.
In summary, diff erences between the two groups were that MPCI procedures were only 
performed if one of the two trained operators were present or had on-call duty and the 
magnetic room was available. In addition, patients in the PASSION trial were only randomized 
after successful wire passage (and therefore with enough fl ow to assess vessel size) and that 
complex anatomy such as in-stent restenosis or stent thrombosis were contraindicated, while 
the magnetic procedure registry includes all patients who had their procedure in the MPCI 
room and complex anatomy was not excluded.
All patients gave informed consent to the proposed procedure. Thrombectomy was 
performed at the discretion of the operator. Angiography of the other coronary vessels was 
performed routinely in all cases in both groups. 
The magnetic navigation system
The Niobe® II magnetic navigation system (MNS; Stereotaxis, St Louis, MO, USA) has been 
described in detail previously (1-3). The system comprises two external magnets with the 
controls and software for applying and changing the magnetic fi eld (Figure 1). A 15–20 cm 
spherical volume with a uniform magnetic fi eld is produced that is centred on the heart of 
the patient and can be reliably and reproducibly directed in 360o in all planes. A number of 
methods are available to alter the direction of the magnetic fi eld. The 2D clockface is dis-
played in the plane of the fl uoroscopy screen and so 360o can be selected in this plane, and 
two icons at the bottom corners of this window direct the fi eld into (denoted by a circled ‘X’), 
and out of (denoted by a circled ‘.’), the plane of fl uoroscopy giving the operator 3D control 
(Figure 2). Selection by presets uses the average directions of vessel segments taken from 50 
MSCT scans and thus automatically incorporates 3D directions. The use of a 3D reconstruc-
tion from patient images is essentially an individualized set of presets. The selection of a 
direction by the operator leads to movement of the two external magnets to change the 
magnetic fi eld vector in three dimensions that will actively defl ect the magnetic wire tip and 
result in reproducible steering. The operator interfaces with the system via the Navigant™ 
Work Station software. Navigation in MPCI cases was performed using preset and clockface 
Mark bw.indd   320 25-05-10   15:16
321
Primary PCI by magnetic navigation compared with conventional wire technique
navigation for two reasons. First, it was felt to be suitable in terms of practicality and feasibil-
ity in order to reach and cross most/all lesions as it can be used as soon as the magnets 
are in position rather than waiting for the production of a reconstruction that can be time 
consuming. Secondly, the 3D reconstruction can only be made properly with a patent vessel 
so this excluded a signifi cant proportion of cases.
The use of the system requires the patient to be placed at the fl uoroscopic and magnetic 
isocentre. This is performed directly on engagement of the coronary artery by fl uoroscopy 
in a lateral position for the correct vertical table height and then a further angulation such 
as LAO 45o to obtain a suitable horizontal position. Angiographic fi lms can then be taken to 
identify the site and anatomy of the occlusion. The magnets are then brought in. These ma-
noeuvres were routinely performed as the wire, thrombectomy device, indefl ator, and other 
equipment were being unpacked and prepared. The procedural time for MPCI includes all the 
time needed for system preparation such as isocentering and adjusting patient position (see 
Discussion). The angioplasty wires for magnetic procedures were the standard magnetically 
enabled wires supplied by the company. 
Figure 1 The Niobe® Magnetic Navigation System in position for PCI. M indicates magnets in tilt position 
for better lateral movement of the image intensifi er. T indicates touch screen interface to give real-time 
instruction to the MNS. S indicates in-lab main screen monitor, C indicates the controls for magnet 
deployment. See this fi gue in color in the Appendix page 394.
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Magnetically enabled wires 
A series of magnetically enabled disposable guide wires, which are custom designed for use 
with the MNS, are available in a variety of sizes and a range of stiff ness. For this comparison, 
the Titan™ guidewires were used (Figure 3). They are specifi cally designed to be more fl ex-
ible and steerable for magnetic navigation. They are 180 cm moderate support, hydrophilic 
coated wires with a diameter of 0.014 in/0.36 mm having a fl exible 2 cm distal coiled tip at the 
end of which is a gold cup attached to a 2 or 3 mm neodymium-iron-boron magnet. 
Figure 2 The screen of the Navigant™ workstation (2.11 version), the panel (P) shows virtual coronary tree 
of the preset navigation with the list of preset vectors (V) seen above. The panel (C) shows the 2D clockface 
with two icons in the bottom corner that allow direction of the vector into (denoted by circled ‘X’), or out of 
(denoted by circled ‘.’), the plane of fl uoroscopy. See this fi gue in color in the Appendix page 395.
Figure 3 The structure of TitanTM Soft Support magnet wire tip. See this fi gue in color in the Appendix page 400.
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Percutaneous coronary intervention procedure
The inner diameter of all 6 F guides was 0.70 in. The choice of guiding catheter and equip-
ment was left entirely to the discretion of the operator and followed routine practice as did 
the use of drug-eluting stents, bare metal stents, and the use of glycoprotein IIb/IIIa receptor 
antagonists. There were no restrictions on the operators’ choice of conventional wire or rou-
tine practice. Routine procedure in our institution is to take at least two orthogonal planes 
after the intracoronary administration of 100–200 mg of nitroglycerine and to repeat these 
at the end of the procedure. There were no additional views in the PASSION trial patients 
that were only for study purposes. Thrombectomy was performed at the discretion of the 
operator. Angiography of the other coronary vessels was performed routinely in all cases in 
both groups.
The interventional staff  includes fi ve senior operators; CPCI procedures were performed 
by all fi ve operators, whereas MPCI procedures were performed by two of the fi ve operators. 
Aspirin, 500 mg i.v. and clopidogrel, 600 mg p.o. were given to all patients. Unfractionated 
heparin, 10 000 IU/kg, was given as an intravenous bolus at the beginning of the procedure. 
Routine access was via the radial approach.
Angiographic variables
All angiograms were stored in a computer database and analysed off -line by an independent 
observer, using CAAS 2003 Camtronics (Philips Medical Systems, Eindhoven, The Netherlands).
Defi nition of endpoints
The major endpoint was the amount of contrast media used to complete the procedure. 
Secondary endpoints were fl uoroscopy time, total procedural time, number of wires, number 
of balloons and stents, and major adverse cardiac events. The aim was to evaluate procedural 
outcome in both groups in terms of contrast media use, technical success, procedural and 
fl uoroscopy duration, and material consumption. Technical success was defi ned as an intra-
luminal wire position distal to the stenoses. Procedural success was defi ned as (i) TIMI Grade 
III fl ow (16), (ii) 30% residual stenosis, and (iii) absence of clinical events during the admission 
(death, acute stent thrombosis, re-infarction before discharge, emergency coronary artery 
bypass grafting, and stroke). Procedural duration was measured from the time of sheath in-
sertion until the removal of the guiding catheter at the end of the procedure (and included all 
the time needed for system preparation such as isocentring and adjusting patient position, 
see Discussion). Fluoroscopy times were automatically recorded by the Poly Diagnost (C2) 
Digital Cardiac Imaging System (Philips). Additional endpoints were the length and diameter 
of stents per patient. Distal embolization was specifi cally noted in the MPCI patients. 
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Statistical analysis
For comparison of continuous variables between the two groups, the unpaired two-tailed 
Student’s t-test was used or, for skewed data, such as contrast media, the Wilcoxon’s rank 
sum test, and these were expressed as the median and inter-quartile range. Comparison of 
categorical variables between the two groups was performed using the Chi-squared test, 
or in cases of a minimum expected count less than 5, the Fisher exact test, and these were 
expressed as the number and/or percentage.
A two-sided P-value less than 0.05 was considered statistically signifi cant. Statistical tests 
were carried out with the SPSS 14.0 statistical software package (Chicago, IL, USA). All con-
tinuous endpoints were dichotomized according to the worst tertile vs. the other two tertiles. 
As the number of MPCI patients was restricted, a propensity score was used and included in 
a logistic model to adjust MPCI vs. CPCI for contrast media consumption, fl uoroscopy, etc.
RESULTS
Baseline demographics
Primary MPCI in 65 consecutive patients was compared with primary CPCI of 405 historical 
control patients. Baseline clinical characteristics were similar in both groups, although there 
were fewer patients with previous coronary artery bypass grafting (CABG) and hypertension 
in the CPCI group compared with the MPCI group. 
Table 1. Clinical characteristics.
Characteristics  Magnetic PCI
(N=65)
Conventional PCI
(N=405)
P Value
Age-yr 61±15 61±13 0.97
Male sex 75.4 75.3 1.00
Diabetes mellitus 4.6 13.3 0.22
Hypertension 40.2 32.3 0.05
Hypercholesterolemia 15.4 25.7 0.07
Family history of CAD 46.2 35.8 0.11
History of smoking cigarettes 44.6 51.4 0.31
Previous PCI 7.7 3.7 0.14
Previous CABG 4.6 0.9 0.03
Previous myocardial infarction 4.6 7.4 0.41
Presented as percentages (within parentheses) or in other cases means ±SD. N= number. 
There were fewer patents with diabetes in the MPCI group. Baseline angiographic variables 
showed that the reference vessel diameter in the MPCI group was marginally, but statistically, 
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smaller than the CPCI group and that there was a statistically signifi cant predominance of 
ACC/AHA type C lesions in the MPCI group.
Table 2. Angiographic characteristics.
Variable Magnetic PCI
(N=65)
Conventional PCI
(N=405)
P value
Vessel disease % 0.23
 1VD 47.7 55.1
 2VD 38.5 28.0
 3VD 13.8 16.9
Target lesion mm (SD)
 Reference diameter 2.88±0.51 3.13±0.48 <0.001
 MLD 0.12±0.35 0.18±0.39 0.21
 DS 95.6±13.19 92.5±16.4 0.16
TIMI fl ow %
 0 70.8 64.4
 1 4.6 8.1
 2 15.4 14.1
 3 7.7 13.3
ACC/AHA lesion class <0.001
 A 0.0 2.8
 B1 3.1 23.0
 B2 7.7 10.6
 C 89.2 67.2
Presented are the percentages of patients or in other cases means ±SD. N= number.
Lesions had a similar distribution in the three coronary arteries 
Table 3. Target vessel location.
Target vessel Magnetic PCI
N (%)
Conventional PCI
(N=405)
RCA 20 (30.7) 169 (41.7)
 RCA1 3 (4.6) 73 (18)
 RCA2 13 (20) 56 (13.8)
 RCA3 3 (4.6) 35 (8.6)
 RCA4 0 (0) 2 (0.5)
 RCA16 1 (1.5) 3 (0.7)
LCA 32 (49.2) 209 (51.6)
 LMS 0 (0) 9 (2.2)
 LAD
  LAD6 26 (40) 116 (28.6)
  LAD7 5 (7.7) 75 (18.5)
  LAD8 0 (0) 6 (1.5)
  LAD9 1 (1.5) 3 (0.7)
  LAD10 0 (0) 0 (0)
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Cx 11 (16.9) 23 (5.6)
 Cx11 6 (9.2) 11 (2.7)
 OM12b 5 (7.7) 13 (3.2)
 Cx13 0 (0) 3 (0.7)
 Cx14 0 (0) 6 (1.5)
 Cx15 0 (0) 0 (0)
SVG 2 (3.1) 3 (0.7)
Presented are the absolute numbers of lesions with percentages (within parentheses).
Overall technical and procedural success was high (95.4% MPCI vs. 98.0% CPCI) in both 
groups. 
Table 4. Procedural outcome.
Variable Magnetic PCI
(N=65)
Conventional PCI
(N=405)
P value
Procedural success % 95.4 98.0 0.19
No. of wires per patient 1,48±0.85 1,3±0.60 0.04
No. of balloons used per patient 0.71±1.04 0.51±0.73 0.059
No. of stents implanted per patient 1.42±0.90 1.32±0.63 0.30
Procedural duration-min 29 (19-36) 31 (23-41) 0.20
Fluoroscopy time-min 7.4 (3.58) 9 (6-31) <0.05
Contrast consumption (Mean)-ml 170 (100-200) 200 (150-250) 0.001
Sidebranch involvement
 Sidebranch present 40.0 11.6 <0.0001
 Sidebranch protected 12.3 4.2 0.6
 Sidebranch deteriorated 18.5 5.7 <0.0001
 Sidebranch treated 13.8 3.7 0.1
Complex lesions
 SVG 3.1 0.7 0.02
 In-stent thrombosis 6.2 0 0.01
 Calcifi cation 10.7 11.1 0.9
 Tortuosity 12.3 8.2 0.01
Presented are the means ±SD or otherwise percentages. N= number.
There was signifi cantly less contrast media use in the MPCI compared with the CPCI group 
[170 mL (100–200) vs. 200 mL (150–250); P < 0.001]. Procedural times were not signifi cantly 
diff erent for MPCI compared with CPCI [29 min (18–35) vs. 31 min (23–41), P = 0.20], whereas 
the reduction of fl uoroscopy times reached statistical signifi cance [7.4 min (3.58–11) vs. 9 min 
(6–13.1), P < 0.05].
Multivariate analysis showed that there was signifi cantly less contrast media use in the MPCI 
compared with the CPCI group, OR = 0.41 (0.21–0.81) (Table 5). Fluoroscopy times were 
signifi cantly reduced for MPCI compared with CPCI, OR = 0.42 (0.20–0.79).
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Table 5. Results of logistic regression.
End point OR 95%CI
Contrast consumption
 MPCI vs CPCI 0.35 0.16-0.75
Fluoroscopy time-min
 MPCI vs CPCI 0.36 0.17-0.77
Procedural duration-min
 MPCI vs CPCI 0.35 0.16-0.76
No. of balloons used per patient
 MPCI vs CPCI 0.66 0.33-1.31
No. of wires per patient
 MPCI vs CPCI 1.57 0.78-3.18
Distal embolization was seen in 7.7% (5/65) of patients in the MPCI, unfortunately that data 
was not available from the PASSION trial, but this fi gure is below the 15.2% incidence quoted 
in the literature (17).
DISCUSSION
This comparison of magnetic navigation with conventional wire technique in patients 
undergoing primary PCI suggests that MPCI procedures can be performed as eff ectively, as 
defi ned by contrast media use, procedural time, fl uoroscopy time, and success rate, as CPCI. 
Indeed, the results show equivalent procedural performance with signifi cant reductions in 
the contrast media use and fl uoroscopy time. Previously published data from this registry 
showed that magnetic navigation in simple lesions signifi cantly benefi ted only one of these 
three parameters (with a small reduction in median contrast media use and non-signifi cant 
trends in fl uoroscopy and procedural times in simple lesions) (6), whereas all three were 
signifi cantly improved in complex lesions (7). In this comparison, two of the three parameters 
were signifi cantly improved and one was not signifi cantly improved, suggesting an interme-
diate position for this subgroup However, these comparisons are hypothesis-generating and 
there may be other confounding factors, thus to reach a defi nitive conclusion, randomized 
studies are required.
The rapid restoration of full TIMI 3 fl ow is crucial in primary PCI (9) with strong evidence 
that swift restoration of fl ow in the obstructed infarct artery is a key determinant of short- 
and longterm outcome (10-14). However, reported rates of achieving TIMI 3 fl ow, range from 
only 70 to 90% (10-14) and this leaves a proportion of procedures where improvement is 
possible. Potentially this lack of success could be due to the more complex anatomy where 
the MNS would help.
This new technique gives the operator new and defi nable capabilities. Active tip adjust-
ment can change the angle of approach of the tip as required, in order to maintain the tip 
coaxially through normal vessel, or in order to steer around bends or into sidebranches. 
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Three dimensional directability is obtained by using the clockface (automatically displayed 
in the plane of the 2D image), by using presets (average directions of vessel segments), or, 
in cases with more complex anatomy, by using a 3D reconstruction from patient images. 
Furthermore, primary PCI using the MNS could conceivably give benefi ts such as minimizing 
wire-tip rotation thus reducing wire entwinement, or allowing circumnavigation around fri-
able thrombotic lesions, a known predictor of distal embolization and no-refl ow phenomena 
(18). In this comparison, embolization was recorded only in the MPCI group (and not in the 
PASSION group), but the rate seen was lower than reported in the literature (19). In this 
comparison, an increased use of wires was seen. The cases where multiple wires were used 
have been reviewed and a number of reasons appear to be related to this. First, there were 
more bifurcational lesions in the MPCI group and a greater tendency to choose a second wire 
(Table 4). Second, there was a more complex case mix in the MPCI group that included, for 
example, in stent thrombosis. In two of the fi ve in-stent thrombosis cases, multiple wires were 
used. Third, the stainless steel core of the Titan wire has a poorer memory (or the tendency to 
return to its previous shape), than conventional wires and a replacement was needed in three 
bifurcation lesions. Fourth, the use of conventional wires was not prohibited. This occurred in 
two cases. In one case, a Filterwire Ex wire (Boston Scientifi c, Natick, MA, USA) was deployed 
in one saphenous vein graft (SVG) case after the magnetic wire had been successfully passed 
and the restored fl ow showed a lesion in which distal protection was felt to be necessary. In a 
second case, the magnetic wire failed to enter a sidebranch so a conventional wire was tried 
but also failed to cross. However, fl ow improved and the result was accepted. 
With regard to the performance of the rigid magnetic wire tip, no traumatic problems were 
seen with forward passage as the shaft behind the magnetic tip buckles similar to a conven-
tional wire. However, in principle this rigidity could be an issue in sharply angulated turns 
that are narrow and constrained, and it is known that MPCI requires extra attention in order 
to avoid such problems as magnetic wire lock (19). This comparison included procedures 
performed from approximately 3 months after system acquisition (as a previous publication 
(5) suggested a learning curve) and was performed with the normal emergency team (that 
is two nursing staff  in addition to the attending physician). The data in this comparison sup-
port the premise that, when the procedure is performed by experienced staff , there is no 
additional time delay but rather could lead to an advantage.
In this study, even at this early stage in its development, the use of MPCI appears as safe, 
feasible, and successful as CPCI.
Study limitations
This comparison has the limitations associated with comparing a registry with historical 
controls and the lack of randomization. There were diff erences in the performance of the 
procedures. Only two of fi ve CPCI operators performed MPCI and, although all fi ve opera-
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tors are experienced operators, and there was proportionately more experience in the CPCI 
group, operator bias cannot be excluded. The patients and the performing physicians were 
not blinded to the type of procedure. The inclusion of the two groups was slightly diff erent 
as inclusion in the magnetic procedure group depended on the presence of an operator and 
the availability of the magnetic room, whereas the PASSION study patients were performed 
by all operators. The target lesion characteristics were also slightly diff erent. The PASSION 
study included those patients in whom the wire had successfully crossed the lesion and may 
have led to exclusion of more complex anatomy such as SVGs, stent thrombosis, or in-stent 
restenosis, whereas the MPCI group included all patients irrespective of stent thrombosis 
(fi ve patients) or the presence of SVGs. In addition, MPCI was generally performed in smaller 
vessels (reference diameter 2.8 vs. 3.1 mm, P < 0.0001), the occurrence of hypertension was 
higher (40.2 vs. 32.3%, P = 0.05) and the occurrence of previous CABG was higher (4.6 vs. 
0.9%, P = 0.03) compared with CPCI. However, these data suggest that more favourable 
patients were in the CPCI group, and had there been an equal distribution of these variables 
the results might have been further in favour of MPCI.
CONCLUSION
Primary PCI using the MNS appears feasible and does not negatively infl uence use of con-
trast media or irradiation. This is coupled with potential advantages such as reduction of 
wire entwinement. In addition, the option of 3D reconstruction remains available if complex 
anatomy is uncovered. This comparison suggests the feasibility and non-inferiority of the 
MNS in performing primary PCI and could aid the complex procedures sometimes needed 
in this emergent situation. Randomized controlled trials are warranted in order to further 
investigate the use of MPCI in this population.
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ABSTRACT 
Background: Magnetic navigation is a novel technology that actively steers an angioplasty 
wire-tip and may improve PCI procedures. There are no large multicenter reports of long term 
MACE and survival. The systems in the Netherlands represent some of the most intensively 
used systems for percutaneous coronary intervention and this report describes the results of 
nearly 1500 patients to 3 years.
Methods and Results: We compared 1441 sequential patients (mean age 65±11yr) undergo-
ing magnetically navigated percutaneous coronary intervention (MPCI) with those of 1441 
patients (mean age 64±12yr) undergoing conventional percutaneous coronary intervention 
(CPCI) who were matched by the propensity score. The major endpoint was mortality at an 
average of 2 years with secondary endpoints of MACE, procedural duration and fl uoroscopy 
time, and contrast media use. Technical success and procedural outcomes were evaluated. 
Clinical demographics and angiographic characteristics of the two groups were similar, 
except for fewer patients with hypercholesterolaemia in the CPCI group and fewer patients 
with previous myocardial infarction in the MPCI group. 
Overall technical and procedural success was high (95.4% MPCI versus 98.0% CPCI) in both 
groups. There was signifi cantly less contrast media use in the MPCI compared to the CPCI 
group (130.5ml ± 89.9 versus 288.7ml ± 148.3; P<0.0001). Fluoroscopy times were not signifi -
cantly diff erent for MPCI compared to CPCI while the reduction of procedural times reached 
statistical signifi cance (34.15min ± 22.5 versus 84.3min ± 46.3; p<0.0001). 
Cumulative mortality was better in the magnetic navigation group at 1, 2 and 3 years com-
pared to the conventional PCI.
Logistic regression showed that there were a number of factors infl uencing outcome with 
older patients multi-vessel disease (1.44 [1.15-1.81]) and had a greater incidence of diabetes 
(1.41 [1.10-1.81]) benefi ting the most.
Conclusion: This comparison, that is the largest series reported to date, suggests a reduction 
in mortality and MACE at 3 years.
Dutch Magnetic PCI experience
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Abbreviations and acronyms 
PCI - percutaneous coronary intervention 
MPCI - magnetic guidewire navigation PCI 
CPCI - conventional guidewire navigation PCI 
MNS - magnetic navigation system 
ACC - American College of Cardiology 
AHA - American Heart Association 
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INTRODUCTION
Magnetic navigation gives the operator new capabilities for approaching percutaneous 
coronary intervention (PCI) such as precise tip adjustability, computer-enhanced, image-
guided tip orientation and computer-enhanced image processing.(1,2) The Stereotaxis 
magnetic navigation system has been shown to be feasible in general populations for PCI. (3-
8) Subgroup analysis of registry data has suggested that benefi t increases with increasingly 
complex anatomy (6-8). The use of the system suggests that increasingly complex lesions 
benefi t proportionately more. In addition, case reports describe the successful completion of 
procedures that have failed conventionally (9,10).
The systems in the Netherlands are some of the most intensively used systems for percuta-
neous coronary intervention world-wide in centres with an interest in innovation. This article 
describes the experience of the systems in the Netherlands and the series represents the 
largest with the longest follow-up to date.
METHODS 
Patients 
A total of 1523 patients underwent magnetically navigated percutaneous coronary interven-
tion (MPCI) in the 2 centres with one centre performing 489 procedures from June 2005 to 
April 2009 and the other performing 952 procedures between September 2006 and May 2009. 
All patients were included irrespective of their clinical presentation and lesion characteristics. 
These patients were matched by propensity score with 3855 concurrent patients from 2 
consecutive registries. Control patients were selected from the T-SEARCH and X-SEARCH reg-
istries. The methods and design of T-SEARCH (11) and the X-SEARCH (12) have been described 
previously. Control patients for matching in this analysis were eligible if their procedure had 
been performed in the same time period as the magnetic procedures (from June 1, 2005 until 
Feb 28, 2007 patients were taken from the T-SEARCH registry and from March 2007 until April 
30, 2009 patients were taken from the X-SEARCH registry). 
The magnetic navigation system
The Niobe® II magnetic navigation system (MNS; Stereotaxis, St Louis, Missouri, USA) has 
been described in detail previously (1-10). The cost of the system is $1.9 million. The size of 
a typical modern Stereotaxis cath lab room is 770 square feet (72 square meters). The cost of 
magnetic shielding generally ranges from $50,000–$100,000 and consists of minimal com-
mon steel shielding in the walls, ceiling and fl oor. The cost may be a reason why the system 
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has relatively limited market penetration and the institutions that use it have had a pioneer 
role. Training of operators and nurses/technicians is needed before effi  cient use, a learning 
curve of approximately 150 procedures has been suggested (4). In one center the MNS is 
fully integrated with the Integris Allura FD10 cardiovascular imaging system (Philips Medical 
Systems, Eindhoven, The Netherlands) while at the other center the MNS is fully integrated 
with the C-arm digital angiography system (AXIOM Artis dFC;Siemens, Forchheim, Germany). 
The operator interfaces with the system using a touchscreen to the Navigant™ Work Station 
software (NWS, Stereotaxis, Inc., St. Louis, MO). 
A 15-20 cm spherical uniform magnetic fi eld volume is produced that is centered on the 
heart of the patient and can be reliably and reproducibly directed in 360o in all planes. Select-
ing a 3D direction on the computer screen, leads to movement of the 2 external magnets to 
give a precisely directed magnetic fi eld vector that will actively defl ect the magnetic wire tip 
resulting in reproducibly precise steering.
Magnetically Enabled Wires 
A series of magnetically enabled disposable guide wires, that are custom designed for use 
with the MNS, are available in a variety of sizes and a range of stiff ness. In this comparison, 
all three generations of magnetic guidewires, Cronus™, Titan™ and Pegasus™ guidewires 
were used, see fi gure 1. These are specifi cally designed to be more fl exible and steerable 
for magnetic navigation. These are 180cm moderate support, hydrophilic coated wires with 
a diameter of 0.014 in / 0.36 mm having a fl exible 2 cm distal coiled tip with a 2 or 3mm 
neodymium-iron-boron magnet attached at the end.
PCI procedure 
All patients gave informed consent to the proposed procedure. The choice of guiding cath-
eter and equipment was left entirely to the discretion of the operator and followed routine 
practice as did the use of drug-eluting stents, bare metal stents and the use of glycoprotein 
IIb/IIIa receptor antagonists. There were no restrictions on the operators’ choice of conven-
tional wire. The angioplasty wires for magnetic procedures were the standard magnetically 
enabled wires supplied by the company, see previous paragraph.
Standard procedural medication was aspirin, 500 mg i.v. and clopidogrel, 600mg p.o. for 
all patients. Weight adjusted unfractionated heparin, 100 IU/ kg, was given as an intravenous 
bolus at the beginning of the procedure. The standard approaches were those routinely used, 
the radial artery or the femoral artery, at each respective center. 
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Angiographic variables 
All angiograms were stored in a computer database and analyzed off -line by an independent 
observer, using CAAS 2003 Camtronics (Phillips Medical Systems). Lesion types were graded 
according to the ACC/AHA lesion classifi cation (13). 
Follow-up
At the time of the follow-up, June 1 2009, vital status was obtained retrospectively by review 
of the hospital records and checked against the civil registries. A postal questionnaire was 
sent to patients. A distinction was made between cardiac death (sudden death within 1 h of 
complaints, fatal acute myocardial infarction, congestive heart failure) and non-cardiac death 
(all other causes). Follow-up was complete in over 90% of patients at 2 years and median 
follow-up was 1.9 years. 
Figure 1. The three generations of magnetic guidewires used in the procedures, the Cronus™, the Titan™ 
and the Pegasus™ wires. See this fi gue in color in the Appendix page 375.
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Statistical analysis 
Methods for Propensity Scoring Matching 
In order to correct for diff erences in baseline characteristics between the treatment groups, the 
propensity score methodology was used to identify comparable patients treated with diff erent 
strategies. The propensity score was initially proposed by Rosenbaum and Rubin and has been 
used in prior observational studies to help adjust for treatment selection bias (14–16) .
A propensity score for each patient was constructed, providing an estimate of the pro-
pensity for belonging to one treatment group rather than the other by performing multiple 
logistic regression with the endpoint the type of intervention (CPCI coded as 0, MPCI as 1). 
All factors that might be predictive of receiving either intervention were evaluated. These 
included age, sex, prior myocardial infarction, prior angioplasty, unstable versus stable 
angina, diabetes, dyslipidemia, hypertension, and ejection fraction (normal, moderate or 
poor). The patient characteristics before the matching according to 1523 MPCI patients and 
conventional patients from the T-SEARCH and X-SEARCH registries are shown in Table 1. 
Table 1. Baseline Characteristics before matching. For age means ±SD are given, and in all other cases 
percentages of patients. CAD denotes coronary artery disease. 
Characteristics  Magnetic PCI
(N= 1523)
Conventional PCI
(N= 3855)
Age-yr 64.6±11.4 63,5±11.8
Male sex 73.7 72.8
Diabetes mellitus 19.6 21.0
Hypertension 43.2 46.3
Hypercholesterolemia 40.7 55.6
Family history of CAD 41.0 39.9
History of smoking cigarettes 20.9 29.0
Previous PCI 32.9 25.0
Previous CABG 11.0 8.1
Previous myocardial infarction 25.4 28.1
Presented as percentages (within parentheses) or in other cases means ±SD. N= number.
The two study populations were far from similar. To obtain improved insight in the diff er-
ences, patients were divided into four quartiles according to their propensity score. 
Second, each MPCI patient was matched with 1 CPCI patient with the same or nearest 
propensity score. As a result, the matched CPCI population resembled the MPCI cohort after 
the matching, see Table 2. 
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Table 2. Baseline Characteristics after matching. For age means ±SD are given, and in all other cases 
percentages of patients. CAD denotes coronary artery disease. 
Characteristics  Magnetic PCI
(N= 1441)
Conventional PCI
(N= 1441)
Age-yr 63.8±11.4 63.8±11.4
Male sex 73.7 73.4
Diabetes mellitus 19.6 20.5
Hypertension 43.2 46.0
Hypercholesterolemia 40.7 54.8
Family history of CAD 41.0 43.9
History of smoking cigarettes 20.9 20.3
Previous PCI 32.9 32.9
Previous CABG 11.0 10.1
Previous myocardial infarction 25.4 30.8
Presented as percentages (within parentheses) or in other cases means ±SD. N= number.
For comparison of continuous variables between the two groups, the unpaired two-tailed 
Student`s t-test was used or, for the skewed data (as for median of the contrast use), the 
Mann-Whitney U-test. Comparison of categorical variables between the 2 groups was 
performed using the Chi-square test, or in case of a minimum expected count less than 5, 
the Fisher exact test. Continuous variables were expressed as mean ± SD for non-skewed 
data, medians were expressed as 95% CI for skewed data. Categorical data were expressed 
as numbers of patients and percentage of patients. A P value less than 0.05 was considered 
statistically signifi cant. Statistical tests were carried out with the SPSS 14.0 statistical software 
package (Chicago, IL). 
Cumulative survival curves were constructed using the Kaplan–Meier method. Among pa-
tient subgroups the log-rank test was used to compare survival curves. A logistic multivariable 
regression, stratifi ed by the procedure type CPCI or MPCI, was used to adjust for the baseline 
diff erences to determine the impact on in-hospital mortality and hospital complications. 
Odds ratios and 95% confi dence intervals were calculated to test for signifi cant diff erences.
RESULTS 
1441 patients who had undergone MPCI were successfully matched. 1412 (98.0%) were fol-
lowed up by interrogating the civil registry, and by postal questionnaire. The median follow-
up was 1.9 years with a low overall mortality was 3,5%.
Propensity matched demographics
The mean age was 64 years, and approximately 73% of patients were men in both groups. 
After matching, the baseline characteristics were similar in both groups although there were 
Mark bw.indd   340 25-05-10   15:16
341
Dutch Magnetic PCI experience
fewer patients with hypercholesterolemia (40.4% MPCI versus 53.6% CPCI; P = <0.001) and 
more patients with previous MI in the CPCI group compared with the MPCI group (25.0% 
MPCI versus 29.5% CPCI; P = 0.006), see Table 2. There were equal numbers of patients with 
diabetes (19.4% MPCI versus 21.3% CPCI; P = NS), a family history of coronary artery disease, a 
history of smoking within 1 year and previous percutaneous intervention (32.5% MPCI versus 
31.3% CPCI; P = NS) and CABG (10.8% MPCI versus 10.6% CPCI; P = NS) in both groups. Lesions 
had a similar distribution in the 3 coronary arteries, see Table 4.
Table 3. Angiographic characteristics. Presented are the percentages of patients with percentages (within 
parentheses) or in other cases means ±SD.
Variable Magnetic PCI
(N= 1441)
Conventional PCI
(N= 1441)
Vessel disease %
 1VD 55.0 54.5
 2VD 30.5 27.6
 3VD 14.4 17.9
0 224(18.1%) 224(18.1%)
1 45(3.6%) 45(3.6%)
2 65(5.2%) 65(5.2%)
3 905(73.0%) 905(73.0%)
ACC/AHA lesion class
A 6.6% 9.9
B1 24.7% 33.0
B2 18.3% 28.5
C 50.3% 28.5
Stable angina 65.3 69.4
Unstable angina 25.8 23.4
Acute MI 8.9 7.2
Presented are the percentages of patients or in other cases means ±SD. N= number.
Procedural parameters
Overall technical and procedural success was high (95.4% MPCI versus 98.0% CPCI) in both 
groups. There was signifi cantly less contrast media use in the MPCI compared to the CPCI 
group (130.5ml ± 89.9 versus 288.7ml ± 148.3; P<0.0001). Fluoroscopy times were not signifi -
cantly diff erent for MPCI compared to CPCI (19.6min ± 129.0 versus 21.7min ± 18.5; p=0.56) 
while the reduction of procedural times reached statistical signifi cance (34.15min ± 22.5 
versus 84.3min ± 46.3; p<0.0001), see Table 5. 
Multivariate analysis showed that there was signifi cantly less contrast media use in the 
MPCI compared to the CPCI group, OR = 0.41 [0.21-0.81] see Table 5. Fluoroscopy times were 
signifi cantly reduced for MPCI compared to CPCI OR = 0.42 [0.20-0.79], see Table 5. 
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Table 4. Target vessel location.
Target vessel Magnetic PCI
(N = 1523)
Conventional PCI
(N= 1441)
RCA
 RCA1 130(9.2%) 129(10.4%)
 RCA2 177(12.5%) 141(11.4%)
 RCA3 69(4.9%) 54(4.4%)
 RCA4 23(1.6%) 22(1.8%)
 RCA16 19(1.3%) 3(0.2%)
LCA 
 LMS 19(1.3%) 38(3.2%)
LAD
 LAD6 290(20.5%) 195(15.8%)
 LAD7 194(13.7%) 238(19.2%)
 LAD8 25(1.8%) 51(4.1%)
 LAD9 69(4.9%) 64(5.2%)
 LAD10 12(0.8%) 10(0.8%)
Cx
 Cx11 119(8.4%) 79(6.4%)
 OM12b 144(10.2%) 74(6.0%)
 Cx13 66(4.7%) 96(7.8%)
 Cx14 32(2.3%) 32(2.6%)
 Cx15 4(0.3%) 3(0.9%)
SVG 23(1.6%)
Presented are the absolute numbers of lesions with percentages (within parentheses).
Table 5. Procedural parameters.
Variable Magnetic PCI
(N= 1523)
Conventional PCI
(N= 1523)
P value
Procedural duration-min 34.15±22.5 84.3±46.3 P < 0.0001
Fluoroscopy time-min 19.6±129.0 21.7±18.5 P = 0.56
Contrast consumption (Mean)-ml 130.5±89.9 288.7±148.3 P < 0.0001
Presented are the means ±SD or otherwise percentages. N= number
Table 6. Cumulative survival, (see also Kaplan-Meier Curves (fi gure 3.)
 1 year 2 year 3 year
Magnetic PCI 97.4% 95.7% 91.7%
Conventional PCI 93.5% 91.3% 88.9%
Cumulative mortality was better in the magnetic navigation group at 1, 2 and 3 years 
compared to the conventional PCI group (97.4, 95.7 and 91.7% versus 93.5, 91.3 and 88.9% 
respectively), see table 7 and fi gure 3.
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Table 7: Results of logistic regression.
End point OR 95%CI
Age
 MPCI vs CPCI 1.03 1.02-1.04
Unstable angina
 MPCI vs CPCI 0.71 0.54-0.93
Previous CABG
 MPCI vs CPCI 1.36 1.01-1.85
Multi-vessel disease
 MPCI vs CPCI 1.44 1.15-1.81
Diabetes
 MPCI vs CPCI 1.41 1.10-1.81
AHA/ACC Type B2/C
 MPCI vs CPCI 1.48 1.18-1.86
Bifurcation
 MPCI vs CPCI 0.73 0.64-0.84
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Figure 2. Kaplan-Meier curve for MACE free survival.
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Figure 3. Kaplan-Meier curve for all cause mortality.
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Logistic regression
Logistic regression showed that there were a number of factors infl uencing outcome, see 
table 7. Patients who benefi ted more from a magnetic procedure were older (1.03 [1.02-1.04]) 
with more multi-vessel disease (1.44 [1.15-1.81]) and had a greater incidence of diabetes (1.41 
[1.10-1.81]) and AHA/ACC type B2/C lesions (1.48 [1.18-1.86]). Patients with unstable angina 
(0.71 [0.54-0.93]) and bifurcation lesions (0.73 [0.64-0.84]) benefi ted less.
DISCUSSION 
This is the fi rst multi-center study examining the real-world experience MACE and long-term 
survival of using the Niobe Stereotaxis MNS for describing the total Dutch experience of 
magnetic navigation PCI. The cases have been matched with patients from concurrent CPCI 
registries as a control, the T-SEARCH registry (11) and X-SEARCH (12) registries. The results 
suggest that procedures can be performed with a use of time and contrast media use that is 
at least as short as conventional and is in line with previous studies that indicate a reduction 
in procedural time and contrast use (6,7).
Furthermore in this follow-up, mortality is not adversely aff ected and again suggests that 
there could be a survival advantage. Logistic regression identifi es markers for more complex 
procedures such as the clinical factors of increasing age and diabetes as well as the ana-
tomical/angiographic factors of previous CABG and AHA/ACC grade of B2 or C as benefi ting. 
However, in contrast to these, the presence of unstable angina or a bifurcation does not 
benefi t from magnetic navigation.
PCI by magnetic navigation in this study appears to be at least as safe as conventional 
PCI. In this study the Kaplan-Meier curves suggest a mortality benefi t. However such non-
randomized data must be interpreted with care as bias could be caused by anything ranging 
from pure coincidence to striving for a more complete revascularization.
Challenges for the future include improving identifi cation of patients who might benefi t, 
the further development of wires, and the investigation and development of integrated 
information procedures.
Study Limitations
This comparison has the limitations associated with retrospective cohort studies in that pro-
cedures were not randomized. This limitation was addressed by using propensity matching, 
however as shown in table 2, matching did not remove all diff erences in patient demograph-
ics.
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This article describes the results over nearly 4 years, and the system and the wires have 
undergone a transition in this time. It has been shown that there is an improvement in the 
wires that is refl ected in success and decreased fl uoroscopy times (5). This suggests that there 
may have been a heterogeneity in attempted and/or completed procedures 
In addition, a combined database for the magnetic patients from 2 hospitals was used but 
matched with conventional patients from one center. This could lead to bias due to diff erent 
practices between hospitals. 
The CPCI patients were taken from the T-SEARCH and X-SEARCH registries where the patients 
all received Taxus or Xience V stents while the magnetic procedures used unselected stents i.e. 
both bare metal stents and other DES. As the results for the Xience V have been superior to 
BMS or other DES, this would have been a factor in favour of the conventional group. 
In one center, procedures are often performed by supervised trainees who might have 
more of a tendency to more frequent checks that could aff ect contrast media use and fl uo-
roscopy use. This may be compounded by a frequent use of invasive diagnostics such as IVUS 
or novel technologies such as optical coherence technology.
The system and it’s consumables are under continuing development and this article de-
scribes all cases using diff erent software system (2.7, 2.10, 2.11 and 3.0) and diff erent wires 
(Cronus™, the Titan™ and the Pegasus™ wires). This will lead to heterogeneity.
CONCLUSION
This article describes the real-world use of the Stereotaxis Magnetic Navigation system and 
describes the initial results and suggests the possibility of a survival benefi t that is main-
tained at 3 years. More complex procedures appear to derive more benefi t as refl ected by the 
benefi t in older patients with more diabetes, multivessel disease and a higher incidence of 
AHA/ACC type B2/C lesions.
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Summary and Conclusions
The treatment of ischemic heart disease has both medical treatment with a range of drugs 
coupled with invasive, mechanical treatments such as percutaneous coronary intervention 
and coronary artery bypass grafting. This PhD examines the use of a new technology, the 
magnetically controllable direction of a wire tip that is to be used to deliver the balloons and 
stents used in percutaneous coronary intervention.
SUMMARY OF POINTS FROM THE LITERATURE
The current thesis has examined the development of magnetic navigation from early feasibil-
ity testing through early clinical development and use. 
Feasibility
Magnetic navigation for percutaneous coronary intervention has been illustrated in the wide 
range of coronary lesions, from simple lesions to complex, from acute occlusion to chronic 
occlusions. 
In addition, the system can be used in a wide range of cardiac procedures that not only 
includes percutaneous coronary interventions but also other procedures such as stem cell 
delivery or coronary sinus lead placement.
There appears to be a learning curve that may be optimised by the use of an defi ned, small 
group of users that regularly perform procedures. In addition early experience should not 
concentrate solely on diffi  cult cases.
Lesion type
The use of magnetic navigation appears safe and feasible in percutaneous coronary inter-
vention of all lesion types. There is a gradation in the benefi t derived from the use of the 
system with lesions that are considered more complex deriving more benefi t. While there 
is a potential benefi t in the use of this system in reduction of contrast media use, irradiation 
and procedure times, diffi  cult lesions appear to be more or less amenable to benefi t from this 
technique.
Angiographically simple elective lesions benefi t the least. In these cases the anatomy is 
already known from before and the patient is normally clinically stable. Here thought and 
preparation can be thorough from decisions regarding angiographic angle and material use. 
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A method to select patients based on the 3D morphology of the target vessel and lesion that 
could benefi t from the use of the system has been developed.
The system is designed to facilitate navigation by accurate and 3D guided wire-tip navigation 
and this appears to have the most benefi t when the anatomy is complex such as extreme 
tortuosity or chronic occlusion, the information from angiography is supplemented by inte-
gration of non-invasive diagnostic investigations such as MSCT. 
The system also appears to be feasible and produce benefi t in acute situations such as myo-
cardial infarction. This benefi t appears to be intermediate between the minimal or lack of 
benefi t in simple lesions and the benefi t in complex lesions. While it is possible to postulate 
that this is because these procedures are a mixture of these 2 types, other explanations can-
not presently be ruled out.
FUTURE DEVELOPMENT
Software developments include newer versions of the Navigant software. In particular, ease 
of use of current functions and improvements in integration are planned.
Hardware projects in development include;
Figure 1. Magnetically controllable RF wire for hard and tough lesions. See this fi gue in color in the Appendix 
page 380.
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Figure 2. Remote control system. See this fi gue in color in the Appendix page 380.
Figure 3. Stem cell delivery catheter combined with better electromechanical measurements. See this fi gue 
in color in the Appendix page 379.
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Figure 4. Odyssey screen. See this fi gue in color in the Appendix page 380.
Concluding remarks
The system has a number of new capabilities that are potentially advantageous to a PCI 
procedure. Individually a specifi c advantage may not play a crucial role in each and every 
procedure but together may allow for smoother and less troubled wire passage. Ultimately 
magnetic navigation could potentially increase effi  ciency, reduce procedure time, facilitate 
the application of advanced technologies, decrease irradiation of the operators and thus 
better use hospital resources to lower overall hospital costs. 
The current advantages of this system in PCI include precise tip orientation, computer control 
and computer processing.
This new technology allows 3D reconstruction of a virtual coronary artery to be performed 
while the patient is on the table during an interventional procedure. These images may not 
only give a better appreciation of the anatomy with regards to tortuosity but also give a vol-
ume-rendered model with the computer-calculated vectors that allow magnetic navigation. 
These individualized, scale models supply the directions for defl ecting the wire as it passes 
through the vessel. Potentially this software, and the improvements in image acquisition and 
image processing, may improve wire passage and cannulation of vessels to result in reduc-
tions of complications, procedural time, irradiation and contrast usage. This new technology 
could transform the practice of interventional procedures with the introduction of computer 
enhanced imaging that revolves particularly around the production of 3D models. 
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Samenv atting en conclusies
Samenvatting van punten uit de literatuur
De behandeling van ischemische hartziekte bestaat uit zowel de medische behandeling van 
een reeks van medicijnen in combinatie met invasieve, mechanische behandelingen, zoals 
percutane coronaire interventie en een coronaire bypassoperatie. Dit doctoraat heeft de 
ontwikkeling van magneet navigatie doorgemaakt vanaf onderzoek in toepasbaarheid tot 
analyse van klinische resultaten in patientengebruik.
Toepasbaarheid
Magneet navigatie is toepasbaar in percutane coronaire interventie van verschillende type 
laesies, van simpele laesies tot complexe, van acute laesies tot chronische.
Het systeem kan gebruikt worden voor verschillende procedures. Dit includeerd niet alleen 
percutane coronaire interventie, maar tevens ook andere procedures zoals stamcel toedie-
ning of het plaatsen van een lead in de Sinus Coronarius.
Een onderzoek laat zien dat er een leercurve nodig is om met het magneetsysteem te leren 
werken. Deze leercurve kan geoptimaliseerd worden door een kleine groep van gebruikers 
die frequent met het systeem werken, en de procedures te laten uitvoeren.
Tevens moeten beginnende gebruikers van het systeem zich niet alleen focussen op de 
moeilijk te behandelen laesies.
Type laesie
Het gebruik van magneet navigatie blijkt veilig en toepasbaar te zijn in alle type laesies bij 
percutane coronaire interventies. 
Er is een gradatie in het voordeel van het systeem. Dit voordeel wordt meer gezien bij 
complexe coronaire anatomie.
Er is tevens een potentieel voordeel in het gebruik van dit systeem, namelijk vermindering 
van het gebruik van contrastvloeistof, vermindering van doorlichtingstijd tijdens de proce-
dure, en vermindering van de proceduretijd.
Verschillen in anatomie kunnen verschillende voordelen geven bij het gebruik van deze 
techniek.
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Angiografi sch simpele laesies geven het minste voordeel met dit systeem. In deze omstan-
digheden is de anatomie reeds bekend, en is de patient meestal klinisch stabiel.
Voorbereiding en planning bij deze procedures kan vaak vooraf al gedaan worden.
Er is een methode, gebasseerd op de 3-D anatomie, ontwikkeld om patienten te selecteren 
die het meeste voordeel krijgen van het gebruik van het systeem.
Het systeem is ontworpen om een precieze 3-D richting van de draad te bewerkstelligen. Dit 
blijkt het meeste voordeel te geven in complexe anatomie. Tevens als de anatomie complex 
is, bijvoorbeeld bij extreem tortueuse vaten of chronische totale occlusies, kan de informatie 
van angiografi e aangevuld worden door middel van de integratie van andere onderzoeken, 
zoals CT-scan.
Het systeem blijkt ook toepasbaar en voordelig te zijn bij acute situaties, zoals bij een myo-
card infarct.
Dit voordeel lijkt te liggen tussen het ontbreken van het voordeel in eenvoudige laesies en 
het voordeel bij complexe laesies. Het is mogelijk dat dit komt doordat deze procedures een 
mengeling is van twee soorten.
Anderen verklaringen kunnen momenteel niet worden uitgesloten.
TOEKOMSTIGE ONTWIKKELINGEN
Softwareontwikkelingen, inclusief nieuwe versies van de Navigant software.
Met name, het vergemakkelijken van voorlopige functies en verbetering in integratie zijn 
gepland.
Hardware projecten in ontwikkeling zijn:
1- Magneet bestuurbare RF draad voor harde laesies
2- Op afstand bedienbaar systeem
3- Stamcel delivery catheter, verbeterd met betere elektromechanische metingen
4- Odyssey scherm
Slotopmerkingen
Het systeem heeft een aantal nieuwe mogelijkheden die potentieel voordelig zijn voor een 
PCI-procedure. 
Een individueel of specifi ek voordeel kan geen cruciale rol spelen in elke procedure, maar 
samen kunnen zij zorgen voor soepelere passage van de draad met minder problemen. 
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Samenvatting en conclusies
Uiteindelijk kan het magnetisch navigatiesysteem de effi  ciëntie verhogen, de procedure-
tijd verlagen, het toepassen van geavanceerde technologieën vergemakkelijken, het vermin-
deren van de doorlichtingstijd en dus leiden tot het beter gebruik van ziekenhuismiddelen 
m.a.g. lagere algemene kosten voor het ziekenhuis. 
Het magnetisch navigatiesysteem(Niobe ®, Stereotaxis Inc, USA) is ontwikkeld voor het 
navigeren met magnetische producten (draden, catheters) in het menselijk lichaam door het 
regelen van een magnetisch veld. 
De huidige voordelen van dit systeem bij percutane coronaire interventies zijn: precieze 
orientatie van de tip van de draad, controle van een computer en de computer verwerking. 
Deze nieuwe technologie maakt het mogelijk om een 3D-reconstructie van een virtuele 
kransslagader te maken terwijl de patiënt op de tafel ligt tijdens een ingreep. Deze beelden 
geven niet alleen een betere beoordeling van de anatomie met betrekking tot kronkeligheid, 
maar geven ook een volume-gereguleerd model met daarin de computer berekende vecto-
ren die magnetische navigatie mogelijk maken. Deze geïndividualiseerde modellen geven 
de richting weer voor het buigen van de draad bij het passeren door het vat. 
Deze software, en de verbeteringen in beeld verwerving en beeldverwerking, kunnen 
bijdragen aan het beter passeren van de draad, canulatie van de vaten, wat leidt tot een 
vermindering van complicaties, procedurele tijd, doorlichtingstijd en het contrast gebruik. 
Deze nieuwe technologie kan in de praktijk transformeren tot interventionele procedures 
met de introductie van de computer Enhanced Imaging die vooral draait rond de productie 
van 3D-modellen.
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